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3ABSTRACT
Introduction: Cotrimoxazole prophylaxis (CTX-p) is a cost-effective intervention that saves
lives of HIV positive individuals. It is recommended by WHO for all infants born to HIV
positive women (HIV-exposed infants). Despite this it is poorly implemented in resource-
limited countries including Zimbabwe. This project aimed to explore health system and
patient-level factors that affect implementation of CTX-p among HIV-exposed infants in
Harare, Zimbabwe.
Methods: In the first phase of the study, policy and implementation procedures for CTX-p
were studied at national and health care centre level through document review and key
informant interviews. In the second phase, a detailed study of implementation procedures was
conducted at Mbare Clinic, Harare, to explore challenges to CTX-p at various points in the
prevention of mother to child transmission (PMTCT) cascade. This involved 1) a survey
among post-partum women, 2) qualitative interviews with women who delayed/did not seek
antenatal care (ANC), 3) follow-up of HIV positive women at six-weeks postpartum to
investigate initiation of CTX-p, and 3) follow-up of HIV-exposed infants until six months to
explore adherence. In addition, a systematic review was conducted to investigate the
magnitude of loss to follow-up (LTFU) of HIV exposed infants from real-life PMTCT
programs.
Results: CTX-p is recognised as important by the Zimbabwe Ministry of Health; it has been
incorporated into guidelines and treatment procedures for HIV-exposed infants. Health
systems face challenges implementing CTX-p due to lack of human resources and poor
supply chain management. For women, the first hurdle is seeking ANC, where user fees, fear
of HIV testing, unsupportive husbands/partners, nurses’ discourteousness and long queues are
barriers. Lack of knowledge of the importance of a six-week visit is the main barrier to six-
week visit attendance. Adherence challenges include: unsupportive husbands/partners, drug
stock-outs and fear of unwanted HIV disclosure and associated stigma. The systematic
review revealed that there is unacceptable LTFU of HIV-exposed infants along various points
of the PMTCT cascade.
Conclusion: Health care systems need to put in place measures to ensure optimum
implementation of life-saving interventions and retention of HIV-exposed infants in care.
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CHAPTER 1: AIM OF THE STUDY
The aim of this PhD project was to describe the challenges with provision of HIV services to
infants born to HIV positive women (HIV-exposed infants). This was achieved through 1)
conducting a systematic review that was aimed at determining the magnitude of loss to
follow-up of HIV-exposed infants from real-life PMTCT programs and 2) Conducting a
research study that investigated the process of and barriers to provision of cotrimoxazole
prophylaxis for HIV-exposed infants at one site in Harare, Zimbabwe, focusing on issues
relating to policy, as well as health system and patient-level barriers to initiation and
adherence to paediatric cotrimoxazole prophylaxis.
1.1 SPECIFIC OBJECTIVES
The specific objectives of the systematic review are as follows:
 To determine, for the various stages of the PMTCT cascade, the magnitude of loss to
follow-up of HIV-exposed infants enrolled in real-life PMTCT programs
 To describe programme characteristics which are associated with lower rates of infant
loss to follow-up
The research project is divided into two phases with the following specific objectives:
Phase 1
 To describe the Zimbabwe national policies and processes for the:
a. provision of cotrimoxazole prophylaxis for HIV exposed babies
b. care of HIV infected women in the pre and post-natal periods
Phase 2
 To describe implementation of the national cotrimoxazole guidelines and identify
barriers affecting each stage of the implementation process
 To estimate levels of adherence to cotrimoxazole among HIV-exposed infants and
describe the factors affecting this adherence
 To describe the care that is given to HIV positive pregnant women from diagnosis of
infection to initiation of ART.
Chapter 2-Introduction
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CHAPTER 2: INTRODUCTION
2.1 COTRIMOXAZOLE AND ITS IMPORTANCE FOR HIV DISEASE
Cotrimoxazole is a cheap antibiotic that is widely available in adult and child formulations. It
is composed of two antibiotic drugs, trimethoprim and sulfamethoxazole in a 1:5 ratio. The
two drugs work on different parts of the same pathway to inhibit bacterial DNA synthesis,
thus preventing the multiplication/growth of bacteria. The drug combination (cotrimoxazole)
is recommended for treatment of bacterial infections with susceptible organisms (mainly
Gram-positive bacteria). The most common use of cotrimoxazole in children is for first line
management of acute respiratory tract infections1. It is also used for treatment of diarrhoea,
infections of the urinary tract, middle ear and skin and soft tissue infections. Cotrimoxazole
also has activity against other organisms besides bacteria: it can be used against fungal
infections, e.g. Pneumocystis jiroveci, a common human pathogen especially among
immunocompromised individuals like AIDS patients. Cotrimoxazole also acts against
protozoal infections like toxoplasmosis and isosporiasis.
In HIV disease, cotrimoxazole is mainly recommended as prophylaxis against opportunistic
infections, particularly Pneumocystis jiroveci infection (it is used to treat the same infection
in high doses). Many studies have shown that it reduces HIV-related morbidity and mortality
when taken as daily prophylaxis. In a randomised controlled trial among adults in Cote d’
Ivoire, there was a higher probability of remaining free of severe disease events (defined as
death or hospitalisation for any cause) among HIV infected patients in the cotrimoxazole
prophylaxis group than those on placebo2. Cotrimoxazole prophylaxis was reported to reduce
mortality and hospital admission rates among HIV infected adults with TB in Cote d’ Ivoire,3
South Africa4 and Zambia5, and in Uganda was associated with 46% and 31% reductions in
mortality and hospital admission respectively 6. Among children aged 1-14, a randomised
controlled trial in Zambia reported a 43% reduction in mortality in the cotrimoxazole group
compared to placebo7. More recently, there was demonstration that cotrimoxazole remains
important even in the HAART era: cotrimoxazole prophylaxis was associated with reduced
mortality when taken alongside antiretroviral therapy in adults, at least up to 72 weeks after
starting combination ART8. In children a recent trial found that continued cotrimoxazole in
children above 3 years who have been on ART for at least 96 weeks is beneficial: children
Chapter 2-Introduction
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who stopped cotrimoxazole were more likely to be hospitalised or die, HR 1.57, (95%
confidence interval 1.09- 2.26.9 Thus cotrimoxazole leads to an improvement in the quality of
life of the HIV infected person, while at the same time it reduces the burden on the health
care system and caregivers.
There is evidence that the beneficial effects of cotrimoxazole prophylaxis are not limited to
prevention of opportunistic infections but also include prevention of intercurrent illness due
to other infections, most notably acute respiratory tract infection in infants or other common
childhood infections.9 10 Also of note, it has been reported to protect against malaria in both
adults and children.9,11-14 This is very important as malaria is endemic to many countries
where HIV prevalence is high. In addition, evidence from the DART trial cohort (a
randomised trial of management strategies in HIV-infected, symptomatic, previously
untreated adults starting triple drug ART in Zimbabwe and Uganda) indicates that
cotrimoxazole may have activity that goes beyond the prevention of intercurrent illness: it
may increase and accelerate reductions in immune activation through lowering bacterial load
in the gut8. This is in support of earlier findings in Uganda where cotrimoxazole prophylaxis
was associated with a stabilising effect on immune function as seen in the reduction in annual
rate of decline in CD4 cell count and decrease in annual rate of increase in viral load6.
Cotrimoxazole prophylaxis has also been found to have favourable outcomes on growth and
anaemia in children15, an important finding given that HIV infected children in Africa are
frequently underweight and stunted. A study in Zambia among HIV infected children who
were not on ART showed that cotrimoxazole prophylaxis was associated with at least a two-
fold reduction in weight-for-age decrease and a three-fold reduction in height-for-age
decrease compared to placebo15. The same study also reported a four-fold greater increase in
haemoglobin level among those on cotrimoxazole prophylaxis compared to placebo.
Prophylaxis with cotrimoxazole has also been reported to reduce morbidity and mortality
among HIV-uninfected family members: In Uganda, over a 22-month period it was
associated with 63% reduction of deaths from all causes among family members <10 years
old, 38% reduction in malaria incidence among family members, 41% and 43% reductions in
incidence of diarrhoea and hospitalisations for any cause among family members,
respectively. 16
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There are operational benefits of cotrimoxazole prophylaxis, which include improved
retention in follow up of ART ineligible patients in countries where cotrimoxazole is given to
individuals regardless of CD4 count in line with WHO guidelines for settings with high
infectious disease prevalence. In Kenya, there was improvement in the 12-month retention of
ART-ineligible clients following the implementation of the national guidelines on provision
of cotrimoxazole prophylaxis to all ART-ineligible clients (84% in the period after vs 63% in
the period prior to implementation of the guidelines, p<0.001) .17 Maintaining ART ineligible
patients in follow up is vital to ensure timely identification of ART eligibility and subsequent
initiation on antiretroviral drugs. Mothers or caregivers may be more likely to bring their
babies for HIV testing and follow-up care if they know that an effective treatment is
immediately available18. This gives the health care system an opportunity to provide HIV-
related care to the mother and other family members. In addition, since cotrimoxazole
prophylaxis usually precedes ART in resource limited settings, it can provide an opportunity
to develop strategies that ensure good adherence to medication, which will become
invaluable once ART is initiated.
Although it is generally regarded as a safe drug, the use of cotrimoxazole has associated side
effects. It exhibits side effects of the two drug compounds that it is made of. The most
common adverse effects of sulfamethoxazole are allergies, fever, skin rashes,
photosensitivity, nausea, vomiting, diarrhoea, urinary tract disturbances due to precipitation
in urine and blood disorders like anaemia. Trimethoprim also causes blood disorders. Patients
with AIDS and Pneumocystis pneumonia have a particularly high frequency of adverse
reactions to cotrimoxazole, especially fever, rashes, leukopenia and diarrhoea19.
2.2 RECOMMENDATIONS FOR COTRIMOXAZOLE PROPHYLAXIS FOR
HIV EXPOSED INFANTS
In 2000 the World Health Organisation (WHO) and Joint United Nations Program for HIV
(UNAIDS) recommended cotrimoxazole prophylaxis for all infants born to HIV infected
women (HIV exposed children), starting at age six weeks (or first contact with the health care
provider) and continuing until HIV infection had been excluded20. This was followed by poor
implementation in many resource-limited settings, partly because there were no WHO
guidelines for national programmes in such settings. In 2006 WHO issued operational
recommendations for global implementation of cotrimoxazole prophylaxis among HIV-
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exposed children, children living with HIV, and adolescents and adults living with HIV in the
context of scaling up HIV care in resource-limited settings21. By 2008 there was still sub-
optimum implementation (see section 2.3), so WHO issued more guidance on practical
approaches to implementation and scale-up, with practical guidance on mechanisms to
systematically identify and follow-up HIV-exposed infants at and after birth and on supply
chain management.1 Fig 2.1 below shows the current (2009) WHO guidelines on paediatric
cotrimoxazole prophylaxis.
Fig 2.1: Extract from WHO guidelines on paediatric cotrimoxazole prophylaxis1
The Zimbabwe Ministry of Health and Child Welfare adopted the same WHO guidelines for
paediatric cotrimoxazole prophylaxis. Initiation of cotrimoxazole prophylaxis is however
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only done at the six-week postnatal visit (or later) and there are no guidelines to begin as
early as 4 weeks as suggested by the WHO guidelines22.
The recommended dosages for cotrimoxazole are as shown in the next table1:
Table 2.1: Extract from WHO guidelines on dosages for paediatric cotrimoxazole
prophylaxis
Recommended
daily dosage
Suspension
(5ml of syrup
200mg/40mg)
Child tablet
(100mg/20mg)
Single strength
adult tablet
(400mg/80mg)
Double
strength adult
tablet (800
mg/160mg)
<6 months
or <5 kg
100 mg
sulfamethoxazole/
20mg
trimethoprim
2.5ml One tablet
mixed with feed
or small amount
of milk or water
¼ tablet,
possibly mixed
with feed
or small amount
of milk or water
-
6 months–5 years
or 5–15 kg
200 mg
sulfamethoxazole/
40 mg
trimethoprim
5ml Two tablets Half-tablet -
6–14 years
or 15–30 kg
400 mg
sulfamethoxazole/
80 mg
trimethoprim
10mls Four tablets One tablet Half tablet
>14 years
or >30 kg
800 mg
sulfamethoxazole/
160 mg
trimethoprim
- - Two tablets One tablet
Frequency once a day
These are the same dosages that have been adopted by the Zimbabwean Ministry of Health
and Child Welfare22.
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The timely administration of cotrimoxazole prophylaxis requires knowledge of the infant’s
HIV exposure/infection status. To achieve this WHO also have guidelines for infant/baby
testing, table 2.2 below. The guidelines have also been adopted by Zimbabwe22.
Table 2.2: Summary of WHO recommended testing approaches23
Category Test required Purpose Action
Well, HIV-exposed
infant
Virological testing at
4–6 weeks of age
To diagnose HIV Start ART if HIV
infected
Infant – unknown
HIV exposure
Maternal HIV
serological test
or
Infant HIV
serological test
To identify or
confirm HIV
exposure
Need virological test
if HIV-exposed
Well, HIV-exposed
infant at 9 months
HIV serological test
(at last
immunization,
usually 9 months)
To identify infants
who have persisting
HIV antibody or
have seroreverted
Those HIV
seropositive need
virological test and
continued follow up;
those HIV negative,
assume uninfected,
repeat testing
required if still
breastfeeding
Infant or child with
signs and
symptoms
suggestive of HIV
HIV serological test To confirm exposure Perform virological
test if <18 months
of age
Well or sick child
seropositive
>9 months and
<18 months
Virological testing To diagnose HIV Reactive start HIV
care and ART if
under 24 months,
or based on national
start criteria if
24 months or more
Infant or child who
has completely
discontinued
breastfeeding
Repeat testing six
weeks or more after
breastfeeding
cessation – usually
initial HIV
serological
testing followed by
virological testing for
HIV-positive child
and <18 months
of age
To exclude HIV
infection after
exposure ceases
Infected infants
and children
<24 months of age,
need to start HIV
care, including ART
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The cotrimoxazole prophylaxis recommendations are important as there is evidence that
HIV-exposed infants face more morbidity and death than do those born to HIV uninfected
mothers because they are exposed to a greater burden of pathogens. A study in Zimbabwe
showed that among HIV infected and uninfected infants who survived to age six months,
those born to HIV infected mothers were 16 times more likely to die by 12 months of age
compared to those unexposed to HIV24. The major cause of death was acute respiratory tract
infection. This study not only reinforces the importance of cotrimoxazole prophylaxis for
HIV infected infants, but also shows that it is of immense benefit to the uninfected HIV
exposed infants, although recent studies have not shown its benefit on non-malarial morbidity
for the HIV negative infants.13,25 The same study24 demonstrated that infants who are infected
during pregnancy or labour are at increased risk of dying in the first 2-6 months of life, which
underlies the importance of initiating cotrimoxazole prophylaxis in the first few weeks of life.
The successful roll-out of antiretroviral drugs (ARVs) and PMTCT programmes in resource-
rich countries has diminished the importance of cotrimoxazole prophylaxis for HIV-exposed
infants in such settings. However, there is recent evidence of continued benefit of
cotrimoxazole prophylaxis in children who have been on HAART for more than two years in
resource limited countries where there is high prevalence of bacterial and protozoan
infections9. In addition, in many resource-limited countries the scale-up of ART and PMTCT
programmes is still incomplete; hence cotrimoxazole prophylaxis remains vital in the
management of HIV disease outcomes. Furthermore, treatment of HIV infected infants is
complicated by the limited availability of definitive virological tests for diagnosis of HIV in
resource-limited settings. The more widely available, low-cost, rapid HIV test kits, which test
for the presence of HIV antibodies, are not appropriate for use in this population because of
the persistence of maternal antibodies. Although availability of early infant diagnosis (EID)
using DNA PCR has increased in recent years as a result of the introduction of the dried
blood spot (DBS) specimen collection on filter paper and PCR testing on these specimens, in
many settings the only available option is for health care workers to test only at 18 months
with antibody tests1. By that age many HIV infected children will have died if no intervention
has been made24. Fortunately in Zimbabwe EID using DBS on filter paper is now widely
available and is the standard of care in the public health system.
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2.3 PROGRESS IN IMPLEMENTATION OF COTRIMOXAZOLE
PROPHYLAXIS
Despite the convincing evidence of effectiveness, widespread recommendations and
availability of cotrimoxazole at low cost, the implementation of cotrimoxazole prophylaxis
for HIV exposed infants in developing countries has been poor18,26. WHO estimated that only
1% of the 4 million children who needed cotrimoxazole were getting it in 200627. In 2008,
this figure had only risen to 8%1, and to 14% in 200928. In Eastern and Southern Africa,
coverage increased from 9% in 2008 to 18% in 200928. In Zimbabwe in 2007, of the 194,000
children aged 0-14 years who needed cotrimoxazole prophylaxis, only 11% received it
(figure 2.2)29. In three rural Zimbabwean districts where expansion of the national PMTCT
program benefits from the technical support of a partner organization (ZVITAMBO), only
~35% of infants known to be HIV-exposed were started on cotrimoxazole prophylaxis in
200730, indicating that an unacceptably high proportion of infants fail to access
cotrimoxazole. By 2010, coverage of cotrimoxazole prophylaxis had only increased to 34%
in Zimbabwe31.
Fig 2.2: Trends in the estimated number of children (age 0-14 years) needing
and receiving cotrimoxazole in Zimbabwe29
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2.4 BARRIERS TO IMPLEMENTATION OF COTRIMOXAZOLE
PROPHYLAXIS IN INFANTS AND CHILDREN
There is limited literature on the specific challenges or barriers that each country has faced in
rolling-out cotrimoxazole prophylaxis. The barriers summarised below have been reported in
reviews and reports, but not as part of detailed case studies.
2.4.1 Barriers in the process of translating evidence into policy
The WHO/UNAIDS recommendation for cotrimoxazole prophylaxis among HIV exposed
infants issued in 2000 met a lot of resistance from clinicians and policy makers18,32. A review
by Zachariah et al18 described some of the policy barriers that prevented the scale up of
cotrimoxazole prophylaxis. First, as initial studies that demonstrated the effectiveness of
cotrimoxazole were conducted in countries where the prevalence of microbial resistance to
cotrimoxazole was low, there was concern that the intervention may not work in areas where
resistance to cotrimoxazole is high. Fortunately there is now convincing evidence from
Zambia and South Africa that it is effective even in these settings, and indeed the beneficial
effects persist even as resistance to cotrimoxazole increases5,7,33. Clinicians and policy
makers have also worried that blanket use of cotrimoxazole prophylaxis will increase
microbial resistance not only to cotrimoxazole, but to other antibiotic classes as well. These
fears may be allayed by findings from a recent systematic review that found no evidence of
increase in bacterial resistance to antibiotics other than cotrimoxazole as a result of
cotrimoxazole prophylaxis34.
There were also concerns that cotrimoxazole prophylaxis may not be cost effective. Again
this concern can now be allayed by evidence that cotrimoxazole prophylaxis is a highly cost
effective intervention35,36, with a unit cost of only about US$0.03 per child per day, or about
US$10/year27. In Zambia, cotrimoxazole prophylaxis was associated with incremental cost-
effectiveness ratios (ICERs) of US$72 per life-year saved, US$94 per QALY saved and
US$53 per DALY averted which is substantially less that the country’s cost effectiveness
threshold of US$1,019 per outcome35. In comparison, in Sub Saharan Africa the average cost
per DALY averted for first-line antiretroviral therapy without intensive monitoring is $556
(international dollars)37.
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More recently, some clinicians and researchers have called for a review of the cotrimoxazole
prophylaxis guidelines to stop blanket cotrimoxazole prophylaxis as there have been
improvements in the following areas: PMTCT coverage, ARV prophylaxis for infants born to
HIV positive mothers and early infant diagnosis through dried blood spot testing 38. They
argue that it no longer makes sense to roll-out cotrimoxazole prophylaxis to all HIV exposed
infants because the majority of them have been prevented from acquiring HIV from their
mothers. However, current data show that there is still incomplete roll-out of programmes
aimed at reducing transmission of HIV from mothers to their children. In 2009, coverage for
ARVs for preventing mother-to-child transmission was at 54% in sub-Saharan Africa,
although it was higher (68%) in Eastern and Southern Africa28. By 2010 the coverage for
PMTCT ARVs had increased slightly in Sub-Saharan Africa to 60% (50% received most
effective PMTCT regimens and 10% received single dose nevirapine, which is no longer
recommended)39. In 2009, 35% of HIV exposed infants received ARV prophylaxis in sub-
Saharan Africa (45% in Eastern and Southern Africa); in 2010 this increased to 43% in Sub-
Saharan Africa and 55% in Eastern and Southern Africa. Early infant diagnosis still remained
a challenge, with WHO/UNAIDS/UNICEF reporting that in 2009 only 6% (5-10%) of infants
were tested for HIV within the first two months of birth in low-and medium-income
countries; this had increased to 28% in 2010.28,39 Given these limitations it still makes sense
to roll-out cotrimoxazole prophylaxis to all HIV exposed infants, particularly in those settings
were PMTCT and early infant diagnosis coverage is low.
Despite this compelling evidence of effectiveness and assurances on potential fears, this has
resulted in little improvement in rates of implementation: more barriers need to be overcome.
A study of the processes for national policy development on cotrimoxazole prophylaxis in
Malawi, Uganda and Zambia showed that the availability and widespread dissemination of
results did not necessarily result in translation of research into policy, but that the context
(including the influence of donor agencies) was important in the adoption of the policy on
cotrimoxazole prophylaxis. In addition, the nature of the evidence played a significant role: in
all three countries the policy makers believed that the preliminary WHO recommendations in
2000 were based on weak evidence, where the main deterrent was fear that cotrimoxazole
prophylaxis would not be effective in settings of high microbial resistance to cotrimoxazole
as described at the beginning of this section. Other factors that were found to be important
were links between researcher, policy makers and those seeking to influence the policy
process. 40,41.
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2.4.2 Barriers related to challenges in operational issues
Even after the adoption and formulation of cotrimoxazole prophylaxis policies, challenges are
faced in translating policy into practice. There was delay in getting policy guidance on how
cotrimoxazole prophylaxis should be implemented as initial guidelines on HIV/AIDS focused
on antiretroviral drugs for treatment and PMTCT.1,18 Since 2006 WHO have been producing
guidelines for the implementation of cotrimoxazole prophylaxis in infants and children.1,18,21
Many health care services do not have in place processes for the identification of all infants
or children who are eligible for cotrimoxazole prophylaxis.1,18 In addition, shortages of
trained staff and stock-outs of cotrimoxazole have resulted in suboptimal scale-up of the
intervention1,18.
2.4.3 Challenges faced in Zimbabwe
There is no published literature on the specific challenges that the Zimbabwean health
services face in scaling-up cotrimoxazole for HIV exposed infants. Despite a recent well
documented decline in HIV prevalence42 to 15%43, Zimbabwe still has one of the most severe
HIV epidemics globally. It was estimated in 2009 that 9,400 children aged 0-14 died of
AIDS; representing 14% of total annual AIDS deaths. It is therefore of paramount importance
to explore why only 11% of children who needed cotrimoxazole prophylaxis were getting it
in 2007, and why this had only increased to 34% in 2010. In addition, the high rates of loss to
follow-up of HIV exposed infants implies that their mothers are also not engaged in HIV-
related care and will not be assessed for ART eligibility on time and will thus not have good
health outcomes.
More generally, the issue of effective implementation of pharmaceutical interventions is
becoming an increasingly important issue in resource limited settings as ARV treatment
becomes more widely available. Drug delivery mechanisms that were established when
WHO’s 3 by 5 Programme was launched ten years ago may not be able to cope with the rapid
scale up that is required. As outlined by the International Network for Rational Use of Drugs
(www.INRUD.org) being able to monitor implementation and adherence to HIV drug
interventions is crucial to their successful scale up.
In the study outlined here, information was collected to identify the barriers to effective
cotrimoxazole implementation among infants born to HIV infected women. Many of the
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findings of this research will likely be generalisable to other resource poor settings. In
addition it is likely that some aspects of the research methodology will be adapted and used to
evaluate rollout of other pharmaceutical interventions (e.g. ARVs or isoniazid prophylaxis).
2.4.4 Implications of poor coverage of cotrimoxazole prophylaxis on the wider PMTCT
cascade services
Poor coverage of cotrimoxazole prophylaxis will result in unnecessary morbidity and
mortality among HIV-exposed infants. It might mean that health care workers failed to
prescribe cotrimoxazole prophylaxis, or that cotrimoxazole was out of stock, or more
critically, that infants have been lost to follow-up from the PMTCT cascade. In the next
chapter, I present results of a systematic review which explores the extent of and factors
associated with loss to follow-up of HIV-exposed infants from PMTCT programmes
globally. The data combined with locally generated data on facilitators and barriers to
cotrimoxazole prophylaxis implementation can be used to inform future program and policy
development.
2.5 STRUCTURE OF THE THESIS
The thesis is divided into ten chapters. The objectives of the study are given in Chapter 1. In
this chapter there is discussion of the importance of paediatric cotrimoxazole prophylaxis,
challenges in implementation and the rationale for conducting the study. In the third chapter I
describe a systematic review I conducted to investigate the magnitude of loss to follow-up of
HIV-exposed infants from real-life PMTCT programs. The methods are described in Chapter
4. Results are presented in Chapters 5-9. In Chapter 5 I present policy findings related to
paediatric cotrimoxazole. Chapters 6 to 9 describe results at specific steps on the
cotrimoxazole prophylaxis care cascade: identification of infant HIV exposure status
(Chapter 6), qualitative findings on barriers to antenatal care (Chapter 7), initiation of
cotrimoxazole prophylaxis among HIV exposed infants at six weeks of age (Chapter 8), and
experiences with adherence to cotrimoxazole prophylaxis (Chapter 9). All results chapters
have short discussions at the end, and the final discussion of all findings with
recommendations is made in Chapter 10.
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2.6 ROLE OF THE CANDIDATE
Under the supervision of the primary supervisor, Dr Frances Cowan, and with input from
Professor Ian Weller, the candidate designed the study project and submitted it for funding by
Wellcome Trust as part of a Masters Fellowship Programme. The candidate was awarded the
fellowship, which was later upgraded to a PhD fellowship. The candidate designed the data
collection tools and trained the study nurse who collected the bulk of the quantitative data
(the candidate administered some of the questionnaires). All qualitative data collection (in-
depth interviews) was done by the candidate. All quantitative and qualitative analyses were
done by the candidate. Under supervision from the primary supervisor the candidate designed
the systematic review, designed the search strategy, implemented the search, identified
eligible papers and did all analyses and write-up of the systematic review
Chapter 3-Systematic review
28
CHAPTER 3: SYSTEMATIC REVIEW
3.1 OVERVIEW
In this chapter I describe the results of a systematic literature review that I conducted to
determine the extent of loss to follow-up of HIV-exposed infants and children from the
PMTCT continuum of care. Although the focus of this PhD is on resource-limited settings,
the literature review was not restricted to such settings because I wanted to look at some
programme characteristics in high income countries that might be responsible for the
differences in retention rates. Nevertheless, due recognition was taken of the inherent
differences in the health care systems in different parts of the world: during synthesis of
results only studies that were conducted in Sub-Saharan Africa were included in the meta
analyses.
Publications were eligible for review if they reported on loss to follow-up of infants from
standard/routine PMTCT programs, rather than from intervention studies. Literature searches
were conducted in Medline, Embase, Web of Knowledge, Maternity and Infant Care and
CINAHL Plus. Eligible studies were subjected to quality assessments using checklists that
were adapted from the UK National Institute for Health and Clinical Excellence (NICE)
methodology checklist for cohort studies. Information extracted from publications included
the following: programme years and year of publication, country of study, setting (whether
urban or rural), method of offering HIV testing (whether opt-in or opt-out) methods of
follow-up of infants including follow-up schedule, PMTCT regimens for mothers and infants,
and whether replacement feeding was freely offered at the programme site/s during the
reported years. The outcome extracted was the percentage loss to follow-up of infants at any
point along the PMTCT cascade. Random effects meta-analyses were done to find the pooled
estimates of percentage loss to follow-up at various stages of the PMTCT cascade. Because
of the significant heterogeneity in study findings, predictive intervals PrI, (approximate 95%
confidence intervals of a future study based on the observed heterogeneity) were calculated.
Meta-regression analysis was done to investigate the heterogeneity between the program
findings. Analysis was done using Stata version 10.
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3.2 BACKGROUND TO THE SYSTEMATIC REVIEW
As described in Chapter 1, implementation of cotrimoxazole prophylaxis among HIV-
exposed infants in many resource-limited settings is sub-optimum. Poor implementation of
cotrimoxazole prophylaxis points to poor retention of HIV-exposed infants in HIV-related
care. This attrition results in failure to access not only cotrimoxazole prophylaxis, but other
life-saving interventions as well. For example, current WHO guidelines recommend HIV
testing of infants at 4-6 weeks23 post-natally (early infant diagnosis, EID), and immediate
initiation on ART for those testing positive. As early cessation of breastfeeding is associated
with poor health outcomes for HIV-exposed babies44-48, current guidelines support continued
breastfeeding with extended infant prophylaxis with nevirapine (WHO option A)49, and re-
testing of the exposed baby at least six weeks after cessation of breastfeeding23. These
guidelines necessitate continued follow-up of exposed babies to provide the continuum of
care. Yet despite the advances in knowledge of effective interventions to save the lives of
HIV exposed infants, many infants do not access the full package of services because of loss
to follow-up50-53. There is literature on loss to follow up of infants in research settings, and
also in real-life programme settings. This systematic review is being conducted in order to
determine the magnitude of loss to follow-up of HIV-exposed infants from real-life (non-
research intervention) PMTCT programs. This is important in order to gauge the real world
experience of implementing current interventions and inform future program and policy
development.
3.2.1 Aim of the systematic review
The overall aim of the systematic review is to determine the magnitude of loss to follow-up
of HIV-exposed infants from real-life PMTCT programs in order to inform programmers and
policy-makers about the progress made and likely interventions for improving retention.
Specific objectives
1. To determine, for the various stages of the PMTCT cascade, the magnitude of loss to
follow-up of HIV-exposed infants enrolled in real-life PMTCT programs
2. To describe programme characteristics which are associated with lower rates of infant
loss to follow-up
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3.3 METHODS
3.3.1 Inclusion criteria for publications
Publications were eligible for inclusion if they met all of the following criteria:
i) Population: Children or infants born to HIV positive women. The infants could
be HIV infected, uninfected or of unknown HIV status.
ii) Intervention: The infants/children or mother-infant pairs had to be enrolled in a
programme for usual or standard care for HIV positive women and their infants in
their setting. This could be a PMTCT programme, or any programme that was
publicly set up to provide care for HIV-exposed or infected children rather than as
intervention research studies.
iii) Outcome: Studies should have reported on retention or loss to follow-up of HIV-
exposed infants.
iv) Study design: Longitudinal studies; i.e. publications had to report on programmes
that longitudinally followed HIV exposed infants. Data collection could be
prospective or retrospective.
v) Publications had to be in English (for practical reasons due to unavailability of
funds that could be used for any translation work), and must have been published
in peer reviewed journals.
3.3.2 Exclusion criteria
Publications were excluded if the setting was not considered routine or standard of care for
that community.
3.3.3 Search methods
3.3.3.1 Databases searched
The following databases were searched:
i) Medline: accessed on 06 August 2012.
ii) Embase: accessed on 06 August 2012.
iii) Web of knowledge: accessed on 06 August 2012.
iv) CINAHL Plus: accessed on 06 August 2012.
v) Maternity and infant care: accessed on 06 August 2012.
Chapter 3-Systematic review
31
All the databases were selected because of their relevance to the systematic review topic.
Medline and Embase were selected because they both have wide international coverage of
clinical and biomedical research findings and were therefore highly likely to have
publications on the systematic review topic. Web of knowledge was also selected because of
its wide subject coverage but more specifically for its usefulness in reference and citation
searches. Maternity and Infant Care was chosen because its focus is closely related to the
topic of this systematic review. CINAHL Plus was chosen because of its focus on nursing and
allied health topics, including biomedicine.
3.3.3.2 Search strategy
The research question was split into three components: 1) children or infants, 2) HIV
exposure, and 3) retention/loss to follow-up. Literature covering this topic was read in order
to identify synonyms that are normally used in the subject. For each component, text searches
in the databases using identified synonyms were carried out. To ensure inclusiveness of text
searches, truncation of word endings was done. In addition there was allowance for various
ways of adjacency for words in a phrase, see table 3.1 below. Medical Subject Headings
(MeSH) were used in addition to text searches for Medline, Embase and Maternity and Infant
Care. In each database, for each component, the results of the text searches and MeSH
heading searches (where applicable) were combined using the Boolean operator “OR” in
order to include all papers that related to the component. Results from the three components
were then brought together using the operator “AND”, which narrowed the search to include
only the publications which featured all the three components of the research question (see
table 3.1 below).
The search process was iterative: pilot searches using the above method were done and
checks for the suitability of the search terms were done by looking at whether the search
identified papers which were already known to be eligible for review. Refinements of the
search terms were made and the final search terms were run in all the databases on 06 August
2012.
The search terms and strategy were discussed with a librarian at UCL Cruciform Library.
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Table 3.1: Search terms used
Concept 1: HIV exposure Concept 2: Retention/LTFU Concept 3: Child/Infant
HIV exposed Continuum of care Child* OR infant* OR
newborn OR baby OR
babies
HIV positive adj3 mother* Retention OR attrition OR
"patient dropout" OR "los? to
follow up" OR LTFU OR
LFU OR "lost follow up"
MeSH terms specific to each
database as applicable
HIV infected adj3 mother* Early infant diagnosis or EID All the above terms were
combined with operator
“OR”
born adj3 HIV positive
wom#n
MeSH terms specific to each
database as applicable
born adj3 HIV infected
wom#n).
All the above terms were
combined with operator
“OR”
PMTCT OR "prevention of
mother to child transmission"
MeSH terms specific to each
database as applicable
All the above terms were
combined with operator
“OR”
Results from Concept 1, Concept 2 and Concept 3 were brought together using the operator
“AND”
adj3 means the two terms are within three words of each other
* is a truncation sign
# allows for different spelling/words; in this case will capture both ‘woman’ and ‘women’
3.3.4. Selection of eligible papers and additional searches
The papers that were identified from each of the databases were uploaded into a single file (or
library) in the Endnote reference management software. Duplicates were identified and
removed. The endnote file (which had all the titles and abstracts, where available) of the
identified papers was then printed. Each title and abstract was carefully reviewed to
determine whether the paper met the study inclusion criteria. Where it was obvious that the
paper was not eligible based on title and abstract review, the paper was deemed ineligible,
and this was documented against the specific paper on the printed document. Where it was
less clear from the title and abstract review whether the paper was eligible, the full paper was
reviewed. If the full paper was deemed ineligible the reasons for rejection were documented
i.e. it was documented which of the inclusion criteria the paper had failed to meet.
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The reference and citation lists of papers which were deemed to be eligible for review, and
those of other relevant papers which published on the subject of the review, were downloaded
to another Endnote library using the Web of Knowledge database. This library was integrated
with that of the general database search, duplicates were removed and a review of the
additional papers identified through reference and citation lists was done.
The review for eligibility was done by the candidate.
3.3.5 Review of eligible papers for quality
Each eligible publication was assessed for quality of reporting and quality of the study. The
assessment was made using a checklist that was adapted from the UK National Institute for
Health and Clinical Excellence (NICE) methodology checklist for cohort studies54. In
developing the checklist, careful reference was also made to other popular guidelines that
have been published on quality reporting of observational longitudinal studies, e.g. criteria
published by Tooth et al55 and The Strengthening the Reporting of Observational Studies in
Epidemiology (STROBE statement).56-64 Of note, as the outcome of interest in this review
was retention or loss to follow up, which was not the main outcome of interest in most
papers, many NICE criteria which related to analysis methods or effect estimates were not
applicable. The checklist that was used after disregarding the inapplicable criteria is shown in
the next page.
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Checklist for quality assessment (adapted from UK NICE Guidelines54)
Author & date:
Quality criterion Well
covered
Adequately
addressed
Poorly
addressed
Not
addressed
Not
reported
N/A Comments
1. Are the objectives or hypotheses
of the study stated?
2. Is the target population defined?
3. Is the sampling frame defined?
4. Is the study population defined?
5. Are the study setting (venues)
and/or geographic location stated?
6. Are the dates between which the
study was conducted stated or
implicit?
7. Are the eligibility criteria stated?
8. Are the issues of ‘selection in’ to
the study mentioned?
9. Are the numbers of participants
justified?
10. Was the number of participants
at the beginning of the study
stated?
11. Were the methods of data
collection stated?
12. Was the reliability
(repeatability) of measurement
methods mentioned?
13. Are the methods of follow-up
given?
14. Was the number of participants
at each stage/wave specified?
15. Were the reasons for loss to
follow-up quantified?
16. Was the missingness of data
items at each wave mentioned?
17. Were missing data accounted
for in the analyses?
18. Was the impact of biases
estimated quantitatively or
qualitatively?
19. Was there any there any other
discussion of generalizability?
20. Overall assessment of the study
(good quality; fair quality; poor
quality) and comments
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For each study, an overall subjective judgement was made on how well the findings of the
study were protected against bias and confounding. Studies were judged as good, fair or poor.
The following criteria were used for the judgement:
Good- if the study met all or most quality criteria as detailed in the quality assessment tools.
Where some criteria were not met the study would only be judged as good if findings of the
study were unlikely to alter if the criteria were met.
Fair-Some of the criteria were met; those criteria that have not been met are thought unlikely
to affect the conclusions; findings were thought unlikely to be biased.
Poor-Few criteria met or important criteria which are thought very likely to change the
conclusion when met have not been met; the reported findings were thought to be
significantly biased.
In summary the studies were not judged according to how many criteria they met but
according to whether the conclusions of the study were likely to change if the unmet criteria
applied.
3.3.6 Data extraction
Data were extracted using a data collection form which captured the following information
where reported: place of study including name of study sites, setting (urban or rural),
programme years covered by the report, stage at which antenatal care was sought, testing
strategy at the site (whether opt-in or opt-out), schedule and methods of follow-up of infants,
PMTCT regimens offered to mothers and their babies, whether replacement feeding was
freely given at the site during the years studied, study quality, and finally magnitude and
timing of loss to follow-up. To avoid data extraction errors, after data had been extracted
from all papers a quality control check was done where each paper was re-read to verify that
the captured information was correct.
3.3.7 Synthesis of results
The findings of the studies were split into categories relating to timing of loss to follow-up as
follows: 1) loss to follow-up of pregnant HIV positive women between ANC registration and
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delivery; 2) loss to follow-up of HIV-exposed infants by age 3 months; 3) loss to follow-up
of HIV-exposed infants by age 12 months and by age 18 months, and 4) loss to follow-up of
infants after determination of HIV status but before enrolment into ART programs. For
studies that were conducted in Sub-Saharan African countries, random-effects meta-analysis
using the method of DerSimonian and Laird65 was conducted for each category/timing of loss
to follow up using the ‘metan’ command in Stata version 10, after supplying the reported
proportion and lower and upper limits of the confidence intervals of the loss to follow up
data. As confidence intervals were not typically reported in the study results, they were
computed for all the studies. To increase the normality of the distribution of the proportion
data, data values were log-transformed (natural logarithms) before analysis and the results
back-transformed to percentages. During the analysis it was clear that there was extensive
heterogeneity of study findings. Because it is not recommended to only report pooled
estimates in the presence of significant heterogeneity66, predictive intervals, PrI,
(approximate 95% confidence intervals of a future study based on the observed
heterogeneity) were computed and reported together with the pooled estimates.
To investigate the source of the heterogeneity in studies, random-effects meta-regression
analysis using the metareg command in Stata67 was done with each of the extracted variables
that were suspected to explain the heterogeneity: setting (urban/rural), strategy for offering
HIV testing (opt-in/opt out); mother’s PMTCT regimen (single dose nevirapine vs. more
intensive regimens); and whether replacement feeding was offered for free during the
programme years.
In the synthesis of results, all studies were included in the primary analyses; additional
analyses were conducted without the poor quality studies.
3.4 RESULTS
3.4.1 Identification and selection of papers
A total of 826 papers from database and reference/citation lists were reviewed, see Fig 3.1. 18
eligible papers were identified from database searches, and an additional 7 were identified
after reviewing reference and citation lists, bringing the total of eligible papers from which
data were extracted to 25 (see figure 3.2 below). Fig 3.2 details the selection process for the
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353 papers that were identified during the database searches; it does not include the selection
process for reference and citation lists because the reference and citation lists are not as
selective as the database searches, they have a much greater proportion of papers that are not
relevant to the search. As a result it is usual practise to record the selection process for the
database searches and to only state how many papers from the reference and citation lists
were found to be eligible for review.
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Fig 3.1: Results of literature searches
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FIG 3.2: Selection of eligible papers
353 papers from
database searches
124 full papers
reviewed
220 papers deemed ineligible (or full text
not available, 2 cases) after title and abstract
search
18 papers from
database searches
were eligible
22 studies did not longitudinally
follow-up HIV exposed babies
9 papers were not in
English
* 4 French
* 2 Polish
* 1 Spanish
* 1 Italian
* 1 Chinese
50 papers were not reporting on
routine/standard care but were
intervention studies
31 papers did not report on
retention/loss to follow-up of
HIV exposed infants
25 eligible papers
from which data
were extracted
Review of reference and citation
lists of eligible papers and other
relevant papers
7 more eligible papers identified
3 eligible papers excluded as
they were presenting data from
the same already included
studies
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3.4.2 Description of eligible papers
20 studies were from sub-Saharan Africa: four68-71 from South Africa, two each from
Kenya72,73, Nigeria74,75, Mozambique76,77, Malawi78,79, Uganda80,81 and Ethiopia82,83, one from
each of the following: Zimbabwe84, Cameroon85, Angola86, and Tanzania87. Three studies
were from India88-90, and one each from United Kingdom and Ireland.91,92 See table 3.2 for a
description of the studies. All studies were viewed as either good (17 studies) or fair (eight
studies) quality, as a result they were all included in results syntheses as applicable. Seven
studies were set in rural areas, 14 in urban areas and three included both urban and rural sites.
The PMTCT regimen provided for mothers during the study period was single dose
nevirapine for nine studies and was more intensive (i.e. dual or triple therapy or even
initiation of HAART) for 13 studies. The model for offering HIV testing was reported in 16
publications; five studies reported that an opt-in strategy was predominantly practised during
the study period, for seven it was opt-out and in four studies opt-in was initially offered and
opt-out was introduced as the programme progressed.
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Table 3.2: Description of eligible studies
Author &
Year
City &
Country
Description of programme Programme
years
Study quality
Perez et al
200484
Buhera;
Zimbabwe
Setting: Semi-Rural
Study site/s: Murambinda Mission Hospital and 27 satellite clinics.
Stage at which ANC sought: Not reported
ANC testing strategy: Opt-in
Follow-up schedule: HIV positive women and babies were followed up at 6weeks
postnatally, then monthly for growth monitoring until age18 months. The baby was
tested for HIV at 15 months. Follow-up was only done at hospital level.
PMTCT Regimen for mother: Single dose nevirapine
PMTCT regimen for infant: Single dose nevirapine
Whether replacement feeding freely offered: No
Other: This was a pilot PMTCT programme; first site to offer PMTCT in
Zimbabwe
Aug 2001 to
Jan 2003
Good
Nlend et al
201285
Yaonde,
Cameroon
Setting: Urban
Study site/s: 25 facilities in the Djoungolo Health District PMTCT programme.
Stage at which ANC sought: Not reported
ANC testing strategy: PITC (opt-out)
Follow-up schedule: Early infant diagnosis at 6 weeks, done at a referral centre
PMTCT Regimen for Mother: HAART for eligible women. Those not eligible
were given dual therapy with zidovudine and single dose nevirapine
PMTCT regimen for infant: Nevirapine syrup for 1 week or 1 month depending
on length of maternal treatment
Whether replacement feeding freely offered: Not clear
Other: CD4 testing given at same site for HIV positive clients. There was patient
follow-up using mobile phones (90% of women had mobile phones)
March 2008
to March
2010
Fair
Possibility of
misclassificati
on bias
Chapter 3-Systematic review
42
Author &
Year
City &
Country
Description of programme Programme
years
Study quality
Moses et al
200879
Lilongwe.
Malawi
Setting: Urban
Study site/s: Maternity hospital in Lilongwe, and three District health centres in
Kawale and Areas 18 &25
Stage at which ANC sought: Not reported
ANC testing strategy: Between April 2002 and July 2003, opt-in; test using
ELISA, results collected 1-2 weeks later. Rapid testing from Jul 2003. Opt-out
introduced in 2005
Follow-up schedule: Infants were tested using DNA PCR at six weeks (ELISA
was used at 18 months).
PMTCT Regimen for Mother: Single dose nevirapine
PMTCT regimen for infant: Single dose nevirapine
Whether replacement feeding freely offered: Not reported
April 2002 to
December
2006
Fair
Lussiana et
al 201286
Luanda,
Angola
Setting: Urban
Study site/s: General population hospital, Municipal Hospital Divina Providencia
Stage at which ANC sought: Not reported
ANC testing strategy: Not reported
Follow-up schedule: HIV testing of infants using rapid tests at 9, 12 and 18
months. Infants are followed on a monthly basis until 24 months of age.
PMTCT Regimen for Mother: Immediate ART for eligible women. If not
eligible ART is started in third trimester (stopped after delivery if not indicated
unless baby is breastfeeding
PMTCT regimen for infant: Zidovudine for four weeks for infants of late-
presenting mothers
Whether replacement feeding freely offered: Yes
Other: A retrospective analysis of hospital records
March 2007
to June 2011.
Good
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Year
City &
Country
Description of programme Programme
years
Study quality
Geddes et al
201170
Durban, South
Africa
Setting: Urban
Study site/s: McCord Hospital, a state-aided general hospital in Durban
Stage at which ANC sought: Not reported
ANC testing strategy: Opt-out since 2006
Follow-up schedule: Babies were brought to the HIV clinic at the hospital for
HIV testing by PCR at six weeks. HIV positive babies were managed at the same
HIV clinic, and HIV negative babies were referred to government immunization
clinics.
PMTCT Regimen for Mother: HAART for eligible women. Up to May 2005,
single dose nevirapine, dual or triple therapy depending on woman’s ability to pay.
Thereafter funds were secured for all women for dual and triple therapy
(depending on viral load).
PMTCT regimen for infant: Single dose nevirapine and zidovudine for one week
Whether replacement feeding freely offered: Not reported
Other: User fees were paid at each ANC and postnatal visit. A retrospective
cohort design
March 2004
to February
2007
Good
(although
probably not
generalizable
to South
African public
institutions)
Doherty et
al 200569
18 sites across
all nine
provinces in
South Africa
Setting: Equal representation of rural and urban sites
Study site/s: 18 sites, two in each of the nine provinces. Purposively selected to
have representation of first level and second level facilities
Stage at which ANC sought: Not reported
ANC testing strategy : Predominantly opt-in
Follow-up schedule: Infants were to be followed up for testing using a rapid HIV
test kit at 12 months of age. Babies who tested HIV positive at 12 months were to
be followed up for re-testing at 18 months.
PMTCT Regimen for Mother: Single dose nevirapine
PMTCT regimen for infant: Single dose nevirapine
Whether replacement feeding freely offered: Freely given to women who opted
for it
Other: This was an evaluation of the pilot PMTCT programme in South Africa.
January 2002
to December
2002
Good
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Author &
Year
City &
Country
Description of programme Programme
years
Study quality
Azcoaga-
Lorenzo et
al 201172
Busia District,
Kenya
Setting: Rural
Study site/s: 11 Health care centres including 3 dispensaries, five health centres,
two sub-district hospitals and one mission hospital.
Stage at which ANC sought: Not reported
ANC testing strategy: Opt-out
Follow-up schedule: HIV exposed babies were tested twice, at six weeks (or as
soon as possible afterwards), and if negative again at least six weeks after
cessation of breastfeeding.
PMTCT Regimen for Mother: In three health centres eligible women were
started on HAART. In the rest of the sites the standard of care was short course
zidovudine plus single dose nevirapine.
PMTCT regimen for infant: Zidovudine
Whether replacement feeding freely offered: Not provided
Other: The Ministry of Health PMTCT programme in this district was supported
by MSF which improved decentralisation of the PMTCT services within the
district and supported integration of PMTCT activities with ANC.
Data were prospectively collected.
01 January
2006 to 31
December
2008
Good
Chapter 3-Systematic review
45
Author &
Year
City &
Country
Description of programme Programme
years
Study quality
Ahoua et al
201080
Arua, a rural
region in
North-Western
Uganda
Setting: Rural
Study site/s: Arua Regional Referral Hospital
Stage at which ANC sought: 233 of 327 (71.3%) enrolled during third trimester
of pregnancy
ANC testing strategy: Opt-in
Follow-up schedule: Mother-infant pairs were followed at week 1, 6, 10 and 14,
and every three months up to 18 months post-partum. Infants were tested for HIV
at 18 months using two rapid HIV test kits.
PMTCT Regimen for Mother: Short course zidovudine from 36 weeks of
pregnancy or single dose nevirapine. ART for eligible women.
PMTCT regimen for infant: Zidovudine for one week or single dose nevirapine
Whether replacement feeding freely offered: Freely provided up to June 2004
(was stopped to encourage exclusive breastfeeding)
Other: Pilot Ministry of Health PMTCT programme (with support from MSF).
The study retrospectively collected data from hospital records.
July 2000-
July 2005
Good
Anoje et al
201274
Cross River
and Akwa
Ibom States,
South-South
Nigeria
Setting: Rural (46%) and Urban (54%)
Study site/s: Six health facilities in two Nigerian states in the South-South region.
Stage at which ANC sought: Not reported (reported standard is 14 weeks)
ANC testing strategy: Not reported
Follow-up schedule: The infants were tested for HIV at six weeks of age, using
DNA PCR on dried blood spots. HIV negative infants were tested at least six
weeks after cessation of breastfeeding
PMTCT Regimen for Mother: HAART for eligible women. Ineligible women
received short course zidovudine from 28 weeks and single dose nevirapine.
PMTCT regimen for infant: Single dose nevirapine and zidovudine for six weeks
Whether replacement feeding freely offered: Not reported
Other: Data were collected retrospectively from medical records.
November
2007 and
July 2009
Fair
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Year
City &
Country
Description of programme Programme
years
Study quality
Black et al
200868
Johannesburg,
South Africa
Setting: Urban
Study site/s: An integrated ANC ARV clinic at Johannesburg Hospital, a teaching
hospital that offers ANC and HAART services
Stage at which ANC sought: Mean gestational age at initiation of HAART was
27 weeks; HAART was normally initiated a week after first ANC visit
ANC testing strategy: VCT (Opt-in)
Follow-up schedule: Babies were tested for HIV using DNA PCR at six weeks.
PMTCT Regimen for Mother: Eligible women are given HAART and referred to
ANC ART clinic
PMTCT regimen for infant: Not reported
Whether replacement feeding freely offered: Not reported
Other: The ANC ARV programme at this hospital is integrated with ANC in order
to prevent delays of HAART initiation to women thus prevent transmission.
A retrospective analysis of hospital records.
August 2004
–February
2007
Good
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Year
City &
Country
Description of programme Programme
years
Study quality
Ciampa et al
201176
Zambezia
Province,
Mozambique
(rural)
Setting: Rural
Study site/s: Alto Molócuè and Namacurra District hospitals
Stage at which ANC sought: Not reported
ANC testing strategy: Opt-out
Follow-up schedule: HIV testing by DBS PCR at age one month
PMTCT Regimen for Mother: HAART for those eligible; if not eligible twice
daily zidovudine from 28 weeks and zidovudine/lamivudine/nevirapine during
labour and twice daily zidovudine/lamivudine for one week after delivery
PMTCT regimen for infant: If mother was on HAART, single dose nevirapine; if
on zidovudine short course then twice daily zidovudine for four weeks
Whether replacement feeding freely offered: No
Other: Retrospective analysis of hospital patient data. The paper reports on the
outcome of an intervention that was undertaken to improve uptake of EID by direct
accompaniment of mothers from the maternity clinic to the EID centre. However
for this systematic review focus will be on the non-exposed group of the cohort i.e.
the one that got standard care.
September
2009-June
2010
Fair
Possibility of
misclassificati
on bias as
there was no
tracking of
babies; some
who died could
have been
classified as
LTFU
Cook
201177
Zambézia
Province,
Mozambique
Setting: Rural
Study site/s: Alto Molócuè district hospital
Stage at which ANC sought: Not reported
ANC testing strategy: Opt-out
Follow-up schedule: Infants referred to “child at risk” clinics. EID using PCR test
PMTCT Regimen for Mother: HAART or short course zidovudine and single
dose nevirapine
PMTCT regimen for infant: Zidovudine and single dose nevirapine
Whether replacement feeding freely offered: No
Other: This was an evaluation of the EID program within one year of inception.
Retrospective hospital record review for patients who were seen in the PMTCT
program.
January 2007
to November
2008
Fair
Possibility of
misclassificati
on as mortality
might have
been classified
as loss to
follow up
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Year
City &
Country
Description of programme Programme
years
Study quality
Ferguson et
al 201192
Ireland Setting: 10-year observational cohort in Ireland
Study site/s: PMTCT programme in Ireland
Stage at which ANC sought: Not given
ANC testing strategy: Opt out
Follow-up schedule: All HIV exposed infants are referred to one clinic, Rainbow
Clinic for management and follow-up
PMTCT Regimen for Mother: ART for those eligible; if not eligible triple
therapy ARVs for prophylaxis
PMTCT regimen for infant: Changing with contemporary practise in the course
of the study.
Whether replacement feeding freely given: Not reported
January
1999-
December
2008
Good
Goswami et
al 201188
Kolkata, India Setting: Urban
Study site/s: OBGYN Medical College, Kolkata
Stage at which ANC sought: Not reported
ANC testing strategy: Opt-in.
Follow-up schedule: Babies were followed up at the paediatric clinic of the
hospital, and were tested using ELISA at age 18 months
PMTCT Regimen for Mother: Single dose nevirapine
PMTCT regimen for infant: Single dose nevirapine
Whether replacement feeding freely given: No
Other: Method of data collection not given.
January
2004-
December
2007
Good
Chapter 3-Systematic review
49
Author &
Year
City &
Country
Description of programme Programme
years
Study quality
Manzi et al
200578
Thyolo
District,
Malawi
Setting: Rural
Study site/s: Thyolo district hospital
Stage at which ANC sought: Not reported
ANC testing strategy: Opt-out
Follow-up schedule: Infants followed according to EPI schedule at 6, 10 and 14
weeks, and 6, 12 and 18 months. CTX-p was started for the baby at six weeks.
HIV testing at 18 months
PMTCT Regimen for Mother: Single dose nevirapine (dispensed at 36 weeks of
pregnancy)
PMTCT regimen for infant: Single dose nevirapine
Whether replacement feeding freely given: Provided for free for 12 months
Other: The hospital provided centralised PMTCT activities for the whole district
(peripheral clinics/health care centres did not provide PMTCTC activities at the
time of the study). Retrospective record review of hospital records.
March 2002-
September
2003
Good
Mirkuzie et
al 201182
Addis Ababa,
Ethiopia
Setting: Urban
Study site/s: 12 public health centres and three private hospitals in Addis Ababa
with representation of the 10 sub-cities in Addis Ababa
Stage at which ANC sought: 65% were enrolled before 28 weeks of gestation
ANC testing strategy: Not reported
Follow-up schedule: Infant followed at six days (routine post-partum follow-up).
HIV testing by DBS PCR at six weeks. Cotrimoxazole prophylaxis for
breastfeeding infants at six weeks. Monthly follow up until six months, then every
three months until 18 months.
PMTCT Regimen for Mother: HAART for those eligible; twice daily zidovudine
from 28 weeks for those who are not eligible. Zidovudine/lamivudine/nevirapine
intra-partum; zidovudine/lamivudine one week after delivery
PMTCT regimen for infant: Zidovudine for 1 week or one month depending on
how long mother has been on medication
Whether replacement feeding freely given: Not reported
Other: Facility-based prospective cohort
January
2009-
December
2009
Good
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Year
City &
Country
Description of programme Programme
years
Study quality
Namukwaya
et al 201181
Kampala,
Uganda
Setting: Urban
Study site/s: Mulago Hospital, Kampala
Stage at which ANC sought: Median gestational age 28 weeks (IQR 24-32)
ANC testing strategy: Not reported
Follow-up schedule: Infant testing using PCR at six weeks.
PMTCT Regimen for Mother: HAART for those eligible; if ineligible
zidovudine twice daily from 28 weeks, single dose nevirapine and
zidovudine/lamivudine tail after delivery or twice daily zidovudine/lamivudine
from 33 weeks, single dose nevirapine and zidovudine/lamivudine tail after
delivery
PMTCT regimen for infant: Single dose nevirapine and one week zidovudine
Whether replacement feeding freely given:
Other: Strategies to encourage completion of visits were use of “peer” mothers,
telephone reminders (50% of women had telephone contacts), home visits for
women on HAART, treatment supporters for reminder of medication and clinic
visits, and psychosocial support meetings by counsellors and “peer” mothers.
Retrospective review
January 2007
to May 2009
Good
Chapter 3-Systematic review
51
Author &
Year
City &
Country
Description of programme Programme
years
Study quality
Nuwagaba
et al 201087
Lake region,
Tanzania
Setting: Not clear whether the region is urban or rural or both
Study site/s: Two regional hospitals, one zonal hospital and one health centre
Stage at which ANC sought: Not reported
ANC testing strategy: Not reported
Follow-up schedule: HIV testing by DNA PCR by DBS. Carers were given
appointment cards to collect results after one month. Infants who were HIV
positive who did not collect their results within 28 days were actively followed by
phone and home visits.
PMTCT Regimen for Mother: Single dose nevirapine (53% did not receive it)
PMTCT regimen for infant: Single dose nevirapine (35% of infants did not
receive it)
Whether replacement feeding freely given: Not reported; unlikely
Other: The paper was mainly aimed at reporting on the EID aspect, and not much
was reported on the ANC packages. This was a pilot EID programme
October 2006
to June 2007
Fair
Oladokun et
al 201075
Ibadan,
Nigeria
Study site/s: Urban
Stage at which ANC sought: University College Hospital Ibadan and its satellite
clinics
ANC testing strategy: Initially opt-in, then opt-out from 2005
Follow-up schedule: Infants were tested at 18 months, using ELISA. DNA PCR
since 2006.
PMTCT Regimen for Mother: Single dose nevirapine until 4th year when more
complicated regimens were introduced
PMTCT regimen for infant: Single does nevirapine
Whether replacement feeding freely given: Freely provided from second year of
programme
Other: The hospital was one of the pilot PMTCT sites in Nigeria. For infant
testing results only infants enrolled by December 2005 were included, to allow for
testing by 18 months using ELISA (so the outcome used in this analysis is not
affected by changes in PMTCT regimen and introduction of PCR testing).
Retrospective review of hospital records.
July 2002 to
June 2007
Good
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Year
City &
Country
Description of programme Programme
years
Study quality
Panditrao et
al 201189
Maharashtra,
India
Setting: Urban and rural
Study site/s: 43 private sector hospitals in Maharashtra state, India
Stage at which ANC sought: 76% registered after 20 weeks gestation
ANC testing strategy: Not reported
Follow-up schedule: Testing of infants using DNA PCR (stage of testing not
given). Women are contacted by letter, phone calls or home visits when they miss
their scheduled visit
PMTCT Regimen for Mother: Zidovudine-based as per WHO guidelines
PMTCT regimen for infant: WHO guidelines
Whether replacement feeding freely given: Not reported
Other: This was a private sector program. The study assesses risk factors for loss
to follow up from the PMTCT program.
September
2002 to
December
2008
Good
Sam et al
200391
London,
United
Kingdom
Setting: Urban
Study site/s: King’s College Hospital London
Stage at which ANC sought: Not reported
ANC testing strategy: Not reported
Follow-up schedule: Infant follow-up visits, including HIV testing. Carers were
contacted if there were missed appointments
PMTCT Regimen for Mother: Not reported
PMTCT regimen for infant: Not reported
Whether replacement feeding freely given: Not reported
Other: This study was published as a letter
1992 to April
2001
Good
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Year
City &
Country
Description of programme Programme
years
Study quality
Seth et al
201290
New Delhi,
India
Setting: Urban
Study site/s: Kalawati Saran Children’s Hospital
Stage at which ANC sought: Not reported
ANC testing strategy: Not reported
Follow-up schedule: All HIV exposed infants are followed until they are 18
months old. Those who tested positive were started on HAART and followed
further.
PMTCT Regimen for Mother: Single dose nevirapine; 38% had no prophylaxis
PMTCT regimen for infant: Single dose nevirapine; 61% got it
Whether replacement feeding freely given: Not reported
Other: This study is in a paediatric hospital, where HIV exposed infants have
already been referred. No PMTCT activities are described. Retrospective review of
hospital records
30 November
2006 to 31
December
2010
Fair
Shargie et al
201183
Addis Ababa,
Ethiopia
Setting: Urban
Study site: Zewuditu Memorial and Yekatit 12 Hospitals, in Addis Ababa
Stage at which ANC sought: Not reported
ANC testing strategy: Not reported
Follow-up schedule: Testing of infants with DNA PCR at six weeks of age, and
follow up for cotrimoxazole prophylaxis
PMTCT Regimen for Mother: HAART for eligible women; zidovudine for
ineligible with triple drugs intrapartum and two-drug tail for seven days
PMTCT regimen for infant: Zidovudine for one week or one month depending
on mother’s duration of treatment
Whether replacement feeding freely given: Not reported
Other: Retrospective record review. The two hospitals serve patients with referral
slips from all over the country
October 2008
to August
2009
Fair
Possible
selection bias
due to
exclusion of
records with
missing data
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Year
City &
Country
Description of programme Programme
years
Study quality
Sherman et
al 200471
Johannesburg,
South Africa
Setting: Urban
Study site/s: Coronation Women and Children’s Hospital
Stage at which ANC sought: Not reported
ANC testing strategy: Not reported; likely opt-in
Follow-up schedule: Follow up of infants from six weeks to twelve months, with
HIV testing using ELISA at 12 months
PMTCT Regimen for Mother: Single dose nevirapine
PMTCT regimen for infant: Single dose nevirapine
Whether replacement feeding freely given: Freely given for first six months of
life
Other: Retrospective analysis of hospital records.
01 October
2001 to 31
October 2002
Good
Hassan et al
201273
Kilifi, Kenya Setting: Rural
Study site/s: Kilifi district hospital
Stage at which ANC sought: Not reported
ANC testing strategy: Opt-out
Follow-up schedule: At the time, the standard was to follow all HIV exposed
infants until 18 months with the following HIV testing schedule: PCR at 6 weeks,
HIV rapid test at 12 months, and at 18 months if previously tested and continued
breastfeeding
PMTCT Regimen for Mother: Not reported
PMTCT regimen for infant: Not reported
Whether replacement feeding freely given: Not reported
Other: The hospital followed all HIV exposed infants up to 18 months according
to guidelines operating at that time, before guidelines to immediately treat any
child testing HIV positive were in place.
August 2006
to August
2008
Good
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3.4.3 Study findings
Table 3.3 shows the outcomes reported by each of the eligible studies. Twelve studies
reported more than one outcome along the PMTCT cascade. It was possible to categorise the
study outcomes of all studies according to timing of loss to follow-up along the continuum of
care as follows: loss to follow-up of HIV positive mothers between ANC registration and
delivery, loss to follow-up of infants by the age of three months, loss to follow-up of infants
by 12-18 months of age and loss to follow-up of HIV positive infants before enrolment into
ART programs. This classification enabled most outcomes reported in table 3.3 to be used in
the synthesis of results.
Chapter 3-Systematic review
56
Table 3.3: Reported Outcomes
Author & Year Loss to Follow-up Outcome reported Total at
baseline
Number (%) lost
Perez et al
200484
1) HIV positive women who did not collect results after testing during
ANC
437 111 (25.4%)
2) HIV positive women who did not deliver within health facility
network (lost to follow up between ANC registration and delivery)
326 167 (51.2%)
3) % Mother-infant pairs who were not among those attending at least
two follow-up visits within the 18-month follow-up period
70 22 (31.4%)
Nlend et al 201285 Infants who did not come for testing at 6-8 weeks 587 103 (17.5%)
Moses et al 200879 Infants who did not come for testing at six weeks 3,160. 2,070 (65.5)
Lussiana et al
201286
1) HIV positive women not returning for subsequent ANC visits or
delivery
382 164 (42.9)
2) Infants lost to follow-up (not returning to hospital for evaluations
after delivery).
218 42 (19.3)
Geddes et al 201170 Infants who did not return for testing at six weeks 699 128 (18.3)
Doherty et al 200569 Infants who did not return for testing at 12 months 1907 958 (50.2)
Azcoaga-Lorenzo et
al 201172
1) HIV positive mothers lost to follow-up between ANC registration
and delivery
1,668 632 (37.9)
2) Infants lost to follow-up before determination of HIV status 767 148 (19.3)
Ahoua et al 201080 1) HIV positive mothers lost to follow-up before delivery (refused to
enrol in PMTCT programme)
1. 1037 520 (50.1)
2) Infants lost to follow up (defined as infants who had unknown HIV
status at 18 months and who had missed their last scheduled
appointment for at least two months before the beginning of the study)
2. 567 303 (53.4)
3) HIV positive infants who remained lost to follow up after active
follow-up
567 174 (30.7)
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Author & Year Loss to Follow-up Outcome reported Total at
baseline
Number (%) lost
Anoje et al 201274 HIV positive infants lost to follow up after PCR testing (infants were
not enrolled into a paediatric ART programme)
125 85 (68)
Black et al 200868 Infants who did not come back for PCR testing at six weeks 493 191 (38.7)
Ciampa et al 201176 Infants who were not brought for HIV testing by age three months 332 247 (74.4)
Cook et al 201177 Infants who did not come back for early infant diagnosis 443 333 (75.2)
Ferguson et al
201192
1) Infants lost to follow-up before six weeks of age 964 17 (1.8)
2) Infants lost to follow up before 3 months of age 964 40 (4.1)
Goswami et al88 1) Loss to follow up of pregnant HIV positive mothers between ANC
registration and delivery
248 113 (45.6)
2) Babies who did not return for testing at 18 months 95 36 (37.9)
Manzi et al 200578 1) Loss to follow up of mother at 36 weeks of pregnancy (did not come
to collect single dose nevirapine)
646 358 (55.5)
2) Loss to follow up of mothers by the time of delivery 646 440 (68.1)
3) Loss to follow up of infant at six week post natal visit 206 10 (4.9%)
4) Loss to follow up of infant at six month post natal visit 206 84 (40.8)
Mirkuzie et al
201182
Infants who did not return for HIV testing at six weeks 221 106 (48.0)
Namukwaya et al
201181
1) HIV positive women who were lost to follow-up between ANC
registration and delivery
7,941 3,134 (39.5)
2) Infants who did not come for HIV testing by age three months 4,807 2,442 (50.8)
Nuwagaba et al
201087
1) Infants whose HIV PCR results were not collected after testing
(time point not given) includes both positive & negative
441 199 (45.1)
2) HIV positive infants whose PCR results were not collected after
testing (time point not given)
75 24 (32)
Oladokun et al 1) Infants who did not return to the hospital for testing at 18 months 303 63 (20.8)
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Author & Year Loss to Follow-up Outcome reported Total at
baseline
Number (%) lost
201075 2) Infants whose HIV results were not collected (includes both HIV
positive and negative)
207 88 (42.5)
Panditrao et al
201189
1) Loss to follow up of HIV positive women between ANC registration
and delivery
733 80 (10.9)
2) Infants who were not brought for early infant diagnosis 770 151 (19.6)
Sam et al 200391 Loss to follow up of infants before final determination of HIV status 104 27 (26.0)
Seth et al 201290 Loss to follow up of infants at a paediatric hospital before
determination of HIV infection
162 47 (29.0)
Shargie et al 201183 Loss to follow up of infants during follow up period after PCR testing
at six weeks
118 36 (30.5)
Sherman et al
200471
Infants who did not turn up for testing with ELISA at 12 months 67 57 (85.1)
Hassan et al 201273 1)Infants lost before final determination of HIV status at 18 months 180 119 (66.1)
2) Loss to follow up of HIV positive infants during follow-up 33 19 (57.6)
3) Loss to follow-up of infants who were tested for HIV before
collection of results (did not return to collect results)
102 46 (45.1)
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3.4.3.1 Loss to follow-up of HIV positive pregnant women
Eight studies reported on loss to follow-up of HIV positive pregnant women between ANC
registration and delivery. Two were from Uganda, two from India and one from each of the
following countries: Kenya, Angola, Malawi and Zimbabwe. The percentage loss to follow
up in these studies ranged from 10.9-68.1%, pooled estimate among the six Sub-Saharan
African countries, 49.08% (39.6-60.9) PrI 22.0-100%, I2 value 98.9% (variation in study
outcomes that is attributable to heterogeneity), (fig 3.3). The lowest proportion of 10.9% was
reported in Maharashtra, India, a private sector PMTCT programme where women who had
missed their appointments were followed up by letter, phone calls or home visits89.
Fig 3.3 Loss to follow-up of HIV positive pregnant women between ANC registration and
delivery
LTFU=Loss to follow-up
On meta-regression analysis, only the type of PMTCT regimen (whether single dose
nevirapine or more intensive regimens) was associated with LTFU; there was higher LTFU in
the sites that offered single dose nevirapine than in those which offered more intensive
regimens p=0.006. However this did not account for all heterogeneity; there was 92%
residual heterogeneity.
Overall (I-squared = 98.9%, p = 0.000)
Namukwaya 2011
Ahoua 2010
Azcoaga-Lorenzo 2011
Lussiana 2012
Manzi 2005
Perez 2004
Author
Uganda
Uganda
Kenya
Angola
Malawi
Zimbabwe
Country
49.08 (39.58, 60.87)
39.47 (38.39, 40.54)
50.15 (47.10, 53.19)
37.89 (35.56, 40.22)
42.93 (37.97, 47.90)
68.11 (64.52, 71.70)
63.62 (59.11, 68.13)
% LTFU (95% CI)
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Fig 3.3: LTFU between ANC registration and delivery
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Of note, the literature search and eligibility determination were set-up to find routine
programs reporting on LTFU outcomes among HIV-exposed infants, and not pregnant HIV
positive women. Therefore the outcome of LTFU among pregnant HIV positive women
reported here does not reflect findings from those studies which did not report LTFU
outcomes for infants.
3.4.3.2 Loss to follow-up of infants by age 3 months
Fourteen studies reported on loss to follow-up of infants soon after delivery; the infants
typically did not return to the health care centre for HIV testing at six weeks. About half of
the studies reported this as loss to follow-up at six weeks, but some studies allowed some
time after the six weeks and reported loss by 8 weeks, or three months. In order to synthesise
data from all the studies which reported on infants who did not come back for early infant
diagnosis (EID) of HIV, a cut-off point of 3 months was reported i.e. synthesis of studies
which reported LTFU by the age of three months. The percentage LTFU by age 3 months in
the fourteen studies ranged from 4.1-to 75%. The pooled estimate from 11 Sub-Saharan
African countries was 33.9% (27.6-41.5) PrI 15.4-74.2, fig 3.4.
Fig 3.4: Loss to follow-up of infants by age 3 months
. (15.45, 74.22)with estimated predictive interval
Overall (I-squared = 99.1%, p = 0.000)
Author
Mirkuzie 2011
Azcoaga-Lorenzo 2011
Ciampa 2011
Manzi 2005
Nlend 2012
Namukwaya 2011
Moses 2008
Geddes 2011
Lussiana 2012
Black 2008
Cook 2011
Country
Ethiopia
Kenya
Mozambique
Malawi
Cameroon
Uganda
Malawi
South Africa
Angola
South Africa
Mozambique
33.86 (27.59, 41.55)
% LTFU (95% CI)
47.96 (41.38, 54.55)
19.30 (16.50, 22.09)
74.40 (69.70, 79.09)
4.85 (1.92, 7.79)
17.55 (14.47, 20.62)
50.80 (49.39, 52.21)
65.51 (63.85, 67.16)
18.31 (15.44, 21.18)
19.27 (14.03, 24.50)
38.74 (34.44, 43.04)
75.17 (71.15, 79.19)
1 10 20 40 100
Fig 3.4: LTFU of infants by age 3 months
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The lowest LTFU percentages were reported in Ireland and Malawi. In Ireland there was a
system in place for follow-up of HIV-exposed infants which was enhanced by having a single
centre for the coordination of the care of HIV-exposed infants. However, although the study
in Malawi (Manzi et al)78 reported low LTFU rates at six weeks, by the six-month postnatal
visit 41% of infants had been lost; they were initiated on cotrimoxazole prophylaxis but were
lost from further evaluation. In that study all PMTCT services were centrally provided at the
hospital during the reported period. This is one example where centralisation of PMTCT
services did not appear to reduce loss to follow up: authors reported that women may have
increasingly found it more difficult to come back to the hospital because of long distances in
an area where there was no public transport (women had to either walk or use bicycles) and
would therefore have benefitted from decentralised services at local clinics. The programme
in Cameroon85 tracked clients using mobile phones; 90% of clients had mobile phones. This
tracking may have improved their LTFU rates as they had comparatively lower LTFU rates
than other sites of 17%. There was also good tracking of defaulters in the UK study in
London91, which reported a loss to follow-up rate of 26%. Of note, the majority of infants lost
to follow-up in that programme were born to African mothers, 89% compared to 71% of
those who completed follow-up.
The two Mozambican studies both reported LTFU rates of about 75%, in a setting where
there was lack of confidential counselling for women in crowded postnatal wards. The
authors reported that this environment resulted in HIV positive women feeling uncomfortable
about the possibility of disclosure thereby lessening their chances of returning to the hospital
for the baby’s early HIV testing. In addition, authors reported that the provision of EID
services occurred in a different building from the one where referral was made possibly
resulting in women getting lost between referral and follow-up. Related to this, in one of the
studies in Ethiopia82 some infants who had defaulted from EID had been to a health care
centre for pentavalent vaccination at six weeks: 86% of infants were brought for pentavalent
vaccine compared to 52% for EID at six weeks postpartum. This indicates that loss to follow-
up from HIV-related care does not necessarily mean LTFU from the health care system,
signifying the importance of integration of child health with EID services. These findings
also point to the possibility that fear of stigma influenced the uptake of services.
None of the variables extracted from the studies explained the heterogeneity in the findings of
LTFU by age three months.
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3.4.3.3 Loss to follow-up of infants at 12 and at18 months
Two studies (both from South Africa) reported on LTFU of infants after 12 months. The
studies reported losses of 85.1% and 50.2% respectively. Both programs offered single dose
nevirapine.
Five programs, three of which offered single dose nevirapine, reported on LTFU of infants by
18 months. Two were from India, with LTFU percentages of 37.9% and 29%, and one each
from Uganda (53.4%), Kenya (66.1%) and Nigeria (20.8%).
3.4.3.4 Loss to follow-up of infants after HIV testing
Five studies reported on loss to follow-up infants after HIV testing (mostly during early
infant diagnosis using PCR tests, and one used ELISA at 18 months): infants were lost during
the recommended follow-up period after testing83, did not enrol into ART programs74 or did
not come back to collect HIV test results67,75,87. The percentage loss to follow-up of infants
after testing ranged from 30.5-68.0%, I2 91.2% pooled estimate, 45.5 (35.9-57.6), PrI 18.7-
100%, fig 3.5.
Fig 3.5: LTFU of infants after HIV testing
Overall
Hassan 2012
Nuwagaba 2010
Shargie 2011
Oladokun 2010
Anoje 2012
Author
Kenya
Tanzania
Ethiopia
Nigeria
Nigeria
Country
45.49 (35.94, 57.58)
45.10 (35.44, 54.75)
45.12 (40.48, 49.77)
30.51 (22.20, 38.82)
42.51 (35.78, 49.25)
68.00 (59.82, 76.18)
% LTFU (95% CI)
20 40 60 100
LTFU of infants after HIV testing
Chapter 3-Systematic review
63
Again the benefit of active follow-up of defaulters was apparent in the study in Tanzania87,
where the program actively tracked HIV positive infants who had not returned to collect
results. As a result a lower percentage LTFU of 32% among HIV positive infants was
observed compared to 48% among the HIV negative infants.
3.5 DISCUSSION
This systematic review revealed that there is unacceptable loss to follow-up of HIV-exposed
infants at various points of the care cascade. There was significant heterogeneity in the study
findings; pooled estimates were reported together with predictive intervals to indicate the
uncertainty in the estimates. An estimated 49% of HIV positive pregnant women are lost to
follow-up between ANC registration and delivery (although this relates only to studies that
reported on infant LTFU outcomes), while about 34% of infants do not return to the health
care facilities for evaluations or early infant diagnosis. A further 45% of infants are lost to
follow-up after HIV testing.
Of importance is that retention in a program is not necessarily equivalent to retention in the
health care system; those women who have self-transferred out of a program to another
facility should not be regarded as lost to follow-up. In this review, a third of programs either
actively sought but did not find evidence of women self-transferring to other neighbouring
health sites or provided the only PMTCT services in the communities in which they operated.
Four studies68,76,77,91 acknowledged the possibility of migration being misclassified as LTFU
and the rest of the studies did not discuss this kind of LTFU.
If a woman is LTFU before delivery, she may not take her intrapartum ARV prophylaxis, and
the baby will not be initiated on the necessary prophylaxis after delivery, and may not be
registered for regular follow-up in the PMTCT programme. Current WHO guidelines which
recommend that infants of unknown HIV exposure status who are seen at health care centres
around the time of birth or at the first postnatal visit should have their HIV exposure status
determined23 are critical to reduce MTCT and need to be fully implemented by health care
systems in order to re-enrol infants who have been lost from care before delivery.
Loss from care before delivery is not only unsafe for the baby, but for the mother as well. If
the mother is lost to follow-up there may be delayed evaluation of her own disease
progression and initiation of life-saving ART. Interventions are needed to retain pregnant
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women in care. In this systematic review we found that programs which had an effective
system for tracking defaulters had higher retention rates suggesting that programmers should
consider incorporating interventions to actively track all women who have missed their
appointments. It is important that tracking methods be appropriate for the setting. The
programme in Uganda81 had a high LTFU rate of 40% despite having a telephone tracking
system, which may not have worked well because only 50% of clients had telephone
contacts. On the other hand, telephone follow-up was appropriate in the programme in
Cameroon where authors reported that more than 90% of women had phones85. Unfortunately
tracking requires resources, and can be expensive depending on the setting. It is therefore
important to have data on the relative costs and benefits of introducing such follow-up
activities. In addition as tracking poses the risk of disclosure of HIV status, it is important
that the tracking services are designed to ensure as much confidentiality as possible.
Of importance is the observation that even with active tracking there are still unacceptably
high levels of loss to follow-up by the time of delivery, which means that there are likely
other barriers that need to be overcome. Many qualitative interviews have been conducted to
understand patient-level factors that influence HIV positive women’s decisions to deliver in
health care facilities. 93-97 Fear of involuntary disclosure of HIV status, fear of stigma,
traditional beliefs, unfriendly health care workers, disbelief of HIV result, distance from
health facility and cost of transport have been some of the barriers that have kept HIV
positive women away from health care facilities. These patient-specific challenges have to be
addressed so that programmes offer acceptable, culturally-sensitive services that will attract
all intended beneficiaries.
Another programme characteristic that was found to be associated with loss to follow-up of
HIV positive pregnant women was the type of ARV prophylaxis regimen that was provided;
programs that offered single dose nevirapine had higher rates of LTFU that those which
offered more intensive regimens. Single dose nevirapine was used in earlier programmes than
dual/triple prophylaxis, when programmes were still learning how best to provide PMTCT
services. An improvement as care shifts from single dose nevirapine to dual/triple therapy
might indicate the progress made with time. In addition, dual and triple therapy necessitate
more visits for prescription refills, exposing the woman to more counselling and support from
health care workers which may increase knowledge and understanding of importance of
PMTCT, acceptance of HIV status and the client’s connectedness with the health care
Chapter 3-Systematic review
65
system. Client-connectedness with the system has been found to be important in reducing
missed clinic appointments98. The recent introduction of the WHO Option B+ programme,
where all HIV positive pregnant or lactating women are given ARVs which are continued for
life may help increase retention rates of women. Results from the Malawian Option B+
programme indicates encouraging retention rates of 77% 12 months after initiation of ART
among women who did not transfer care during follow-up. Retention of mothers in care will
likely reduce MTCT and likely also keep the HIV-exposed infants in care.99
By the age of three months, about 34% of infants delivered within the health system have
been lost to follow-up. Again the importance of effective tracking of defaulters is apparent at
this point of the care cascade. In the same way as for LTFU of pregnant women, other factors
preventing attendance of infant testing visits are at play, meaning that active tracking of
defaulters alone will not achieve optimum results. Qualitative studies97,100-102 have reported
barriers to early infant testing from the carer’s perspective: the barriers are intrapersonal e.g.
fear of positive result, believing that the child was healed through faith or traditional
medicines, disbelief that PMTCT interventions work and intent to shorten the life of the
child, time and money constraints and fear of disclosure of HIV status; interpersonal and
community e.g. unsupportive male partners, stigmatising attitudes from family and
community, cultural norms; health care system e.g. unfriendly health care workers, long
queues and waiting times and different appointments for mothers and infants. Programmers
in each context need to be aware of the barriers affecting their community and make
appropriate culturally-specific interventions to enable a higher uptake of paediatric testing.
Paediatric testing of HIV is a relatively new phenomenon that is being accepted at different
rates in different communities. In a study in Western Kenya an acceptance rate of only 57%
among children who had been offered testing was recorded103, yet a nationally representative
survey in Zimbabwe reported positive attitudes towards paediatric testing; 92% reported that
they would feel happier if their children were tested 104. That cultural norms play a significant
part may be further evidenced by the fact that the majority of infants who were lost to follow-
up in the programme in London were born of African mothers; their reasons for dropping out
of care may be similar to the barriers reported in African settings, where LTFU rates are
highest. In addition, authors in the London programme reported that the mothers could have
been facing immigration challenges, which may mean that as foreigners they might have felt
less connected to London health services. There is evidence from a study conducted in Cote
d'Ivoire that women who are more socioculturally and economically disadvantaged find it
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more difficult to participate in PMTCT programmes105, the authors suggest implementation
of structural interventions to promote retention, eg community mobilisation in affected
communities, and economic and educational interventions.
Another way to address LTFU of infants is integration of child health or EPI services with
PMTCT programmes, as has already been recommended by WHO106. In one of the reviewed
programmes in Ethiopia82, infants who had been lost to follow-up from the PMTCT
programme at six weeks were documented to be attending the child health programme (i.e.
had received pentavalent vaccine) at the same time that they were expected to have attended
the EID facility. Integration of these two services may have reduced LTFU in the PMTCT
programme. This necessitates proper documentation of HIV-exposure status on the child
health card, a practise that has already been adopted in Lesotho, Zambia, Zimbabwe and
several other countries1. Importantly, integration should ensure maintenance of
confidentiality because fear of involuntary disclosure is a recurring theme in many qualitative
studies exploring barriers to continued attendance of HIV-related care visits. The two
programmes in Mozambique had very high levels of LTFU of 75%, which the authors partly
attributed to lack of confidential counselling space.
Most programmes which reported on loss to follow-up at 12-18 months were older, and had
mostly been giving single dose nevirapine. Higher levels of loss were reported at these points,
indicating a progressive increase in LTFU with time. This also shows the value of continuous
engagement with the health care system: appointments which are a very long time apart may
promote greater loss to follow-up than regular appointments107. This may be less of an issue
nowadays given the many effective interventions that necessitate regular follow-up of HIV-
exposed infants for evaluations and prescription refills. The other potential reason for LTFU
could be that mothers with thriving babies could have felt falsely reassured that the baby was
HIV negative. Education of women on PMTCT is clearly important. Also it is possible that
many of the babies had died.
The pooled LTFU of infants after HIV testing was 45.5%. All the programs reporting this
outcome offered PCR (four studies) or ELISA tests (one study), where typically samples are
sent to a central lab, and mothers are given appointments to collect results at a later date.
Transport delays and other logistical challenges have been reported to increase result
turnaround times52,108,109 , and infants are lost during the waiting period. Fortunately, point-
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of-care machines for EID are being tested and are likely to be on the market soon.110,111 These
will hopefully facilitate immediate decision-making and reduce LTFU. WHO recommend
immediate initiation of ART in infants who test HIV positive23. There should be active
tracking of infants whose results are positive in order to bring them into care. This was shown
to be feasible and effective in the EID programme in Tanzania87 which actively followed up
HIV positive infants by phone and home visits if the HIV results had not been collected 28
days after the appointed date.
If we simulate a cumulative LTFU cascade using data obtained in this systematic review we
will see that out of 100 HIV positive pregnant women who are enrolled into a PMTCT
programme, only 19 infants are still in care after HIV testing, fig.3.6 below.
The strength of this systematic review is that it is a synthesis of real-life data from
programmes which are actively implementing PMTCT services. It gives us a picture of how
adept routine services are at implementing interventions that have already been proven to
prolong the lives of children born to HIV infected mothers. Although studies were
observational, they were generally of reasonable quality and did not suffer from significant
bias in the measurement of LTFU outcomes.
There was significant heterogeneity in the study findings, with very wide predictive intervals.
The main limitation of this review was our inability to fully explore the causes of the
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heterogeneity in the study findings in meta-analyses. Accounting for the heterogeneity would
have given us more information on the characteristics of programmes that achieve lower rates
of LTFU. Although we were able to explain the bulk of the heterogeneity for programmes
reporting LTFU of pregnant mothers before delivery, we were not able to do so for
programmes reporting LTFU by age three months, and for those reporting LTFU at 12-18
months and after HIV testing. Nevertheless it was clear that programmes that have effective
methods of tracking defaulters had better rates of follow-up.
Another limitation of the review is that it did not include grey literature, which is likely to
have had some reports from routine programs. This is a trade-off that was made by preferring
peer-reviewed publications which were viewed to have been more vigorously reviewed.
Another limitation is related to the use of one researcher in the review. As per standard in
systematic reviews, 5-10% of abstracts should be checked by another researcher for inter-
rater reliability. However this was not done because of logistical and financial challenges.
Although due care was exercised during determination of eligibility of papers, and in using
standard procedures and forms for quality review and data extraction, a quality check on 5-
10% of abstracts would have been helpful.
In conclusion, there are unacceptably high levels of loss to follow-up of HIV-exposed infants
at important points of the PMTCT cascade. Effective tracking of defaulting clients reduces
loss to follow-up rates. Programmers should consider initiating effective interventions for
tracking defaulting clients. In addition, investigation of patient level and context specific
factors that limit adherence to visit schedules could be used to develop culturally sensitive
retention interventions.
***
This systematic review has been published as a journal article in AIDS journal; a copy of the
paper in appended in Appendix 8.
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CHAPTER 4: METHODS
The study was conducted at Mbare Polyclinic, in Harare. Written approval to conduct the
study was obtained from the Ministry of Health and Child Welfare (MoHCW) and City of
Harare. Ethical approval was obtained from the following three committees: University of
Zimbabwe College of Health Sciences Ethics Committee, the National Ethics Committee
(Medical Research Council of Zimbabwe), and the UCL Ethics Committee.
4.1 STUDY DESIGN
The study was divided into two phases. Phase 1 was aimed at understanding the policy and
guidelines for implementation of cotrimoxazole prophylaxis among HIV exposed infants in
Zimbabwe. In addition to studying the policy and guidance documents, this involved
conducting key informant interviews with individuals holding key positions in the
implementation of PMTCT services at MoHCW and City of Harare.
Phase 2, which was a study of implementation activities for cotrimoxazole prophylaxis at
Mbare Clinic, was aimed at understanding the implementation challenges in the various
stages of the cotrimoxazole care cascade. This involved conducting a cross-sectional survey
among women who had just delivered at the clinic to evaluate the care given during the
antenatal care period, with particular reference to whether there had been identification of
HIV exposure status for the infant i.e. whether the mother had been tested for HIV. In
addition, HIV positive women were followed up at six weeks post-delivery to investigate
whether their babies had been started on cotrimoxazole prophylaxis. Willing HIV positive
women whose babies had been started on cotrimoxazole prophylaxis were followed up
monthly until 6 months post-delivery to study their experiences with collecting prescription
refills and keeping the baby on cotrimoxazole prophylaxis. As part of this, qualitative in-
depth interviews were conducted with the women at 4-5 months post-delivery to explore their
experiences with keeping their babies on cotrimoxazole prophylaxis.
Preliminary analysis of Phase 2 data revealed that a critical impediment to the first part of the
PMTCT cascade (identification of HIV exposure status) was that some women did not get
tested for HIV because they had not sought antenatal care. Therefore qualitative in-depth
interviews were conducted with women who had not registered for ANC, and those who had
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registered late, to explore their reasons for this. Preliminary analysis also revealed that there
was poor attendance of the six week postnatal visit, which is the visit when the baby should
be started on cotrimoxazole prophylaxis. In-depth qualitative interviews were held with
women who had failed to attend the six week visit to explore their reasons for this. In
addition, clinic records for participants delivering at the clinic over a one-month period were
surveyed to investigate whether attendance of the six-week postnatal visit differed according
to HIV infection status.
This thesis focused to a large extent on the earlier part of the PMTCT cascade but did not
look at later parts (e.g. evaluating the coverage of maternal and infant ART prophylaxis
around delivery and uptake of infant HIV testing and ART uptake for HIV positive infants)
because the later parts entailed larger sample sizes and longer follow-up in the study, which
could not be done with the limited PhD fellowship funding.
4.2 METHODS FOR PHASE 1
Key informant interviews (in-depth interviews) were conducted with the following:
1. The national representative of MoHCW responsible for implementation of PMTCT
services. This key informant was a 50-year old, Shona woman who is a paediatrician.
She holds a very senior position in MoHCW where she is the national PMTCT
services coordinator. As head of the PMTCT department her role is to ensure the
proper implementation of PMTCT services in all public health institutions. She
reports directly to the head of AIDS and TB services in the MoHCW. During the
interview she was asked about the policy for cotrimoxazole prophylaxis and follow-
up of HIV infected mothers, and about implementation procedures and challenges
faced.
2. A representative of the City of Harare Clinic Management responsible for
Reproductive Health Services. This was a 52-year old woman who held a senior
position within the City of Harare, where her role was to provide oversight of the
implementation of sexual and reproductive health services across all the clinics within
the City of Harare Network. She is a nurse midwife, with decades of experience in the
nursing field. She has spent most of her nursing career within the City of Harare,
having been promoted through various management positions up to the position she
held at the time of interview. In her position she worked very closely with the
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MoHCW department responsible for sexual and reproductive health services. During
the interview she was asked about the policy for cotrimoxazole prophylaxis and
follow-up of HIV infected mothers, and about implementation procedures and
challenges faced.
3. The Stores Manager at NatPharm, the national agency responsible for drug
distribution. This was a 25-year old pharmacist with two years’ experience in that
position. She was responsible for managing the Stores: receipt of drugs and medical
supplies from donors or wholesalers and distributing them to health care centres in the
public health system. Although she had a management position and supervised a few
staff she worked with, her position within NatPharm was not very senior. She was
asked about the drug distribution process, challenges faced and the adequacy of
human and material resources.
The key informant interviews were audio-recorded.
Selection of the key informants was not done by the candidate. In all three instances the
candidate wrote a formal letter to the heads of the institutions asking for permission to have a
discussion on the study topic with a relevant person from the organisation. Upon granting
permission to the candidate, the head of institution would refer the candidate to the member
of staff who (because of the work they were doing) was believed to be best suited to respond
to the questions. None of the three key informants were known personally by the candidate.
In addition to the key informant interviews, MoHCW and City of Harare guidelines, M&E
tools and standard operating procedures relevant to the implementation of cotrimoxazole
prophylaxis to HIV exposed infants and care of HIV infected mothers were reviewed.
4.3 METHODS FOR PHASE 2
Phase 2 of the study was conducted at Mbare Clinic, a description of which follows.
Background information on Mbare clinic
Mbare Clinic is a large polyclinic situated in one of the oldest suburbs in Harare, called
Mbare. Mbare is home to the largest food and vegetable market in the country, a market for
traditional artwork, and a second-hand clothing market. It is one of the poorest communities
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in Harare, with high levels of unemployment and crime. Most employment is informal, being
centred around the markets mentioned above.
Mbare Clinic is centrally-located in Mbare suburb. It is owned and financed by the City of
Harare although it gets assistance in the form of supplies, equipment and clinic renovations
from some humanitarian organisations e.g. ICRC, Zimbabwe Network for Health and
ZimPro. About 100 metres from the clinic is the country’s busiest long-distance bus terminus.
The terminus is adjacent to Harare’s busiest bus stop where local commuter buses from most
high-density suburbs drop-off and pick up passengers. Although the clinic has a catchment of
about 140,000, in reality it caters for a much larger population than this as it is frequently
used by patients who come from other residential suburbs or cities. The Clinic is made up of
three departments described below:
Outpatients Department - This is a busy clinic for curative services for adults and children.
It sees about 4,000 patients a month. Chronic care patients, including those coming for HIV
care (ART prescription refills and cotrimoxazole prophylaxis) are seen at this clinic. It is
open every day of the week; from 8am to 4.30pm. Patients pay fees to access services as
described above. The outpatients department is staffed by nurses, who refer complicated
cases to Harare Central Hospital or to the attention of the district medical officer who visits
Mbare clinic on Mondays, or to a volunteer doctor, who conducts weekly clinics on
Tuesdays.
Family Health Services (FHS) Clinic-This is the clinic where babies and children are seen
for immunizations and growth monitoring. All children under five years within the clinic’s
catchment area are expected to visit the clinic on a monthly basis, starting with an initial visit
at about 10 days after birth. No charges are levied for services provided. However, should a
child fall sick and there is no proof that they regularly attend the child health clinic, they will
be asked to pay a consultation fee of US$3 when they seek treatment at the Outpatients
Department. The FHS clinic also provides family planning services. In addition, it has a
community department which conducts home and community visits to ensure the general
upkeep of community health standards (eg through inspecting day care centres and schools
for compliance with set hygiene standards) or to attend to individuals who need medical help
but are unable to visit the clinic.
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Maternity Clinic (also called Edith Opperman Maternity Clinic)-This is the department
responsible for providing antenatal care (ANC), delivery and post-natal services (to 6 weeks
post natally). About 400 babies per month are delivered at the clinic.
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Phase 2 of the study was made up of different studies which employed different study
designs. Figure 4.1 shows a schematic overview of all the phase 2 studies.
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Fig 4.1: Summary of Phase 2 Studies
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4.3.1 Assessment of implementation activities at Mbare Polyclinic
Staff Interviews
Two nurses at Mbare Clinic were interviewed to determine what systems were in place for
identifying HIV positive women, enrolling them into the PMTCT programme and ensuring
that HIV exposed infants were offered cotrimoxazole prophylaxis. The nurses were also
asked to assess the efficiency of the system and barriers to implementation of cotrimoxazole
prophylaxis including any challenges with drug supply. The interviews were audio-recorded.
One of the nurses was a middle-aged (age not asked) Sister-in-charge (a midwife) responsible
for oversight of the outpatients clinic. Although at the time of interview she was in charge of
the outpatients clinic, she had experience of being in charge of the other two clinics, the
family health services clinic and the maternity clinic. The sisters-in-charge at Mbare Clinic
frequently rotate positions among the three clinics.
The other nurse who was interviewed was a nurse midwife (in her thirties) who did not have
a management role at the clinic. At Mbare Clinic, nurses frequently rotate positions and can
work in any of the three clinics. At the time of interview she was working at the maternity
clinic where she was providing care to labouring and postnatal women.
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As for the other key informants described in section 4.2, the candidate did not select the key
informants: they were recommended by the clinic manager. None of the key informants were
known personally to the candidate.
Assessment of stock levels
At three time points (unannounced to clinic staff) during the course of Phase 2 of the study,
stock levels of cotrimoxazole were audited. Expiry dates were noted and conditions (e.g.
temperature and security) under which these supplies were kept were examined. The means
of accounting for stock was also assessed.
Patient survey
Between 21 September 2010 and 10 February 2011, a cross-sectional survey was conducted
among women who had just delivered babies at the clinic. Women who met all the following
criteria were asked to participate in the survey:
 Women who had delivered on or after 21 September 2010, as long as they were not
yet due for the six weeks postnatal visit
 Women who resided in Mbare at the time of recruitment (as determined by the
address on the participant’s medical record). This was necessary because women who
did not reside in Mbare were not expected to come back to Mbare Clinic for postnatal
visits but to go to the clinics in their respective places of residence
 Women who were willing and able to give written informed consent for participation.
(There were procedures for consenting illiterate participants in the presence of a
literate witness of their choice).
Participants were recruited from the maternity clinic post-natal ward and the well-baby
clinics (mainly at the 10 day post natal visit). Recruitment was conducted during daytime
hours (8am to 430pm) during weekdays; no recruitment was done on weekends. All women
who attended the two clinics above and met the inclusion criteria were asked to participate in
the study.
It should be noted that recruiting from the clinic was not ideal because only the views of
clinic attendees were captured, and no data was captured on women who did not deliver at
the clinic or those who chose not to attend the 10-day postnatal visit. Data from this study is
therefore only applicable to attendees of Mbare Clinic, and cannot be applied to the general
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population in Mbare since it is highly likely that the views and challenges faced by non-
attenders differ from those of attenders. With the limited PhD fellowship funding, it was not
possible to employ extensive techniques to recruit women who delivered at home (they
would be more difficult to find and so the study would be more costly).
Participants who had given written informed consent were asked to complete an interviewer-
administered questionnaire where they were asked about their experience of antenatal care
(ANC), specifically the location and timing of their ANC visit(s), whether they underwent
HIV testing, received their HIV result and if positive whether they disclosed their HIV status,
received and took ARVs for PMTCT. In addition women were asked about their past
obstetric history including pregnancy loss and vital status of previous children, their general
health and previous HIV testing behaviour (see Appendix 1 for the questionnaire). The
questionnaire was translated into Shona, the local language in Zimbabwe. In Zimbabwe
medical records are kept on a patient-held medical record card. Where possible, participant
responses were cross-checked with the medical record card, e.g. for date of ANC registration
and HIV results. Participants held this medical record and were asked to show it to study staff
with the understanding that they could refuse if they did not want study staff to have a look at
their record.
The cross-sectional survey interviews were conducted by a trained nurse-interviewer. There
were standard operating procedures for identification and recruitment of participants and for
completing the questionnaires. The nurse was trained in these procedures and was supervised
to ensure that she adhered to them.
Women were asked if they intended to return to the clinic for their 6-weeks post-natal visit.
HIV positive women who said they were planning to return were asked if they could be re-
interviewed at that time. Written informed consent was obtained for participation at the six-
week visit and for home follow-up in the event that they failed to attend. Their locater details
were collected.
Participant interviews at six-week post natal visit
The following participants were eligible for interviewing at the six-week visit:
 HIV positive
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 Having participated in the baseline patient survey
 Having had a live birth
 Women intending to return to the clinic for the six-week visit
 Women who had given written informed consent to participate at the six-week visit
As HIV positive participants completed their 6 weeks post-natal visit they were interviewed
to collect information on their own health and the baby’s health using a semi-structured
questionnaire (Appendix 2). The mother’s medical records were reviewed to see if HIV
positive women had been examined to determine their WHO clinical disease stage and if they
had been referred for further HIV care (e.g. clinical staging, CD4 testing, ART). The baby’s
medical record cards were examined to see if they had been prescribed cotrimoxazole
prophylaxis and if so if it had been dispensed. When this did not happen reasons for this were
explored. Women and babies who had not received appropriate referral/care were referred
back to clinic staff. Women who did not attend their 6 weeks post-natal visits were contacted
at home and their reasons for non-attendance were explored in qualitative in-depth
interviews.
4.3.2 Assessment of adherence to cotrimoxazole prophylaxis
HIV positive women (including some who did not participate in the study at the six-week
visit) who were prescribed cotrimoxazole prophylaxis for their baby at their six weeks post-
natal visit were invited to take part in the adherence sub-study. Separate written consent was
obtained. Women who agreed to take part were seen by the study nurse at the following clinic
visits over the following 6 months: 3, 4, 5, and 6 months. They were asked to bring their
cotrimoxazole container for assessment of remaining amounts at each of the visits.
Adherence study participants were also asked to provide permission to be visited at home by
the nurse interviewer for home assessment of adherence. Adherence was estimated using the
following parameters:
 comparison of observed with expected remaining amounts of medicine at each clinic
visit and at unscheduled home visits
 completion and timing of prescription refill visits at the clinic
 direct observation of mother dispensing cotrimoxazole to her baby in home
environment
 self-reports
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In addition to assessing adherence directly, women taking part in the adherence sub-study
were interviewed in-depth at 4-5 months post-delivery to assess their understanding of their
HIV status and what it meant for them and their baby in terms of follow-up, their
understanding of the rationale for cotrimoxazole prophylaxis and its administration and the
importance of adhering to it. Women were asked whether their partner was supportive of
cotrimoxazole prophylaxis for their child. The in-depth interviews were held in private in one
of the clinic rooms at Mbare Clinic.
All survey tools and data collection forms used in Phase 2 of the study were piloted before
use.
Participants in all the studies were offered an incentive of $5 for study participation. This is
the amount that the Zimbabwean national ethics committee (Medical Research Council of
Zimbabwe) recommends as not cohesive for study participation.
4.3.3 Preliminary analyses of survey data
Preliminary analysis of survey data were conducted after 199 women had been enrolled
(December 2010).
Purpose and methods
The purpose of the preliminary analysis was to evaluate data collected up to December 2010
for its adequacy and thus inform future data collection procedures. Data analysis proceeded
as described in section 4.5, data analysis.
4.3.4 Incorporation of findings of preliminary analysis into study design
The main findings of the preliminary analysis were:
1. 23% of participants did not register for antenatal care (ANC). Of those who
registered, the mean number of weeks gestation at registration (time to ANC
registration) was 28.9 (95% CI 27.7-30.1), which was much later than the 16 weeks
recommended by Ministry of Health and Child Welfare (MoHCW) at that time.
2. Some HIV positive participants who had not registered for ANC but had been tested
for HIV at other testing centres chose not to disclose their HIV status to the health
care workers at delivery. As a result, at the time of delivery they (and their infants)
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did not receive appropriate care for HIV positive women or HIV exposed infants. This
applied to three participants.
3. Of 19 HIV positive women who were due for attendance of 6-weeks post-natal visits,
only 6 attended.
Based on these findings, the following changes were made to the study procedures:
4.3.4.1 In-depth interviews
In-depth interviews were conducted with the following participants:
1. Participants who did not register for ANC to explore why they did not register.
HIV positive participants were also asked about the possible reasons why some
women who have been tested in other testing centres choose not to disclose their HIV
status to the nurses.
2. Participants who registered later than 24 weeks gestation to explore why they
delayed registering.
3. Participants who did not attend the six-week post-natal visit to explore the reasons
for non-attendance.
Ethical approval for these changes was obtained after the baseline patient survey was
complete, so additional participants were recruited for the qualitative study on barriers to
ANC registration.
The in-depth interviews were held in private in one of the clinic rooms at Mbare Clinic.
Interviews took between 30-minutes to one hour, with an average length of 45 minutes.
When the study was initially designed, there were plans to do the patient survey and
longitudinal follow-up of HIV positive women at two sites, one urban and one rural. The
fellowship funding for the study could not extend to both expanding the study within the
urban site at Mbare Clinic and going to a rural site as originally proposed. Given the
importance of exploring the barriers to cotrimoxazole prophylaxis in full, the candidate felt it
would be better to collect more in-depth data from the urban site instead of collecting less in-
depth data from both rural and urban sites. An additional financial constraint was that after
the fellowship was funded HIV prevalence in Zimbabwe declined and, with the change of the
economy following the adoption of the US dollar as currency, the cost of implementing the
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study at the rural site increased making it logistically impossible to include a rural site using
the very limited fellowship funding.
The methods for data collection and analysis of in-depth interviews are described in the
section for qualitative data collection and analysis, section 4.6.2.
4.3.4.2 Assessment of rates of non-attendance of six-week post-natal visit
The six week post-natal visit is important for HIV positive women because it is when their
babies are initiated on cotrimoxazole prophylaxis. Given the poor attendance rates of HIV
positive women at the six week visit, I sought to determine whether this was a general trend
for all women or whether it was limited to HIV positive women. It would be important to
investigate the reasons if it emerged that HIV positive women were more likely to miss their
six week visit appointment than HIV negative women. An assessment of six-week visit
attendance rates at the clinic was done using the methods described below.
Methods
Data on characteristics of women delivering at Edith Opperman Maternity Clinic (the
Maternity Clinic at Mbare Clinic) over a four-week period from 15 November to 12
December 2010 were extracted from the delivery register kept by nurses at the clinic using a
standard questionnaire (Appendix 3). The following characteristics were recorded: name, age
of participant, date of delivery, whether the woman had registered for antenatal care, HIV
status and area of residence. The number of characteristics collected was limited by the data
recorded in the delivery register. In addition, the six week clinic attendance register was used
to check whether the woman had attended the six week visit. To ensure that we did not miss
any six week visit attendance, for each woman we searched entries made at 5, 6, 7 and 8
weeks after her delivery. As the women often use their married and maiden names
interchangeably, both names were extracted from the delivery register and both were used
when searching the six week register. In cases where there wasn't an exact match between our
questionnaire and the name in the six weeks register, identity was verified using the home
address and date of delivery of the baby.
Data extraction was done by the study nurse.
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Fig 4.2 below is a flow chart which indicates which women participated in each of the studies
(does not include in the clinic record review).
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Fig 4.2: Flow chart of women participants in the various studies
4.3.4.4 Details of the study team (data collection team)
All key informant and in-depth interviews were conducted by the candidate. The candidate is
a black Zimbabwean woman who is fluent in Shona and Ndebele, the two main local
languages in Zimbabwe. At the time of data collection in 2011, the candidate was 32 years
old and was employed as a research fellow in the research organisation where the research
was done.
Patient survey data were collected by the study nurse, who was 27 years old in 2011. The
study nurse was a black Zimbabwean woman who was fluent in Shona, the main local
language in Harare.
4.4 DATA ANALYSIS METHODS FOR PHASE 1 OF THE STUDY
Key informant interviews were transcribed and analysed thematically. A description of the
content of the policy and guidance documents was made. A retrospective policy analysis was
Patient Survey at time of delivery
299 participants; 35 (11.7%) HIV positive
Patient interviews at 6-week visit
20 HIV positive women interviewed
Recruited separately
Adherence Study Qualitative study on barriers to ANCregistration
11 women 9 women 21 women
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performed using data obtained from both the key informant interviews and document review.
The analysis was done using a health policy framework called the policy triangle
framework112,113 as an analytical framework. This framework has four components to it,
namely context, content, process and actors. Using data from the key informant interviews
and document review as appropriate for each component, a description of the policy under
each of the four components was undertaken. This ensured that the policy analysis did not
only focus on content of the policy, but also on actors, context and process, as is good
practise in policy research (see fig 4.3 below).
Fig 4.3: A model for health policy analysis112
4.5 DATA ANALYSIS METHODS FOR QUANTITATIVE DATA
4.5.1 Data Quality Control and Cleaning
The nurse-counsellor who collected much of the clinic based data was trained on how to
interview and on questionnaire completion, including how the skip patterns worked. The first
20 questionnaires completed were checked by the candidate for errors, and feedback on errors
was given to the nurse counsellor.
Quantitative data were entered by a data assistant into a Microsoft Access database.
As a quality control measure the data were double-entered, and the two data files were
compared. Where there were discrepancies the source document was used for verification.
ACTORS
*as individuals
*as members of groups
CONTEXT
CONTENT PROCESS
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The data were then exported into Stata Version 9.0114, the statistical package that was used in
the analysis.
The data were cleaned by running the following checks through each variable:
 Checking for missing values
 Checking for inconsistencies between related questions
 Verifying that values made sense or were within normal ranges (for example dates,
participant ages, number of weeks gestation when ANC was first sought)
Where errors or missing values were noted, source documents were used to verify the data.
Values which were clearly wrong and were interviewer errors (e.g. implausible year of birth
for the participant) were marked as missing. Values which were suspicious but had been
reported as such by participants, e.g. a very high monthly income figure, were left as they
were.
4.5.2 Analysis Methods for Patient Survey Data
The proportions of women in various categories of participant characteristics were calculated.
4.5.2.1 Determination of Factors Associated with ANC Registration
Chi-squared tests of association for each of the variables with ANC registration and with each
other were computed. Using Maentel-Haenzel methods, the effect of each of the participant
clinical, demographic and socio-economic characteristics on ANC registration was
investigated. Classical methods were used first in order to get a sense of how the variables
were associated with each other before going on to logistic regression. Univariable analysis
was then conducted using logistic regression.
Multivariable analysis
Using information obtained from the investigation of chi-squared tests, and also general
knowledge of how factors may relate to one another in real life, including possible
interactions (effect modifications), a causal diagram was drawn (fig 4.4). The causal diagram
was useful in providing a visual picture of how all the studied factors related to each other
and to ANC registration. When thinking about which variables to include in the multivariable
analysis model, consideration was made of the principle that variables which are on the
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causal pathway should not be included in the model. The causal diagram was helpful in
identifying which variables were on the causal pathway.
Figure 4.4: Causal diagram used to make decisions on which factors to include in model
for multivariable analysis
Another guiding principle in the selection of variables for the model was that variables that
are deemed to measure the same thing (collinear variables) should not both be included in the
same model because this can result in an unstable model, or the computer might fail to fit the
model. In light of this, decisions had to be made on which socio-economic variables to
include in the adjusted logistic regression model to avoid collinearity. Available variables
were:
1. Whether the participant earned an income
2. Monthly income earned by the participant (those who reported that they did not earn
an income were assigned an income of zero)
3. Whether the partner earned an income (if the woman was married)
4. Monthly partner income (an income of zero was assigned for partners who did not
earn an income)
5. Combined household income (which was obtained by adding the participant’s income
to the partner income for married women, and keeping the participant’s monthly
income as it was for unmarried women)
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6. The food security variable. This variable was derived from the two food security
questions in the questionnaire. One asked whether, in the past week, an adult in the
participant’s household had not eaten or eaten less in order to ensure that there was
enough food for children. The other question asked whether, in the past week, the
participant had spent the whole day without eating because there was no food in the
house. The binary food security variable was created to have 1) participants who had
no food security problems i.e. answered no to both questions; and 2) participants who
answered yes to either of the food security questions.
7. Whether the woman was financially dependent on anyone
8. Number of people per room in the participant’s household
9. Tenancy (whether the house is owned/rented/participant lived with relatives)
10. Type of toilet used
11. Source of water
For quantitative continuous variables, decisions had to be made on whether to fit the model
with the variable as a continuous variable or as a grouped categorical variable. Care had to be
taken in fitting models with continuous variables because such models assume a linear
relationship between the explanatory variable and the dependant variable. In view of this
checks for departure from linearity were done using likelihood ratio tests, comparing models
with continuous variables and those with grouped categorical variables. Where it was clear
that a linear relationship existed between the quantitative explanatory variable and the
dependent variable, the model was fitted with the continuous variable so as not to lose data
through grouping.
Investigations for effect modification were done between the following variables:
1. Education and marital status
2. Marital status and whether pregnancy was planned
3. Whether pregnancy was planned and history of miscarriage
4. Marital status and household income
Likelihood ratio tests were used to test for effect modification by comparing the models with
interaction terms and those without.
An explanatory variable was eligible for inclusion in the final model if there was evidence of
its association with ANC registration at the p<0.1 level. Having decided which variables were
potentially suitable for inclusion in the final model, multivariable logistic regression was
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conducted by adding to the model each of the potential variables in turn, and conducting a
likelihood ratio test to check if the model was improved by the addition. Interaction terms
were included where effect modification had been noted to be present.
4.5.2.2 Determination of Factors Associated With Knowledge of HIV Status
During Pregnancy
The proportion of women who knew their HIV status during pregnancy was computed by
adding the number of women who were tested during pregnancy to those who had tested HIV
positive prior to the most recent pregnancy. Because HIV testing is closely linked to ANC
registration, ANC registration was considered the main determinant of knowledge of HIV
status. The factors which were associated with ANC registration were thus expected to be
distally associated with knowledge of HIV status during pregnancy. Nonetheless chi-squared
tests of association were run to determine the association of demographic and clinical
participant characteristics with knowledge of HIV status during pregnancy. The same
procedures described above were conducted, namely
1. Initial use of classical methods to investigate associations of variables with
knowledge of HIV status during pregnancy
2. Multivariable analysis using factors that were found to be significantly associated (at
p<0.1 level) with knowledge of HIV status
3. Checks for effect modification
4. Selection of variables for the final model
4.5.3 Data Analysis Methods for Six Weeks Clinic Attendance Data
Descriptive statistics were run for each of the variables. Chi squared tests of association were
run to determine association between each of the variables with each other and with six week
visit attendance. Univariable and multivariable logistic regression analyses were conducted to
investigate factors associated with six week visit clinic attendance.
4.6 SAMPLE SIZE AND JUSTIFICATION
The initial sample size for the cross-sectional survey, based on pragmatic considerations, was
300, where it was anticipated that 200 recently delivered women would be recruited from
Harare and 100 from a rural site (n=300 in total). It was estimated at the time the proposal
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was written that 18% (n=54) will be HIV antibody positive (n= 36 in Harare and n=18 at
rural site; n=54 in total). With 54 HIV positive participants the study would be able to
measure rates of non-adherence to cotrimoxazole (in the longitudinal adherence study) with
the following levels of precision: 33% (95% CI 21-48); 50% (95% CI 36-64%); 66% (95%
CI 53-79%). Although with this sample size, the precision of estimates was suboptimal this
was based on pragmatic considerations relating to availability of funding. Useful information
was anticipated despite the imprecise estimates.
4.7 METHODS FOR QUALITATIVE DATA COLLECTION AND
ANALYSIS
4.7.1 Justification for Incorporating the Qualitative Approach
Qualitative interviews are used to study the meaning of experience for different people. They
elicit in-depth meaning and nuanced understanding of what or how individuals perceive and
interpret phenomena and why people do what they do115. These methods were therefore
appropriate for understanding the reasons why women had not registered for ANC, or why
they had not attended the six week visit, or their experiences with adherence to cotrimoxazole
prophylaxis.
4.7.2 Epistemological Position
The qualitative studies were conducted from an interpretative perspective, which means that
the researcher seeks to understand how the participant understands and interprets her
reality115. Another perspective taken in the qualitative interview is that of social
constructivism, which means that there is realisation that there is co-construction of meaning
during the interview process116-118: there is awareness that the interviewer is not a neutral
observer, but by conducting the interview he or she participates in the social world that is
being studied. It is therefore essential for the interviewer to be aware of his/her own values
and interests and reflect on how s/he can affect the interview process and outcome, a process
known as reflexivity. In addition, by recognising the co-construction of meaning during the
interview process, as part of the reflexivity process care was taken to also focus on how the
participant’s circumstances might have shaped the narratives of the interview. It is well
known that a participant can use the interview as a platform for creating an identity for
herself116. For example, because women who had not registered for ANC knew that they were
being interviewed for this very purpose, they may have had a sense of shame, or failure or
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irresponsibility and might have felt pressured to use the interview to defend their roles or to
create an identity of a responsible mother. Exploring the reasons behind a participant’s
chosen identity can help achieve greater understanding of the phenomenon under study.
4.7.3 Approach to Data Analysis and Justification
Qualitative data analysis was done according to thematic content analysis115. Thematic
content analysis aims to report on key elements of participant accounts.
At the time of conception of the protocol the plan had been to analyse qualitative data using
Framework analysis115. Framework analysis is an analysis strategy that is suited to research
that has targeted questions, typically those used for policy-oriented research. As data
collection and analysis unfolded it was clear that the participant data had broader themes and
categories than initially envisaged. Therefore a more inductive approach was required i.e. a
method that would focus more on themes that had emerged from participant data than does
framework analysis, hence the use of thematic content analysis. The grounded theory
approach, the prototype approach for analysis that discovers theory from data119, was not
employed in this analysis because many of its elements are not possible to work with. For
example grounded theory requires that you disregard findings from the published literature
and focus only on participant data119. In this and many other studies it is difficult to work
without doing a literature review as it guides the research question and is a criterion that
funding agencies use for evaluating the merit of a study proposal.
4.7.4 Detailed Methods for Qualitative Data Collection and Analysis
All qualitative interviews were conducted using interview guides (Appendix 4). Interviews
were conducted by the candidate in Shona and were digitally recorded. Soon after each
interview detailed field notes (see sample in Appendix 5) were written, with reflection on
how the interview had progressed and on emerging themes. Analysis thus began during the
data collection phase. Themes which needed additional exploration were identified when
writing field notes and were probed in subsequent interviews.
Interviews were transcribed verbatim, and translated into English by the candidate. After
translation interview summaries were written for each interview, where a more analytic,
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rather than descriptive, summary of the interview was made. The summary was written using
information from the transcribed interview and from the field notes (see sample in Appendix
6). In the interview summary, comparisons were drawn between what the participant had said
with what other participants had said, and questions were asked about potential reasons for
discrepancies or deviant cases. Using themes that had emerged from interviews, as
documented in interview summaries, a coding framework was developed, where a list of
codes that were thought applicable to the data was generated. The list also contained codes
which were considered analytical, rather than just descriptive. From each group of interviews,
five transcripts were coded line by line on paper using the coding framework. Additional
codes that were identified through line by line coding were added to the coding framework.
The transcripts, field notes and interview summaries were then entered into NVIVO8, a
computer package used for data management and retrieval. Coding of the transcripts was then
done using the modified coding framework, keeping an eye to include any new codes which
emerged. Analytic memos (see example in Appendix 7) were written for each theme that
emerged from the data. During writing up, themes were illustrated using verbatim quotes.
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CHAPTER 5: ANALYSIS OF POLICY AND
IMPLEMENTATION PROCEDURES FOR COTRIMOXAZOLE
PROPHYLAXIS IN ZIMBABWE
5.1 OVERVIEW
In this chapter I describe findings of an analysis of policy and implementation procedures for
the provision of paediatric cotrimoxazole prophylaxis in Zimbabwe. A literature search of
relevant documents describing the following was conducted: 1) the Zimbabwe policy and
guidelines on paediatric cotrimoxazole prophylaxis, 2) implementation procedures for
cotrimoxazole prophylaxis among HIV-exposed infants in Zimbabwe, 3) implementation
procedures for the care of HIV infected women after delivery and 4) outcome indicators for
paediatric cotrimoxazole prophylaxis and care of HIV positive women after delivery. In
addition key informant interviews were held with a representative of MoHCW responsible for
implementation of PMTCT and ARV rollout and a representative of the City of Harare Clinic
Management responsible for Reproductive Health Services. In addition to questions covering
the domains listed above, the key informants were asked about challenges faced with
implementation. Also, a key informant interview was held with a representative from
NatPharm, the company responsible for national drug distribution to get information on the
drug distribution process, challenges faced and the adequacy of human and material
resources. To obtain information on health care provider experiences with implementing
cotrimoxazole prophylaxis, key informant interviews were held with two nurses at Mbare
Clinic. Lastly, an assessment of cotrimoxazole stock levels at Mbare clinic during the period
September 2010 to December 2011 was conducted.
Using information obtained from document review and key informant interviews a
retrospective policy analysis was conducted. The analysis was done using a health policy
framework called the policy triangle framework112,113 as an analytical framework. This
framework has four components to it, namely context, content, process and actors. It ensures
that the policy analysis does not only focus on content of the policy, but includes all four
components which are known to affect implementation outcomes.
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5.2 RESULTS
5.2.1 Context
This is a description of background factors that may have an effect on the implementation of
paediatric cotrimoxazole prophylaxis.
Zimbabwe has a population of 12.97 million120. It is administratively divided into ten
provinces (see figure 5.1 below). The most populous province is Harare, with a population of
2.1 million people contributing 16% to the total population in the country120.
Figure 5.1: Distribution of the Zimbabwe Population by Province120
5.2.1.1 Zimbabwe’s economic position and state of health services
Zimbabwe is classified by World Bank as a low income country with a GDP per capita of
$698 at the end of 2011121. The country is currently recovering from a politico-economic
crisis that saw the decline of social services, including health care, during the period 1999-
2008. The recovery started in 2009 after the signing of a Global Political Agreement between
the three main political parties in Zimbabwe, which was followed by formation of a
Government of National Unity in February 2009. The Zimbabwe dollar lost its value due to
inflation, and introduction of multi-currency in 2009 helped stabilise the economy.
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The economic problems, which peaked in 2008, resulted in various problems for the health
care sector. There was a massive shortage of health care workers as they left the county to
seek employment elsewhere. Vacancy levels in the public health sector in 2008 were at 69%
for doctors, over 80% for midwives, over 63% for medical school lecturers and over 50% for
pharmacy, radiology and laboratory personnel122. In addition there were shortages of
medicines and equipment: availability of vital drugs in 2008 was between 29% and 58%. As
a result of these shortages the quality of service provision in public health institutions
significantly deteriorated; some government central hospitals closed for a period of several
months.
After the formation of the Government of National Unity in 2009 there were urgent meetings
to resuscitate the Zimbabwe health care system, starting with the formation of the 100-day
plan to ‘kick-start’ the revival of the health care system, using funding from the Government
of Zimbabwe and various donors123. This involved recruitment of staff, provision of retention
allowances to key health care workers, repair of dilapidated heath care facility infrastructure
and recapitalisation of NatPharm, the national drug procurement and distribution company,
among other things123. The health care system has been improving since that time. For the
longer term, in 2009 the Ministry of Health and Child Welfare launched the National Health
Strategy for Zimbabwe 2009-2013 whose major thrust is to improve equity and quality in
health122.
5.2.1.2 Structure of the Zimbabwe health care system
The Government of Zimbabwe subscribes to the Primary Health Care Approach through the
Alma Ata declaration of 1978124 and Ouagadougou declaration 2008125 where it aims to
ensure the provision of health care services to every person in the nation through a network of
health care centres organised from primary level clinics to secondary, tertiary and central
hospitals.
Primary level care consists of a network of clinics and community health workers and forms
the first point of contact between the community and the formal health care system.
Community health workers are responsible for implementing various health promotion
strategies with the support and supervision of health care workers at the clinic. Primary care
clinics provide basic but comprehensive care including primary curative services, maternal
and child health services such as antenatal care, delivery of uncomplicated births, family
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planning and routine immunization of children. Primary level clinics refer complicated cases
to district hospitals, which in turn refer to provincial hospitals which are themselves
supported by central hospitals122.
In Harare, where the work for this PhD thesis was conducted, the set-up is somewhat
different because there are no district or provincial hospitals. The public health care centres
are managed by The City of Harare Department of Health Services. The network of City of
Harare health care centres consist of 12 polyclinics which provide the full range of primary
level services as above, 13 satellite clinics which provide all primary level services except
delivery, and 6 family health clinics which only provide child health and community health
services such as home visits126. The City authority also manages two infectious disease
hospitals namely Beatrice Road Infectious Diseases Hospital and Wilkins Infectious Diseases
Hospital. Any patient with serious/complicated conditions that cannot be managed at primary
care level are referred directly to either an infectious disease hospital or a central hospital.
HIV positive patients are referred to the two infectious disease hospitals for ART initiation.
National Drug Supplies
The procurement and distribution of drugs and other supplies for the public sector is done by
NatPharm, a non-profit organisation that was formed through an act of parliament to improve
efficiency in the supply of medicines. Zimbabwe has an essential drugs list127 which gives
guidance on drugs that are supposed to be stocked at the various levels of care. C drugs are
required at primary care level and should be available at all levels of care; B and A drugs
should be stocked at district and central hospitals only, although some B drugs may be held at
a primary care centre on a named patient basis, for example for patients with chronic
illnesses. Drugs are further classified according to priority: V-(vital) drugs are those that are
considered to be life-saving; whose unavailability would cause serious harm. Effort should be
made to keep them 100% available. E-(essential) drugs are given second priority and N-
(necessary) drugs are still important but of lower priority. This classification is used in the
prioritisation of scarce resources, and is the same list that guides NatPharm’s procurements.
Cotrimoxazole is classified as a category C and V drug which means it is expected to be
100% available at all levels of health care127.
Financing of the Zimbabwe health system
Funding for the health care system comes from the Government of Zimbabwe through
taxation, donations from private voluntary organisations, donations from bilateral and multi-
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lateral partners, health insurance, and direct out of pocket payments by patients122. During the
period of politico -economic upheaval there was significant decline in bilateral funding to
Zimbabwe, but the country continued to receive support from UN agencies such as WHO,
UNICEF, UNFPA as well as European Union and the Global Fund for HIV and AIDS, TB
and Malaria122, CDC and USAID.
In 2011 Zimbabwe launched The Health Transition Fund, a donor fund that is administered
by UNICEF and is aimed at abolishing user fees for all women and children128.
Financing of City of Harare Health Services
Since 1976 there has been an agreement that Government will fund 50% of recurrent and
capital costs of City of Harare Health Services, but because of economic challenges this has
not happened129. Since 1991 the government grant to City of Harare Health Services has been
less that 1% of the City’s total health expenditure129. City of Harare now relies on donors,
user fees, and allocations from the municipality rates department. Since 2008 the
International Committee of the Red Cross (ICRC) has provided 75% of City of Harare drugs,
while the other 25% comes from other donors through NatPharm and the City of Harare’s
own purchases129.
City of Harare levies user fees for all patients except children under the age of 5, adults above
the age of 65, and ART patients. Children 5-12 years pay $3 and adults pay $5. Maternity
fees are currently charged at $25, down from $30 in 2011 and $50 in 2009129. The maternity
fees have been a source of contention between Government and City of Harare in recent
years. In the first place, Government required that City of Harare reduce their fees from $50
in 2009 to $25. City of Harare complied, but later made representations that they could not
manage with the reduced fees, and sought to revert to the $50 in January 2012, a move which
Government rejected130. Instead there have been calls from the Government for City of
Harare to scrap maternity fees entirely. Government have already removed user fees for
women and children in their own institutions. City of Harare have none the less resisted the
directive to remove fees, maintaining that they cannot provide ANC and delivery services
without them and wish to revert to the previous figure of $50 because they are incurring
deficits130,131.
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5.2.1.3 HIV prevalence in Zimbabwe
According to the Zimbabwe Demographic and Health Survey (ZDHS 2010-2011) the HIV
prevalence in Zimbabwe in the 15-49 age group is 15%, down from 18% in the 2005-06
ZDHS.43 The prevalence among women of the same age group is 18%, compared to 12%
among men. The highest prevalence of 29% is among women aged 35-39 years. Although
Zimbabwe is among the highest HIV prevalence countries, it has registered a decline in
prevalence from 29.3% in 1997, 26.5% in 2001, 23.2% in 2003, 19.4% in 2005 and 15.6% in
2007 in the 15-49 age groups122. Figure 5.2 illustrates this. It is believed that the adoption of
safer sexual behaviour i.e. increased use of condoms and decrease in multiple partnering, is
responsible for the decline132.
Figure 5.2: Trends in Adult HIV prevalence and incidence in Zimbabwe, 1980-2007132
In the 2010/11 ZDHS 90% of Zimbabwean women reported receiving antenatal care (ANC).
However 34% of deliveries were reported to have occurred at home. The percentage mother
to child transmission rates from modelled data in 2007 and 2009 respectively are 29% and
30%132. Another model, which looked at 12-month mother-to child transmission risks in 2008
(when single dose nevirapine was being implemented), showed a risk of 20.3%, which
improved to 18% with modelled improvements in PMTCT uptake in 2009133. HIV prevalence
among children aged 0-14 was 3.1%, 2.9% and 2.8% in 2009, 2010 and 2011 respectively132.
In 2008 there were 107,388 children living with HIV; the number came down to 105,740 in
200942 but in 2011 it was estimated to be much higher, 138,642134. An estimated 26,687
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children died of AIDS in 1997. Since then there have been sharp decreases in annual AIDS
deaths as a result of scale-up of ART programs, fig 5.342.
Fig 5.3: Modelling of Trends in annual AIDS deaths of children42
5.2.1.4 Levels of cotrimoxazole prophylaxis
In Zimbabwe only 11% of children 0-14 years who needed cotrimoxazole received it in
200729. This figure increased significantly to 34% in 201031, but was still short of the
MoHCW target of 80%. Within the City of Harare system, of 2, 279 women who tested HIV
positive in 2009, 835 (36.6%) had their babies started on cotrimoxazole prophylaxis. This
increased to 51.5% (1,797/3,491) in 2010135.
5.2.1.5 Leadership in HIV/AIDS
There is government leadership and commitment to the response to HIV and AIDS;
Government declared HIV and AIDS a national emergency in 2002 and is committed to
achieving a national multi-sectoral response to the disease. To this end Government formed
through an act of parliament, the National AIDS Council (NAC), the organisation that is
tasked with coordinating the national multi-sectoral response to HIV.136 The Government
adopted the “three ones” principle which specifies that there should be “one national multi-
sectoral HIV and AIDS strategic plan, one coordinating authority, and one national
monitoring and evaluation system.”136,137 Since its inception the activities of NAC have been
guided by national plans or frameworks. In 2006-2010 it was guided by the Zimbabwe
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National HIV and AIDS Strategic Plan (ZNASP 2006-2010)137 which was superseded in
2011 by ZNASP 2011-2015136. PMTCT and retention of HIV-exposed babies and their
mothers in care is strongly advocated for in both ZNASP 2006/10 and ZNASP 2011/15. The
aim is to strengthen the national PMTCT program through strengthening the four prongs of
PMTCT: 1) primary prevention, 2) prevention of unplanned pregnancies, 3) prevention of
mother-to-child transmission, and 4) care and support for mothers and babies. The ZNASP is
aligned to other regional and international frameworks that the Government of Zimbabwe is
committed to, including: Millennium Development Goals, the Global Plan towards
elimination of new HIV infections in children and keeping mothers alive, United Nations
Declaration of Commitment (UNGASS Declaration), 2011 Political Declaration on HIV and
AIDS, Maseru and Brazzaville Declarations, and the Maputo Plan of action136.
To fund the activities of the national response to HIV, the Government of Zimbabwe has
established The National HIV and AIDS levy, that is anchored in the national tax system. The
Government provides additional funding through direct government budget allocation.
However this money is not sufficient to cover all the requirements of the national response to
HIV so there is considerable reliance on external funding. In 2008, the government national
budget allocation was US$354,000; then it increased to US$7.5 million in 2009. External
funding from development partners and donors was US$25 million in 2008 and US$38
million in 2009. Collections for the AIDS levy amounted to US$5.7 million in 2009 and
increased to $15.9 million in 2010136. Following the Paris declaration on harmonisation of
funding mechanisms, the Government formed the Expanded Support Programme which was
supported by many donors. Between 2007 and 2009 a total of US$46 million was made
available to the national HIV response through the Expanded Support Programme136.
The Ministry of Health and Child Welfare is responsible for implementing the national
PMTCT program according to national targets. There is a dedicated unit within MoHCW, the
AIDS and TB unit, which was tasked to provide guidance and oversight in the
implementation of preventive, support and treatment services to the network of public health
care institutions.
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5.2.2 Content
This section describes the content of the policy and guidance for implementation of
cotrimoxazole prophylaxis.
There is no stand-alone policy for cotrimoxazole prophylaxis but there are clear guidelines
for its use in HIV-exposed infants and HIV positive children in the National PMTCT138 and
ART guidelines22. The guidelines are comprehensive and are based on WHO guidelines.
They are clear about the need to prevent mother to child transmission and to keep both the
mother and child in regular care. In summary, early booking of pregnancies before 14 weeks
of pregnancy is recommended in order to ensure timely initiation of PMTCT activities. The
guidelines instruct the health care worker to ask the HIV positive mother to bring the baby for
HIV testing using a DNA PCR test at six weeks. The health care worker is also instructed to
commence the HIV-exposed baby on cotrimoxazole prophylaxis at six weeks of age 138.
Cotrimoxazole prophylaxis should continue until HIV infection is excluded. If the baby is
HIV positive, cotrimoxazole should be continued and the baby referred for ART.
The guidelines also instruct health care workers to ensure that all infants have their HIV
exposure status determined at first contact with the health care system. To prevent loss to
follow-up of HIV-exposed infants, the child health card has a section for documentation of
HIV exposure status which health care workers must complete at time of delivery. HIV-
exposed infants are supposed to be followed on a monthly basis. Also, to enhance follow-up
infants should be entered into the HIV-exposed register which is intended to track the baby’s
HIV care.
The guidelines also provide clear guidance on the HIV care for HIV positive women: clinical
staging according to WHO guidelines should be done; women in stages 3 or 4 should be
prescribed cotrimoxazole prophylaxis and referred for ART, and women in stages 1 and 2
should be given ARV prophylaxis starting at 14 weeks. All HIV positive mothers should
have a CD4 count test. The ART guidelines emphasise the need for regular 6-monthly
assessment for ART eligibility for women who have previously been found to be ineligible22.
5.2.3 Process
This is a discussion of the process of policy development, communication of the policy to
implementers, and the procedures conducted during implementation of the policy, including
measures to ensure that the policy is followed.
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5.2.3.1. Policy development
According to the key informant from Ministry of Health and Child Welfare, their policies are
guided by recommendations and guidelines from World Health Organisation, WHO. If there
are new guidelines or recommendations, the Ministry of Health will meet with health care
managers, implementers and their funding and implementing partners in order to reach
consensus on how best to incorporate the new recommendations into practise.
5.2.3.2 Policy implementation
Box 5.1 has information on procedures conducted by Ministry to ensure the implementation
of cotrimoxazole prophylaxis, as given by the key informant from Ministry of Health.
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BOX 5.1: Key Informant Discussion with MoHCW Representative
Date of interview: 13 January 2011
The Policy on Cotrimoxazole Prophylaxis
Although there may not be a stand-alone policy on cotrimoxazole prophylaxis, the national
PMTCT and ART guidelines include specific guidance on the use of cotrimoxazole
prophylaxis for HIV exposed infants. Various methods are employed to make health care
workers aware of the guidelines:
i) Training
ii) Support and supervision visits-These are done through the existing Ministry structures
at provincial or district level. The visits are not designed to provide support for
cotrimoxazole prophylaxis alone but for the full range of health care services provided
at health care centres. In addition, MoHCW also works with Implementing Partner
Organisations (e.g. Elizabeth Glazer Paediatric AIDS Foundation (EGPAF), Kapnek
Trust, ZAPP (Zimbabwe AIDS Prevention Project), and Organisation for Public
Health Interventions and Development (Zimbabwe) (OPHID) who conduct support
and supervision visits to the specific regions they support.
iii) Monitoring and Evaluation Tools-The HIV exposed infant register asks for specific
information on cotrimoxazole prophylaxis and so can serve as a reminder to the health
care worker. Furthermore MoHCW have revised the mother held Child Health Card
to capture information on cotrimoxazole prophylaxis for the HIV exposed baby.
iv) For the private sector training is provided through the College of Primary Care
Physicians. There was funding in Global Fund Round 8 to cover training in the
private sector. In addition, although this is limited to those based in Harare, some
private practitioners are academic lecturers at the UZ College of Health Sciences.
MoHCW believes/hopes they practise what they teach.
Implementing Targets
It is MoHCW’s desire to get all HIV-exposed infants on cotrimoxazole prophylaxis. However
as this may not be practically achievable the current target is 80%, based WHO’s goal of
universal access. At time of interview the implementation rates were still unsatisfactory, with
2010 estimates indicating that 34% of HIV-exposed infants who needed cotrimoxazole
prophylaxis received it (based on comparing the number of HIV positive women identified
during pregnancy and the number of infants who have been prescribed cotrimoxazole
prophylaxis).
Challenges faced
Not all women are tested for HIV, so there are some unidentified HIV-exposed infants.
MoHCW statistics on cotrimoxazole prophylaxis coverage may not be accurate as they do not
capture the HIV exposed babies who have not been identified. To solve this problem
MoHCW is encouraging PITC for mothers who bring their babies to well-baby clinics.
Babies born to mothers who test HIV positive at these clinics should also be treated as HIV
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exposed infants who should be initiated on cotrimoxazole prophylaxis. To date, there are no
statistics on the proportion of HIV exposed infants who are identified post-delivery.
The other challenge is that babies are lost to follow-up before the six-week post natal visit
because their mothers do not attend. In many instances the women are in contact with the
health care system before the six weeks. The Ministry of Health might need to think about
allowing the prescription CTX before the six-week visit especially if it is foreseen that the
mother might not be able to attend the six-week visit.
A further challenge is that PMTCT training is usually given only to health care workers in the
ANC and maternity departments, without including nurses in the child health clinics. It is
important to train the child health workers about cotrimoxazole prophylaxis because they see
the babies on a monthly basis and are thus able to facilitate its optimum uptake.
Any worries about microbial resistance as a result of cotrimoxazole prophylaxis?
Although there is recognition that cotrimoxazole prophylaxis may increase microbial
resistance, there have not been any active objections to its implementation in MoHCW.
Procurement of Cotrimoxazole Prophylaxis Supplies
MoHCW have asked funding partners to provide financial support to purchase the larger
stocks required for universal cotrimoxazole prophylaxis. Although cotrimoxazole is not
expensive, MoHCW sometimes has insufficient funds to procure it.
Care of HIV Positive Women After Delivery
There is a general feeling that many women diagnosed HIV positive during pregnancy are
lost to follow up before they are assessed for ART eligibility.
“You almost get the sense that most health care workers think that after that baby is born, the
whole PMTCT issue is done.”
“I don’t have the maternal follow-up rates but my gut feeling is that we are missing out a lot
of women. A lot of them are probably not enrolled in chronic HIV care.”
To solve this problem, MoHCW have introduced the pre-ART register. Once a patient is
entered into this register they are supposed to have scheduled appointments which will keep
them engaged in care during the period before they become eligible for ART. An additional
check is the HIV exposed infant register which collects information on the mother. In
addition it is hoped that as mothers bring their babies for cotrimoxazole and extended
nevirapine prophylaxis they will be kept engaged in care.
Provision of cotrimoxazole prophylaxis depends on good supply chain management system.
Box 5.2 shows a summary of the interview that was conducted with the key informant from
NatPharm, the national drug procurement and distribution company.
Chapter 5: Policy findings
105
BOX 5.2: Description of NatPharm and its Supply Procedures given by NatPharm key
informant
Date of interview: 01 July 2010 (see note at end of box)
NatPharm is the national drug distribution company that has been set up to distribute drugs to
the public health care institutions. It is headquartered in Harare and has several offices across
the country. The Harare regional office distributes drugs and other supplies to three provinces
namely Mashonaland Central, Mashonaland East and Harare Province. Most NatPharm
stocks are procured by donors and NatPharm provides the storage and distribution services.
Procedures for supplying drugs
Each district is expected to place a monthly order with NatPharm. NatPharm have a calendar
of activities; each district has specific days on which their orders are processed. However
NatPharm also have a system for accepting urgent orders which can be processed on the same
day they are received. The company generally delivers the supplies to the respective districts,
although in some cases districts choose to collect their supplies themselves.
Supplies for City of Harare are ordered centrally through Beatrice Road Infectious Diseases
Hospital. Individual clinics are then expected to order from the hospital.
All donated drugs are distributed to institutions or districts at no cost.
In addition to supplying according to requisitions, once every three months NatPharm
distributes packages of drugs and supplies called primary care kits to primary health care
centres in their districts. These kits contain the basic drug stocks that are needed in a primary
health care facility. Like most drug stocks at NatPharm the kits are a donation. They were
necessitated by shortages of qualified/motivated drug procurement personnel at primary care
centres and are a way of ensuring that primary care centres do not run out of essential drug
stocks.
Current situation with cotrimoxazole stocks
There are no problems with stock levels of both adult and paediatric formulations of
cotrimoxazole.
“As I am speaking right now I think we have seven donors for cotrimoxazole. We have
to put in place measures to ensure that it does not expire on us.”
Challenges faced at NatPharm
Sometimes there is no transport to deliver drugs and supplies to the districts. This problem
has been eased by funding partners who have assisted with transport. Some institutions do not
place their orders on time, they do urgent orders which disrupt the normal flow of activities
and thus delay the processing of regular orders.
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Comment on length of time since key informant interview: The candidate was kept up to
date on NatPharm procedures and stock situation through regular attendance of national
quarterly PMTCT forum meetings, where NATPHARM gives stock updates for all products
that are used for PMTCT and HIV Care. Although it has been a long time since the key
informant interview was held, the regular meeting reports showed that the situation
(procedures and good supply of cotrimoxazole) was generally unchanged.
5.2.3.3 Perspectives and experiences of policy implementers: Key informant
interviews with nurses at Mbare Clinic
The City of Harare Health Services operate using national guidelines and recommendations
from Ministry of Health and Child Welfare. A key informant interview was held with a
representative of the City of Harare Clinic Management, a nurse who is responsible for
management of reproductive health services within City of Harare, who was based at Mbare
Clinic. She was asked about 1) the process of receiving new policy and guidelines from
Ministry of Health, 2) the process of informing health care workers at the clinic of new
guidelines, and 3) her experience of implementation of paediatric cotrimoxazole at the clinic,
including challenges faced.
Procedures for receiving new policy or new guidelines
When there are new policies or guidelines, MoHCW will normally call for training meetings
or workshops and invite some nurses (typically one or two senior nurses from each clinic)
and managers from City of Harare. These trained nurses will in turn conduct one-on-one on
the job training sessions with nurses who were unable to attend the training meetings or
workshops themselves. Ministry of Health normally provide training manuals and guidance
documents that staff take back to the clinic to train their colleagues and use as reference
material. New employees are given training on existing manuals during induction. Clinic
managers also conduct spot checks/supervisory visits to support new staff and to check their
understanding of existing guidelines. Another method of getting communication from
MoHCW is through the district nursing officer. If there is new information the district
nursing officer will bring it to the attention of clinic management who will in turn inform
their colleagues at the clinic as above. In addition, clinic managers hold monthly meetings
with the district nursing officer where policy and guideline issues may be discussed.
Because the clinic is busy, however, the process of training the nurses who did not
themselves attend the training workshops is not usually done systematically. As a result there
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are some staff who are not aware of new guidelines: “Not everyone is aware. New staff may
not be aware of the guidelines.” Clinic manager, head of reproductive health services
Experience with implementation of cotrimoxazole prophylaxis: findings from three key
informant interviews with nurses
Discussions with nurses revealed that they were generally aware of Ministry of Health
guidelines on implementation of cotrimoxazole prophylaxis in children. Nurses stated that
mothers were informed that they should bring the baby to the six-week post natal visit where
the baby would be tested for HIV and commenced on cotrimoxazole. However there were
instances where a nurse had incorrect information about a certain procedure, which might
reflect the inadequacy of training as it is cascaded down from Ministry of Health to nurses
who would not have attended formal training sessions. For example one nurse (the
reproductive health services manager) said if a baby tested HIV negative at six weeks then
there would be no need to keep giving cotrimoxazole yet the guidelines are clear about
continued cotrimoxazole until exclusion of HIV infection, when the baby is no longer
exposed to HIV through breast milk.
The same nurse was not aware of the procedures for follow-up of HIV positive women after
delivery. While two nurses clearly described that HIV positive women who were not yet
eligible for care were registered for follow-up at the clinic and given appointments to return
for assessments on a six-monthly basis, the third nurse reported that there was no system for
follow-up of HIV positive women: “We are depending on the women to come back to us
when they are not feeling well. We are always telling the women that if they have a problem
they should come back.”(reproductive health services manager) Not following protocols for
the follow-up of women is likely to result in significant loss to follow-up of HIV infected
women; something that was identified as a challenge by the Ministry of Health key
informant.
Nurses also did not give uniform responses about the dosage of cotrimoxazole prophylaxis.
The national guidelines (which are based on WHO guidelines which are shown on fig 2.1)
clearly state that babies 0-6 months should be prescribed 2.5mls once daily, those 6 months to
3 years old should be given 5mls, and those over three years should be given 10mls. One of
the nurses reported that babies should be started on 5mls, and another one correctly stated
that they should be started at 2.5mls but she thought the higher dose should be commenced at
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3 months. This may be another indication of the inadequacy of one-on-one on the job training
of nurses who would not have attended the MoHCW training courses. Incorrect dosing was
encountered in the group of women who were followed in the adherence study (Chapter 9).
Nurses generally felt that women who have had babies started on cotrimoxazole are keen to
give it. This is what the Clinic Manager who also the head of sexual and reproductive health
services within the City of Harare said: “They are very motivated. The education we continue
to give has helped.” The challenge faced was that the women did not come back to the six-
week visit. “More than half of women are not coming. We don’t know why they are not
coming.” One nurse suspected that it was because participants have gone to rural areas.
Nurses had seen many women who came to tell them that they were leaving to go to the rural
areas before six weeks, and were asking for cotrimoxazole prophylaxis. The nurses would not
prescribe it because the policy requires that they prescribe it at six weeks. Nurses felt this was
a down side to the programme because the woman was likely to be lost to follow-up.
“She can come and tell you that I am going to the rural areas, please can I have the
cotrimoxazole. But we tell her to come back at six weeks, yet she is already telling you
that she is going away. That woman will be lost unless she is able to transfer to
another clinic.” Clinic manager, head of reproductive health services
The head of the reproductive health services also stated that some HIV positive women
default from the six-week visit because they are having trouble adjusting to their HIV
diagnosis. Such women need additional counselling. There is a clinic department that is
responsible for home follow-up of such women through the use of community health
workers/health promoters. However the department is short-staffed and is overwhelmed with
work, so is unable to conduct as many home visits as are required. Some patients give the
wrong home address so when health promoters visit patients who have defaulted from their
visits they are unable to find them. In general about 40 women register for ANC on a given
ANC registration day and nurses suspect that five or six of these women give a false address.
Nurses reported that this is because the women want to be cared for at Mbare Clinic but think
they will be turned away if they give their correct non-Mbare addresses. Nurses reported that
a customer service study that was conducted within City of Harare found that some women
prefer Mbare Clinic and do not go to the clinics in their own neighbourhoods because the
nurses in those clinics are rude. Some have said they prefer Mbare Clinic because they
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always have drugs in stock. Nurses believe most of this is influenced by information shared
in the communities; patients then seek care according to what they would have heard from
their friends or family.
When women come to the clinic at the six-week visit, they are first seen at the maternity
clinic, and then referred to the chronic disease clinic which is housed within outpatients
department where the baby will be registered in the HIV-exposed infant register and have
cotrimoxazole prescribed. Because prescription of cotrimoxazole happens in a separate
building, maternity nurses worried that women might be lost to follow-up when referred from
one building to another, particularly because of the long waiting times to be seen at the
chronic diseases clinic. “That clinic is busy. Some may not want to join the queue.” (nurse-
midwife at Mbare Clinic). Women are instructed to bring the baby to Mbare clinic on a
monthly basis; they would first be expected to take the baby to the Family Health Services
Clinic where growth monitoring and immunization services were offered. The woman would
then be expected to go to the chronic disease clinic for cotrimoxazole prescription refills.
Nurses worried that this non-integrated approach might discourage women as they had to
wait in long queues at both clinics. However nurses thought this approach served to protect
women against unwanted HIV disclosure: the set-up at the family health services clinic does
not offer privacy; babies are weighed, given their immunizations and the mother asked
questions about the baby’s well-being in the same room where all mothers will be waiting. If
HIV care were to be given in this setting the mother’s HIV status would be disclosed to all
the other mothers in the room. Because of large numbers of attendees seen at the family
health services clinic, private one-on-one consultations are not manageable.
The other challenge nurses reported was that women generally register for ANC very late in
their pregnancy, sometimes as late as 36-37 weeks. This is despite encouragement to register
as early as three months gestation. Some women do not register at all; they will just come to
deliver at the clinic. Such women will have an unknown HIV status. Nurses said they are
supposed to offer HIV testing during labour or soon after delivery, but in practise this is
difficult: “The clinic is busy. We are not always able to test those women in the labour ward.
We miss most of them.” (nurse-midwife at Mbare Clinic).
The major challenge nurses reported was with stock-outages of cotrimoxazole. Nurses
reported that there were many instances when cotrimoxazole stocks were out for long periods
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at a time. The clinic obtains its supplies from Beatrice Road Infectious Diseases Hospital
(BRIDH) where the main City of Harare pharmacy is located. Nurses reported that it can take
up to a month to get the orders back because BRIDH are very busy. They worried that
women might not afford the cost of cotrimoxazole in private pharmacies. “If only we could
find a sponsor or donor to give us cotrimoxazole so that we do not run out of cotrimoxazole
stocks,” (Sister-in-charge, Mbare Clinic). Ironically, the key informant at NatPharm
reported that they had “seven donors for cotrimoxazole” and were having to “put in place
measures to ensure that it does not expire on us.” This indicates that Harare City Health has
challenges with managing the supply chain from NatPharm to the main pharmacy at BRIDH
hospital and then to the clinics.
One of the objectives when this project was first designed was to conduct an audit of drug
orders that had been generated at the clinic and submitted to BRIDH and then to NatPharm. It
was not possible to do this because the nurses kept saying they were busy and they were not
able to give us information on purchase requests they had generated and submitted to
BRIDH. It was clear that the clinic nurses were having challenges managing the supply chain,
mainly because they were busy and possibly because of lack of training in supply chain
management. A report on the City of Harare website that was inserted by the pharmacy
department identified that there was need for training of nurses on supply chain management,
and that logistical challenges prevented optimum performance of the main pharmacy at
BRIDH, fig 5.4.
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Figure 5.4 Extract from City of Harare Website126
About The Pharmacy Department
The department has a central pharmacy that is located at Beatrice Road Infectious Diseases
hospital and has the responsibility to purchase, supply and monitor the drugs and medical
sundries for the department. Thanks largely to the support the department has been
receiving from the International Committee of the Red Cross and the German government
and the City of Munich, the city averaged 70% availability of essential drugs and over 90%
of vital drugs in 2008 and 2009. The supply of sundry materials also improved.
While the department welcomes and appreciates the support it received from partners, this
support will not be in perpetuity and the city needs to find a more sustainable funding
arrangement. There is need to drastically improve our stock management systems. Firstly,
there is need to computerise the central pharmacy at Beatrice Road Hospital. All the
clinics and hospitals dispensaries need to be computerised and networked to the central
pharmacy. There is need to continuously train all staff in stock management. The
department also faces considerable challenges in terms of logistics. Currently the
department uses the same pool vehicles used for linen, clinic waste and other logistics to
ferry drugs and medical sundries. The pharmacy moves enough quantities of drugs and
sundries to justify a lorry dedicated for that purpose.
Accessed from
http://www.hararecity.co.zw/index.php/departments/healt
h/pharmacy on 14 March 2013
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5.2.3.4 Results of the assessment of cotrimoxazole suspension stock levels
The dispensary is located in the Outpatients Clinic building. It is a secure room which has
double-locking doors and a lockable security screen to prevent unauthorised entry. It is
manned by nurses. At any time there is a nurse who is in charge of ordering, storage and
distribution of drugs to all departments in the clinic. Nurses take on this role on a rotational
basis, with one person acting in this capacity for about three months.
There is a stock card for all the drugs that are kept at the clinic, including cotrimoxazole
suspension. Study staff noted that in general, the minimum stock is not recorded on the stock
cards.
Three assessments for stocks of cotrimoxazole suspension were made: on 27 Sep 2010, 07
April 2011 and 07 December 2011.
27 September 2010 Assessment
There were only sixteen bottles of 50mls each at the time of assessment. Nurses reported that
because cotrimoxazole stocks were so low, they had stopped prescribing it for acute
infections and were limiting its use to cotrimoxazole prophylaxis. A requisition for additional
supplies of the drug had been raised on 10 September 2010, but had only been submitted to
the BRIDH on 24 September. It was not clear why there had been this delay. The nurses had
been given assurance that they would receive a consignment from BRIDH by 29th of
September.
27 April 2011 Assessment
There were 680 units of 50mls each in stock. Seven hundred units had been received from
ICRC on the previous day (26 April 2011). Before receipt of this consignment, cotrimoxazole
had been out of stock since 22 March 2011. At the time of assessment, a requisition (in which
cotrimoxazole suspension was one of the requested items) had been submitted to BRIDH on
31 March 2011 as an urgent request. It had not yet been received from BRIDH and it was not
known when supplies were expected.
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07 December 2011 Assessment
On this day there were 423 bottles of 60ml cotrimoxazole in stock. A review of records from
27 April 2011, when the previous stock assessment was made, showed that cotrimoxazole
went out of stock on 20 May 2011, and the next supply was received on 07 June 2011. It
again went out stock on 29 July 2011, and on 02 August the clinic asked for 10 bottles of
cotrimoxazole from another City of Harare Clinic, Matapi Clinic. All the bottles were
dispensed on the same day and cotrimoxazole was out of stock again. The clinic then
received 50 bottles from another clinic on 03 August, and on 04 August they received a
consignment of 400 bottles from ICRC.
5.2.4 Actors
Document review, key informant interviews and assessment of stock levels at the clinic
revealed that there were many stakeholders involved in the implementation of cotrimoxazole
prophylaxis. Table 5.1 shows a list of stakeholders, the level of importance they attached to
implementation of cotrimoxazole prophylaxis and kind of influence they had on
implementation. Of note, the actors were included only at organisational level. However the
policy analysis would have benefited from an examination of the contribution of key
individuals to policy. Examination of these individuals required time and financial resources
to study their values and motivations, which was difficult to do with the limited PhD
fellowship funding.
Table 5.1: Cotrimoxazole Prophylaxis Stakeholder Analysis
Stakeholder Level of importance
attached to
implementation
Level of influence Limitations of the
influence
Government of
Zimbabwe through
National AIDS
Council
High importance
attached to response
to HIV issues. This is
mainly because of the
Government’s own
values where there is
a great drive to reduce
AIDS-related deaths
following the
declaration of
HIV/AIDS as a
national emergency.
High influence at
macro level,
particularly in
mandates to
MoHCW.
High influence on day
to day
implementation
activities; funding for
drug supplies allows
implementation
High influence at
macro-level and at
micro level (through
provision of funding)
but no direct
supervision of health
care workers so little
influence on
performance of
individual health care
workers.
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Stakeholder Level of importance
attached to
implementation
Level of influence Limitations of the
influence
Ministry of Health
and Child Welfare
Ministry of Health
attach a lot of
importance to
cotrimoxazole
prophylaxis. They
initiated and
developed the policy
and guidelines and
communicated it to
the implementers.
High influence at
macro level as they
have mandated/
directed the
nationwide adoption
of guidelines.
Medium influence on
day-to-day activities
at clinic level through
support visits
Influence is mainly at
macro-level, little
influence on
performance of
individual health care
workers, who are the
implementers on the
ground.
Bilateral and multi-
lateral donors
High importance
attached to alleviating
HIV disease burden
and reduction of
mortality
High influence at
macro level; funding
enables
implementation of
activities.
Also high influence at
clinic level as donated
supplies enable
implementation
Influence is mainly at
macro-level, with no
influence on the
performance of health
care workers, who are
the implementers on
the ground.
Implementing
partners working
with MoHCW
(These are non-
governmental
organisations that have
set-out to help
MoHCW implement
PMTCT processes in
selected districts across
the country)
 EGPAF1
 Kapnek2
Trust
 ZAPP3
 OPHID4
 And others
High importance.
Work together with
MoHCW in crafting
the policy and
guidelines. Help
MoHCW in printing
and disseminating
guideline and
promotional materials
High influence at
macro level.
High influence on
day-to-day activities
in the areas where
they provide support
visits.
Medium/low direct
influence at Mbare
Clinic because they
have no direct
influence on day to
day activities.
The influence of these
implementing
partners is limited to
the districts in which
they work they have
no influence on day to
day activities in
districts where they
are not located.
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Stakeholder Level of importance
attached to
implementation
Level of influence Limitations of the
influence
NatPharm High importance
attached to ensuring
uninterrupted drug
supplies
High influence on
day-to-day activities;
drug shortages
prevent
implementation
No direct supervision
of pharmacy staff at
City of Harare health
care centres, so
limited influence on
the stock management
roles at City of Harare
Clinics.
BRIDH Pharmacy Not clear; not directly
researched (see
explanation in section
5.2.3.3)
High influence on
day-to-day activities;
drug shortages at
clinic prevent
implementation
Not clear, not directly
researched (see
explanation in section
5.2.3.3).
Mbare clinic nurses High importance
attached to
cotrimoxazole
prophylaxis
High influence on
day-to-day
implementation of
cotrimoxazole
Influence limited
mainly to Mbare
Clinic attendees.
1- Elizabeth Glazer Paediatric AIDS Foundation
2-Kapnek Trust
3-ZAPP-Zimbabwe AIDS Prevention Project
4-OPHID- Organisation for Public Health Interventions and Development (Zimbabwe)
5.3 SHORT DISCUSSION ON POLICY ANALYSIS
There is Government commitment to respond to HIV issues in the country. Ministry of
Health and Child Welfare attach great importance to cotrimoxazole prophylaxis for HIV
exposed infants; together with partners they came up with guidelines for implementation of
cotrimoxazole and circulated them to implementers, based on WHO guidelines. Bilateral and
multi-lateral donors also value this intervention and have donated drug/funds towards it: there
were more than adequate supplies of cotrimoxazole in the country during the time of study.
What is clear from this policy analysis is that the commitment and support at national and
international level needs to be extended to clinic level in order to ensure appropriate
implementation. The economic challenges facing the country have resulted in limited support
of City of Harare health services by Government, which in turn has affected the City’s ability
to hire adequate numbers of trained staff. That staff were overwhelmed with work provided
the greatest barrier to policy implementation: staff did not have time to offer HIV testing to
women who came with unknown HIV status during delivery, which is a missed opportunity
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for a significant number of women given that only 77% of women registered for ANC
(Chapter 6). The other challenge was the inadequacy of staff training on policy issues.
Ministry of Health trains a limited number of staff who are expected to in turn train their
colleagues on site. In practise this is difficult in a busy clinic/short-staffed clinic, resulting in
some staff doing the work without full knowledge of the guidelines they are implementing,
which in turn will compromise the quality of the work. There were serious supply-chain
management issues: the country had more than adequate supplies of cotrimoxazole yet the
clinic experienced four cotrimoxazole stock outages during the course of the field work for
the study (September 2010 to December 2011). In summary, there was commitment at
national and international level but without adequate follow-up to ensure site capacity to
implement policy procedures resulting in sub-optimal implementation. A list of challenges
that were identified during the policy study is given in table 5.2 below.
Table 5.2: List of challenges identified in the policy study
Policy Analysis
Component
Source of data Key challenges
Context Findings for this component
mainly came from review of
official documents and the
candidate’s prior knowledge.
Economic problems in the country resulting in
 Inadequate funding for the national
HIV/AIDS response
 Failure of Government to fund City of
Harare Health Services, resulting in City
of Harare’s strong reliance on user fees
 High HIV prevalence and high rates of
mother-to-child transmission of HIV in
Zimbabwe
Content Findings for this component
mainly came from review of
official documents.
Challenges with the content of the policy will be
stated below as they were brought to light in key
informant interviews under the “process”
component.
Process Findings for this component
mainly came from key
informant interviews.
Ministry of Health Key informant
 Unidentified HIV-exposed infants because
some women are not tested during
pregnancy statistics on cotrimoxazole
prophylaxis uptake are an overestimate
 Loss to follow-up of infants before the six-
week visit (when cotrimoxazole
prophylaxis should be initiated)
 Training gaps: PMTCT training often does
not include nurses who work in the child
health clinics (child health nurses see
babies on a monthly basis and are thus
able to facilitate optimum uptake of
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cotrimoxazole prophylaxis)
 Reliance on external funders for adequate
supplies of cotrimoxazole
 Loss to follow-up of HIV positive women
after delivery
NatPharm Key Informant
 Transport problems preventing smooth
delivery of supplies to health care centres
 Poor supply chain management at health
care centres
Key informant interviews with nurses
 Training not optimally cascaded down
from Ministry of Health to implementing
health care workers some health care
workers are not aware of the guidelines on
cotrimoxazole prophylaxis
 Non-attendance of the six-week visit (the
visit when cotrimoxazole prophylaxis
should be initiated).
 Travel of mothers to rural areas before the
six-week visit; requests for cotrimoxazole
prophylaxis before the six-week visit but
nurses are bound by policy which
stipulates prescription at six weeks
 Understaffing of clinic departments; long
queues and long waiting times
 False home addresses given by clinic
attendees
 Non-integrated services (PMTCT and HIV
care services provided at separate clinic
from child health services clinic)
 Delayed (sometimes none) registration for
antenatal care leads to challenge of
unidentified HIV exposed babies
 Workload challenges prevent HIV testing
of women of unknown HIV status at time
of delivery
 Stock-outs of cotrimoxazole
Cotrimoxazole stock assessments
 Frequent cotrimoxazole stock-outs
 Poor supply chain management
Actors Findings for this component
came from review of official
documents, key informant
interviews and candidate’s
prior knowledge.
Each actor organisation had limitations to their
power which prevented optimum implementation
of cotrimoxazole prophylaxis.
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These findings will be discussed in more detail in the discussion chapter.
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CHAPTER 6: PATIENT SURVEY RESULTS
6.1 OVERVIEW
In this chapter I report on the findings of the patient cross-sectional survey. This survey was
conducted among women residents of Mbare who had just delivered babies. Eligible women
were recruited from the post-natal wards at Edith Opperman Maternity Clinic, and from the
post-natal clinics at Mbare clinic (mainly at day ten postnatally), between September 2009
and February 2010. Those who were willing to participate first gave written informed consent
before completing an interviewer-administered questionnaire. The questionnaire sought
information on demographic and clinical characteristics of participants and the care they
received during pregnancy, particularly the timing of ANC and testing for HIV. The
questionnaires were completed by a trained nurse-counsellor. The quantitative survey data
was analysed using Stata Version 9.0.
6.2 DEMOGRAPHIC AND CLINICAL CHARACTERISTICS OF
PARTICIPANTS
299 participants (54% of women who delivered at Mbare Clinic during the recruitment
period) were interviewed soon after delivery (either while they were still in the postnatal
ward or at the 10-day postnatal clinic) between 21 September 2010 and 10 February 2011.
The participation rate of 54% is considered low and could be a source of bias if there are
differences between participators and non-participators. The rate was so low because
participants in the postnatal wards often refused to participate, often saying they were in too
much pain to participate. Recruitment from the 10-day postnatal visit was introduced to get
round this problem; at that clinic non-participators often said they had no time as they needed
to rush back home. In addition, some women might not have attended the 10-day visit. No
data on characteristics of non-participators were collected; however comparison of survey
participant characteristics and characteristics of participants in the clinic record review
(Chapter 8, section 8.2) revealed a similarity in the two participant groups, suggesting that
survey participants were representative of women delivering at Mbare Clinic.
See table 6.1 for demographic and clinical characteristics of participants. Participant mean
age in years was 26.1 (95% confidence interval 25.4-26.7). The majority (64.5%) had
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delivered at Edith Opperman Clinic, and a quarter (24.7%) at Harare Central Hospital. Of
note, 20 (6.8%) of participants had delivered at home.
207 (69.2%) of women had been educated to O Level. Only 30% participants earned their
own income, with an average monthly income of US$33.76 (95% CI 25.08-42.45). Most
(89.3%) women were married, 20 (6.7%) were divorced. The majority of partners/husbands
(91.8%) earned an income. Five women did not know the amount of money earned by their
partners. The mean monthly income for partners was $165.86 ($149.36-$182.35), and mean
household income was $180.89 ($161.74-$200.03).
About half (47.8%) the women lived in rented accommodation, with an average of 2.4 (95%
CI 2.3-2.6) people living per room.
The mean number of children per woman was 2.27 (2.13-2.42). 8.7% and 13.1% had a
history of children who had died or who had miscarried respectively.
145 (48.5%) of pregnancies were unplanned. Of the participants with unplanned pregnancies,
74 (51.0%) were not using any contraception. Of the 71 women who were using
contraception when they got pregnant, 55 (77.5%) were on the oral contraceptive pill, 8 were
on the injectable contraceptive and the other 8 reported that they were using condoms.
104 women reported that they had worried when they discovered that they were pregnant.
The main reasons for worrying were financial implications of a new baby (45 women); some
women just did not want another child (54 women). 18 women said they worried about their
own health; this was strongly associated with HIV status (25.7% of HIV positive women
reported this compared to 3.0% of HIV negative women, p<0.001).
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Table 6.1: Demographic and Clinical Characteristics of participants
Characteristics N (%) Characteristics N (%)
Food security
No food problems
Food problems
217 (73.1)
80 (26.9)
Whether own income earned
Yes
No
90 (30.2)
208 (69.8)
Marital Status
Married
Divorced
Widow
Single
267 (89.3)
20 (6.7)
3 (1.0)
9 (3.0)
Whether partner earned
money Yes
No
245 (91.8)
22 (8.2)
Combined household income
(US$/month) None
1-50
51-100
101-200
201-300
301-400
401-500
>500
34 (11.7)
24 (8.28)
55 (18.97)
103 (35.52)
31 (10.69)
15 (5.17)
10 (3.45)
18 (6.21)
Financial support
No support
Has support
50 (16.7)
249 (83.3)
Number of children 1
2
3
4
5
6
7
99 (33.1)
91 (30.4)
60 (20.1)
31 (10.4)
14 (4.7)
3 (1.0)
1 (0.33)
Whether pregnancy was
planned No
Yes
145 (48.5)
154 (51.5)
Feelings about pregnancy
Happy
Neither happy/troubled
Troubled
184 (61.5)
11 (3.7)
104 (34.8)
Clinic of delivery
Edith Opperman
Harare Hospital
Home delivery
Other
191 (64.5)
73 (24.7)
20 (6.8)
12 (4.0)
Participant age (years)
15-19
20-24
25-30
30-34
35-39
40 and above
41 (13.9)
100 (33.0)
86 (29.1)
38 (12.9)
27 (9.1)
3 (1.0)
Religion
Roman Catholic
Anglican
Methodist
Baptist
Presbyterian
Seventh Day
Apostolic
Pentecostal
Moslem
Traditional
No religion
Other
43 (14.4)
18 (6.0)
25 (8.4)
2 (0.7)
1 (0.3)
4 (1.3)
84 (28.1)
82 (27.4)
1 (0.3)
1 (0.3)
12 (4.0)
26 (8.7)
Education
Primary
Junior Certificate
O level
A level
Tertiary
20 (6.7)
59 (19.7)
207 (69.2)
9 (3.0)
4 (1.3)
Tenancy
House owner
Lodger
Family member
Other
32 (10.7)
143 (47.8)
121 (40.5)
3 (1.0)
Type of toilet
Flush toilet
Own Blair* toilet
Neighbour’s Blair
282 (94.3)
12 (4.0)
5 (1.7)
*Blair toilet is similar to a pit latrine
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Association of factors with each other
There was strong association of socioeconomic variables with each other e.g. availability of
financial support was associated with household income, p=0.008: 69.0% of women who had
household incomes of $0-$50 received financial support from someone, compared to 83.6%,
89.3%, and 86.5% among those with household incomes of $51-$100, $101-$200, and >$200
respectively. There was evidence of a strong association between tenancy and availability of
financial support; 90.4% of people who rented accommodation were had financial support,
compared to 75.0% and 76.9% for house owners and people who lived with family/relatives
respectively. 14.3% of married women had household incomes of $0-$50, compared to 60%
in those who were divorced, p<0.001. Women who had household incomes of $50 or less
were less likely to have planned pregnancies than those with higher incomes (34% compared
with >50% for each of the higher categories), p=0.03.
Household income was not associated with parity; neither was it associated with history of
miscarriage.
Out of 154 women who planned their pregnancies, 75 (48.7%) and 12 (7.8%) discovered that
they were pregnant within the first month of pregnancy and after the first trimester
respectively, compared with 28.3% and 16.6% among women who did not plan their
pregnancies, p<0.001. Chi-squared tests of association showed no evidence of an association
between timing of discovery of pregnancy and timing of ANC registration, p=0.28. There
was a strong association, p<0.001between whether the pregnancy was planned and how the
woman felt about the pregnancy: 68.3% of women who did not plan their pregnancy were
worried when they discovered that they were pregnant, compared with only 3.2% among
those who had planned their pregnancies.
There was strong evidence of association, p=0.05, between history of a child who died and
education: 13.9% of those who did not reach ordinary level education had a child who died,
compared to 6.8% among those who had reached ordinary level education.
6.3 ANC REGISTRATION AND ASSOCIATED FACTORS
229 women (76.6%, 95% CI 72%-81%) registered for ANC. Of women who did not register
for ANC, 59 (85.5%) reported that they did not register because they could not afford the
ANC registration fees. Four women reported that they did not think it important to seek
ANC; two were not allowed to seek ANC by their husbands, and one woman’s religion did
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not allow her. The mean number of weeks gestation at time of registration was 29.5 (95% CI
28.6-30.4). Table 6.2 shows the times at which women registered.
Table 6.2: Gestation weeks at time of ANC registration
Gestation weeks at time
of ANC registration
N (%) Cumulative %
5-8 2 (0.95) 0.95
9-12 3 (1.43) 2.38
13-16 6 (2.86) 5.24
17-20 12 (5.71) 10.95
21-24 16 (7.62) 18.57
25-28 39 (18.57) 37.14
29-32 65 (30.95) 68.10
33-36 45 (21.43) 89.52
37+ 22 (10.48) 100.00
208 (90.8%) women who had registered for ANC had more than one ANC visit, i.e. returned
to the clinic for at least one ANC visit after the initial ANC registration visit. Of 21 women
who did not return to a heath care facility after registration, 9 said they had had no money.
These are women who would have initially registered at a rural clinic and then relocated to
Harare. They are expected to re-register and pay the registration fee when they transfer to
Mbare Clinic; and they reported that they could not afford to do so. The other 8 participants
reported that they had registered so late that they delivered before they were due for their next
appointment. Only one woman reported that she did not think it important to have return
ANC visits.
There was evidence of decreased levels of ANC registration with most factors which were
measures/proxy measures of financial stress (Table 6.3). There was a 23% decrease in ANC
registration associated with a unit increase in number of people living in a room, odds ratio
0.77 (95% CI 0.61-0.96).The odds of registering for ANC increased by 3% for every $10
increase in household income, OR 1.03 (1.01-1.05), p=0.008. In addition, women who had
financial support were twice as likely to register for ANC. Of note, some variables which
might reflect poverty in other settings were positively associated with ANC registration,
which needs caution in interpreting. For example, lodgers and family members were more
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likely to seek ANC registration than house owners. Because Mbare is such a poor
community, house ownership is not necessarily an indication of good financial standing as
most accommodation in Mbare (particularly the flats) is of a very poor standard; it was
allocated to bachelors during the colonial period and has been passed along as an inheritance
within families. On the other hand, having rented accommodation might indicate an ability to
pay rent and therefore implies possession of a regular income. Indeed section 6.3 above
shows that women who lived in rented accommodation had better financial support than
those who owned the accommodation they lived in. Therefore the house ownership variable
is not a good indicator of financial standing, particularly in the ultra-poor community of
Mbare. The same uncertainty is seen with type of toilets; the older accommodation mainly
has flush toilets, but some of the newer houses (which are considered to be generally of a
better standard than the old flats) have not yet had running water installed and therefore use
Blair toilets.
Attention was therefore focused on the variables that were thought to clearly indicate the
economic position of individuals, for example household income, food security and
availability of financial support.
Table 6.3: Univariable analysis of association of factors with ANC registration
Characteristics N (%) N (%)
Registered for
ANC
Odds ratio (95%
CI)
p
Age
15-24
25-30
30+
141 (47.8)
86 (29.1)
68 (23.0)
107 (75.9)
60 (69.8)
58 (85.3)
1
0.73 (0.40-1.34)
1.84 (0.85-4.00)
0.31
0.12
Religion
Non-apostolic
Apostolic
215 (71.9)
84 (28.1)
161 (74.9)
68 (80.9)
1
1.43 (0.76-2.67) 0.27
Education
Did not reach O Level
Reached O Level
79 (26.4)
220 (73.6)
54 (68.3)
175 (79.6)
1
1.80 (1.01-3.20) 0.05
Tenancy
House owner
Lodger
Family member
32 (10.7)
146 (47.8)
121 (40.5)
20 (62.5)
115 (78.8)
94 (77.7)
1
2.23 (0.98-5.04)
2.09 (0.91-4.81)
0.05
0.08
Type of toilet
Flush toilet
Blair toilet
282 (94.3)
17 (5.7)
214 (75.9)
15 (88.2)
1
2.38 (0.53-10.69) 0.26
Source of water
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Characteristics N (%) N (%)
Registered for
ANC
Odds ratio (95%
CI)
p
Shared tap
Unshared tap
Other
218 (72.9)
60 (20.1)
21 (7.0)
166 (76.1)
48 (80.0)
15 (71.4)
1
1.25 (0.62-2.54)
0.78 (0.29-2.12)
0.53
0.63
Food security
No food problems
Food problems
217 (73.1)
80 (26.9)
173 (79.7)
54 (67.5)
1
0.53 (0.30-0.94) 0.03
Income
Earns an income
No own income
90 (30.2)
208 (69.8)
64 (71.1)
164 (78.5)
1
1.51 (0.86-2.66) 0.15
Marital Status
Married
Divorced
Other (includes single
and widowed women)
267 (89.3)
20 (6.7)
12 (4.0)
212 (79.4)
7 (35.0)
10 (83.3)
1
0.14 (0.053-0.37)
1.30 (0.28-6.09)
<0.001
0.74
Husband Income
Earns income
No income earned
245 (91.8)
22 (8.2)
196 (80.00)
16 (72.7)
1
0.67 (0.25-1.79) 0.42
Financial support
No support
Has support
50 (16.7)
249 (83.3)
32 (64.0)
197 (79.1)
1
2.13 (1.11-4.10) 0.02
Number of children
1
2
3
4
5+
99 (33.1)
91 (30.4)
60 (20.1)
31 (10.4)
18 (6.0)
79 (79.8)
70 (76.9)
43 (71.7)
23 (74.1)
14 (77.8)
1#
0.84 (0.42-1.69)
0.64 (0.30-1.35)
0.73 (0.28-1.87)
0.89 (0.26-2.99)
0.63
0.24
0.51
0.84
Whether any children
died
Yes
No
26 9 (8.7)
273 (91.3)
23 (88.5)
206 (75.5)
2.49 (0.73-8.57)
1
0.15
History of miscarriage
Yes
No
39 (13.1)
259 (86.9)
34 (87.2)
194 (74.9)
1
0.44 (0.16-1.17) 0.1
Stage at which
pregnancy was
discovered
First month
2nd month
3rd month
After 3rd month
116 (38.8)
88 (29.4)
59 (19.7)
36 (12.0)
94 (81.0)
65 (73.9)
43 (72.9)
27 (75.0)
1
0.66 (0.34-1.29)
0.63 (0.30-1.32)
0.70 (0.29-1.70)
0.22
0.22
0.43
Whether pregnancy was
planned
No
Yes
145 (48.5)
154 (51.5)
101 (69.7)
128 (83.1)
1
2.14 (1.24-3.72) 0.007
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Characteristics N (%) N (%)
Registered for
ANC
Odds ratio (95%
CI)
p
Feelings about
pregnancy
Happy
Neither happy/troubled
Troubled
184 (61.5)
11 (3.7)
104 (34.8)
151 (82.1)
8 (72.7)
70 (67.3)
1
0.58 (0.15-2.31)
0.45 (0.26-0.78)
0.44
0.005
# Score test for trend p=0.42
Although there appeared to be an increasing trend of ANC registration with age, it was not
statistically significant, with a score test for trend p=0.26. There was no evidence of an effect
of age on ANC registration when age was used as a continuous variable in logistic regression.
There was no difference in ANC registration between apostolic and non-apostolic women.
Women who lived in rented accommodation and those who lived with family as dependents
were more likely to register for ANC than those who owned the accommodation.
6.3.1 Variables selected for multivariable analysis and justifications
Selection of the socioeconomic variable to use in the model
Only one socioeconomic variable could be included in the model to avoid collinearity. The
following results were used in deciding which would be the best variable to be included in the
model: There was no evidence of association of ANC registration with whether a woman
earned an income (and also with monthly income earned by participant), therefore neither of
these variables were included in the model. There was an association of partner income with
ANC registration, but the household income was deemed more appropriate because it
captured the total financial resource that was potentially available to the participant. The food
security variable was deemed to be on the causal pathway from household income to ANC
registration as it is a direct result of how much money there is in the household, so it was
eliminated from the model. The variable for whether the woman had financial support from
someone was eliminated from the model because it was also deemed to be on the causal
pathway for household income. The other three variables (tenancy, type of toilet used, and
source of water) were eliminated from the model because they were considered proxies for
socio-economic status, and could also be perceived as directly influenced by household
income.
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After these considerations, the household income variable was considered the appropriate
socioeconomic variable to include in the model. A decision had to be made on whether to use
it as a continuous variable (which assumes a linear relationship between the explanatory
variable and the dependant variable) or as a grouped categorical variable. The likelihood ratio
test for departure from linearity favoured a linear relationship, p=0.41, hence it was decided
to use the household income variable as a continuous variable in order not to lose data
through grouping. The variable was divided by ten in order to give odds ratios for a unit
increase of household income of US$10, which is easier to conceptualise than a unit increase
of a single dollar.
Consideration of the history of miscarriage variable
In univariable analysis this variable was weakly associated with ANC registration, p=0.10;
possibly because women who have had previous miscarriages might be more conscious of the
need for health care during pregnancy. It therefore needed further investigation to see if it
should be included in the model. The likelihood ratio test revealed that there was no evidence
of an interaction between whether pregnancy was planned and history of miscarriage, p=0.14.
Also, addition of the miscarriage variable into the model without the interaction term was not
supported by the LR test, p=0.17. Thus this variable was eliminated from the model.
Final factors used in multivariable logistic regression model
After careful consideration of factors as stated above and in the methods section, (section
4.5.2.1), the following factors were included in the final logistic regression model of factors
associated with ANC registration: education (whether the woman reached ordinary level
education), whether pregnancy was planned, household income and marital status. There was
an interaction between education and whether pregnancy was planned, likelihood ratio test
p=0.008; women who attained ordinary level education and had planned their pregnancy
were more than four times more likely to register for ANC than women who attained
ordinary level education but had not planned their pregnancies (likewise when comparing
women who attained ordinary level education and planned their pregnancies with women
who planned their pregnancy but did not reach ordinary level).
There were no interactions noted between the following variables:
1. Marital status and whether pregnancy was planned, LR test p=0.5
2. Marital status and household income, LR test p=0.59
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Household income and marital status remained associated with ANC registration, see table 6.
4 for multivariable analysis results.
Table 6.4: Multivariable analysis of factors associated with ANC registration
Factor Adjusted odds ratio
(95% CI)
p value
Ordinary level Education
Did not reach ordinary level
Reached ordinary level, did not plan pregnancy
Reached ordinary level, planned pregnancy
1
0.75 (0.32-1.77)
4.24 (1.70-10.55)
0.51
0.002
Whether pregnancy was planned
Did not plan pregnancy
Planned pregnancy, did not reach ordinary level
Planned pregnancy, reached ordinary level education
1
0.58 (0.21-1.58)
3.27 (1.55-6.70)
0.28
0.002
Household income 1.02 (1.0-1.04)* 0.07
Marital Status
Married
Divorced
Other (includes single and widowed women)
1
0.20 (0.07-0.58)
2.40 (0.48-11.98)
0.003
0.29
* Odds ratio for a $10 increase in household income
Of 70 women who did not seek ANC, only 6 reported visiting a health care centre to seek
medical care (because they were not feeling well) during their pregnancy.
6.4 KNOWLEDGE OF HIV STATUS DURING PREGNANCY
6.4.1 Data on women who had ever been tested for HIV
272 (91.0%) of women had ever been tested for HIV. Most had last been tested at a local
clinic (Fig 6.1).
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86.3% of those who had registered for ANC were last tested at a local c1inic, compared to
41.9% of those who had not sought ANC.
HIV Results
35 (12.9%) of participants were HIV positive, and 86.0% were HIV negative (fig 6.2).
214
79%
37
14%
16
6%
3
1%
Fig 6.1: Where last tested for HIV
Local Clinic
Hospital
VCT Centre
Other
35
13%
234
86%
2
1%
1
0%
Fig 6.2: HIV Status of Participants
HIV Positive
HIV Negative
Not given result
Unwilling to disclose
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According to Ministry of Health guidelines at the time of the study139, pregnant women who
tested HIV positive during pregnancy were to be started on twice daily zidovudine
prophylaxis from 28 weeks of pregnancy, unless they were already on ART. At onset of
labour, they were to take single dose nevirapine, stop zidovudine prophylaxis and take twice
daily combivir (zidovudine +lamivudine) until one week after delivery. Women who were
eligible for ART according to WHO clinical staging were to be referred to the ART clinic for
initiation of ART. Those who were already on ART were supposed to continue on the
regimen they had been prescribed.
7 (20%) of the HIV positive women reported that they were already on antiretroviral therapy
(ART) which had mostly been initiated before they got pregnant; this was confirmed by
examination of their hand-held maternity medical records which had this information. All
reported that they took their ART drugs at all times as prescribed.
Of 28 women who were supposed to be started on ARV prophylaxis with twice daily
zidovudine in line with Zimbabwe Ministry of Health guidelines, 19 (67.9%) received it.
There was strong evidence of association (p=0.008) between having registered for ANC and
having taken Zidovudine prophylaxis: none of the women who failed to register for ANC had
taken zidovudine, compared to 76.0% of those who had. No data were collected on the
reasons why 24% of ANC-registered women did not receive zidovudine.
14 (73.7%) of the 19 participants who were given zidovudine prophylaxis reported that they
took it every time as prescribed. Of the five women who reported adherence challenges, two
reported that they sometimes forgot, one reported that she gave birth to her baby the day after
she was prescribed the drugs, while one said she often travelled away from home, which
made it difficult to take the zidovudine.
23 (82.1%) of the 28 women who were supposed to be given single dose nevirapine to take
during labour received it. This was also strongly associated (p<0.001) with having been
registered for ANC (none of three women who failed to register had received it, compared to
23 of 25 (92%) of those who had registered). When asked why they did not receive single
dose nevirapine to take during labour, three women said it was because they had not
registered for ANC, one said the drug had been out of stock at the clinic, and one said she had
initially tested HIV negative at the time she registered.
All 23 women who were given single dose nevirapine reported that they took it as directed.
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ARV prophylaxis for babies born to HIV positive women
According to Ministry of Health and Child Welfare guidelines at the time of the survey139, a
baby born to an HIV infected mother was to be given single dose nevirapine and zidovudine
for either 7 or 28 days depending on whether (and for how long) the mother had been on
ARV prophylaxis. If the mother was already taking ART, the baby was not to be given single
dose nevirapine, but zidovudine prophylaxis for either 7 or 28 days (7 days if the mother had
been on ART for less than 28 days and 28 days if they had taken it for longer than this
period). Using these guidelines, of the 35 babies born to HIV positive mothers, 12 were
eligible for single dose nevirapine plus zidovudine for 7 days. Of these 12, eight were
prescribed both drugs as appropriate, three were prescribed only zidovudine, and one got
single dose nevirapine only. Sixteen were eligible for single dose nevirapine plus zidovudine
for 28 days. Of these 16, eight (50%) were prescribed both drugs as appropriate, four were
not prescribed any ARV prophylaxis (all four mothers had not received zidovudine
prophylaxis during pregnancy), three were prescribed only zidovudine for 28 days, and one
got single dose nevirapine at birth and zidovudine was only initiated at day 14. Seven infants
were eligible for zidovudine alone. Of these seven, five were prescribed the zidovudine as
appropriate, one got both single dose nevirapine and zidovudine while one received single
dose nevirapine only. Participants who had not been prescribed the appropriate regimens
were referred to the clinic nurses for prescription of the appropriate medicines.
27 (90%) of 30 babies (one missing value for this question; 31 babies were given ARV
prophylaxis) who were started on ARV prophylaxis received it within 24 hours of birth.
Disclosure of HIV positive status
30 (85.0%) of women who had tested HIV positive reported that they had disclosed this
status to someone. The majority (25) of these participants told their husband or sexual
partner; ten told a friend and nine told their mothers.
6.4.2 HIV testing of partners
38% of all participants reported that their partner had been tested for HIV, (fig 6.3).
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Fig 6.3: HIV testing of partners
Of 11 HIV positive women who reported that their partners had been tested for HIV, six
reported that their partners were also HIV positive, 4 reported that their partners were HIV
negative, and one did not know her partner’s HIV status. None of the 102 HIV negative
women (who reported partner testing) reported that their partner was HIV positive.
6.4.3 Knowledge of HIV Status during Pregnancy
The number of participants who knew their HIV status during pregnancy was obtained by
adding the number of women who tested for HIV during their most recent pregnancy to those
who had tested HIV positive prior to their most recent pregnancy.
272 (91.0%) women had ever been tested for HIV. However, only 241 (80.6%) of
participants knew their HIV status when they were pregnant. There was a very strong
association of knowledge of HIV status during pregnancy and having registered for ANC:
21.2% of women who failed to register for ANC knew their HIV status during pregnancy,
compared to 98.7% among those who had registered, p<0.001. Table 6.5 shows results of the
univariable analysis of factors associated with knowledge of HIV status during pregnancy. As
expected, many of the factors which were found to be associated with ANC registration were
also associated knowledge of HIV status.
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Table 6.5: Univariable analysis of factors associated with knowledge of HIV status
during pregnancy
Characteristics N (%) N (%) Knew
HIV status in
pregnancy
Odds ratio (95% CI) p
Registration for ANC
Yes
No
229 (76.6)
70 (23.4)
226 (98.7)
15 (21.4)
276.22 (77.27-987.40)
1
<0.001
Age (years) 15-24
25-30
30+
141 (47.8)
86 (29.1)
68 (23.0)
111 (78.7)
67 (77.9)
59 (86.8)
1
0.95 (0.50-1.83)
1.77 (0.79-3.98)
0.88
0.17
Religion
Non-apostolic
Apostolic
215 (71.9)
84 (28.1)
215 (71.9)
84 (28.1)
1
1.45 (0.74-2.84)
0.29
Education
Did not reach O Level
Reached O Level
79 (26.4)
220 (73.6)
58 (73.4)
183 (83.2)
1
1.79 (0.97-3.30) 0.062
Food security
No food problems
Food problems
217 (73.1)
80 (26.9)
178 (82.0)
61 (76.2)
1
0.70 (0.38-1.31) 0.27
Income
Earns an income
No income
90 (30.2)
208 (69.8)
70 (77.8)
170 (81.7)
1.28 (0.70-2.35)
1
0.43
Marital Status
Married
Divorced
Other (includes
widowed and single
women)
267 (89.3)
20 (6.7)
12 (4.0)
221 (82.8)
9 (45.0)
11 (91.7)
1
0.17 (0.67-0.43)
2.29 (0.28-18.17)
<0.001
0.43
Husband Income
Earns income
No income earned
245 (91.8)
22 (8.2)
203 (82.9)
18 (81.8)
1
0.93 (0.30-2.89) 0.9
Financial support
No support
Has support
50 (16.7)
249 (83.3)
35 (70.0)
206 (82.7)
1
2.05 (1.03-4.09)
0.04
Number of children 1
2
3
4
5+
99 (33.1)
91 (30.4)
60 (20.1)
31 (10.4)
18 (6.0)
79 (79.80)
77 (84.6)
48 (80.0)
24 (77.4)
13 (72.2)
1#
1.39 (0.66-2.95)
1.01 (0.45-2.25)
0.88 (0.33-2.30)
0.66 (0.21-2.06)
0.39
0.97
0.78
0.49
Whether any children
Died Yes
No
26 (8.7)
273 (91.3)
22 (84.1)
219 (80.2)
1.36 (0.45-4.10)
1
0.59
Previous miscarriage
Yes
No
39 (13.1)
259 (86.9)
35 (89.7)
205 (89.1)
1
0.43 (0.15-1.27) 0.13
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Characteristics N (%) N (%) Knew
HIV status in
pregnancy
Odds ratio (95% CI) p
Whether pregnancy
was planned No
Yes
145 (48.5)
154 (51.5)
107 (73.8)
134 (87.0)
1
2.38 (1.31-4.33) 0.005
# Score test for trend p=0.46
When thinking about factors to include in the model for multivariable analysis of factors
associated with knowledge of HIV status during pregnancy, ANC registration was considered
as the main determinant of knowledge of HIV status. However, because it was deemed to be
on the causal pathway for all the factors which were deemed associated with knowledge of
HIV status during pregnancy, it was not included in the final model. The factors included in
the final model were: education, whether pregnancy was planned, household income, and
marital status. Only education, whether pregnancy was planned and marital status remained
associated with knowledge of HIV status during pregnancy (Table 6). There was an
interaction between education and whether pregnancy was planned, LR test p=0.006
Table 6.6: Multivariable analysis of factors associated with knowledge of HIV status
during pregnancy
Factor Adjusted odds ratio
(95% CI)
p value
Ordinary level Education
Did not reach ordinary level
Reached ordinary level, did not plan pregnancy
Reached ordinary level, planned pregnancy
1
0.57 (0.23-1.44)
6.72 (2.43-18.53)
0.23
<0.001
Whether pregnancy was planned
Did not plan pregnancy
Planned pregnancy, did not reach ordinary level
Planned pregnancy, reached ordinary level education
1
0.42 (0.15-1.23)
4.99 (2.11-11.81)
0.11
<0.001
Household income 1.01 (0.99-1.03)* 0.45
Marital Status
Married
Divorced
Other (includes single and widowed women)
1
0.22 (0.08-0.62)
3.99 (0.48-33.25)
0.004
0.20
*Odds ratio for a $10 increase in household income
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6.4.4 HIV Testing Behaviour before Pregnancy
Of women who had ever been tested, 150 (55.1%) of women had tested prior to the last
pregnancy. 84 (55.6%) had been tested once before, and a quarter had been tested twice
before. The most common reason for testing was the desire to know HIV status, fig 6.4.
The time that had elapsed since last test for women who tested during pregnancy and those
who did not test is given in Table 6.7.
48
21
114
52
3
12
4
0
20
40
60
80
100
120
Fig 6.4: Motivators for Past HIV Testing
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Table 6.7: Time since last HIV tested
a) Number of months
since tested for those
tested during pregnancy
N (%)
1-3 6 (4.9)
4-6 11 (9.0)
7-9 13 (10.7)
10-12 37 (30.3)
13-18 8 (6.6)
19-24 15 (12.3)
25-36 19 (15.6)
>36 13 (10.7)
10 of 127 (7.3%) women reported that they had previously been tested HIV positive. Three of
these women did not seek ANC. Two of them had known their HIV status for about a year,
and one had known for about two years. All three reported that they had not sought ANC
because they had had no money for the registration fees.
10 women had seroconverted since their last HIV test. The median number of years since the
last HIV test was 3.5 years.
6.4.5 Referral for HIV-related care
13 (37.1%) of 35 HIV positive women reported that they had not been referred for HIV-
related health care by clinic staff i.e. they did not know what next to do regarding their own
or their baby’s HIV health care. Three of these women were still in the postnatal ward at the
time of interview, but the other ten had already been discharged and they did not know where
to go next for HIV-related care.
Four of the 22 women who had been referred for care did not know when they were supposed
to seek that care. Eleven women had already sought HIV related care, including seven of
those who had tested HIV positive before pregnancy.
b) Number of YEARS
since tested for those
NOT tested during
pregnancy
N (%)
1 year 8 (29.6)
1-2 years 10 (37.0)
3 years 3 (11.1)
4 years 1 (3.7)
5 years 5 (18.5)
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6.4.6 Participants’ perception of risk of mother to child transmission of HIV
18 of the 35 HIV positive women believed that their baby was at risk of acquiring HIV. 13
reported that they thought their baby was not at risk, and four said they did not know. The
participants who said the baby was not at risk believed that the ARV prophylaxis they had
received (or that given to the baby), rendered them protected from HIV. 31 of 35 women
reported that they had been educated on how they could reduce the chances of transmitting
HIV to their babies.
It emerged during the interviews that some HIV positive women who had not registered for
ANC, and thus had not been tested for HIV at the clinic chose not to tell the nurses about
their HIV status. They did not therefore receive the appropriate ARV prophylaxis at time of
delivery. Such women were referred back to the nurses after the interview for institution of
the appropriate care.
Intention to attend the six weeks visit
Almost all participants (99.3%), regardless of HIV status reported that they intended to attend
the six-week postnatal visit.
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6.5 SHORT DISCUSSION OF FINDINGS
This chapter gives a quantitative estimate of the magnitude of the problem of entry into the
PMTCT continuum of care. For a woman to receive the appropriate PMTCT interventions,
her HIV status must be known. Similarly, for a baby to be started on cotrimoxazole
prophylaxis at age six weeks, he or she must be identified as HIV exposed. In the setting at
Mbare Clinic (and indeed in many other settings), ANC registration is the main determinant
of knowledge of HIV status during pregnancy (and of HIV exposure status for the baby). This
chapter provides data on the uptake of ANC registration and the factors that are associated
with it. Awareness of these factors will help in the formulation of targeted interventions for
increasing the uptake of ANC registration and associated knowledge of HIV status during
pregnancy.
This cross-sectional survey revealed that almost a quarter of women did not register for ANC.
Those who registered did so very late, at an average of 29.5 weeks gestation. Most (85%)
participants who did not register reported that it was because they could not afford the ANC
fees. That user fees were a barrier is supported by the fact that there was a 2% increase in
odds of ANC registration with each $10 increase in household income. It therefore follows
that poverty-alleviation programs may have a significant impact on the rates of ANC
registration in this community. As expected, ANC registration was found to be highly
associated with knowledge of HIV status during pregnancy.
Because ANC registration is a critical step in the PMTCT cascade, it is clearly important to
explore the barriers to ANC registration further. In the next chapter, a more nuanced
understanding of the barriers to ANC registration is presented, where results of a qualitative
study that was conducted among women who did not register for ANC and those who
registered late are presented.
An important finding of this study is the interaction of education and planned pregnancy in
bringing about higher levels of ANC registration. This means that the importance of
education of the girl child cannot be over-emphasized. An educated woman is better able to
plan her pregnancy and all associated events. It is important to put in place measures to
discourage unplanned pregnancies, as they are less likely to be registered. In this study, about
half of the pregnancies were reported to have been unplanned. Prevention of unplanned
pregnancies has already been identified by WHO as the second of four prongs of the strategy
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for elimination of mother to child transmission of HIV. Key in achieving this objective is the
elimination of unmet need for family planning.
The results presented in this chapter will be discussed more fully and in the light of other
findings in the Discussion Chapter.
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CHAPTER 7: QUALITATIVE FINDINGS ON BARRIERS TO
ANC REGISTRATION
7.1 OVERVIEW
In this chapter I describe results of the qualitative study undertaken to explore reasons for
failure to register for ANC. The study was conducted among women in Mbare who had just
delivered babies. Women were eligible for participation in this qualitative study if they1) had
recently delivered a baby, 2) were residing in Mbare as evidenced by the address given on the
participant’s medical record, and 3) had registered for ANC later than 24 weeks of pregnancy
or had not sought ANC at all. Written informed consent was obtained from all women before
participation. The first 21 eligible participants were invited for in-depth interview. The
number of 21 was based on pragmatic considerations and on the belief that with 21
participants it was highly likely that theoretical saturation would be reached. Interviews were
conducted by the candidate in Shona (the local language in Zimbabwe), in private, in a closed
room at Mbare Clinic. The interviews were digitally recorded, transcribed, translated into
English and analysed according to thematic analysis.
7.2 DESCRIPTION OF MATERNITY SERVICES AT MBARE CLINIC
As described in Chapter 5, Mbare Clinic is a large polyclinic that is divided into the
outpatients department, family health services clinic and maternity clinic. An average of 400
babies are delivered in the maternity clinic in a month. The ANC clinic is housed within the
maternity clinic. It is open four days a week on Mondays, Wednesdays, Thursdays and
Fridays. On three of the days the clinic sees about 70 clients a day, half of which are
existing/repeat ANC visit clients and the other half are bookings and new registrations. Only
repeat ANC visit clients are seen on Wednesdays (also about 70 women).
The ANC clinic operates under guidelines of City of Harare, which are based on the national
guidelines from the Ministry of Health and Child Welfare which at that time required that
women seek ANC before 16 weeks gestation. The clinic has posted fliers throughout the
clinic buildings to encourage women to register their pregnancies from three months
gestation. Women are asked to pay US$30 for ANC booking fees (previously this amount
was $50, and was reviewed downwards a few months after this study began, in December
2009). The fees cover all examinations and tests done during pregnancy, delivery, and all
Chapter 7: Barriers to ANC
141
postnatal care up to six weeks post-delivery. To discourage late registration Harare City
Health Department has fixed the fees at $30 regardless of time of registration. Thus women
who did not seek any ANC but come to the clinic for delivery are still expected to pay the
fees in full. To ensure recovery of fees owed, the clinic detains women in the clinic after
delivery until they have paid the required $30.
The clinic operates an appointment system for ANC registration where a woman must first
come to the clinic to make an appointment for the day of registration. On the appointed date
women start by paying the fees. Women then take part in a group education session with all
the other mothers who registered for ANC on that day (usually 35-40 women). The education
session is given by a midwife and covers what to expect during ANC, any clinic procedures
that may be conducted, and how to take good care of themselves during pregnancy. Women
are also given a tour of the clinic and given instructions on what to do and where to go when
they are in labour. Each woman undergoes a physical examination and has blood drawn for
various tests including HIV.
The maternity clinic is open 24 hours a day and is staffed by qualified registered nurse
midwives. Should there be complications that cannot be managed at the clinic, women are
referred to Harare Central Hospital, one of the two largest central hospitals in the country
which is about 10 minutes ride by ambulance/taxi.
7.3 RESULTS OF THE QUALITATIVE STUDY
Twenty one participants with a median age of 26 years (age range 16-38 years) were
interviewed in-depth. All participants who were asked to participate in this study agreed to
participate. Six were HIV positive, one did not know her HIV status and the rest were HIV
negative. The majority (17) were married. Only seven of the 21 women earned their own
incomes. 16 women had registered late for ANC, mostly at eight months, with some
registering as late as one week before delivery. Four women did not seek ANC at all. All
registered women delivered at a health care facility (Mbare Clinic or Harare Hospital). Of the
four unregistered women, two delivered at a health care facility and two delivered at home.
There were six principle reasons that were cited as barriers to ANC registration, including
user fees, fear of HIV testing, nurses’ discourteousness, unsupportive male partners, long
waiting queues at the clinic and unplanned pregnancy.
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Before presenting findings from the participants’ narratives two case studies will be presented
in order to give a wider picture of the context of the women’s lives.
Box 7.1: Fari’s Case Study
Fari was 24 years old. She was married with three children, including the baby. She was self-employed as a
meat vendor. Her husband was not employed. She registered for ANC when she was eight months pregnant with
the recently delivered baby, and was at that time diagnosed HIV positive.
Fari’s previous HIV test was done three years ago, when she was pregnant, and she was HIV negative at that
time. She reported that she delayed seeking ANC because she did not have money. She and her husband
struggled to make ends meet: she did not make much money from her vending business and her husband was
finding it difficult to get a job. She said she had to meet all the household expenses which made it difficult to
save up for ANC registration, but she would put aside a small amount whenever she could. During her
pregnancy (before she registered), she was often unwell. She longed to seek health care for her illness but she
worried that if she went to the clinic she would use up all the money that she was saving up for ANC
registration. As a result she did not seek any health care for her illness until she was eight months pregnant
(when she finally registered for ANC). Fari reported that during her pregnancy she was often worried about her
health and the health of the baby. She needed to know whether her baby was alright. She knew a woman who
did not seek ANC whose baby had died in the womb and she had not known.
Another woman we lived with…her baby died in the womb and she had not registered…. So those are
things which kept bothering me. What if it happened to me when I was not registered; how would I
know that this is what had happened?
Fari disclosed her HIV status only to her husband. She reported that she could not disclose to anyone else
because she did not trust other people to uphold confidentiality. She reported that her community was one that
did not accept HIV positive people. She felt that if people knew her HIV status they would not buy her meat,
and her relatives would not want to eat the food she had prepared. Because of this she was determined to keep
her HIV status a secret. She lived with her sister in the same one-roomed residence that she and husband and
children shared, but she did not disclose her status to her.
You first have to examine your family to see if there are no people who gossip, okay. You may say a-a
let me tell my younger sister but then at the end of the day everyone knows about your HIV status.
At the time of interview (when the baby was two weeks old), Fari had not yet sought any HIV care for herself;
she had not had a CD4 count and had not been told anything about how she should seek care for her HIV
infection. Her baby was taking nevirapine prophylaxis and she was aware that the baby would be started on
cotrimoxazole prophylaxis at six weeks. She was hoping that at that time (at the six weeks visit) the nurses
would also prescribe something for her HIV care.
Box 7.2: Mutsa’s Case Study
Mutsa was 19 years old. She was married with one baby and lived in Mbare with her husband together with her
in laws (at the in-laws’ residence). She was not employed. She registered for ANC at seven months of
pregnancy. She was tested for HIV when she was pregnant, and she tested HIV negative.
She reported that she delayed registering because her husband would refuse to give her the money for
registration. He had the money, but would not give it to her. She tried to convince him to but he kept refusing
because he did not appreciate the importance of ANC, and kept saying he would give the money to her at a later
date, towards delivery.
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“…men do not really know the purpose of ANC registration. They just think that one registers so that
she will give birth at the clinic. Because I kept telling my husband on a daily basis; he actually drank
beer yet I was telling him that I needed money for registration. And he would say, “Why do you want to
register the pregnancy when it’s still this small? You will register later isn’t it there is still plenty of
time until you are nine months pregnant?”
When Mutsa was pregnant she visited her aunt who lived in another town. The aunt gave her $50 at the end of
her visit. She took $30 out of that money and registered herself for ANC. Her mother-in-law seemed to have
been very supportive of her, and seemed to be aware of the irresponsible nature of her son. She told Mutsa not to
reveal to her husband that she was already registered, and to keep requesting the registration money so that she
would use it for something else when she was eventually given. To help keep Mutsa’s registration status from
her son, Mutsa’s mother in law offered to hide the ANC registration records in her bedroom. Mutsa’s husband
eventually gave her the registration money a few weeks before she was due to deliver.
Mutsa reported that she felt helpless when her husband refused to give her money for registration, she felt there
was nothing she could do because he refused with his money. She longed for some financial independence, and
wished she could get some capital that would put her into a buying and selling business. That way she would be
able to spend the money however way she felt appropriate.
“If only there were things that one could do, for example if you can get some capital then you can start
selling your things, then you will know that I have got my own money that I can use for whatever I want
to do…There will be no need for you to wait for someone to give you money. Like in my situation, my
husband had the money. But you can’t snatch it away or forcibly take the money from him because it is
his money.”
During the interview, Mutsa also reported that nurses at the clinic do not treat women courteously. She said this
was something that was widely discussed in the community, and also in her family. Her sister had tried to
discourage her from registering at Mbare Clinic, telling her to go to a private clinic where patients were treated
better. But she could not afford the private clinic, and had registered at Mbare Clinic hoping that the bad reports
she had heard about the clinic were not true. Mutsa reported feeling very disappointed to have people’s reports
confirmed: she reported that she herself was not treated well. She had an unassisted delivery while the nurses
were sitting in the same room. (Quote on this is in the main text).
7.3.1 User fees are a barrier to ANC registration
Poverty
In this study, the main finding reported by women was that user fees are an insurmountable
barrier to ANC registration. All interviewed participants reported that it was difficult to raise
the ANC registration fees. Discussion with most participants revealed that they were very
poor and were struggling to make ends meet; the majority talked about the tiny incomes that
they or their partners earned and how it was nearly impossible to save up any money towards
ANC registration.
On a particular day my husband can bring home a meagre income of three dollars, on
another day maybe he brings a mere five dollars, yet on another day he brings a
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paltry dollar. So it is quite a challenge to save up a substantial amount of money. 24-
year old HIV positive mother of three
Many participants reported that they had attempted to bring a partial fee to the clinic in the
hope that they could reach an agreement where they could pay the balance in instalments but
were disappointed that the clinic only accepts full payment before ANC registration.
800-311-3: I couldn’t go to the clinic with a partial fee because they would not accept
it. As you know if you just keep money in the house, nowadays it is a problem. You
may encounter a problem and then you use that money.
As a solution, the majority of participants wanted the authorities to reduce the fees to
amounts that they could afford or to remove them altogether. Participants believed that once
ANC fees were removed there would be a huge increase in the number of people who register
for ANC. Indeed, there was evidence from the interviews that when the fees had been
reduced from $50 to $30 this had resulted in more women registering.
With me it (the reason for late ANC registration) was failure to raise money because
initially it was at fifty dollars, is it? When it was reduced…that’s when I was given
money, and I came to register when it had come down to thirty dollars.
However, because this is a very poor community, $30 was still considered a lot of money for
the majority of women. Only one woman said the fee of $30 was affordable. She was
different from the other women as she had a regular job which paid her a much higher salary
than the average income of the women seeking care at Mbare Clinic.
Managing priorities
In this community where abject poverty is the norm, ANC registration competed with many
basic household priorities. The dilemma caused by poverty was apparent in many interviews.
Women sometimes had to choose between saving up for ANC registration and other,
sometimes critical or potentially life-altering alternatives. For example, some women who
became unwell during their pregnancy would further endanger themselves and their babies by
declining to seek health care in order to protect the savings they had made towards the ANC
registration fees. They argued that seeking health care for their illness meant that they would
have to pay a consultation fee and possibly buy some drugs, which would deplete the savings
they were making towards ANC registration. This is particularly sad because if they had
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afforded to register all these health care costs would have been free. Unfortunately, it turned
out to be particularly important for those women who became ill to have registered early or to
have an earlier HIV test; two of these women turned out to be HIV positive when they
eventually tested at eight months of pregnancy and at delivery respectively. The following
text is the justification that one of them gave for not seeking health care for the illness she
experienced during pregnancy:
When you get here you are asked to pay five dollars for the card (consultation fee).
After you have paid five dollars you will then buy medicines, okay. The total amount
you pay can go up to ten or fifteen dollars. That fifteen dollars is a substantial amount
of money; if you keep it diligently it can increase to thirty dollars. 24-year old HIV
positive mother of 3 (was tested HIV positive when she registered for ANC at
eight months of pregnancy).
For some participants, however, ANC registration was further down the list of priorities;
these women described more immediate expenses to be dealt with, for example food, rent and
school fees for the children. Other priorities included the requirements for a new baby e.g.
clothes, diapers and other new-born requirements, known locally as ‘preparation’.
I had too many expenses in that the little boy…the first born child goes to school…you
have to see to the food in the house, and he needs to go to school. So there are many
expenses…that is why I registered at eight months.
We were facing difficulties to the extent that we even had problems getting food in the
household…So the financial burden will be heavy; you need food, then the
registration fees; then ‘preparation’. There will be too many expenses at the same
time.
Feelings about non-registration: Anxiety due to exclusion from the clinic
For women, not having paid the required ANC registration fees meant exclusion from the
health care system. Women reported feeling helpless and “distressed” by this exclusion. As
stated above, a number of women stated that they had wanted to go to the ANC clinic
because they had been ill during pregnancy. However they opted not to seek care because
they could not afford the consultation fees and other costs associated with health seeking as
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stated above, or the belief that the primary care clinic would not assist any woman who had
not registered. As a result, for many women the period before seeking ANC was laced with
anxiety with some women reporting worrying about their own health while others worried
about the welfare of the baby they were carrying; specifically whether the baby was healthy
and properly positioned in the womb. Other women reported worrying about their unknown
HIV status and the possibility of passing on HIV to their baby in the event that they had HIV.
It was clear that the majority of women appreciated the importance of ANC attendance and
longed for the reassurance that would only come through ANC registration.
It bothered me because the people in my family kept telling us to find some money (for
ANC registration). They would say nowadays there is HIV. You might be infected with
HIV, and the baby may contract the disease. But if you receive protection early, the
baby may be born without HIV. 19-year old married mother of one, HIV negative
I worried most about the baby; that it could possibly be in a breach position and I
wouldn’t know about it. Or that the baby could die in the womb.25 year-old married
mother of one, HIV negative
Another woman we lived with…her baby died in the womb and she had not
registered…. So those are things which kept bothering me. What if it happened to me
when I was not registered; how would I know that this is what had happened? 24-
year old HIV positive mother of 3 (was tested HIV positive when she registered
for ANC at eight months of pregnancy).
Although in general participants displayed a strong appreciation of the importance of ANC,
there were a few exceptions: three women reported that they had not been bothered by their
delay in ANC registration. One of these women reported that she was not worried because
she and her husband had tested for HIV before she got pregnant, so she was not bothered
because she already knew that she was HIV negative. The other two women reported that
they had not been worried because they had felt they had had plenty of time before they
delivered. These women showed a lack of understanding of the holistic importance of ANC,
believing in one instance that early ANC registration was only important for HIV testing, and
in the other instances it was important for assisted delivery at the end. The implications of
these exceptions will be discussed in the next and later sections.
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In addition to user fees, other important barriers to ANC emerged from the interviews; some
of which were interwoven with user fees, as will be seen in the discussions to follow.
7.3.2 Fear of HIV testing as a barrier to ANC registration
Fear of an HIV positive diagnosis
One barrier to ANC registration that was frequently discussed in the interviews was the fear
of HIV testing, although none of the interviewed women reported it as her own experience.
Women suggested that it is difficult for some women in their community to test because they
are afraid of discovering that they are infected with HIV. There was indication that the fear is
driven by suspicion that they had been exposed to HIV, for example because of
husband/partner infidelity.
A-a, you know what happens in life; you can discover that your husband is having
extra marital affairs. So you can find such a woman saying a-a, that woman who is
having a relationship with my husband, does she not have the disease, and the like. So
one would have been thinking that oh my god, I think I have the disease. But for me to
think about it…for her to think about going for testing really she will be scared…what
if I am found to be infected? 24-year old HIV positive mother of 3 (was tested HIV
positive when she registered for ANC at eight months of pregnancy).
There was perception that knowledge of an HIV positive status could cause someone to
“become stressed” as they worried about their health. Another potential source of mental
unrest that was reported to deter HIV testing was the fear of stigma. There was recurrence of
the idea that women worried about “how people would perceive them” if they discovered
their HIV positive status. The community was viewed as one that has not accepted HIV
positive people: there was fear that disclosure of an HIV positive status would result in
ridicule:
There were other people who had tested HIV positive whom people talked about
saying, “hee-e this person has such an HIV status,” and they would laugh.33-year
old widowed mother of five, tested HIV positive at eight months of pregnancy
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There could be some talk that could affect you such that you would never have a
peaceful mind, such things as ah! This is the HIV status of this person; this is how it
happened, and the like. Do you know that if you have an argument or heated
exchange with a relative it can degenerate into them saying “Ha-a (after all) you
have such an HIV status”, and the like…maybe in the public with many people
around. 24-year old HIV positive mother of 3 (was tested HIV positive when she
registered for ANC at eight months of pregnancy).
There was also fear of losing existing social relationships as people in the community were
reported to be unwilling to associate with an HIV positive person. In particular women were
said to be afraid of abandonment by partner/husband as narrated by this 24-year old HIV
positive mother of three: “Now how do you tell your husband that you have been found to
have the disease? He may… like…, maybe he can say I am no longer interested in you, and
he just leaves you.”
Because of these fears women were reported to find it preferable to live in ignorance, with
the belief that the emotional stress and pain that followed an HIV positive diagnosis could
itself result in deterioration of one’s physical health: “Maybe you can end up being sick
because of thoughts of, “A-a, what is everyone’s perception of me?”
Perception of ANC Clinic as an HIV Testing Site
Although overall, study participants were aware of the importance of ANC, the fact that fear
of HIV testing was a barrier to ANC suggests that the ANC clinic is being perceived by some
women as mainly an HIV testing clinic. The other benefits of enrolling for ANC are either
ignored or are unknown, as typified by the participant who delayed seeking ANC because she
already knew her HIV status.
Another important finding was the view among women that it was difficult to refuse testing.
Although women understood that in theory they could refuse testing if they did not want to,
they reported that the environment at the clinic did not make it easy to opt-out: registering
women were told to go into the testing clinic all at once, and if someone was unwilling then
they would remain sitting outside. Participants reported that women found it difficult to
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remain outside while everyone else was going in because they feared that other women would
assume that they had already been diagnosed HIV positive. This assumption could lead to
unpleasant talk and potential stigma, and women were keen to avoid that by just going in for
testing even if they really did not want to.
A-a , what happens is when we are in a big group like that and it is called out, “It is
now time for people to get tested,”…so if you think you are…some are going and you
are not going…the people wonder why you are not going. So in the end you will just
say let me also go where the others are going…One will think that if she refuses
everyone will wonder what she is afraid of; “Oh my god, maybe she is HIV positive.”
33-year old widowed mother of five, tested HIV positive at eight months of
pregnancy
Whilst it is encouraging in public health terms that the clinic manages to test the majority of
registering women, the difficulty they perceive in opting-out of testing could make someone
who is undecided about HIV testing avoid ANC altogether. Indeed, participants reported that
they knew of many women who chose to only come to the clinic when they were in labour
because they wanted to avoid HIV testing. This is obviously a draw-back to the provision of
PMTCT services as the principal component of the services i.e. HIV testing, is the very thing
that keeps some women away.
Accounting for fear of HIV testing in the interviews
None of the women who talked about HIV testing as a barrier to ANC reported it as their own
experience. Rather, each woman who talked about it described it as the experience of other
women in her community. The participants would then add that it was foolish not to test for
HIV because then one would not get the appropriate PMTCT services that could benefit the
baby. “We could regard this as having a shallow mind because you could be harming your
own and you could be killing yourself.” Thus it is clear that even if the woman may have
been describing her own experiences she would consciously distance herself from such
actions, describing them as the actions of others in order not to be associated with the image
of a “foolish” woman who risked the health of her baby by not testing for HIV early. In
addition, there is some sort of shame associated with admitting that one is scared of HIV
testing, as seen by the women’s inability to refuse testing if they did not want to. Thus it is
possible that some women could have used the interview to deliberately create an identity of
a responsible woman who is not scared of HIV testing.
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Therefore this analysis suggests that there may be additional reasons that hinder early
registration, such as fears around HIV testing, but that these may be considered more
shameful to admit as they may transgress expectations of what is involved in being a
responsible woman and mother. As a result not being able to afford the ANC fees may be
perceived to be the more socially acceptable reason and therefore the one more readily
proffered in the interview. Whilst this may still be the primary reason, the focus on
registration fees may conceal additional reasons at play.
Another instance where some identity creation work could have occurred in the interviews
was on the other commonly discussed barrier, the bad treatment of clients by nurses.
7.3.3 Nurses’ discourteousness as a barrier to ANC registration
As with the case of fear of HIV testing, none of the interviewed women reported that they
had failed to register for ANC because they feared the nurses. However, seven interviewed
women reported that they knew other women in the community who did not seek ANC
because they wanted to avoid the clinic nurses, who were reported to be discourteous towards
clients. They each went on to describe personal experiences of how badly they had been
treated by the nurses. They used these examples as reinforcements of their view that women
stayed away from the ANC clinic in order to avoid this bad treatment.
Each time I had my blood pressure checked; they first checked my blood pressure
okay? Then…the nurse was shouting at me saying, “You young people you rush to
engage in sexual relations with men, this and that.” 16 year old married mother of
one
This kind of accounting is similar to that of the fear of HIV testing in that none of the women
gave this as the reason that they themselves had failed to register. They instead preferred to
talk about the more ‘respectable’ reason (that they could not afford the ANC fees) which they
could demonstrate was beyond their control. However, it is different from fear of HIV in that
there is no shame associated with admitting to an unpleasant experience with a nurse, hence
the readiness to describe their personal experiences (set out below).
Unequal treatment of clients at time of delivery
There was feeling that there were ‘good’ and ‘bad’ patients; good patients/clients were
treated well, and bad clients not so well. Three types of ‘bad’ patients were identified in the
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interviews: 1) women who had not registered for ANC; 2) women who did not behave well at
the clinic, e.g. those who made a lot of noise during labour or those who kept asking for
clinical examinations despite nurses’ advice against it, and 3) HIV positive women.
Unregistered women
Women who did not seek ANC or those who registered late were made to feel unwelcome at
the clinic; they were treated as if they did not belong. As a result, a few women reported that
they felt ANC registration was a way of guaranteeing good treatment by nurses at the time of
delivery as indicated by this 22-year old woman’s response when asked what she thought
were the advantages of ANC registration: “So that the nurses will serve you more
nicely…without shouting at you because they know that ‘A-a, really, this person registered,
she is our patient who belongs here.” Both registered and unregistered participants expressed
this view. Examples of differences in treatment included 1) discourteous communication; 2)
if there were many women who had given birth, unregistered women were made to sleep on
mattresses that were placed on the floor, even when there were vacant beds in the wards; 3)
being made to wait while nurses were serving those who had registered.
(If you have not registered) you are not even civilly treated, you will actually be made
to sit on the benches and wait for a long time while they help those ones who would
have registered…No one (i.e. no nurse) examined us. We were eventually examined
by a man who works on the ambulance who eventually came. 22 year-old mother of
three who did not register for ANC
When I delivered I saw some who were made to sleep on the floor, in the maternity
wards. They had not paid…They had not registered. I think if there is a shortage of
beds some who have delivered will be told to sleep on the floor…But in that room I
was admitted to there were some who were…there were no people on the beds…The
beds were vacant but the women had delivered without having paid the fees. 34-year
old mother of three who registered when she was eight months pregnant
The prospect of being treated differently makes unregistered women stay away from the
clinic. What this therefore means is once the pregnant woman sees that she no longer fits the
‘good patient’ definition in terms of early registration, she might miss ANC altogether, and
possibly not come for delivery as well (i.e. deliver at home) in order to avoid being treated
badly by the nurses.
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HIV Positive Women
HIV positive women were another group of patients who felt they were treated differently by
the nurses. For example, this 33-year old mother of five reported that she felt the nurses had
not wanted to perform clinical examinations on her because she was HIV positive:
On the days I delivered the baby…Some women were examined more frequently, but
you the (HIV) positive one maybe they will just look at you only once; or maybe they
will say to you, “Haghh i-i, wait, your time is not yet up,” They would not check on
your progression in labour. I thought they do a bit of discrimination in that area. 33-
year old HIV positive woman
One of the findings in the wider study is that some women who had not registered (and had
therefore not been tested for HIV at the clinic) chose not to disclose the fact that they already
knew they were HIV positive to the nurses. These interviews suggest that this may be due to
fear of differential treatment. Unfortunately this increases the risk of HIV transmission to the
baby as the mother does not receive the appropriate HIV prophylaxis to prevent transmission.
Interviewed women reported that HIV positive women may choose not to disclose their status
to the nurses because they are afraid of being mistreated, judged or ridiculed by them:
A-a I think….I think in the person’s mind they think that if I tell them (nurses), maybe
they will laugh…maybe they will do some things. They will keep saying that this
person is HIV positive, or maybe they will not treat you well. 33-year old HIV
positive woman.
One may think that maybe the nurses will think that I am a promiscuous person. 24-
year old mother of three, HIV positive
Women who ‘misbehaved’
Women believed that bad behaviour in the eyes of the nurses could result in punishment. The
‘punishment’ that was particularly dreaded was transfer to the central hospital, Harare
Hospital (nicknamed Gomo). Some women reported that if the nurse did not like you, or was
annoyed with you for some reason, she could get back at you by transferring you to the
central hospital, ‘claiming’ that you had developed a complication that warranted referral.
This was perceived as a punishment because the cost of transfer was very expensive: the
woman would have to pay an ambulance fee of $20, and at the hospital they would be asked
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to pay about $90 in hospital fees. This was of course too much money for many women. As a
coping strategy, some women have resorted to not registering for ANC so that they could
hold on to the $30 registration fee. In the event that they are transferred to Harare Hospital
they will use the money they have saved to contribute to the cost of the hospital fees. That
way they will not have to pay both the clinic and the hospital.
So now I kept going back there (to the examination room). That’s what irritated them.
Then they said to me…after they had examined me they said the foetus had deposited
its excrement in the womb. But the foetus had not deposited its excrement in the
womb…The people at the hospital actually asked me why I had been referred to them.
And I said they told me that the baby had deposited its excrement in the womb. And
they (the hospital people) said how come it’s not written anywhere. When I delivered
they noticed nothing wrong…they did not even see the baby’s excrement in the womb.
Interviewer: Ok. So why do you think they sent you to Harare Hospital? Participant:
Because I kept going back to the labour ward and telling them that I was about to
give birth….Actually I went (to the hospital) together with another person. The other
person I went with was screaming a lot when we were in the ward. They kept coming
to the ward to tell her to keep quiet. They said to her, “You keep quiet; this is not your
house!”
In addition some people do not register because…hmm…(chuckles)…if you pay the
money…for example in my case , I paid $30 at this clinic, but when I came here when
I was in labour they said my labour was not progressing in terms of the centimetres of
dilatation. ‘You must go to Gomo and give birth from Gomo.’ Yet there was not even
a problem. Then I went to Gomo as said. And at Gomo I paid some additional money.
Upon arrival (at Gomo) I was told that I had dilated eight centimetres. Yes. I
delivered immediately upon arrival. Yet I had been transferred from here after being
told that my labour was not progressing. And I had to pay eighty-six dollars at Gomo.
They actually said they wanted cash. And the ambulance fee was twenty dollars. So
one may deliberately delay, and only come when they are in labour. I will not pay any
money beforehand, but will pay at the time of discharge from the clinic. That way, if I
am transferred to Gomo I will still have my $30 which I would not have paid, then I
will use it to make the payment at Gomo.
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While it is possible that nurses may have made the referrals to the central hospital out of
spite, it is more likely that the nurses made the decision to refer based on clinical criteria.
However, it seems in these instances the nurses did not communicate their decisions clearly
and courteously, and transferred women against a background of having already shouted at
the client for ‘bad behaviour’, resulting in the client interpreting referral as a punishment. It
appears from these interviews that nurses may have made conservative decisions about
whether to refer the clients (it is better to be safe than sorry). However, it does not help the
nurses’ image (and will certainly confirm the client’s suspicion that she has been spitefully
referred) when, upon arrival at the more expensive hospital, the client is told that everything
is alright and she gives birth without complication.
Unassisted deliveries at the clinic
Interviews indicated that due to the reluctance of nurses to assist labouring women when
requested, many women had unassisted deliveries. Nurses were reported to have ignored
women’s cries that the baby was about to come out, resulting in the woman having to resort
to having an unassisted delivery.
…Then I waited, and waited and waited. Ah! I felt ah! This baby…I started feeling
that the baby’s head was coming out. That is when I went back to the labour ward,
and they said, “Why have you come back here?” And I said ‘the baby is about to
come out.’….And they said, “You are saying that the baby is coming out, do you know
the process by which a baby comes out?” Ha-a so I then said…they said go back, and
I said no. What I was now feeling was not good, so I climbed onto the bed. Then I…In
the same room they had told me to leave. And they said this room is not one for
leisurely sitting, go back to that room and sleep there. And I said, “No, Ambuya,
please come and have a look, the baby is about to come out”. Then I stayed there.
That is when the waters broke when I was lying on that bed… I gave birth soon after
the waters broke. They (nurses) were actually sitting there. Because the baby…I
actually delivered the baby and it then…isn’t it the baby…isn’t it your legs will be
positioned this way up, the baby then fell onto the bed, that is when she stood up and
came.19 year old mother of one
This is obviously unsafe for both the mother and baby. Moreover, in this poor community
where it is difficult to raise the required $30 maternity fees and where women have to juggle
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priorities, an unassisted delivery implies to the woman that she did not get good value for her
money. This may make the same woman less likely to prioritise ANC registration during her
next pregnancy. A 22-year old mother of two who reported that her sister-in-law had had an
unassisted delivery in the antenatal ward in full view of other patients and their visitors had
this to say: “It makes you have a lot of thoughts like why should I pay the money if I am going
to deliver by myself”?
Community awareness of nurses’ bad treatment
There seems to be a lot of discussion in the community about the goings on at the clinic.
Many participants reported that they had heard about the nurses’ bad treatment when they
were out in the community. Women in the community were reported to discourage each other
from going to the clinic in order to avoid bad treatment by nurses. A 19-year old woman
reported being very disappointed to have the reports confirmed:
My sister said ‘you shouldn’t have registered at that clinic because Mai T complained
bitterly about that clinic.’ And I told her that a-a, unfortunately I can’t afford
anything else…So I then realised it when I came here that she had been telling the
truth. And so many people keep talking about it but I had ignored it…
It is encouraging to note that not all nurses were discourteous; some participants reported that
some of the nurses were very friendly and helpful: “But the nurse who examined us
later…that nurse was extraordinarily courteous.”
7.3.4 Unsupportive male partners
Another important finding is that as most women were financially dependent on someone,
mostly their husbands, they did not have the power to decide when they would register for
ANC. That decision mainly rested with the breadwinners, the husbands who were reported
less likely to appreciate the importance of ANC: while women said they appreciated the value
of the process of seeking antenatal care and knew what to do, men were viewed as not being
supportive of the process, and were said to be concerned only about making sure that the
woman delivered at the clinic i.e. they were only concerned with the point of delivery. Eight
women reported that they had faced partner opposition to ANC registration. A twenty-five
year old mother of one revealed that throughout her pregnancy her husband was not
concerned that she had not registered, but then he had started panicking when she developed
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abdominal pains which he construed as labour pains. Another woman said she felt men
thought it acceptable for women to deliver at home: “They will be saying that one can even
deliver at home.” Thus women would get negative responses when they asked for money for
ANC fees, often being told that they would only be given the money towards the expected
date of delivery:
I think it’s because men do not really know the purpose of ANC registration. They just
think that one registers so that she will give birth at the clinic. Because I kept telling
my husband on a daily basis; he actually drank beer yet I was telling him that I
needed money for registration. And he would say, “Why do you want to register the
pregnancy when it’s still this small? You will register later isn’t it there is still plenty
of time until you are nine months pregnant?”19-year old married mother of one
In some cases the husband would say he did not have money yet it was apparent to the
woman that he had it: “He would get money but he would tell me that he doesn’t have it. Yet I
could see it, but he would tell me that he didn’t have it.”
Many women made pleas for the government to help them start income-generating projects
that would allow them to make their own decisions about their own health. There was
frustration with men for not being supportive for ANC, and a deep longing for the ability to
make their own decisions about financial matters.
If only there were things that one could do, for example if you can get some capital
then you can start selling your things, then you will know that I have got my own
money that I can use for whatever I want to do…There will be no need for you to wait
for someone to give you money. Like in my situation, my husband had the money. But
you can’t snatch it away or forcibly take the money from him because it is his money.
19-year old married mother of one
The main reasons that participants gave for their partner’s unsupportive behaviour were
unawareness of the importance of ANC, as given above. In some cases, it appeared that the
man’s assertion of authority played a significant part in his decision about ANC registration.
Two women reported that their husbands did not allow them to register because they just
wanted to show their power over them. The men seemed to get satisfaction that they were
dictating what happens.
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He will say, “I will tell you what to do. I will tell you when to do what. I will say when
you should do what. You will register when you are eight months pregnant.” 28 year
old married mother of two, HIV negative
There were some people who wanted to help me but he would not allow me to get the
money… he would say if you are ever given money by anyone you will be in for it. 25
year old married mother of one, HIV negative
In many other interviews, although the women did not explicitly describe their husbands as
domineering, it was clear that the man’s decision was not a point on which he was willing to
negotiate.
Thirdly, there was indication that the fear of HIV testing played a role in the men’s attitudes
towards ANC registration. One twenty-six year old participant said she knew of a woman
whose husband had not allowed her to register because he did not want her to get tested: “Her
husband hadn’t wanted her to register because he said she was going to have a blood test.”
The fear of HIV testing is therefore an important deterrent for both women and their partners,
which needs to be addressed. It again points to the polarised view of the ANC clinic as an
HIV testing centre.
This gendered view is strengthened by the fact that mothers and mothers-in-law played an
important role in getting the woman registered. Many women reported that it was their
mother (or mother- in-law) that had brought about their eventual registration by providing the
required ANC fees, and in the case of mothers-in-law, by pressuring their sons to give the
registration money to the pregnant woman.
On the other hand, three women reported that their husbands had been supportive of ANC
registration. Two of them seem to have acquired this appreciation through the pressure and
encouragement that came from their extended family. The other man who was supportive of
ANC had a strong desire to have an HIV negative baby, having gone for couple testing before
pregnancy, and then encouraging his wife to register so that she could have another HIV test.
These three cases highlight the fact that an intervention that is aimed at increasing the
appreciation of importance of ANC among men (who are the financial decision makers)
through encouragement and education may help in increasing levels of ANC registration
among women. The men could be targeted through the points that seemed to have worked to
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sensitise the three men on the importance of ANC: there could be interventions that promote
the discussion of the importance of ANC among peers and families, including extended
families, and interventions that promote couple counselling and testing for HIV. Once people
know their HIV status, the fear of HIV testing will no longer be a barrier to ANC registration,
as indicated by one of the three cases. As women are already aware of the importance of
ANC, interventions that target them alone will be less effective than those that target men as
well.
7.3.5 Long waiting queues at the clinic
Six participants reported that the ANC clinic was so busy that it prevented some women from
registering. Participants reported that about fifty women come to the ANC clinic on any
given day. The clinic visit would therefore take a long time. Typically, a woman needs to set
aside the whole day for the clinic, which women reported was difficult for those who had to
work.
Some have a perception that antenatal care visits are a waste of time in that they say
a-ah! Instead of going to the ANC clinic where I will spend the whole day sitting I
would rather do something at home…they think it’s a waste of their time…aha-a
instead of…for example some people could have jobs to go to, and some have some
vending to do at the market. So they will start thinking that oh no, who will stay at my
trading table to sell my goods while I am at the clinic? I can’t spend all that time
sitting at the clinic. 19-year old married mother of one
Another participant said she would ask for a few hours off work to get registered but each
time she came to the clinic she found there were so many people that she could not get
through within the short time that she had available. She would therefore go back to work
without having registered, and she reported that she now found it difficult to keep asking her
employer for time off work: I would come. And I would find that there were many people at
the clinic. So it became difficult for me to keep asking for time off from work. Then I didn’t do
it. Even women who do not have to work might be filled with dread at the prospect of
spending a long time at the clinic.
To manage the large numbers of clients the clinic operates an appointment system where
women must first come and make an appointment for a day when they undertake the ANC
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registration procedures. Participants reported that this was sometimes a problem because the
appointed date could be weeks away, which further delays the registration. It is important that
the community is made aware of this delay so that they factor it into their plans. Another
challenge that this raised in the cash-strapped community was that often when the woman
made that first visit it would be because she would have raised the $30 registration fees.
However she can only pay on the day of registration, not on the day she makes the
appointment. This presents a challenge to some women in that if something urgent comes up
they might use that money and when the appointed date finally comes the woman will no
longer have the money.
You will just be given an appointment date. So maybe when the appointed date comes
you may no longer have that money. Yet you would have come before. Those are some
of the things which cause delays, but one would have originally come on time. 27-year
old married mother of four, HIV positive
7.3.6. Unintended pregnancy is a barrier to ANC registration
Five women reported that unintended pregnancies were not easy to get registered. Two
participants who had unintended pregnancies reported that they had been on contraceptives
when they got pregnant (one was on the pill and one on the injectable contraceptive). They
both had not known that they were pregnant until late into the second trimester. They
reported that this did not leave them with enough time to raise the ANC fees, so one of them
did not seek ANC at all, and one registered late. The other challenge was with teenage
pregnancies. Two participants had had teenage pregnancies while they were still at school.
For both teenage mothers the period soon after discovery of the pregnancy was a difficult one
where they tried to hide their pregnancy from their family and school authorities while at the
same time trying to get the boyfriend to accept responsibility for the pregnancy. This all took
a long time; as a result one of the teenage mothers delivered at home because she had not
registered, and one registered late in the third trimester. The importance of preventing
unintended or unplanned pregnancies therefore cannot be over-emphasized.
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7.3.7 Consequences of late registration/non registration
Detainment at the clinic after delivery
The clinic allows women who have not registered to deliver at the clinic, but expects full
payment before releasing the women to go home after delivery. As a result the woman is
forced to find the money while she is still admitted, in some cases plunging the woman
further into poverty as reported by this 29-year old, divorced, HIV positive participant who
was explaining how she raised the required money before she could be discharged: “I sold
my bed. There was somebody who was at home (while I was at the clinic) who sold the bed
for me. Then she came and paid.”
Home delivery
One of the consequences of failure to raise the ANC registration money was delivery at
home. Two of the 21 interviewed women delivered at home. They both reported that they had
had no money to register for ANC. Importantly, both these women had not planned to deliver
at home, but had throughout their pregnancies been hopeful that they would get the money
from somewhere and register for ANC.
That’s not what I had planned…I was hoping that I would register like other people;
and go to routine antenatal care visits as others do. E-e, and also deliver in the
hospital to ensure that if there are other things which have…any challenges, I may get
help.
Both women who delivered at home reported that they had had unpleasant experiences
delivering at home, and wished they had delivered at a health care institution. One of them, a
seventeen year old participant, reported that she had been very scared when she delivered
because the baby had had the cord around his neck when it was born. She reported that her
grandmother, who assisted the delivery, was quick to slip the cord over the baby’s head but
the participant was really scared and wished she had professional help. She sustained a tear
during delivery but there was nothing she could do about it except wash with salt:
It is better (to deliver in a health care institution) in case one needs to have stitches
done...if you deliver at home and you have a tear you will just remain like
that…Interviewer: So did your grandmother tell you what to do now that you had had
a tear? Participant: A-a, I was just told that I needed to wash with salty water.
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Seven other interviewed participants knew of someone who had delivered at home because
they could not afford the ANC fees. One participant reported that she knew of a woman who
had died after she had delivered at home in Mbare:
She had delivered at home, in the evening. And she died on the morning of the
following day…she thought she was okay…so the following morning it is said that she
actually woke up and swept the yard. Then she made her tea and drank it. And it is
said that when she was still having breakfast she just said, “A-a, my head.” And she
kept crying out about her head until she died.28-year-old married mother of three.
HIV negative
Of note, both interviewed women who had delivered at home (and the woman described
above who died after delivering at home) did not seek any medical care afterwards. Although
many women who have not registered choose to go and deliver at the clinic, others choose to
deliver at home because they know that the clinic will still require the $30 maternity fees,
which they cannot afford.
As a solution women have resorted to employing the services of traditional midwives who
can assist at a home delivery. The traditional midwives are known to ask for less money than
the clinic.
Interviewer: Do they (traditional midwives) not ask for money for their services?
Participant: They do ask for money, but they just ask for whatever you can afford.
They just say give me any amount you can. 34-year old married mother of three, HIV
negative
Maybe (they do not register at the clinic) because they have heard of other places
which ask for less money; the traditional midwives who are present in the community.
They ask for ten dollars.16-year old married mother of one, HIV negative
7.4 SUMMARY OF STUDY FINDINGS
This qualitative study revealed six barriers to ANC registration: user fees, fear of HIV testing,
nurses’ discourteousness, unsupportive male partners, long waiting queues at the clinic and
unplanned pregnancies. User fees were reported to be the main barrier to ANC registration. In
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the ultra-poor community that the women came from, the $30 required for user fees was an
unaffordable amount.
Although user fees were reported to be the main barrier to ANC, there was evidence that
there were other important barriers which participants may have found more difficult to admit
to, namely fear of HIV testing and nurses’ discourteousness. While user fees and
unsupportive male partners were seen to offer a barrier that was beyond the participant's
control, there was a view that it was unacceptable to stay away because of the fear of HIV
testing or fear of bad treatment by nurses probably because women understood it was
important to have ANC and it was seen as cowardly to risk jeopardising the pregnancy out of
fear. Although good rapport was established with participants and a non-judgemental attitude
was adopted throughout, aware that they were being interviewed because they had not
registered or had delayed registering, it is possible that participants may have felt that they
were being viewed (or viewed themselves) as bad mothers. This may have influenced the
participant to use the interview to create another identity of themselves for the interviewer i.e.
one of a responsible mother who faced insurmountable barriers to ANC registration. Identity
creation is recognised to happen in interviews116,140 where participants use the interview to
paint a picture of themselves that they want the interviewer to see. It can also be because this
is the view that the participant wants to have of herself because it is too painful to think
otherwise. For example, in a study exploring syringe and needle sharing among injection
drug users most interviewed participants reported that everyone else besides them shared
needles, and they were the exceptions who behaved responsibly.141 Understanding the
reasons why a participant chooses to present themselves in a certain light may offer us greater
understanding of the phenomenon that is under study.
The findings and implications of this qualitative study will be discussed in detail in the
Discussion Chapter.
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CHAPTER 8: ATTENDANCE AT SIX-WEEK POST-NATAL
VISIT AT MBARE CLINIC
8.1 OVERVIEW
In this chapter I explore the facilitators and barriers to women’s attendance at the six-week
post-natal visit. The chapter comprises results from three studies:
i) Retrospective clinic record survey. This study was conducted in order to explore six-week
visit attendance according to HIV status. Briefly, clinic records of women who delivered at
Mbare Clinic between 15 November 2011 and 12 December 2011 were reviewed to extract
information on their six-week visit attendance. Logistic regression was performed to
investigate what participant factors were associated with six-week visit attendance.
ii) Follow-up study of HIV positive women at six weeks. In this study HIV positive women
who participated in the delivery survey were followed up at six weeks post-natally in order to
explore attendance rates and uptake of paediatric cotrimoxazole prophylaxis.
iii) Qualitative study of barriers to six-week visit attendance. In this study women who took
part in the delivery study, but then failed to attend for their six-week visit appointments were
followed-up by study staff and asked to participate in in-depth interviews where their reasons
for non-attendance were explored. Interviews were analysed using thematic analysis.
The information from these three sources were triangulated to piece together a picture of the
facilitators and barriers to attendance at the 6-week post-natal visit.
8.2 RESULTS OF RETROSPECTIVE STUDY OF SIX-WEEK VISIT
ATTENDANCE
333 women delivered within the period covered by the record review (15 November-12
December 2011). Table 8.1 shows their characteristics. 167 (51%) participants were residents
of Mbare. 235 (71%, 95% CI 65.6%-75.5%) had registered for ANC. This ANC registration
rate was lower than recorded in the delivery survey (Chapter 6 - 76.6% (95% CI 72-81),
although there was a slight overlap in the confidence intervals. The delivery survey was
conducted only among Mbare residents and it included women who had registered for ANC
in other health care centres than Mbare Clinic, but the clinic records only captured Mbare
Clinic registrations. The mean age of the participants was 25.3 (24.8-25.9) years and the age
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distribution is as shown in Table 8.1. Thirty four (10.2%) were HIV positive, 222 (66.7%)
were HIV negative and 77 (23.1%) were of unknown HIV status.
Among women who delivered at Mbare Clinic during this period there was no association
between ANC registration and where they lived on chi-squared analysis. As for the delivery
survey there was no association between ANC registration and age (Chapter 6). However
there was strong association (p<0.001) between ANC registration and HIV status: 68% of
women who did not register for ANC had unknown HIV status, compared with 4% among
those who had registered. There was strong association (p<0.001) between age and HIV
status with HIV prevalence of 7.3%, 6.0%, 5.7% in the 15-19, 20-24,25-29 age groups but
28%, and 24% in the 30-34 and 35-39 age groups respectively.
Sixty-five (19.5%, 95% CI 15.2%-23.8%) women attended their six week post natal visit. 26,
31, 7 and 1 attended when the baby was 5, 6, 7, and 8 weeks old respectively. In univariable
analysis, ANC booking status, area of residence and unknown HIV status were strongly
associated with six-week visit attendance (Table 8.1). The strongest association was with area
of residence: residents of Mbare were twelve times more likely to attend the six-week visit
than those who were non-resident, odds ratio 11.8 (4.8-28.7).
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Table 8.1: Participant characteristics and association with six-week visit attendance
Characteristic N (%) N (%)
attended six-
week visit
Odds ratio and
95% CI
p-value
ANC Booking Status
Booked
Unbooked
235 (70.6)
98 (29.4)
56 (23.8)
9 (9.2)
3.1 (1.5-6.5)
1
0.003
Area of residence
Mbare
Non-Mbare
162 (49.2)
167 (50.8)
58 (34.7)
7 (4.3)
11.8 (5.2-26.8)
1
<0.001
Age
15-19
20-24
25-29
30+
41 (12.3)
117 (35.1)
106 (31.8)
69 (20.7)
9 (22.0)
28 (23.9)
18 (17.0)
10 (14.5)
1#
1.1 (0.5-2.6)
0.7 (0.3-1.8)
0.6 (0.2-1.6)
0.8
0.5
0.3
HIV Status
Positive
Negative
Unknown
34 (10.2)
222 (66.7)
77 (23.1)
8 (23.5)
50 (22.5)
7 (9.1)
1
0.94 (0.4-2.2)
0.3 (0.11-0.99
0.9
0.05
# Score test for trend, p=0.2
In multivariable analysis, the final model had ANC booking status, area of residence, and
HIV status (Table 8.2). In the adjusted model, only ANC booking status and area of residence
were associated with six-week visit attendance; after taking account of ANC registration
status there was no association between HIV status and six-week visit attendance.
Table 8.2: Multivariable analysis of factors affecting six-week visit attendance
Characteristic Adjusted odds ratio (95%
CI)
P value
HIV status
Positive
Negative
Unknown
1
1.1 (0.4-2.8)
0.7 (0.15-2.8)
0.88
0.57
ANC booking status
Unbooked
Booked
1
2.9 (1.01-8.4) 0.05
Area of residence
Mbare
Non-Mbare
13.3 (5.8-30.6)
1
<0.001
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8.3 PARTICIPANT ATTENDANCE OF SIX-WEEK VISIT
Of 35 HIV positive women who took part in the delivery survey described in Chapter 6, 31
consented to follow-up at the-six week visit. The main reason given by the four women who
declined follow-up was unwillingness to be visited at home due fear of disclosure of HIV
status. Of the 31 women who consented to follow-up, 20 attended the six-week visit as
scheduled; see figure 8.1 for details of six-week visit attendance.
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Fig 8.1: Six-week visit attendance of 31 HIV positive study participants
35 HIV+ women
31 Women consented to follow-up
20 Attended 6-week visit11 defaulted visits
5 participants tracked
and gave in-depth
interviews on barriers
to attendance
3 participants tracked
and said they attended
six-week visit (not
confirmed on records)
3 participants not
located (gave false
locator information)
299 women in delivery survey
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8.3.1 Prescription of cotrimoxazole prophylaxis for HIV-exposed infants
The clinic operates a Chronic Diseases Clinic where all patients with chronic diseases
including HIV positive patients and HIV-exposed infants are evaluated on a regular basis,
(usually monthly). After the six-week post-natal visit procedures for the mother, she is
referred to the chronic diseases clinic where the infant is supposed to be registered in the
HIV-exposed infant register that is kept at that clinic, be initiated on cotrimoxazole
prophylaxis and have a dried blood spot sample taken for early infant diagnosis by DNA
PCR. At that point a hand-held medical record card for the HIV-exposed baby is also created;
all subsequent monthly evaluations and prescriptions of ARV and cotrimoxazole prophylaxis
will be documented on this card.
Among the twenty women who attended the six-week visit, thirteen had their babies initiated
on cotrimoxazole prophylaxis as scheduled. Five infants were not initially prescribed
cotrimoxazole for various reasons; study staff investigated the reasons and assisted the
participants to have cotrimoxazole prescribed. This investigation was facilitated by the good
relationship that was between the study nurse and the clinic nurses. The study nurse had
previously worked within the City of Harare system, so she was personally known by many
of the nurses who were then able to open up to her about the reasons why cotrimoxazole had
not been prescribed. Figure 8.2 describes the reasons that cotrimoxazole prophylaxis was not
prescribed for the five women. The reasons included oversight by the nurse who was
supposed to prescribe cotrimoxazole, stock-outs of cotrimoxazole, and failure of appropriate
referral of women to the place where cotrimoxazole was to be prescribed. In addition, two
women deliberately chose not to get cotrimoxazole, and their reasons are also documented in
figure 8.2.
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Fig 8.2: Reasons why cotrimoxazole was not initiated among women who attended six-week
visit
Participant 7
The participant said when she came to the six weeks visit one of the other
mothers who was sitting next to her in the queue told her that cotrimoxazole
prophylaxis is only given to HIV positive babies. Because she and her baby had
taken some ARV prophylaxis she believed that her baby was HIV negative, so
she did not get cotrimoxazole for her baby.
Participant 1
The nurse who saw the participant
at the six-week postnatal visit said
she did not refer her to the chronic
diseases clinic because she had
assumed the participant already
knew she was supposed to go there.
Participant 2
Prescription/referral for cotrimoxazole
prophylaxis was overlooked by the
nurse who examined the participant at
the six-week postnatal clinic
Participant 3
Nurses gave the participant another
appointment date (without prescribing
cotrimoxazole) because they did not
have the materials required for DBS
sample collection in stock.
Participant 4
Cotrimoxazole was out-of stock
Participant 6
She was accompanied to the six-week visit by her husband. She had not
disclosed her HIV status to her husband, and because she was afraid that he
would discover her HIV status she left before cotrimoxazole was prescribed
for the baby. Upon follow-up by study staff she indicated that she was not
going to seek any HIV-related care for herself or baby because she did not
want her husband to discover her HIV status.
Participant 5
Cotrimoxazole had previously been out of stock. It was in stock when the
prescription was written for this participant but it was not dispensed because
it had not yet been entered into the stock cards.
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8.4 QUALITATIVE FINDINGS ON BARRIERS TO 6-WEEK VISIT
ATTENDANCE
Interviews were conducted among five women who failed to attend the six-week visit. These
women had been recruited into the delivery survey described in Chapter 6 and agreed to
follow up at 6 weeks then failed to attend. Table 8.3 shows the characteristics of the five
women.
Table 8.3: Characteristics of interviewed participants
Pseudonym Age
(Years)
Marital
Status
No of
children
ANC
Registration
Age of baby
at interview
(months)
Mercy 33 Married Three Registered Three
Chido 27 Married Three Not registered Five
Esther Missing Married Three Registered Four
Linda 32 Married Three Registered Three
Rudo 23 Single Two Not registered Seven
Two main barriers to attendance at the six-week visit emerged: 1) lack of appreciation of
importance of visit, and 2) distrust of the health care system, particularly distrust of nurses.
8.4.1 Lack of appreciation of importance of six-week visit
All participants knew about the six-week visit; it was known as a visit where postnatal
women are physically examined and offered family planning services. At the beginning of the
interviews, when participants were asked to talk about their reasons for non-attendance, four
gave personal reasons: Chido said she had gone to a funeral, Linda said she had been
attending court after her husband was arrested for theft, Esther said she had been
menstruating and had assumed nurses would not examine her because of that, and Rudo said
she had relocated to rural areas because she could no longer afford to live in Harare, and the
rural clinic was too far to walk to. Chido, Linda and Esther reported that they could not come
to the clinic after the appointment date because they assumed nurses would not accept them;
there was a belief that a woman could not be re-scheduled if she had missed her appointment:
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I thought that even if I came they would not help me because they will be helping
those who had appointments for that day. That is their rule at the clinic. If you miss
your appointment next time they will be helping those who have current
appointments; defaulters are not accepted. Chido, 27-year old mother of three
It was apparent from the interviews that all five women placed little value on the maternal
health services that are provided at the six-week visit. None of them seemed bothered that
they had missed these services. Indeed, they expressed the view that women hated the
physical examinations that are a part of the six-week visit procedures, and they did not see its
value.
Some say they don’t like to come and have that object…you know that object that they
listen through to determine whether you are pregnant again…that thing which they
place on your tummy and then they bring their ears close to listen. People say they
don’t like that. And some say they do not like having fingers inserted down there.
Chido, 27 year old mother of three
Some women do go…But I am just lazy…some do go. Some women really think it is
important…but I say, “No, it’s not like I am sick, so why should I go?”…I am the one
who did not think it was important…My mother did ask me about the six-week visit,
and I said, “Ha-a, why should I go. What does it matter? Rudo, a 23-year old mother
of two
As the interviews progressed it emerged that none of the women except one (Mercy) knew
that in addition to maternal health services there were services for HIV-exposed infants
provided at that visit. When they missed the six-week visit, they assumed that they had only
missed out on maternal health services, and had not known that in addition they had missed
out on services that were meant for their babies. There was shock and disappointment when
study staff pointed out that the baby was supposed to have been initiated on cotrimoxazole
prophylaxis at six weeks. Women blamed the clinic nurses for not telling them this
information, insisting that if they had known about the infant services they would have
attended:
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I would have come. I really would have come. I just thought all there was to it (six-
week visit) was the examination and being given family planning pills. I did not know
that it was for the baby. Esther, married mother of three (age not given)
That women valued child health services was supported by the fact that all women (except
Rudo) attended the child health clinic regularly, and their baby immunizations were up to
date. The obstacles to six week visit attendance that had been mentioned earlier became
surmountable when the welfare of the baby was considered. This teaches us three things:
women may face various personal obstacles that prevent them from taking up their
appointments, so health care systems should have clear procedures of how to re-book missed
appointments and communicate this to all clients. Second, if a woman thinks a visit is
important, she will probably do all she can to overcome her personal obstacles and ensure
attendance. This highlights the importance of education in ensuring uptake of services. Third,
all these women would have prioritised their babies health over their own.
There was a strong view that nurses did not educate women enough about available services
for HIV-exposed infants. Only one participant, Mercy, had known that there were infant
services that were to be provided at the six-week visit; in fact her knowledge of HIV and
PMTCT services was strikingly extensive. But she had not obtained her education from
Mbare Clinic; she was enrolled in an ART programme at a Médecins Sans Frontières (MSF)
clinic in Epworth, where she reported she had got all her information. When discussing this
point she had added that she noticed that not much education on caring for HIV-exposed
infants was given at Mbare Clinic:
Ever since the time I enrolled into this clinic, I have not received any PMTCT
education. I have never…I think I have been coming for antenatal care since
September; there was never a day I was given PMTCT education. I don’t know if it’s
because they thought I have…I am already on medication (ARVs) so maybe they
assumed I already knew, I don’t know. Mercy, 33-year old mother of three
The same participant called on nurses to improve on patient education on PMTCT:
I think we should educate each other, really. These PMTCT issues are important.
They (nurses) should not just concentrate on touching our tummies because that
tummy is not important, what is important is what will come out of it, really. We want
it to live. Mercy, 33-year old mother of three
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Although it was clear during the interviews that nurses had not told the study participants
about the infant services at six weeks, it was also apparent that the participants had not been
totally ignorant of these services. Chido had friends whose babies were on cotrimoxazole
prophylaxis, and both Esther and Rudo had heard other people in the community talk about it.
But it was unclear to all three of them when and how they could access the cotrimoxazole
prophylaxis. Of note, although they had been in regular contact with nurses at the child health
clinic and when seeking treatment for her sick baby (Chido) none of them had felt able to ask
the nurses about how to access HIV-related care. This will be discussed in more detail in the
next section.
8.4.2 Distrust of nurses
As discussed above, there was one participant, Mercy, who was aware of the services for
HIV-exposed infants, having received education from the MSF clinic where she was
attending for her own HIV care. She reported that she chose not to come back to the six-week
visit because she did not trust the nurses at Mbare to provide the correct services for her baby
as they had failed her at time of delivery: they omitted to give zidovudine prophylaxis to her
baby; they only gave nevirapine. She reported having been aware that the nurses were
supposed to give zidovudine in addition to single dose nevirapine to her baby, but when they
did not she had not felt able to tell or ask the nurses for fear that they would not receive this
positively. At six weeks she attended the MSF clinic where the baby got the appropriate
services, but she did not get the maternal health postnatal services because they were not
being offered there.
So I started to think about it a lot, that a-a, I registered (for ANC), and it was not a
mistake to register. I wanted for my baby…to save my baby. But why then did they not
provide me with the full package of services that the baby was supposed to get, yet
others are said to get it? That’s why I lost heart and did not return at six weeks. Then
I changed to another hospital…
…It is not easy to open up about your HIV status, yet we opened up because we knew
that was the way to save the coming babies. So it is painful that I opened up, they did
not force me, I opened up by myself. Then they did not do all the stages I expected
they would do for my baby. So I thought they let me down…
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….I actually knew what my baby was supposed to get, but I was not able to demand it.
Most of the time I believe that if someone is doing her job and you look like you want
to teach them the job they will lose their temper. That is what I was afraid of…
Mercy, 33-year old mother of three
This participant was not the only one who felt unable to ask for specific help from the nurses.
Chido had wanted PMTCT services for her baby at time of delivery but had not felt able to
ask. She had not registered for ANC and reported that nurses gave her a “cold shoulder”
because of that. They had ridiculed and taunted her about not having registered. In an effort
to get HIV-related care for her baby, she had tried to tell them that she had been tested for
HIV previously, but they had dismissed her without even asking what the test result had been,
telling her she was lying about having been tested. As a result she felt belittled and unable to
say anything; “Those things really affected me, I felt hurt but there was nothing I could do.”
She had silently hoped that they would test her since they thought she was lying about having
been tested. As a result she did not get any HIV related care for herself or her baby.
In my mind I thought, a-a, since they are saying I am lying…I expected that they
would come back and offer to test me. But they did not say that. I was eventually
discharged without being asked about it again…
…I did not ask them to test me because I was now feeling guilty that I…they would
think I was a nuisance. So I just wanted…I just told myself that ha-a, let me just…let
me ignore everything and concentrate on getting out of here… Chido, 27 year old
mother of three
Chido, Esther and Linda had been in regular contact with the clinic after delivery, bringing
their babies for treatment and child health visits. They all had questions about how and when
they could access cotrimoxazole prophylaxis for their babies, but none of them had felt able
to ask the health care workers. What was striking is that despite these three women’s regular
contact with the clinic, the nurses did not recognise the HIV-exposure status of the infants, so
they did not offer them any HIV-related care.
Another finding was that in some instances, the nurses could not be trusted to keep a patient’s
HIV status confidential. Linda, one of the participants who had been in regular contact with
the clinic said when she came to the one-month and two-month child health visits the nurses
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did not offer any HIV-related care to the baby (and she did not ask as described above). On
the third month she had asked her aunt to bring the baby to the child health clinic. It was at
this visit that the nurses realised from the child health card that the baby was HIV-exposed,
and they disclosed this fact to the aunt. The aunt had not previously known about the
participant’s HIV status. The participant was hurt that the nurses had taken it upon
themselves to disclose her HIV status.
Instead of disclosing to my aunt like that it would have been better if they had said,
“We are not going to examine this baby until the mother comes here herself. Linda,
32-year old married mother of three
Although the nurses had sent a message through Linda’s aunt that she should come and see
them about getting the baby initiated on cotrimoxazole, she had not yet been to see them, but
had instead self-prescribed the cotrimoxazole prophylaxis. She said she had had left-over
cotrimoxazole from a previous prescription and after the aunt’s visit had decided to start
using that for prophylaxis. She appeared to resent the nurses for the breach of confidentiality,
and although she promised to go and see the nurses as they had requested, her promise was
not convincing. She refused further follow-up from study staff.
Chido (the participant who reported that she had been ill-treated by nurses at delivery) also
reported reluctance to approach the nurses about HIV-related care for herself and her baby.
She reported that her experience with nurses at delivery had discouraged her. In addition, she
said that she had an aunt who worked at the clinic and she feared that the nurses would
disclose her HIV status to her aunt. She reported that she grew up in an unstable family
environment and that her grandmother’s family kept chasing her away from home because
she was an illegitimate child. She confided that she had been involved in a lot of risky sexual
behaviour in the past, and her aunt who works at the clinic insulted her about it and kept
telling the whole family that she would die of AIDS:
So you know if you are constantly chased away from home you find that you really
have nowhere to go because nobody loves you. So sometimes I ended up in beerhalls,
participating in whatever was happening at that time. So because I would go to the
beerhalls she (aunt who works at clinic) would start saying, “He-e!...She has AIDS.
She is going to die before December.” For the past three years she has been saying I
will die. Chido, 27 year old mother of three
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Chido had never told anyone in the family that she had HIV, and she did not want her aunt to
know. It could be the combination of her unstable social background (including unloving
family) and ill-treatment by nurses which decreased her feelings of self-worth resulting in
diminished desire for health-seeking. She refused to discuss HIV-related care with the nurses
despite attempts by study staff to get her private appointments with the Sister-in-charge.
Upon further follow-up study staff discovered that Chido's baby had later died.
8.4.3 HIV care for the participants themselves
Only one participant, Mercy, who was enrolled at the MSF clinic, was receiving appropriate
care for herself; she was already taking ART. The other four women had not had their disease
status assessed; i.e. they had not yet had CD4 counts and had not been to the ART initiation
hospital for assessment. Esther was referred to clinic nurses after the in-depth interview, but
Chido and Linda were not successfully referred as described above. Linda, the woman who
had self-prescribed cotrimoxazole for her baby, instead asked if she could get ARVs from her
husband whom she reported worked in the army and had access to them. She was
discouraged from doing this, but her reluctance to speak to nurses and her history of self-
prescription was worrisome. The fourth woman, Rudo, was not interested because she
believed in spiritual healing, and that was the avenue she was pursuing:
There is a church I have been going to; there is some water that is offered there. It is
an Apostolic church, and the water they give is called blue water… It is used for
treating HIV; they say it completely cures HIV. Rudo, a 23-year old mother of two
From her description, the ‘prophets’ at her church make the blue water by dissolving a blue
powder they purchase in pharmacies (most likely this is copper sulphate which is sold in
pharmacies for use as an algaecide in swimming pools). Rudo reported that the blue water
was toxic, and emphasized that it should only be used under supervision of the ‘prophets’
who know the proper dosage: “It is toxic; it is intoxicating, it can wear you out.”
There is a time when she (Rudo) was prescribed cotrimoxazole prophylaxis for herself, but
she reported that she did not like the side effects, so she stopped taking it and started giving it
away to anyone in the rural home who was not feeling well:
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I would give the tablets away. If someone came and was not feeling well, I would give
it to them. Because in my rural home that is the drug that people enquire about the
most; mostly they will ask you if you have cotri. Because it is said to be
powerful….You can take it for a headache…you can just take it for a day or two…
Rudo, a 23-year old mother of two
8.5 SHORT DISCUSSION OF FINDINGS
There is poor attendance of the six-week visit; overall only a fifth of women return for six-
week visit procedures. Six-week visit attendance was not associated with HIV status. Some
of the HIV positive women who did attend the six-week visit did not receive prescription for
cotrimoxazole prophylaxis for their babies for various reasons including omission by clinic
nurses, stock outages, and fear of disclosure of HIV status. Qualitatively, the main barriers
women described to six-week visit attendance are lack of appreciation of importance of visit
for the infant (there was perception that the visit would only benefit the mother, not the
infant), and distrust of clinic nurses.
As expected, six-week visit attendance was associated with area of residence, with more
women from Mbare attending. It is anticipated that women who do not reside in Mbare will
attend their local clinics in their respective places of residence. There is still unacceptably
low attendance if we consider only the Mbare residents: only 35% of them attended the six-
week visit.
Poor postnatal visit attendance is not limited to Mbare; there is general poor attendance of the
six-week visit in Zimbabwe, with overall attendance rates of 25.9% and 31.0% in Harare and
Chitungwiza Provinces and a national average of 44.5%. 142 This low percentage has been
noted as a cause for concern in the most recent Zimbabwe National Health Profile142, and the
need to identify barriers has been expressed. Addressing some of the barriers that were
uncovered in this study might help increase attendance rates.
ANC was associated with nurses’ awareness of infant HIV exposure status: nurses did not
know the HIV status of 68% of women who did not register before delivery compared to only
4% of women who had registered. This shows that nurses were not systematically
implementing procedures to test all women presenting in labour with unknown HIV status,
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despite national recommendations/guidelines to do so. Clearly these systems need to be
strengthened to ensure that appropriate care is given to all mothers and their babies.
Non-attendance of the six-week visit limited the opportunity for women to get their own HIV
care: only one of the five interviewed women was receiving appropriate HIV-related care for
herself (and it was being provided through a separate health system); the other four reported
that they had not yet been examined to determine HIV disease progression. WHO has made
strong recommendations for linkage to care of women who are tested during pregnancy49 ;
Zimbabwe has adopted the guidelines and they were being implemented at Mbare Clinic. It is
clear that the importance of the six week visit needs to be emphasised. To promote attendance
of the six-week visit, the Zimbabwean health care system in conjunction with donors might
consider introducing conditional cash transfers to households; conditional on attendance of
preventive maternal and child health services. Recently conducted systematic reviews have
demonstrated the positive impact of conditional cash transfers on attendance of preventive
health services in low and middle income countries.143,144 Zimbabwe has recently introduced
unconditional cash transfers to the poorest households145, but unconditional transfers may not
result in positive health behaviours as has been demonstrated for conditional transfers143.
Another method that could be employed to incentivise attendance of the six-week visit is to
reduce hospital fees for women who have attended the six-week visit in the event that they
fall sick. Such a system is already being implemented among children in Harare, and could be
contributing to the good uptake of child health services (a child who is under five who falls
sick is treated for free on condition that s/he attends regular child health visits).
One method that can be employed to increase the quality of services provided is continued
training to ensure that all nurses are aware of the PMTCT implementation procedures so that
there are no omissions. Health care workers (including non-clinical staff) should also be
trained to ensure that they are ambassadors of the clinic even in the communities that they
live in. Evidence from this study is that women pick up a lot of information that is discussed
in communities. Health care workers are likely to stand out as a knowledgeable voice that
members of the general public will listen to. It is therefore important that they carry messages
of hope and encouragement for people living with HIV, and ensure that people are aware that
HIV transmission to HIV-exposed infants can be prevented. If Chido’s aunt had been more
positive in her communication she may have instilled more confidence and hope in her,
which may have encouraged Chido to seek her baby’s health care.
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Another worrisome finding is the improper use of drugs that was reported to be happening in
the communities, including the self-prescription of cotrimoxazole prophylaxis, sharing
cotrimoxazole tablets and likely, ARVs as well, and use of potentially toxic chemicals by the
Apostolic group. Not only will improper drug use harm the users but there could be an
increase in microbial resistance which will render many of our first choice anti-microbial
drugs ineffective.
A list of recommendations resulting from this chapter is given below:
1. Because women find it difficult to come to the clinic if they have missed an appointment
(because of the belief that they will not be attended to), health care centres should have ways
of re-booking attendees/patients who have missed their appointments.
2. There is need for education of women on the importance of the six-week visit, both for the
mother and for the baby:
i. Women need to be taught on how attendance of the six-week visit will benefit their
own health.
ii. They also need to be taught on available PMTCT services for HIV exposed infants.
3. City of Harare or Ministry of Health might consider incentivising attendance of the six-
week visit, e.g. by commissioning conditional cash transfers (conditional upon attendance of
the six-week visit), or reducing hospital fees for women who have attended the six-week
visits.
4. Nurses who provide child health services need to pay close attention to the HIV exposure
status of the infants they attend, and also need to ensure that HIV exposed infants are getting
the necessary care. If the HIV-exposure status of the infant is unknown, nurses at the health
care centres need to test the baby to determine the HIV-exposure status. Ministry of Health
have already issued these guidelines, and it is important that they find ways of ensuring that
the guidelines are followed.
5. The findings in this and other chapters show that clients find nurses unapproachable and
unsympathetic. Nurses need to be trained on good client services. City of Harare might need
to do more to ensure that nurses treat patients/attendees well, e.g. by rewarding health care
workers who treat clients well and disciplining those who do not.
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6. The fear of unwanted HIV disclosure prevents uptake of HIV care services. Nurses need to
be reminded (or trained) on the need to maintain confidentiality of HIV status as they carry
out their duties in the various clinics, particularly at the child health clinic where there is little
privacy during consultations.
The findings presented in this chapter will be discussed more fully and in light of other
findings in the Discussion chapter.
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CHAPTER 9: QUALITATIVE FINDINGS ON ADHERENCE TO
COTRIMOXAZOLE PROPHYLAXIS
9.1 OVERVIEW
In this chapter I describe results of a study that was conducted to explore issues affecting the
ability of HIV positive women to keep their babies on cotrimoxazole prophylaxis. All willing
HIV positive women who participated in the cross-sectional survey at time of delivery (or
who were recruited after the survey ended) and whose babies had been prescribed
cotrimoxazole prophylaxis at six weeks were invited to participate in this adherence study.
They were enrolled to be longitudinally followed-up at 3, 4, 5 and 6 months. During the
monthly visits they completed a short interviewer-administered questionnaire about
adherence to cotrimoxazole. At between 4.5 to 5 months they were interviewed in-depth
about their experiences of keeping the baby on cotrimoxazole. In addition, they were visited
at home to investigate how well they were measuring the prescribed dose of medicine. To
ascertain this, staff took a bottle of cotrimoxazole suspension to the participant’s house and
asked her to measure the amount of cotrimoxazole she would normally give to the baby,
using the measure/utensils she typically used. In this chapter the main findings presented are
the qualitative in-depth interview results, but additional information that was gathered during
longitudinal follow-up will be included to illustrate or provide support to the qualitative study
findings. The findings from the home assessments will also be presented.
Written informed consent was obtained from all women before participation in the
longitudinal study. All participants who were being longitudinally followed in the adherence
study agreed to participate in the adherence qualitative interviews. In-depth interviews were
conducted by the candidate in Shona (the local language in Zimbabwe), in private, in a closed
room at Mbare Clinic. The interviews were digitally recorded, transcribed and analysed
according to thematic analysis.
9.2 DESCRIPTION OF STUDY PARTICIPANTS
Twenty participants participated in the adherence sub-study. Most (17) were married and
majority were multiparous (Table 9.1). Twelve were diagnosed with HIV during their most
recent pregnancy, four in previous pregnancies and three had been diagnosed as a result of
theirs or their children’s illness. All participants came from poor families; they either earned
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no income or earned very little from self-employment, mainly vegetable vending in the
nearby market.
Table 9.1: Characteristics of interviewed participants
Pseudonym Age
(Years)
Marital
Status
No of
children
Timing of HIV diagnosis Occupation
Tari 30 Married 4 During ANC, at 3 months Sells vegetables
Grace 23 Married 2 During ANC Not employed
Blessing 35 Married 3 During ANC, at 6 months Sells vegetables
Saru 36 Married 2 Previous pregnancy, 2009 Not employed
Maggie 33 Married 3 During ANC, at 9 months Sells vegetables
Rumbi 33 Married 2 Previous pregnancy, 2003 Not employed
Miriam 37 Married 4 During ANC, at 6 months Sells vegetables
Fungai 27 Married 3 During ANC, at 8 months Not employed
Mucha 41 Divorced 5 2005 when she was sick Meat vending
Irene 19 Single 1 During ANC, at 6 months Not employed
Sekai 35 Married 3 During ANC, at 7 months Not employed
Ruth 23 Married 1 Previous pregnancy, 2009 Not employed
Nyari 24 Married 2 VCT, March 2010 Not employed
Maka 24 Married 3 During ANC, at 8 months Meat vending
Tracy 29 Divorced 3 Tested at delivery Dancer
Vimbai 33 Widow 5 During ANC, at 8 months General vending
Tendai 27 Married 4 2008, child was sick Sells vegetables
Barbara 23 Married 1 During ANC, at 6 months General vending
Vongai 32 Married 2 2007, when she was sick Sex work
Stacy 35 Married 4 Previous pregnancy, 2008 Sells vegetables
The women lived in crowded accommodation, where it was common to find several people
(or more than one family) residing in a single room of less than twenty square metres. Most
participants lived in flats which were originally built for bachelors. Each family occupied a
single room as stated above, with shared toilets and bathrooms at the end of the corridor
(shared by more than 30 families living on the same floor). Sometimes up to 4 families share
one room. An example of such a flat is shown in Fig 9.1 below. This kind of accommodation
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had an influence on how women felt about their HIV diagnosis and their health-seeking
behaviour, as will be described later in this chapter.
Fig 9.1: Picture of Matapi Flats in Mbare
All women-infant pairs were enrolled at Mbare Clinic where their babies were being
followed-up for cotrimoxazole prophylaxis (and extended nevirapine prophylaxis for women
who enrolled after this was incorporated into the national guidelines). They collected their
prescription refills from the chronic diseases clinic at Mbare clinic as described in Chapter 8.
Before discussing the study findings in detail, two case studies will be presented in order to
give a wider picture of the context of the women’s lives.
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Box 9.1: Nyari’s Case Study
Nyari is a 24-year old married mother of two. She lives in Mbare with her second husband. She has two
children; one is from her previous marriage. She is not employed. She tested HIV positive in 2010.
Nyari has a long history of HIV testing. She says there is a time when she would test on a monthly basis. This is
because she suspected that her partner (her current husband, then her boyfriend) might have been HIV infected
because he had had many past sexual relationships, and his child was sick (and later died), with symptoms
which she thought resembled AIDS. Despite these suspicions she had not been able to negotiate condom use
with her partner. Each time she suggested condoms he would accuse her of being unfaithful, saying she wanted
to use condoms because she knew she had contracted a sexually transmitted infection from somewhere and was
worried about passing it on to him. “I tried and tried (to get him to use condoms), but you know what men are
like…he said maybe you are doing something outside our matrimonial home.” As a result she stopped
pressuring him about the use of condoms. She would suggest HIV testing as a couple, but he would refuse.
In 2010, after a series on HIV negative results, she tested HIV positive. She reported that she was devastated,
and was angry with both herself and her husband: herself for not having been firmer in demanding protected
sex, her husband for not caring enough to protect her from HIV. At the time of interview she reported that she
was still dealing with this bitterness. She reported that the bitterness was worsened by the fact that her husband
was cheating on her with his ex-wife.
After her HIV diagnosis she immediately sought HIV care for herself; she has had regular CD4 counts since her
diagnosis and she is not yet eligible for ART. Soon after her HIV diagnosis she suggested HIV testing to her
husband, but he refused until he became very sick. While seeking treatment for the illness he was tested HIV
positive and was initiated on TB treatment and ART.
During the in-depth interview, it was clear that Nyari valued the health of her baby; she reported that she did all
she could to protect her baby from HIV; she was highly motivated to give cotrimoxazole and nevirapine
prophylaxis. She attended all her prescription refill visits and reported that she always gave the medicines to the
baby as instructed. “It causes you to constantly be alert; this is a baby I love, it’s a life...since the nurses who
have the experience said it works so I have to make it possible.” She breast-fed her baby for two months then
she stopped because she wanted to reduce the chances of infecting the baby with HIV. Six weeks after cessation
of breastfeeding she took her baby for HIV testing. The results took a long time coming; she finally collected
the results after the baby had turned five months old, and was devastated when she was told that the baby was
HIV positive. When she was seen for her six-month visit she did not have any of the vibrancy she had had in
previous visits, she looked defeated and was in a lot of emotional pain. She confided that she had even
considered doing things she should not have done, possibly suicide (it was not clear what, it had not been
possible to probe her because she was too distressed).
I was hoping that she would be negative, and that one day I would tell her that I was positive, and tell
her why I was taking tablets. Now I will have to do regular routines of collecting my drugs and hers
also. I will have to do a double job
She reported that she had stopped giving cotrimoxazole because she no longer believed in the health care
interventions.
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Box 9.2: Tracy’s Case Study
Tracy is 29 years old. She is divorced and lives in Mbare with her three children (seven year old twins and the
baby). She is HIV positive; she was diagnosed during labour when she delivered her last baby, who was five
months old at the time of interview. She delivered without having registered for ANC because she could not
afford the user fees; she had not known her HIV status during pregnancy. She got single dose nevirapine at
delivery for prophylaxis and the baby was given a 28-day course of nevirapine. Tracy worked as a dancer; she
owned the dance group she worked for. The group did performances in various towns so sometimes she was
away from home for a few days. When she was away her sister looked after the baby.
Tracy was very happy that her baby was on cotrimoxazole; she believed that it was good for him, saying it
protected him from childhood infections. She felt her baby was healthier than other babies in general because of
this protection. Because of this she was motivated to give cotrimoxazole. She had no challenges giving it at
home. She reported that there was only one time when there were adherence problems; she was out of town with
her dance group and her sister forgot to give the medicine for three days. However she believed the problem had
been dealt with as they introduced the use of an alarm on the phone that would help the sister remember.
Tracy had had challenges collecting cotrimoxazole for the baby from the clinic. The first time she tried to get it
she was told that it was out of stock; the second time she tried to collect it the nurses told her that she was late in
coming to the clinic (it was at about 3pm; the clinic closes at 430pm) and they sent her away without the
medicine: “The nurses said, “You have deliberately come in late, today we are not providing some services, we
are on a go slow.” A go slow is similar to a workers strike where workers withdraw some of their services in a
labour protest. Such a workers’ labour action had not happened at Mbare Clinic (at least during the period
studied) so it was odd that a nurse had said that to Tracy. As a result of these problems Tracy had been getting
her cotrimoxazole supplies from private pharmacies.
At the time of interview Tracy reported that she had a friend who worked at the clinic as a cleaner and that
friend had offered to help get the cotrimoxazole for her. The friend took Tracy’s national identity card and the
baby’s medical record and said she would use these to collect the baby’s cotrimoxazole from the nurses. At the
time of interview Tracy was still waiting to have the medicine delivered by her friend.
Tracy was having problems coming to terms with her HIV status. Although she had suspected that she would
test HIV positive (because she had had many sexual partners), she said it was difficult to come to terms with.
Her coping strategy was to try and block it out of her mind:
I am putting effort to block it out of my mind. I heard some people say if you think about it too much,
he-e-e your mind…you will get stressed and you will die quickly. So if I pretend it doesn’t matter and
ignore it…I block it out of my mind because I could become stressed and leave orphaned children.
It is likely because of this failure to confront the issue of her HIV infection that she had not sought HIV care for
herself. By the time of interview she had not yet sought CD4 testing; she said she kept procrastinating.
Her baby had been tested for HIV (at six weeks) but she had not collected the results (even after 6 months, when
her study participation ended, she had not collected the results); she said this was because there were long
queues at the clinic where the results were collected, which made it difficult for her to collect the results. It is
likely that her reluctance to think about the issue of HIV (stated above) also contributed to her delay in getting
the results.
Tracy disclosed her HIV status to her sister and two other friends. She said it was not wise to disclose to other
people in general because they would spread the information around and people would laugh about it. She
reported that her landlord was HIV positive and people in her community would laugh at her. “I have to avoid
telling someone from my community because I don’t know if they will keep it to themselves or if they will help
me. Maybe she might go about telling everyone about it, laughing at me.”
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9.3 INTERVIEW FINDINGS
In the next sections I will discuss the findings of the study under the following headings: 1)
Women’s feelings about testing HIV positive; 2) Adherence to cotrimoxazole prophylaxis,
where I will describe the adherence experiences and facilitators and barriers to adherence; 3)
Other issues affecting HIV positive women including access to early infant diagnosis services
and dealing with an HIV positive result for the infant, challenges with infant feeding practises
and with access to women’s own HIV care.
9.3.1 Feelings about testing HIV positive
In-depth interviews revealed that women had had a deep-rooted fear of testing HIV positive
which was intertwined with deep concern for their children and lack of good understanding of
HIV disease and available preventive and treatment interventions. During in-depth
interviews, all participants reported that they were devastated when they were told that they
had HIV. They had found the diagnosis difficult to take in, and some reported that they had
even contemplated suicide. Most participants said they had immediately interpreted the HIV
diagnosis as warning of imminent death. This made them worry about the welfare of their
children whom they thought would soon be orphaned.
When I got home I started unpacking my bag, then I saw the tablets (ARV prophylaxis
tablets) I had been given. And I thought: Is this really my status? Does this really
mean I am about to die? All my thoughts were about death. Then I thought: How will
my children cope? Then my head started aching and I started sweating…Maka, 24
year old married mother of two, diagnosed with HIV during the eighth month of
her most recent pregnancy
I immediately thought about my children’s ages...My oldest child is in Grade 2 (about
eight years old), then there is another one who comes after her and then this one I
have just delivered. My children will go through life without me, that’s what I
thought...Fungai, 27, year old married mother of three
Other women worried about being stigmatised, and this will be discussed in detail in later
sections.
For the majority of women the positive results had come as a terrible surprise, which
participants reported made it more difficult. Lack of understanding about HIV infection and
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disease had given some participants a false sense of security. They did not think they were at
risk of HIV infection: some because they had had only one lifetime sex partner and some
because they felt and looked very healthy. There were feelings of blame and betrayal directed
at husbands who were assumed to have transmitted the infection. Husbands were blamed for
not caring enough to protect their wives from HIV infection.
What disturbed me was…where did I get it from? The person who married me gave
me HIV. That is what disturbed me the most. Barbara, 23 year old mother of one
Fungai, a 27-year old mother of three had known that her husband, a long-distance truck
driver, was having affairs because she had often found evidence (e.g. ear rings) that there had
been women in his truck. She had nonetheless not expected to test HIV positive because both
she and her husband looked and felt healthy and she thought he always used condoms in his
extra-marital affairs:
It (HIV diagnosis) surprised me because no part of my body ached. Plus I thought
since I am this strong what problem can I have. When I looked at my husband I
thought haa-a, how can we possibly have such a problem. So it shocked me that ah! ...
... About the ear rings, yes I had seen them, but because he was healthy I didn’t think
he could have it (HIV). Plus every time he went away…my grandmother told me that,
“my granddaughter, men…wherever they go the first thing they look for is a woman,
so if you are wise whenever you pack his clothes for travel you should put condoms in
his pockets.” So I would find the condoms and place them in all the pockets… And he
even said to me, “A-ah, but you are a clever woman!” So I thought if he does it he
will use them… I didn’t think he would throw them away. Fungai, 27 year old mother
of three
Six women reported that they had suspected they would test positive because they (one
woman, Tracy) or their partners had engaged in risky sexual behaviour. They too reported
that it had been devastating to be told that they were HIV positive: having suspected that they
could be infected did not prepare them enough for the result. Stacy, who was diagnosed
during pregnancy in 2008, reported that she had been afraid of testing because she had had a
strong suspicion that she was positive as her husband was promiscuous. When her fears were
confirmed she found it difficult to deal with, and had even contemplated suicide. It was the
thought of her children’s welfare after her death that made her discard the suicidal thoughts.
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Initially when I was tested I sneaked out without collecting the results. I did not
collect them because I was scared. But because we kept coming to the ANC clinic the
nurses kept encouraging us and counselling us, then I understood and I went to
collect the results… When I was told that I was positive it disturbed me, but at that
same time I started thinking about the children, and I thought that if I refused to
accept that I was now positive and committed suicide then who would take care of my
children? Stacy, married mother of four, diagnosed in 2008
Participants reported that their initial reaction to their HIV diagnosis was replaced by more
positive thoughts over the course of time.
9.3.1.1 Factors Affecting Acceptance of HIV Status
1. Support from husbands/partners
Husbands played an important role in helping women come to terms with their HIV
diagnosis: women whose husbands were supportive reported that this helped them cope
better. This is particularly important because some men had specifically forbidden their wives
from getting tested for HIV, while some had allowed the women to get tested on condition
that they did not tell them the outcome: “He said if you are tested don’t tell me the results,
it’s your own business.” Women were therefore in a difficult position: first they did not feel
able to opt-out of HIV testing (because the environment at the clinic did not allow it, as
described in Chapter 7) so they had gone ahead and tested; second, after testing HIV positive
they were battling to come to terms with their HIV diagnosis while at the same time they
worried about whether, and how they would disclose the HIV result to the husband who had
either forbidden them from testing or from disclosing the results.
Before I came to book for ANC I told him that at the clinic we will be required to test
for HIV. So let’s go together. And he refused; he said if you are tested it’s your own
business. So it was incredibly difficult for me when I eventually tested. Stacy, married
mother of four
It was therefore a relief, and it was much appreciated, if upon disclosure, the husband
responded with concern and was supportive, even among women who had initially been
angry or hurt that the husband/partner had given them HIV.
What disturbed me was…where did I get it from? The person who married me gave
me HIV. That is what disturbed me the most. But with time I accepted it because when
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I told him he received it well and we went for couple testing and he accepted it.
Barbara, 23 year old mother of one
Two participants were in a discordant couple relationship; their husbands got tested after they
did, and both appreciated the support they received from their HIV negative husbands. For
Stacy this was a huge relief because her husband had initially been opposed to HIV testing
and had himself tested only after she had put pressure on him to do so.
I was expecting that he would start shouting at me, saying how come you have the
disease, where did you get it from? But he was the one to say ahh it is possible to get
a situation where the man has no disease and the woman has it…So because he did
not get angry the situation did not become too difficult for me; because my husband
showed me love, and said let’s remain together. . Stacy, married mother of four
Unfortunately, out of the 20 interviewed women, 10 had husbands who did not respond so
well. Some showed no interest; they ignored the result and did not do anything about it. Some
took the news very lightly and chastised the women for worrying about it in the first place.
Blessing’s husband told her that he could not understand why she was worried because
everyone in the country has HIV. “He said HIV is now widely distributed in the whole
country…there is no one who is still HIV negative.” As described above, some men remained
disinterested even when the women disclosed the results.
My husband is the only person I told that I had been to the clinic and tested positive.
And he just said alright; and it was in such a way that a-ah you are the one who was
told, I am not involved, deal with it yourself. Fungai, 27-year old married mother of
three
Some husbands dismissed the result, saying it was not true. The reasons given for not
believing it included distrust of the health care workers, distrust of the test procedures or
refusal to believe that a woman who looked healthy could test HIV positive.
He refused to accept the results; he was saying: “From which area of the body was
the blood drawn? How much blood was collected? These results are false; that blood
is going to be sold. They lied to you; all these are lies. How can you have HIV,
looking good as you do?” Maka, 24 year old married mother of two
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It was clear that some men did not have adequate information about HIV, and this limited
their ability or willingness to confront the reality of HIV infection in the family. It was also
evident that men were in communication networks where mythic stories about HIV were told.
Another participant, Saru, reported that all members of her husband’s family were dismissive
of the credibility of HIV tests. Some family members were tested HIV positive but they all do
not believe the results. Ensuring that men are engaged in social or family networks where
correct information on HIV is shared can help families cope with HIV diagnoses.
…my mother-in-law died and had been diagnosed of TB. She got sick, and she came
and got tested here, and the family said to the counsellor, “You are lying that our
mother is HIV positive.” My sister-in-law also tested HIV positive and she refused to
believe the results. So when I disclosed my results he (husband) said, “All these things
which are discussed in Room 15 (the main HIV testing and counselling room at
Mbare Clinic) are lies. How can it be possible that you have AIDS, and my mother
also had AIDS, and my father also has AIDS? How can the whole family be said to
have AIDS? Saru, 36-year old married mother of two
Although it was evident that some men genuinely knew very little about HIV, there was
suggestion that this was slightly exaggerated for the participant’s ‘benefit’. For example,
Maka believed that her husband’s ‘ignorant-sounding’ statements were an effort to make the
moment lighter for her. Because he saw how distressed she was by the result, he may have
thought that by rejecting the results he would make her worry less about the diagnosis.
However this did not work, it added to her worries, as was the case with all women who
reported that their husbands had refused to engage in meaningful discussions about HIV. It
could have been the man’s strategy to avoid dealing with the reality of HIV in the family;
because they had rejected the results they could not be expected to hold meaningful
discussions about HIV with their wives. As will be seen later the men may have used this to
protect themselves from acknowledging that they may also have HIV; they could then keep
their HIV status ambiguous. This not only left the woman without support to deal with her
new HIV diagnosis, but affected medication adherence as well, and this will be discussed in
the next sections.
2. Counselling and education
Women’s poor understanding of HIV issues made the HIV diagnosis more frightening than it
should have been. Some women worried that they were about to die, while some did not
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understand that it was possible to give birth to an HIV negative baby. Participants reported
that they felt better after they had received they got counselling and education about HIV,
particularly when some of the untruths they knew about HIV were addressed. Five women,
who reported that they had felt hopeless soon after being diagnosed HIV positive, said they
felt better after talking to the study nurse; the study nurse counselled and educated them in
response to their concerns and questions.
When I got home I cried, and I thought: what will become of me now that I have the
disease? What if I just die, what difference will it make...is it not better than waiting
until I am seriously ill, when people will be pointing at me, saying look what she has
become? What if I just take rat poison? I got to that point. Then I spoke to Sister T
(study nurse) and she explained to me that if you have the disease it does not mean
that you are different from someone else who is walking next to you, you are just the
same. If you have the disease it does not mean that the diagnosis is stamped on your
forehead…Your life does not stop just because you have been told that you have HIV.
That’s when I realised that ah, really, that’s the way it is. And for sure up to now I
know that even if I have the virus in me I can survive. Fungai, 27, year old married
mother of three
I was really troubled until I met people who counselled me until I understood. I would
ask Sister T (study nurse) how to proceed given my situation. Maka, 24 year old
married mother of two
Another participant, Barbara, sought counselling and support from a social support centre
where she had been referred by the clinic nurses:
She (the counsellor) helped me to accept it as it is…she told me that I can give birth to
a normal baby who can grow up without HIV. Because I have mostly worried about
the baby, what would become of it ... But she (the counsellor) was able to help me by
assuring me that it is possible to have a negative baby. That is what helped me.
Barbara, 23 year old mother of one
Of note, in all cases the education and counselling that participants reported made them feel
better did not come from the clinic nurses, but from other sources. Because the clinic is busy,
clinic nurses may not have had time to spend with women and check understanding of HIV
issues; many women came out of the clinic counselling session with unanswered (and
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unasked) questions which made the period soon after HIV diagnosis difficult. One participant
actually mentioned that the post-test counselling session had been very brief:
They did not really say much because it was just ANC registration, and there were
also many people. One would just speak briefly that (imitates a nurse using a
prescriptive voice, also sounding like a recital),
“You have been found to have the disease,
The baby will breastfeed for six months,
Unless you have money and you are able to buy formula milk…”
Fungai, 27, year old married mother of three
Other participants said they had found the support and encouragement from family very
helpful. The most common support that family/relatives gave was that the woman should not
feel bad because she was not the first one to test HIV positive, there were many other people
living with HIV. Indeed participants themselves reported that there was comfort in knowing
that they were not alone in their situation. They felt particularly encouraged if the HIV
positive people they knew were doing well; which they reported inspired them to follow in
their footsteps in terms of health-seeking behaviour.
Ahh I am no longer worried. I just comfort myself with the thought that how come this
person is surviving, how come this other person is surviving. My mother is living with
HIV; she was diagnosed in 2009 and she is taking ARVs. Even my sister-in-law, my
husband’s sister, she was diagnosed when…the baby she delivered soon after
diagnosis is now seven years old. Sekai, 35 year old married mother of two
3. Belief in the ‘inevitability’ of HIV infection
About a third of women reported that they felt better when they adopted the belief that HIV
was a part of life that could not be avoided. The women thought of it as “an inevitable
occurrence/disease that had come to humankind so there was no point in stressing over it”.
Religious beliefs played a part in the generation of this view: some women felt that God had
allowed it to happen and they were powerless to avoid it. “There is nothing you can do; it is
the will of God.” There was belief that God would provide the solution to the problem and
would protect the participant and her family in the same way that he had already protected
other people living with HIV.
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4. Time
There was evidence that women who have known their HIV status for a long time were doing
better; they were evidently more comfortable with their HIV status than women who have
recently diagnosed. This might have been because they had time to adjust to the status and
gained more confidence that they could survive, and may have been encouraged by
witnessing their own survival. Three women, Mucha, Vongai and Tendai, who tested HIV
positive in 2005, 2007 and 2008 respectively, were so comfortable that they sometimes
provided HIV counselling to other people in their communities, particularly testifying of the
importance of seeking health care to those people who were afraid of testing for HIV.
Women who did not have support to deal with their HIV status
The role of all the above factors in enabling acceptance of HIV status is further evidenced by
the fact that three women who did not have any support and did not have any of the above
factors to their advantage were evidently still struggling to cope with news of their HIV status
at the time the interviews were held. One such participant, Tracy, decided that trying to come
to terms with her HIV status was too painful, so her coping strategy was to block it out of her
mind. As will be discussed later in this chapter, this can have a negative impact on health-
seeking behaviour.
I am putting effort to block it out of my mind. I heard some people say if you think
about it too much, he-e-e your mind…you will get stressed and you will die quickly.
So if I pretend it doesn’t matter and ignore it…I block it out of my mind because I
could become stressed and leave orphaned children. Tracy, 29-year old divorced
mother of three
Another participant, Nyari, did not believe in the inevitability of HIV infection; she had
suspected that her husband (then her boyfriend) had HIV because his child was sick with
what she thought were signs of AIDS. At the time she regularly tested HIV negative, she
asked him to get tested and he refused, and when she tried to get him to use condoms he had
also refused. This participant was having problems coming to terms with her diagnosis
because she could not stop blaming her husband for infecting her, and she also blamed herself
for not being firmer in demanding protected sex.
I was angry because when we were boyfriend and girlfriend he refused to get tested
when I asked him to. I was angry that the person I was with had not paid attention to
what I was saying, which had caused me to eventually test HIV positive. Then I
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blamed myself because I had neglected to put that pressure on myself…I should have
insisted that what I have said goes, without that we cannot go on…
This section describes the difficulty that HIV positive women face at time of diagnosis and
highlights the inadequacy of the post-test counselling session given by nurses in helping
women deal with their HIV status. Husbands/male partners are shown to significantly impact
the responses of women to the new status: supportive men make it easier, but unsupportive
men actually make it worse. While women adjusted to their HIV status they had to give
cotrimoxazole to the babies and I will now describe their experiences with this.
9.3.2 Adherence to cotrimoxazole prophylaxis for babies
All women reported being able to give cotrimoxazole on a daily basis without forgetting; in
fact many were emphatic that they did not forget to give cotrimoxazole because they valued
the health of the baby. However some women experienced some adherence challenges which
were beyond their control and these will be discussed later in this section.
During home assessment of adherence visits women generally confidently measured out the
cotrimoxazole, showing familiarity with the procedure. However a problem was noted with
dosage: among twelve participants for whom home assessments were successfully completed,
only five accurately measured the prescribed amount (within 0.2mls of the prescribed
2.5mls). (The reasons why only 12 of 20 women had successful home visits will be given in
the section on barriers to adherence). Four women measured less than the required amounts:
1.1, 1.3, 2.1 and 2.0mls each. Two exceeded the prescribed amounts with measures of 3.5 and
4.2mls. Participants were instructed by nurses to give 2.5mls or half a teaspoonful. Four of
the participants with inaccurate measurements used teaspoons, but the capacities of the
teaspoons were not 5ml, hence the inaccuracy. One participant used a small measuring device
which she believed measured 2.5mls, but in actual fact it had a capacity of 2.0mls. The
participant who measured 4.2mls, Stacy, reported that she had been told to give 5mls;
however her medical record indicated 2.5mls, so there had been a misunderstanding. Barbara
had had a similar problem; during the monthly visits, before the home visit, study staff
discovered that she was giving a quarter teaspoonful because that is what she understood she
should give. Study staff told her the correct dosage, and when the home assessment was done
she measured the correct amount of 2.5mls.
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9.3.2.1 Facilitators to adherence
1. Desire to ensure the good health of the baby
Participants valued the health of their babies above all else. They all reported a strong
willingness to give cotrimoxazole prophylaxis in order to preserve the health of their babies.
Of note, among fourteen participants in which this was explored in detail, eight women
believed that cotrimoxazole protected the baby from acquiring HIV through breast milk. Five
were aware of its role in protecting against infections in general, and not HIV, and there was
one woman who thought it protected against many infections including HIV. “It prevents the
baby from getting chest infections, and then it prevents the baby from getting HIV from the
mother.” The difference in knowledge of the purpose of cotrimoxazole seemed not to be
associated with a difference in attitude towards cotrimoxazole; all participants valued it
highly and attached great importance to adherence. As mentioned above the desire to keep
the baby healthy ensured that participants did not forget to give the medicine:
It causes you to constantly be alert; this is a baby I love, it’s a life...since the nurses
who have the experience said it works so I have to make it possible. Nyari, 24-year
old married mother of two
What encourages me to adhere is the desire to prevent my baby from becoming HIV
positive. That’s what encourages me mostly. I am really concerned about my baby.
Barbara, 23-year old married mother of one
2. Observed benefits of using cotrimoxazole prophylaxis
Many participants reported that they had experienced the positive effects of cotrimoxazole
prophylaxis. They felt that their babies were healthier than other HIV-exposed babies who
were not on medication. Women who had previous children who had not been on
cotrimoxazole marvelled at how much healthier the new babies were compared to their older
HIV exposed (or positive) siblings. The perceived benefits of cotrimoxazole encouraged the
women to keep giving cotrimoxazole.
Since the time I gave birth I have noticed that giving cotrimoxazole to the baby is
helpful. If you keep giving cotrimoxazole every time he does not suffer from colds, or
diarrhoea like what other children do. A baby who gets it is really different from the
baby who is not taking any medication. Tendai, 27-year old married mother of four
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Cotrimoxazole is important because in the community I live there are some children
who are not on medication, as I speak right now they have been to hospital a
countless number of times. But with this child I have not been to hospital since
delivery. Stacy, 35 year old, married mother of four, thinks cotrimoxazole is
important for PMTCT
Having a baby test HIV negative at six weeks was reported to provide encouragement and
further impetus to keep giving cotrimoxazole. This was likely because of increased
confidence in the health care interventions that were offered at the clinic.
When I was given her HIV test results (tested at six weeks) that’s when I became more
convinced that it is important to adhere to the given instructions. Nyari, 24 year old
married mother of two
Unfortunately, the converse was also true for Nyari. She had been encouraged to adhere to
cotrimoxazole when her baby tested HIV negative at six weeks, but she was discouraged and
she stopped giving cotrimoxazole when her baby later (about a month after the in-depth
interview) tested HIV positive. She reported that she had lost faith in the drugs and could not
bring herself to give cotrimoxazole again. When she was seen at the six-month visit, she had
not given cotrimoxazole for about three weeks. This is especially concerning because it is the
HIV positive baby who needs cotrimoxazole the most. This unfortunate experience could be
one of the adverse effects of believing that cotrimoxazole prophylaxis has PMTCT
properties.
3. Aids to remembering
In general, many of the women were strongly motivated to administer cotrimoxazole and they
took significant steps to remember to give it on time. Women reported that they used their
phone alarms as aids to remembering. Also, women reported that they had already
established their routines of taking medicines (antiretroviral drugs, cotrimoxazole prophylaxis
and ARV prophylaxis) and it was easy to fit the babies into these routines.
4. Social support for adherence
Family members who were aware of the need for cotrimoxazole prophylaxis were reported to
be supportive for adherence mainly through giving reminders. Some husbands were reported
to be supportive, as will be described below. Of note, many women reported that their other
children were often actively involved in medication adherence, some had been trained to give
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the medicines, and some played the role of reminding the mother that it was time for giving
the medication.
As stated at the beginning of this section, some women experienced barriers to adherence;
these will now be discussed.
9.3.2.2 Barriers to adherence
The main challenges faced by women in their efforts to keep the babies on cotrimoxazole
prophylaxis were 1) challenges posed by husbands/male partners, 2) fear of HIV disclosure
and stigma and 3) health system challenges including stock-outs of cotrimoxazole and long
queues at the clinic. These challenges will be discussed in turn.
Husbands/male partners as barriers to adherence
As stated already for some women there was a challenge with getting men engaged in HIV
issues. One problem with this non-engagement is that it affected medication adherence. Of
note, there appeared to be a striking ‘dose-response’ relationship between the level of
engagement in HIV issues and support for adherence: the less engaged a man was the less
supportive for adherence to cotrimoxazole he was. Three groups of men were identified: 1)
the group that provided the most support for adherence, 2) the group that was not opposed to
cotrimoxazole but did not actively support it, and 3) the group that was opposed to
cotrimoxazole prophylaxis. First I will describe the group that provided most support for
adherence. Men who were in regular HIV care i.e. those who were on ART and those who
were not yet eligible for ART but were in regular follow-up at HIV clinics were the most
supportive: they accompanied their wives to consultation visits, and they took an active part
in ensuring that the baby was given cotrimoxazole at home, e.g. by reminding the woman to
give cotrimoxazole, and by buying it from the pharmacies in the event that it was out-of-stock
at the clinic. Out of 16 married women, only six had such husbands.
The next group consists of five men who had taken some steps towards confronting HIV
issues. All initially had negative reactions when the women disclosed their HIV results but
with time they came to a point where they could discuss their family’s HIV care; they
accepted the wife’s HIV status and were not opposed to the baby taking cotrimoxazole,
although they did not actively support it. They allowed the wives to give cotrimoxazole as
instructed by health care workers. Their main challenge was that they were not ready to share
their own HIV status with their wives. All of them refused to go for couple counselling and
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testing, and two of them were believed to be lying about their testing histories. Tari believed
that her husband had not yet been tested although he had told her that on two separate
occasions after her HIV diagnosis he had gone for HIV testing alone, and had tested negative.
When she suggested couple testing he refused and was angry that she had suggested it.
Another participant, Sekai, believed that her husband had already tested HIV positive, but he
did not admit to this and instead told her that he had not yet been tested. There was
suggestion that the response to HIV was shaped by relationship dynamics and gender norms.
It appeared that men felt HIV stripped them of their masculinity; it was more acceptable for
the woman to have HIV than the man. None of the five men were ready to admit their
vulnerability to HIV to their wives. One of the women, Maka, reported her husband, was
scared of HIV testing: “He is afraid that if he tests positive I might leave him.” Since he did
not leave her when she tested positive, this provides support to the notion that men felt
emasculated by HIV and did not want their women to view them in this way in case they
thought less of them than men who did not have HIV. Another man from the least supportive
group, Saru’s husband, provided further support to this view. When his wife told him about
her HIV status “he said a-ah that’s the business of women. I myself will never get tested for
HIV.”
The least supportive group were opposed to cotrimoxazole prophylaxis for the babies. The
group consisted of husbands of five participants: Grace, Saru, Ruth, Fungai and Miriam.
They were reported to have told the women that they did not want to know their HIV status.
When their wives told them their results they refused to accept them and refused to
understand the reasons why the baby had to be on cotrimoxazole. Three of the men forced
their wives (Grace, Saru and Ruth) to stop giving cotrimoxazole to the babies.
I explained that the cotrimoxazole is for prevention of infections. And he said ha-a my
child is not going to keep taking medicines willy-nilly. Grace, 23-year old married
mother of two
Ruth’s husband told her to stop giving cotrimoxazole because he felt it could harm the baby.
Their first child who died and some of his relatives are reported to have had adverse reactions
to cotrimoxazole and he wanted to avoid that happening to the baby. It was not clear how
genuine this concern was because he would steal Ruth’s cotrimoxazole to take himself. The
baby had been on cotrimoxazole for about two months and had not reacted to it, so Ruth did
not understand his concern. She had continued to give it in secret but when he discovered
“He said if I kept giving cotrimoxazole he would take the baby away from me and give him to
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his mother.” Her mother-in-law also stepped in, telling her that cotrimoxazole prophylaxis
was not worth fighting over or losing her marriage over, so Ruth gave in and stopped
administering cotrimoxazole.
Grace and Saru were taking cotrimoxazole for their own HIV care, and the husbands stopped
them taking it as well.
About a month after I delivered he suddenly asked me what the tablets
(cotrimoxazole) were for. I explained to him and he became angry and said, “This is
madness, these are all lies.” Then he took the tablets and threw them away.” Grace,
23-year old married mother of two
Grace’s husband also threw away hers and the baby’s handheld medical records. The men’s
behaviour may be explained by the fact that they did not want to know their own HIV status;
they were not able to deal with the possibility of being HIV infected because they felt that
their masculinity would be threatened, as suggested by Saru’s husband. That their wives had
tested HIV positive might have been indication to them that they were likely to also test HIV
positive, and they did not want to face that. Neither could they face continued confrontation
with the reality of HIV infection in the family in wives/children who were taking daily HIV
medicines, hence the move to stop the women from giving/taking the medicines. This view is
supported by Miriam’s situation: she reported that her husband did not receive news of her
HIV diagnosis well. He is reported to have been so disturbed by the results that she described
him as “unstable”. He no longer said much. “He has lost weight and has lost his appetite.”
Because of this she did not think he was strong enough to receive news that the baby was
taking cotrimoxazole prophylaxis, so she did not tell him. She thought that if he found out it
would push him over the edge because he would assume it meant that the baby was sick. She
worried that he would then leave them. “If I tell him that the baby is taking some medicine he
will start thinking too many things. He might leave us forever because he will think that a-ah
this child is sick with HIV.”
These data suggest that some men (possibly those not exposed to HIV testing and
counselling) are unable to cope with HIV diagnosis. Their response not only delays their own
testing but threatens the health of their partners and children by stopping their access to
medicines. Public health campaigns have tried to educate men about HIV, and to encourage
them to go for counselling and testing. Those men who had been counselled and tested for
HIV did not have negative attitudes to HIV and even had positive health-seeking behaviours.
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The six husbands who were in regular HIV care and had been to couple counselling sessions
provide evidence for this. Sadly, three of them had only sought care as a result of either
themselves or their child being seriously ill. Of importance, however, is the role of women:
Stacy’s husband (one of the group of more supportive men) and Maka’s husband (in the
second group) initially had very negative views about HIV testing and counselling but they
changed after the wives’ interventions. The wives continued to put pressure on the men to
confront the issue of HIV. Stacy reported that she refused to have unprotected sex with her
husband, insisting that he should first get tested for HIV. He resisted this, saying he was “not
going to use a condom with a woman he had paid lobola for” but she remained firm. He
eventually gave in and went for testing. Afterwards they both went for couple testing and he
has been very loving and supportive despite him testing HIV negative. Maka’s husband also
got some pressure to start confronting HIV issues from his wife: she refused to talk to him
until he promised to start working towards confronting the issue of HIV in the family. He was
reported to have changed his attitude considerably, from the initial attitude where he did not
believe her HIV test result to one where he believed the result and was promising to soon get
tested himself. Women therefore have a critical role in supporting the health seeking
behaviour of their husbands, although the capacity they have to intervene is significantly
influenced by their relationship circumstances i.e. risk of violence or having the child taken
away, as in Ruth’s case.
Marital strife may also result in adherence challenges; a look at Fungai’s situation illustrates
this. Fungai is the woman who would pack condoms for her husband. He openly conducted
extra-marital affairs, and he also stole her cotrimoxazole tablets to take himself. The latest
disruption was when he brought his mistress home and spent the night with her on their
marital bed while Fungai was made to sleep on the floor, in the same room. After this
incident Fungai left her husband and went to the rural areas, but because of her distress when
she left, she forgot to take the baby’s medicine. So her baby did not take cotrimoxazole for a
few days. While in the rural areas she found someone who said she used to give
cotrimoxazole prophylaxis to her child, and had some left-over cotrimoxazole; she got that
and started giving it to her baby. This illustrates that she recognises the importance of the
baby taking cotrimoxazole and will do anything to ensure that it happens. It is obviously not
ideal; one would hope that the medicine she got was indeed cotrimoxazole, that it was not
expired or that it had been kept in good enough conditions to still be suitable for giving to the
baby. Her case, like that of a significant proportion of women in this sample, illustrates that
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they have significant motivation to adhere but their capacity to implement is shaped by their
circumstances and relationships.
Fear of HIV disclosure as a barrier to adherence
The fear of HIV disclosure presented challenges to participants both for giving cotrimoxazole
at home and for collecting prescription refills from the clinic. Women felt that the community
generally does not have good understanding of HIV, and does not have a positive attitude
towards HIV positive people. People in the community were reported to laugh at or ridicule
HIV positive individuals and to refuse to associate with them. Women were therefore keen to
prevent unwanted HIV disclosure in order to avoid these stigmatising attitudes. This resulted
in some participants giving us the wrong physical addresses for where they lived because
they feared that the home visits would result in HIV disclosure. This was the main reason
why there were low numbers of completed home visits. Rumbi gave a false address; during
the in-depth interview she said she was worried about disclosure of her HIV status to her
father and step-mother whom she reported had poor understanding of HIV. I have not told
them because I worry that they will look down upon me and they will no longer want me to
live with them because they will think I will spread the infection to everyone who lives in the
house. In two cases participants were visited at home but the study procedures could not be
done because there were other people around in the house/room.
A recurring theme among participants was the fact that stigmatisation results in increased
stress levels which would lead to earlier death. All women who reported that they were
worried about HIV disclosure and associated stigma said they knew of other people living
with HIV who were being laughed at, looked down upon or discriminated against. This was
particularly challenging given the crowded accommodation that the women lived in; they
hated the fact that people could discuss and laugh at someone who was known to be HIV
infected in the shared spaces like bathrooms and corridors where a lot of people would hear.
This gossip was believed to have an adverse effect on the health of HIV positive people,
which participants were understandably keen to avoid.
There is one woman who is on HIV drugs who people always talk about; because of
that her health never improves, she is always sick. She chose to share her HIV status
with everyone but now people just go about spreading word that she is taking HIV
medicines and the like. She is always sickly. Tendai, 27-year old married mother of
four
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There was limited voluntary disclosure of HIV status; the women generally told their
husbands and one other person, but there were four women who had disclosed only to their
husbands. It was common for participants not to have disclosed to other people living in the
same household e.g. sisters and other relatives they lived with. This presented a challenge
with giving the medicine especially given that participants generally lived with many family
members in a single room. Maka, who earned a living through street vending of meat, said
she worried that if people knew her HIV status they would stop buying her meat because they
would think it was infected with HIV. She lived with her sister whom she did not trust
enough to disclose to because she was likely to “spread the information around.” Maka
reported that she did not give the cotrimoxazole in sister’s presence; she would wait until the
sister left to go to the market before giving medicine to the baby. Interestingly, she reported
that before she tested HIV positive she used to have the same attitudes towards people living
with HIV because she was afraid of being infected by them. She found it hard to accept
groceries from a cousin who she knew to be HIV infected. “I would only accept groceries
which came in sealed packages like rice or sugar. If he gave me some meat I would worry
that he might have cut himself and infected the meat…” HIV stigma was therefore a reality
that participants had experience with, having seen it being directed at other people, even by
themselves. They knew the extent of its ugliness and did not want to be recipients of it.
Another participant, Barbara, reported that if there were other people in the room when it was
time to give the medicines she would pretend to go the toilet, and she would give the
cotrimoxazole to the baby there. “The challenge is people can come before I have given the
medicine; then I will take the bottle outside... I can actually go and give the medicine in the
toilet”. This not only highlights the constraints in giving the medicine when there is fear of
HIV disclosure but also highlights the potential hygiene issues given the uncleanness of the
shared toilets.
The other reason why women wanted to keep their HIV status unknown to the general public
was to protect their children. Women desperately wanted to shelter their children from the
‘cruel’ world; they did not want them to be subject to any stigmatising attitudes.
I don’t want people to find out themselves because they will assume that my baby is
HIV positive. Then they will no longer want to hold my baby…I would like an
opportunity to clearly explain everything to them, that I got the baby treated and she
does not have HIV. Barbara, 23-year old married mother of one
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It was also common for women not to have disclosed their HIV status to their other (older)
children. All the women who had not told their children reported that they did not feel the
children were mature enough to handle the information, so they worried that if people talked
about their HIV statuses in the common/shared spaces the children would hear them and they
would be adversely affected.
“We live with small children whom we are not yet able to hold these discussions with
because they don’t understand. So if they find out through someone else they might
not be able to handle it, they will think that a-ah my mum is about to die and they will
be distressed, yet they are such small children.” Tendai, 27-year old married mother
of four
Just as an aside, it was noted that older children of the women must have been facing
difficulties themselves. In many cases they were closely involved with the baby’s adherence
to medicines; in some cases they reminded the mother to give the medicine and in others they
gave it themselves but without having been formally told why the baby was taking the
medicine. They knew that they were supposed to be secretive about the issue, which may
have caused them to worry. Some women reported that they suspected that some of the
children were aware, but they did not feel able to ask. This is what Tendai said about her 12-
year old step-daughter:
“I didn’t tell her but she seems to understand the situation. Let’s say I am doing my
laundry in the evening at around seven she will tell the smaller child to come and
whisper in my ear that it’s time for taking the medicines…Even when there are people
in the room, she will say, “Mum, come here.” Then I will go. Then she will say,
“What about today?”; then I know and will take the tablets.”
The fear of HIV disclosure also acted as a barrier to the collection of prescription refills at
Mbare Clinic. As described previously, there is a chronic diseases clinic where all patients
with chronic disease attend for prescription refills. Despite the inclusion of patients with
various types of illness the community views the clinic as a clinic for people living with HIV.
Some participants reported that they found it difficult to collect their drugs because they
feared HIV disclosure in the event that they were seen at the clinic by someone who knew
them.
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Sometimes it’s hard for me to collect the medicine because I might see someone I
know; then it becomes incredibly difficult because I have not disclosed to anyone
except my husband. Barbara, 23-year old married mother of one
Women who lived in an area of Mbare called Matapi were told by nurses to transfer to
Matapi Clinic, another City of Harare primary care clinic, where they were to collect
prescription refills because that clinic was closer to where they lived. (This process was not
systematically done however; many women who lived in the Matapi area were not
transferred). Four participants were transferred to Matapi Clinic; two of them went without
problems but the other two were not happy with the transfer. They complained that Matapi
Clinic was too close to their place of residence, so they feared HIV disclosure. Attending
Matapi clinic was reported to have a higher risk of disclosure than Mbare Clinic in that it had
separate queues for 1) general patients, 2) TB patients and 3) HIV positive patients.
“Our block of flats faces the clinic, and people know what kind of patients are in each
queue. If a person sees you in that queue she will rush to tell everyone in the flat, so I
don’t feel free to go to Matapi.”
This participant, Tendai, reported after the interview that she was planning to lie to the
nurses, telling them that she had relocated to another area that was within the Mbare Clinic
catchment area. She was warned about the dangers of giving a false address to the nurses and
in the end she took up the transfer to Matapi. So profound is Tendai’s fear of collecting drugs
from Matapi that she refused transfer for antiretroviral drug prescriptions from Harare
Hospital to Matapi. From her meagre earnings she sacrifices to pay the extra transport and
attendance fees in order to avoid collecting her drugs from Matapi. Matapi clinic only asks
for $1 per visit, but Harare Hospital charge $5 and she has to have busfare as well. This
illustrates the significance of the fear of unwanted HIV disclosure and associated stigma,
showing that the environment that women lived in was profoundly unsupportive of HIV
positive individuals. It also illustrates how difficult it is to conceal one’s HIV positive status
when living in a crowded environment where everybody minds other people’s business.
Health system barriers to adherence to cotrimoxazole
The main health systems challenges to adherence experienced at Mbare Clinic were stock-
outs of cotrimoxazole, long queues at the clinic, and the fact that at times nurses did not
dispense enough cotrimoxazole supplies to last until the next appointment.
Chapter 9: Adherence experiences
205
Stock-outs of cotrimoxazole
As reported in Chapter 4, there were several stock-outs of cotrimoxazole over the course of
the study. Nine of the twenty interviewed women were affected by stock-outs. The stock-outs
meant that women had to buy cotrimoxazole from private pharmacies. Consequently, some
babies did not take cotrimoxazole for several days because the mothers could not afford to
buy it. For example, at six weeks Maka’s baby was not given cotrimoxazole because it was
out-of-stock. She was told to go and buy from the pharmacy. However she had no money, so
her baby did not take cotrimoxazole for the next two weeks. Another participant, Mucha, was
told at her six-week visit that cotrimoxazole stocks (which previously had been out-of-stock)
had been received but they had not yet entered into stock cards. She was told to return to the
clinic on the next day, but she did not come back for three weeks, and the baby was not
taking any medicine during that time. Sometimes the stock-outs forced women to look for
alternative informal sources of cotrimoxazole, which may potentially be harmful: Sekai
reported that she had a friend who worked at a clinic in the rural areas and she asked her to
get some cotrimoxazole for her because she could not afford to buy from the pharmacy.
Another problem was with expired drug, which was reported by one participant, Saru. After
one prescription refill visit she discovered that the medicine was expired and she did not
know what to do. She did not give cotrimoxazole for a few days before she came back to ask
the nurses about it.
Long queues at the clinic
Another challenge with prescription refills were long queues at the clinic. Participants
reported that they typically had to dedicate the whole day to a clinic visit, which they found
difficult.
We just know that a clinic appointment means that you will spend the whole day at the
clinic; you will not even have time to wash the baby’s diapers. Like today I started
making preparations to come to the clinic at 6am because I wanted to be one of the
first ones to get help. We got here, we don’t know what the problem was; they only
started helping us at 10. Yet I just left the house without eating anything. I am hungry
and the baby is also hungry.” Mucha, 41 year old married mother of 5
The problem of long queues particularly affected self-employed women who reported that it
was difficult to sacrifice the whole day. They reported that it was especially disheartening
when after waiting for a long time they were told that the cotrimoxazole was out-of stock.
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Tracy, a dancer, reported that she found it difficult to spend a long time at the clinic, and each
time she tried to get cotrimoxazole she found that it was out-of-stock, so she made an
arrangement with a friend of hers, a cleaner at the clinic, who in turn told her that she had a
friend who was a nurse who could get the cotrimoxazole for her. This was indication of
unsafe prescribing practises, and could also be an indication of some drug pilferage at the
clinic.
The other challenge related to this is that women were scheduled to attend the clinic at
different times for appointments for their own HIV care and for their baby's, which meant
spending more days at the clinic.
Disparity between next appointment date and amount of cotrimoxazole dispensed
Several participants reported that one challenge they faced when they first started collecting
cotrimoxazole was that nurses did not give them enough cotrimoxazole to last until the next
appointment. All of them reported that the nurses would give them an appointment date that
was two months away, but only give them 100mls of cotrimoxazole, which was 40-days’
supply. As discussed in chapter 6, women found it difficult to seek clarification from nurses
if there was something they did not understand. As a result, when the medicine ran out before
the appointment date, they started worrying about the nurses’ reaction if they turned up
before the appointment date that was written on the medical record, and started thinking
about what explanations they would give in the event that the nurses asked them why they
had come earlier than scheduled. The women reported that they had to “psyche up” for the
encounter, and they were “relieved” when nurses supplied the cotrimoxazole without asking
questions.
Women reported that as time progressed they no longer worried about it because they found
that nurses would supply the cotrimoxazole without asking questions. It is reassuring that
nurses provided refills without question, but it caused considerable anguish to women who
already had many other issues they were dealing with in their lives. Women who were unable
to summon the courage to face the nurses for early drug refill often reported poor adherence.
Mucha reported that before she knew that the nurses would help she would give less
cotrimoxazole so that it would last until the next appointment:
I stopped giving cotrimoxazole at that time. I could not give it as directed because I wanted it
to last until the next appointed date. But now I know that a-ah! I will keep going back to
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them, nagging them, telling them that I want the baby’s medicine. Mucha, 41 year old
divorced mother of five
9.3.3 Other issues affecting the study participants
9.3.3.1 Early infant diagnosis
Early infant diagnosis was offered at the Mbare Clinic at the six-week visit. Most participants
had their babies tested for HIV at the six-week visit using DNA PCR on dried blood spots.
However there were challenges getting the results back; a few were able to get them at the 3-
month visit but some had not obtained the baby’s results by the 5-month visit. Several women
would complain to study staff that they were having challenges obtaining their results; the
nurses kept telling them to come back later. Study staff enquired with the Sister-in-charge,
and she confirmed that they indeed were having challenges getting the results back from
BRIDH hospital. She said because of manpower issues the hospital required someone to
come to the clinic and make photocopies of the results. The clinic was also short-staffed and
found it difficult to release someone to go and make the copies at BRIDH.
The other challenge with collecting the results is that the nurses were busy, and they confided
to the study nurse that sometimes they did not have the time to go through folders to look for
individual results for the babies. In some cases the nurses gave the study nurse the results
folder and asked her to pull out the results for the study participants. Nurses found it
acceptable to ask the study nurse to do this because she was familiar; she had worked with
them within the same system in her previous job. This also shows the ‘better’ care that the
participants had because they were in the study, which is unlikely to continue once the study
if finished.
Babies who tested HIV positive
Tracy, Maka and Tendai had HIV positive babies. Tracy and Maka’s youngest babies had
recently tested HIV positive. With Tendai, the youngest baby was HIV negative and she had
a three year old son who tested positive at about 18 months of age. Maka and Tendai’s babies
were already on ART. Tracy had recently received the results when she was seen at the clinic
for the six-month visit; she was still to go back to the hospital for ART initiation.
All three participants reported that they were devastated when they were told that their babies
had HIV. They said they could handle their own infection, but it was just too painful to be
told that the baby had HIV. Tracy was seen at the six-month study visit about three weeks
Chapter 9: Adherence experiences
208
after she got results that the baby was HIV positive. Throughout her study participation, she
had looked vibrant and was confident that because of the PMTCT efforts she was putting in,
her baby was going to test HIV negative. She had her baby tested at Harare Hospital at six
weeks, and when she was told at three months that the baby was negative she decided to stop
breastfeeding, and was told to come back for another test six weeks after cessation of
breastfeeding. This was the test that was positive. When she was seen for her six-month visit
she did not have any of the vibrancy she had had in previous visits, she looked defeated and
was in a lot of emotional pain. She confided that she had even considered doing things she
should not have done, possibly suicide (it was not clear what since it had not been possible to
probe her because she was too distressed), and she was grateful that her husband had been
there for her and had supported her.
I was hoping that she would be negative, and that one day I would tell her that I was
positive, and tell her why I was taking tablets. Now I will have to do regular routines
of collecting my drugs and hers also. I will have to do a double job. …I thank God for
my husband who was there for me. He is the one who restricted me.
Maka reported that she also had a terrible blow when her baby’s results were disclosed. She
has however felt better over time because at the hospital where she collects the baby’s ART
she has seen some grown children who were born with HIV, and she was encouraged because
they are healthy.
I-i-i-i-i! The baby’s HIV positive results were more painful (than mine), so it was
like…I felt my hair rising above my head…It really affected me. It would have been
much better if it was just me. But then again I saw other children who come to collect
their medicines; some are grown up girls, actually grown women who are in
universities. They said were they were born like that. So it made me feel better, and I
thought ha-a, what I can I do I just have to deal with the situation.
Despite this hope for their survival with HIV, at the end of her in-depth interview Tendai
pleaded with researchers to find a cure for HIV.
We are crying out to the researchers to find a cure for HIV. That’s what we are
asking. Even if it means that one will take the course for one year, it will be alright
because you will be cured. That’s what we are crying for, especially for the children.
Even if we adults remain with the disease, but if the children are ok, it will be much
better. If there was a cure for the babies I will keep taking my tablets with the hope
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that I will live to see my cured child, it will be better. That’s our request, may those
who are searching please find us medicines that cure.
As has been described in previous sections the women care deeply about their children and
will do all they can to ensure the children’s wellbeing, although their capacity to ensure that
the child receives treatment is undermined by the circumstances in which they are living.
Having a baby test HIV positive caused grief among the women, which underlies the
importance of improving the quality of PMTCT services provided in order to eliminate
mother-to-child transmission of HIV.
9.3.3.2 HIV care for the women
Out of twenty interviewed women, thirteen had received satisfactory HIV care by the time of
the in-depth interview. Four were already on ART (these are women who had been diagnosed
before the last pregnancy; they were already on ART when they got pregnant). Two women
who were diagnosed during pregnancy had already taken all the required steps for ART
initiation: they were eligible for ART, and they had taken the necessary medication adherence
lessons, and had been given appointments for when they would be started on ART.
The other seven women reported that they had not yet taken steps towards their HIV care.
They had all been referred to BRIDH hospital, the hospital that has an HIV clinic where ART
initiation is done. However five of them had not yet gone by the time of interview because
they could not afford the consultation fee of $6. This presented a problem in that some
women were already in need of HIV care, for example Maggie had had a POC CD4 count at
Mbare clinic and her CD4 count was 230. She was thus eligible for ART initiation when she
delivered her baby but by the five-month visit she still had not gone to BRIDH hospital
because she could not afford the $6. Fortunately this problem has been dealt with because the
hospital is no longer charging the consultation fee. Grace and Saru (the women whose
husbands were strongly against HIV care) were in this group as well. Their husbands may
also have played a role in this delayed health-seeking.
The other two women who had not yet sought HIV care were Vimbai and Tracy. Vimbai
reported that she did not have time to go to BRIDH. She was a widow and sole breadwinner
and she reported that it was difficult to take time off her vending business to go to the clinic.
She had already taken some time off when her baby was hospitalised, and the effect of this
was that she failed to pay her rent, which forced her to move in with her mother.
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Tracy did not report any particular reason for not having gone to BRIDH hospital. She is the
woman who reported that she actively tried not to think about HIV. She said it was difficult
to confront the issue of her HIV status, and seemed to be slow in all her health-seeking. For
example, at about 4 months the nurses at the child health clinic told her that her baby was
supposed to be on nevirapine prophylaxis, but she did not go to the chronic diseases clinic to
collect it. In addition, although there generally were problems with obtaining the baby’s HIV
results, she did not seem to be putting as much effort as the other women to get them. She did
not want to join the queues at the chronic diseases clinic; she is the participant who made
arrangements to get cotrimoxazole through the cleaner. This suggests that denial of HIV or
disengagement in HIV issues may adversely affect health-seeking behaviour. This was also
observed among men who refused to confront HIV issues in their families.
9.3.3.3 Challenges with infant feeding practises
Another challenge that women faced in caring for their babies was related to feeding
methods: women were taught about the benefits of exclusive breastfeeding and instructed to
practise it for the first six months of the baby’s life. Some women reported that exclusive
breastfeeding was hard; they felt that the babies were hungry and the breast milk was not
sufficient for them. The cultural beliefs in Zimbabwe made it worse; nurses have for a long
time (before HIV) been instructing women to exclusively breastfeed for the first six months,
and the general response in communities is to ignore that teaching and give porridge within a
few days because ‘the baby will be hungry’. As a result, even women who did not feel that
their babies were hungry were under pressure from people they lived with to give porridge. If
the baby cried the people would complain that the baby was crying because s/he was hungry
and would scold the woman for not giving porridge. This was a dilemma for some women:
on one hand they had a baby they felt was hungry and would benefit from porridge, and on
the other hand they desperately wanted to follow instructions so as to protect the baby from
HIV.
So I am confused because there are times when the baby cries because of hunger and
I can really see that there is not enough breast milk…the baby is not getting enough
milk. Maggie, 33-year old married mother of three
Women also complained that in some cases the people they lived with would give other
foods; this was especially prevalent in women who had not disclosed their status to people
they lived with. They were not taken seriously if they just said the reason they were
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exclusively breast-feeding was that nurses had told them to do so. “They say, “A-ah nurses
are always saying that, but we gave our children porridge and nothing happened.” Because
of fear of stigma women found it difficult to explain that exclusive breastfeeding was
important for PMTCT purposes, and were forced to always have their babies with them, even
when it would have been more convenient to ask someone to watch the baby for a few
moments. “I should never take my eyes off the baby.”
Despite the above challenges none of the participants reported that they practised mixed
feeding. The majority exclusively breast-fed; only two women were giving formula milk.
Participants who came from families that traditionally breast-fed their babies in the first six
months of life had no problems with exclusive breastfeeding. For example Fungai reported
that her mother-in-law has always insisted that a woman should breast-feed exclusively in the
first six months; this is what she did with her first two babies, so exclusive breastfeeding with
the third child was not a challenge as she was used to it. I had no problem because with all
my children…in fact my mother-in-law always says she does not want to see any of her
family’s babies eating porridge soon after delivery.
The other challenge women faced was worry about what they would feed their babies after
six months. The study was conducted when the clinic was transitioning from teaching that
HIV positive women should stop breastfeeding at six months to the AFASS guidelines
(conditions to be met if replacement feeding is to be given to babies. These include the
availability of safe water and sanitation, assurance of continued supplies and ability to
prepare and give the food safely: A-Acceptable, F-Feasible, A-Affordable, S-Sustainable, S-
Safe). Some women were still with the old teaching and were worried that they had no food
to give to their babies after the six-month period. Those women who were aware of the
AFASS guidelines were worried about the continued exposure of the baby to HIV: “We were
told that when the baby is more than six months old s/he will get HIV because at that age s/he
will suck-off all traces of milk that is in the breast.
Many participants therefore wished they could get donations of formula milk.
9.3.3.4 Anxiety about end of study participation
Some participants worried about their end of study participation; they worried about loss of
confidantes as their participation in the study ended. Participants reported that the study had
given them an opportunity to openly discuss their feelings about HIV, and they had found this
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therapeutic. In most cases study staff were the first people that participants had openly
discussed their HIV issues with.
“Sister T was the first person I talked to about my HIV status.” Fungai, 27-year old
married mother of 3
At the end of her in-depth interview, this was what Mucha said:
I am thankful for this project, and these procedures you have been doing. You
know…sometimes…when you are asked questions…when you find someone to talk
to…sometimes I just long to speak to someone, someone I am free and comfortable
with, what we have just been doing; it helps us have a better state of mind. Mucha,
41-year old married mother of five
In addition, participants were aware that their participation gave them privileged access to
certain forms of care as the study nurse had more time. For example she counselled them and
at times assisted them to get ‘privileged’ care for the nurses, like retrieving their results.
It was clear that more has to be done to set up structures that enable the social support of HIV
positive women in Mbare. There is a support group for HIV positive individuals at Mbare
Clinic and a friendship bench for the support of distressed individuals, but none of the
interviewed women reported attending them. It could be the fear of HIV stigma in their
crowded communities that deterred women from participating, suggesting that other methods
of supporting recently diagnosed HIV patients should be sought.
9.4 SUMMARY OF STUDY FINDINGS
This study revealed that recently HIV-diagnosed women go through a lot of anxiety and
distress around the time of diagnosis related to 1) coming to terms with their HIV status, 2)
lack of husband support soon after HIV testing and for medication adherence, 3) fear of
stigma and 4) health system factors like drug-stock outs and long queues at the clinic. The
desire to ensure the health of their children has motivated these women to focus on adhering
to CTX-p and other health care interventions. In addition, most women reported a striking
inability of their male partners to confront HIV issues, which was driven by lack of
knowledge, and likely, fear that HIV infection emasculated them in their partners’ eyes.
Interventions are required to lessen the emotional burden upon women at time of diagnosis.
Many women reported feeling distressed after their HIV diagnosis. In many instances their
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depression was compounded by lack of or incorrect knowledge about HIV, e.g. many thought
they were about to die, and some did not know that it was possible to give birth to an HIV
negative baby. The nurses providing antenatal care were overwhelmed and probably did not
have enough time to educate the woman or go through with her what being HIV positive
meant. The clinic has a friendship bench that provides psychosocial support to distressed
individuals. None of the women used this service. Nurses may need to actively refer HIV
positive women to this bench so that they access this care.
Interventions to encourage testing among male partners, particularly couple testing are
required. This study found that men who had gone through couple testing and counselling
had the model ideals and health seeking behaviours that public health professional would like
to see. It is clear that male support is essential for the optimum uptake of all interventions
along the PMTCT cascade, starting with ANC registration as discussed in Chapter 7.
Potential methods of increasing male involvement in Mbare community, which have been
employed in other settings, will be discussed more fully in the discussion chapter. Finding
ways to encourage men to take a more participatory role within the family may be beneficial.
There are some examples of interventions to encourage men to become more involved in
parenting which will be discussed.
In addition to interventions for male involvement, communities in general should be further
educated about HIV. This is especially important in order to dispel existing myths and
provide up to date information on available health care interventions for people living with
HIV. This might lessen the fear that communities have of HIV testing, and might also lessen
the stigma that is common in communities like Mbare.
One of the main observations in this study is the unwavering determination of women to
adopt health care interventions that they believed were beneficial to their children. This
concept might be employed in health promotion messages. As observed in the last chapter,
women do not pay much attention to interventions that are designed to benefit their own
health but they are particular about interventions for their babies.
This study also highlighted the therapeutic effect of research studies in the context of limited
social support. Study staff were in most cases the first people that participants openly talked
to about their experiences since testing HIV positive. It was a privileged position to have
participants open up about their circumstances and it is also humbling that while data were
being gathered for research purposes the participants felt that the process was therapeutic.
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This also highlights the limited social support that HIV positive women have in their
communities, and should act as a driving force to find interventions that are aimed at
producing communities that can openly talk about HIV without fear of stigma.
The findings if this chapter will be discussed more fully and in light of the other findings in
the discussion chapter.
Chapter 10: Discussion
215
CHAPTER 10: DISCUSSION
10.1 OVERVIEW
This PhD project investigated health system and patient level barriers to the implementation
of cotrimoxazole prophylaxis among infants born to HIV positive mothers. Barriers were
investigated at policy level and at all stages of the cotrimoxazole care cascade, starting with
identification of HIV exposure status during ANC, initiation of cotrimoxazole prophylaxis
six-weeks postnataly and adherence to cotrimoxazole prophylaxis. Although this project
focused on cotrimoxazole prophylaxis, the findings and implications do not relate to the issue
of cotrimoxazole prophylaxis provision alone but to the whole package of services provided
to HIV-exposed infants along the PMTCT cascade. Addressing the challenges to
implementation identified by this study would likely result in improvement in PMTCT
services in general. In order to understand the extent of challenges faced in implementing the
PMTCT cascade more generally, a systematic review was conducted to investigate the
magnitude of loss to follow-up of HIV-exposed infants from real-life PMTCT programs at
various points along the PMTCT cascade.
10.2 SUMMARY OF STUDY FINDINGS
10.2.1 Systematic review findings
There was significant heterogeneity in the reported loss to follow-up outcomes of the
reviewed studies. Despite this it was evident that there is unacceptable loss to follow-up of
infants from real-life PMTCT programs. An estimated 49% of HIV positive mothers are lost
to follow up between ANC registration and delivery. Programmes which offered older
PMTCT regimens (single dose nevirapine) reported greater losses than programmes which
offered dual/triple therapy.
Among fourteen studies which reported loss to follow-up of infants by three months of age,
the pooled estimate of loss to follow-up was about 34%. Another 45% of infants were lost
after HIV testing; they either stopped coming for the recommended follow-up visits after
testing, or did not return to collect results. At all stages of the PMTCT cascade that were
studied in the systematic review, programmes which actively tracked defaulters reported
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better retention outcomes than those which did not follow-up women-infant pairs who missed
their appointments.
10.2.2 Policy study findings
There was Government commitment to a nationwide, multi-sectoral response to HIV.
Ministry of Health and Child Welfare (MoHCW) have formulated comprehensive guidelines
for the implementation of cotrimoxazole prophylaxis, based on WHO guidelines. MoHCW
had support from partners, e.g. EGPAF, Kapnek Trust, ZAPP, and OPHID who supported
implementation of PMTCT services. In addition, the Ministry received funding for HIV
services from bilateral and multi-lateral donors. However all this support at the macro level
did not result in optimum implementation of cotrimoxazole at site level. Countrywide, only
34% of babies who needed cotrimoxazole prophylaxis received it in 2010. At Mbare Clinic,
several barriers to implementation were uncovered, which included: shortage of staff,
inadequate training of site staff on specific procedures for implementation, poor supply chain
management possibly because of lack of training of clinic nurses and logistical challenges at
the main City of Harare pharmacy. Other challenges reported by clinic nurses were patient-
specific: some women were lost to follow-up at the six-week visit because they were having
challenges adjusting to their newly diagnosed HIV status. The department that was
responsible for home follow-up of such women was short-staffed and overwhelmed by work,
and this challenge was compounded by the fact that women often gave false home addresses.
It was clear that the strong commitment to provide cotrimoxazole at the macro level was
insufficient in itself to ensure implementation; there was need for support to continue to be
'cascaded' down to site level to ensure optimum implementation. It is likely that some of the
challenges were caused by the economic challenges that afflicted the country between 2003-
2010 : many experienced workers left the country to seek employment elsewhere, and there
were insufficient financial resources to hire as many new employees as were required.
10.2.3 Findings from studies of the cotrimoxazole prophylaxis cascade
The first challenge observed was entry into the cotrimoxazole care cascade: 23.4% of women
did not seek ANC, a critical step of the cascade where health care workers are alerted of the
HIV exposure status of the infant. Those women who registered generally did so very late in
their pregnancy; mean number of weeks gestation at time of registration was 29.5 (95% CI
28.6-30.4). In multivariable analysis, factors associated with ANC registration were
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education, which interacted with whether the pregnancy was planned, household income and
marital status. In the qualitative study, women reported the following were barriers to ANC
registration: user fees, fear of HIV testing and associated stigma if tested HIV positive,
unsupportive husbands/male partners, nurses’ poor communication, long waiting times at the
clinic and unplanned pregnancy. These factors interacted with each other in a complex way.
There was poor attendance at the six-week visit, the clinic visit where babies are supposed to
be initiated on cotrimoxazole prophylaxis. Overall only 20% of women attended the visit; and
35% of Mbare residents attended. There was no association between six-week visit
attendance and maternal HIV status. Women who registered for ANC were three times more
likely to attend the six-week visit than those who did not. Qualitatively, the main reasons for
non-attendance were lack of appreciation of importance of the six-week visit for the baby;
and that women valued the health of the baby above their own. Distrust of nurses particularly
in relation to unintended HIV disclosure was also reported as a barrier to attendance.
In the adherence study, again it was evident that women valued the health of their babies and
were determined to do all they could to adhere to their baby’s cotrimoxazole prophylaxis
along with any other medicines that had been prescribed. Barriers to adherence included
unsupportive husbands, fear of unwanted HIV disclosure and associated stigma and health
system factors like drug stock-outs, long queues at the clinic and disparity between dispensed
amounts of cotrimoxazole and the next appointment date for prescription refill. The
adherence qualitative study also highlighted that HIV positive women experienced significant
anxiety/anguish, first with coming to terms with their own HIV status along with
unsupportive husbands and constant fear of unwanted HIV disclosure in a community that
was viewed by the women as highly unsupportive of HIV positive people.
10.3 DISCUSSION OF STUDY FINDINGS
Before going into discussion of the findings, it is important to highlight the main limitation of
the study, which is important for understanding the implications of the study findings. The
study was conducted at one clinic, which might not be representative of the other health care
centres in the country. However, it may represent the best of what was happening in the
public health setting at that time. City of Harare rates Mbare Clinic as one of their best
clinics; it is often referred to in the media as one of the model clinics in Harare. This is
confirmed by the fact that half of the women who deliver at the clinic are not residents of
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Mbare, but are women who opt to travel from clinics in the neighbourhoods in which they
live so that they can seek the services at Mbare Clinic. Interviewed nurses reported that
Mbare Clinic was viewed by clients as more organised, and less likely to have drug stock
outages than others in Harare.
A discussion of specific study findings now follows.
10.3.1 Policy findings
10.3.1.1 Adoption of policy at national level does not guarantee optimum
implementation
This study was conducted at a time when cotrimoxazole prophylaxis had already been widely
adopted as an important intervention at national level in Zimbabwe. The challenges related to
adoption of research findings on cotrimoxazole prophylaxis into policy, as reported in
Malawi, Zambia and Uganda40,41 had already been overcome, yet this did not result in
successful implementation at health care centre level. This teaches us that adoption of policy
at national level is insufficient to achieve good results; there needs to be sufficient follow-up
and support at every stage of implementation to ensure adoption of policy recommendations.
As reported in Chapter 5 (policy study), official record review of Ministry of Health
documents revealed that the main challenge preventing optimum implementation was
financial122,136; the country was recovering from a politico-economic crisis. Inability to hire
and retain adequate numbers of trained health care workers meant that the fewer health care
workers were overwhelmed with duties, which limited their ability to provide quality health
services. Although efforts had been made to mobilise financial resources for the national
response to HIV, there was still a gap in funding which prevented hiring of adequate numbers
of health care workers and adequate funding of health services. Continued mobilization of
resources to the health sector is therefore required. Zimbabwe is a signatory to the
Ouagadougou Declaration which emphasises incremental funding of health systems up to
15% of the national budget by 2015125. Health expenditure has for a long time been one of the
top 5 priorities of the country’s national budget122 and indeed Government is regularly
commended for its National AIDS Trust Fund (NATF) introduced in 1999 to increase
Government's ability to finance its HIV response. However in an ailing economy this proved
insufficient; other methods of managing resources need to be considered. For example there
is need for better efficiency in the use of both national and donor funds. That NatPharm
indicated there were plentiful supplies of cotrimoxazole (from more than seven donors), such
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that they were worried the drug could expire could suggest excess supplies due to duplication
in funding. The Paris Declaration, in which Zimbabwe also subscribes122, calls for promotion
of efficiency through avoidance of duplication in funding146. At the time of this study
Zimbabwe had begun this process of harmonisation of funding from donors through the
Expanded Support Programme which was funded by several donors for HIV services122, but
more still needed to be done. Efficient use of resources will result in savings that can be used
for other critical resources like human resources.
One approach to tackling the issue of limited resources other than to employ suitably
qualified staff is to consider task shifting. WHO has recommendations for task shifting across
all levels of qualification and competency to address health care worker shortages and
improve the delivery of HIV and AIDS services147 (figure 10.1).
Fig 10.1: WHO guidance on task-shifting in the health sector147
Task shifting has been undertaken in several countries without compromising safety or
quality of services148-151. For example it has been successfully implemented in Uganda,
Democratic Republic of Congo, Malawi, Ethiopia and developed countries like UK, USA and
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Australia.147 In Zimbabwe, task-shifting of counselling roles from nurses to lay counsellors is
being implemented at varying levels across health care centres around the country, and has
been found to be acceptable to patients152,153. At Mbare Clinic, we found relatively little
evidence of task-shifting of nurses’ roles. The primary counsellor cadre, which has been
widely introduced in public health centres to relieve nurses of non-clinical HIV-related
duties, has not been introduced within the City of Harare system. In addition to primary
counsellors, City of Harare might consider recruiting lay volunteer counsellors who can also
help to reduce nurses’ workloads. Allowing nurses to concentrate on the more clinical duties
might address some of the challenges related to workload that have been identified in this
study: it might result in greater ability to train staff on new policies and procedures, fewer
omissions while caring for patients, more compassionate attitudes towards patients and better
quality service provision in general.
10.3.1.2 Poor supply chain management
It is worrying that during the course of the study (16 months) at Mbare Clinic there were four
periods (sometimes lasting up to three weeks) of cotrimoxazole stock outage while the
national stores had excess cotrimoxazole which they worried would expire before use.
Cotrimoxazole is classified in the Zimbabwe essential drugs list as a vital level C drug, which
means that it is expected to be 100% available at all levels of care. Although not specifically
explored in this study, this finding raises concerns that sub-optimal stock management may
extend to other drugs and supplies used at the clinic, which could potentially include supply
of ARVs given that the clinic is an ARV follow-up site. Stock outs also prevent provision of
essential services at the clinic: for example there was a time at Mbare Clinic when babies
were not being offered EID because the required DBS filter papers were not in stock. The
challenge with supply-chain management is not limited to Mbare Clinic, but is a countrywide
problem; NatPharm, MoHCW and its partners are aware of this challenge and have attributed
it to shortage of experienced staff following the country’s politico-economic problems. A
2005 countrywide logistics system assessment found that most health care sites in Zimbabwe
did not have proper procedures for supply chain management and many drugs and supplies
regularly went out of stock. Most sites did not have cotrimoxazole in stock, and those that
had it had very small amounts154. Recommendations for staff training in logistics
management were made but have yet to be implemented. To solve the problem in the short-
term, at the time the study was conducted NatPharm was sending pre-packaged primary care
kits which contained all the necessary drugs and sundries for primary level centres to
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district/rural health centres on a quarterly basis. They did not wait for the districts to place
orders themselves. This was being done for rural health centres; clinics run by the City of
Harare were not included, resulting in the stock-outs at Mbare Clinic.
In addition to the urgent need for staff training on supply chain management, other logistic
challenges to timely drug provision exist. For example the City of Harare main pharmacy was
reported to have transport problems for the delivery and collection of supplies (Chapter 5).
Furthermore, staff shortages are likely to compound the problem.
10.3.1.3 Gaps in provision of staff training on new implementation guidelines
We found that while some clinic staff had been trained in new policy guidelines, others had
not. MoHCW trains few staff members who are in turn expected to cascade training to their
colleagues at the sites. In practise this is difficult in a short-staffed clinic where staff will be
too busy to train one another, leading to service provision by untrained workers. In this study
some errors were noted which were possibly due to lack of staff training, e.g. omissions of
ARV or cotrimoxazole prophylaxis, prescription of incorrect duration of infant ARV
prophylaxis or wrong dosages for cotrimoxazole prophylaxis. MoHCW might consider
implementing procedures that ensure training of all site staff. For example MoHCW might
train a large group of trainers who in turn provide training to all staff at specific health care
centres. In addition, clinics could implement procedures to minimise the chance of staff who
have not received training from conducting key clinical duties. For example staff might be
required to read the guidance documents and provide evidence that they have done so.
MoHCW could then look for this evidence when they undertake their support visits. In
addition to ensuring that all staff are trained, this site-specific training could enhance team
working amongst clinic staff: a study conducted in Zimbabwe in 2010 found that selective
training of staff members off-site often resulted in discord because there were financial
benefits for attendance of training meetings in the form of travel and subsistence allowances.
Staff who did not attend the training meetings felt left out of the benefits and did not feel it
was their responsibility to provide services they had not been formally trained to do153.
I will now turn to discussing findings from the cotrimoxazole care cascade; this will be
integrated with findings from the systematic review which also looked at a similar cascade.
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10.3.2 Discussion of findings from the cotrimoxazole care cascade
As discussed in previous sections, many factors were found to contribute to attrition along the
cotrimoxazole prophylaxis cascade. These include user fees, fear of HIV testing,
unsupportive male partners, HIV-related stigma, and relationship between nurses and clinic
attendees. These will now be discussed in turn in the following sections.
10.3.2.1 User fees
User fees presented a huge barrier to entry into the cotrimoxazole cascade; all participants in
the ANC qualitative study reported this as a barrier which accounted for both late
registrations and non-registrations. A possible solution to this challenge is removal of user
fees, a process that Government has begun using the Health Transition Fund128. Many
studies, including systematic reviews have shown the positive impact of removal of user fees
on uptake of health services in countries in Sub Saharan Africa including Zambia, Niger,
Ghana, Uganda and South Africa.155-157 However lessons learned from these countries
indicate that careful planning should be undertaken before abolishing user fees.158-160 There is
need to forecast the impact of abolishing fees on demand of health care services, and
resources such as drugs and human resources, followed by mobilisation of sufficient funds to
support this process and ensure sustainability. Removal of user fees without proper planning
can result in significant strain on the health system and poor quality outcomes. For example,
when the Government abolished user fees in public health care institutions in Zimbabwe in
2012 there was chaos in one of the central hospitals in Harare as a large number of women
went to deliver there; the hospital could not cope with the increased numbers because it was
not adequately staffed and there were insufficient beds; some women were forced to give
birth on the floor161. Also, when user fees were reduced at Mbare Clinic from $50 to $30 in
2011 nurses complained that the increase in number of women accessing maternity services
was difficult to cope with, and may have had an impact on the quality of services provided. In
the interim while the challenge with user fees is being addressed, City of Harare might
consider accepting the registration fees in small instalments that women can afford.
To encourage attendance of all antenatal and postnatal visits the City of Harare Health
Department has a flat maternity fee rate which covers all antenatal and postnatal care up to
the six-week visit. Although the fee itself may be a barrier, once women have got together the
money to pay for ANC they are more likely to attend post natal visits: in this study women
who registered were three times more likely to attend the six-week visit than those who did
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not; addressing the challenges with user fees might increase attendance of the six-week visit.
A study in India also found that women who registered for ANC early were retained in the
PMTCT programme better than women who registered late89. This may be because increased
contact with health care workers exposed the women to education, support and counselling
which may have caused them to have better appreciation of the importance of adhering to
clinic appointments. In addition, it may have increased client connectedness with the health
care system, a phenomenon that has been reported to be associated with lower rates of missed
clinic appointments98. Also, women who register early have already demonstrated that they
have positive health seeking behaviours than those who do not; they can be predicted as most
likely to attend for postnatal services in terms of their behaviour.
Zimbabwe is preparing to begin implementing the WHO Option B+ programme (where all
HIV positive pregnant or lactating women are given ARVs which are continued for life); it is
anticipated that this implementation will begin at the end of 2013 or early in 2014. The
continued interaction with women when they collect their prescription refills may help
increase retention rates along the PMTCT cascade for the same reasons mentioned above.
Results from the Malawian Option B+ programme indicate encouraging retention rates of
77% 12 months after initiation of ART among women who did not transfer care during
follow-up. Retention of mothers in care will likely reduce MTCT and likely also keep the
HIV-exposed infants in care.99 Related to this, the recent recommendation by WHO to initiate
HAART at a higher CD4 count threshold might result in better retention rates for the same
reasons mentioned above.
Another challenge which not only affected entry into the PMTCT cascade but also adherence
to cotrimoxazole prophylaxis, was fear of HIV testing, which will be discussed in the next
section.
10.3.2.2 Fear of HIV testing
At Mbare Clinic HIV tests are offered to all women who register for ANC. 99% of women
who registered knew their HIV status. This may be evidence of the effectiveness of the opt-
out strategy of HIV testing in getting high acceptance rates for HIV tests. Many research
studies in Sub-Saharan Africa have documented the superiority of the opt-out strategy over
the opt-in model in the uptake of HIV testing. 153,162-165
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Unfortunately, the high uptake of HIV testing at Mbare Clinic was not all good news; there
was evidence that women did not feel able to opt-out of testing. This is a drawback
particularly in a community where the fear of HIV testing is rife, as reported in qualitative
interviews. Similar findings have been reported in other settings. In rural Uganda women are
believed to have stayed away from the ANC clinic because they were not aware that they
could opt-out of HIV testing166. In South Africa, there were reports that women felt coerced
by nurses to get tested, which resulted in some of them ‘running away’ from the clinic167. In
Kenya women were reported not to be aware that HIV testing was optional168. WHO
guidelines on HIV testing are clear that the offer of HIV testing should not be coercive169.
Health systems need to ensure that HIV tests are offered in a way, and in an environment,
that allows autonomy in HIV testing. This is not only important from a human rights
perspective, but also to ensure that women who do not want to get tested for HIV feel able to
seek antenatal services. Likely, if women who choose not to test are retained within the
health care system, the continued education, counselling and support from health care
workers might enable them to take up HIV testing at a later stage. Related to this, it is likely
that education campaigns have emphasized the importance of PMTCT services during ANC
so much that communities are no longer aware of the other benefits of ANC that are not HIV-
related, but have a polarised view of the ANC clinic as an HIV testing clinic. Education
campaigns emphasising the importance of ANC from a holistic perspective may help
overcome some of these issues.
It is disturbing that HIV testing, the entry point to the PMTCT programme, is the very thing
that keeps some women away from ANC. It is clearly critical to understand the fear of HIV
testing and find ways of addressing it so that women will feel able to get tested. That women
associated an HIV diagnosis with imminent death shows a lack of understanding of HIV
disease and available interventions for saving lives of HIV infected individuals. Education
campaigns to sensitise communities about this might be beneficial. Of note, these educational
campaigns have been happening in Zimbabwe for some years. There may be need to find
other strategies to deliver messages in a way that engages women from poor communities
such as Mbare. However we already know that education on HIV disease and available
interventions alone is unlikely to be sufficient to convince people to get tested as there is fear
of HIV stigma, discussed below. Some studies have shown that the fear of HIV testing is
sometimes so strong that it overrides all the potential positive effects of HIV testing, causing
people to choose not to test.170,171 In this study, the fear of HIV testing was found to be the
Chapter 10: Discussion
225
main factor limiting men’s ability to support their partners to take up services along the
PMTCT cascade. This will now be discussed in the next section.
10.3.2.3 Unsupportive male partners
In this study women reported that their male partners had serious challenges with HIV
testing, either of themselves or their partners. It is likely that men felt that HIV testing and
diagnosis might threaten their masculinity. Other studies in Zimbabwe have reported that
men see HIV as a threat to their manhood, which is associated with unwillingness to use
health services and denying their partners access to HIV-related health care. 172-174. In Malawi
men reported that a woman could be divorced if she tested for HIV without the husband’s
consent175. Interventions are needed that will help men feel that HIV testing can enable them
to have control of their disease and their life i.e. that HIV testing is empowering rather than
emasculating. Education/messaging that emphasises how HIV testing can help a man achieve
his ‘manly’ roles may be beneficial, e.g. accessing treatment after testing HIV positive will
help maintain the man’s health and enable continued participation in masculine roles like
working for the family. Of note, several media campaigns in Zimbabwe have tackled issues
related to what constitutes a ‘real man’ e.g. PSI Zimbabwe have tackled the issue of sexual
violence with advertisements that say that ‘real men’ are not violent to their wives and do not
force women to have sex with them. Again effort needs to be made to ensure that such
messaging is packaged in a way that makes sense and is accessible to men in poor
communities like Mbare.
Couple testing and counselling might be effective in allaying some of the fears that men have
about HIV testing. In this study, men who had undergone HIV testing and counselling,
particularly as couples, were reported to be more supportive of uptake of PMTCT services.
Similar findings have been found in other African countries; in Tanzania176,177, South
Africa178 and Kenya179 women whose male partners had undergone HIV testing and
counselling at the clinic where the women were enrolled for PMTCT were found to have
better uptake and adherence to PMTCT services. Unfortunately, in these settings it was a
challenge to get more men to come and get tested at the ANC sites, signifying the importance
of promotion of male-friendly HIV testing and counselling sites outside ANC sites. In
Democratic Republic of Congo there was greater uptake of HIV testing by men in bars than
in health care centres where their pregnant female partners were being attended to180. Besides
promotion of couple counselling and testing, there is very little literature on interventions that
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can be employed to promote male involvement in PMTCT programmes. A 2012 Cochrane
review on this subject found only one eligible study which evaluated an intervention to
increase male support181. Women in the intervention arm received a letter which invited their
male partners to come to the clinic for HIV testing and counselling177. The study found that
women who were tested as couples were more likely to use preventive measures against
transmission (90% vs 60%) and were more likely to receive single dose nevirapine for
themselves or their babies, 55 vs 25% and 55 vs 22% respectively, although there was
reduced uptake of HIV testing in the couple VCT arm. There is need for development and
evaluation of more interventions to improve male involvement in PMTCT programs.
10.3.2.4 HIV-related stigma
HIV-related stigma played a significant role in the uptake of services along the PMTCT
cascade. It limited women’s ability to register for antenatal care, attend the six-week visit,
and adhere to cotrimoxazole prophylaxis for the baby. This is not the first study to
demonstrate this effect: studies in Kenya94,182, Zambia,183 South Africa,184 India185 and other
countries186 have shown that women might avoid ANC registration, HIV testing and facility-
based delivery because they fear testing HIV positive and consequent stigma. A recent
systematic review found that HIV-related stigma has a significant negative impact on service
uptake along all stages of the PMTCT cascade186. The authors of the systematic review came
up with a conceptual framework that illustrates the mechanisms through which stigma can
result in negative outcomes for the HIV positive mother and her children (figure 10.1). The
psychosocial effects of stigma result in poor health-seeking behaviour and poor health
outcomes.
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Fig 10.2: A framework for the effects of stigma on maternal, neonatal and child health186
There are various forms of HIV stigma that have been identified in the literature, including 1)
self-stigma or internalised stigma, which is a feeling of self-blame or self-deprecation
because of HIV infection, 2) Perceived/normative/felt stigma refers to fears or expectations
that people have about being stigmatised in the event that their HIV status is known, and 3)
enacted stigma, which refers to the actual experience of being discriminated against because
of HIV or suspected HIV183,186. The three qualitative studies that were conducted as part of
this project (barriers to ANC attendance, barriers to six-week visit attendance, and adherence
study) all revealed that women were aware of the existence of enacted stigma in their
communities, having heard accounts of people who had suffered it, or seen it inflicted on
other people, or having previously inflicted it themselves. A new kind of stigma, called
vicarious stigma, has been identified185,187: it describes the channel of communication about
enacted stigma in the community, and is the basis for perceived/normative/felt stigma. Even
if the HIV positive person has not personally experienced enacted stigma, the communication
around enacted stigma in the community makes it more salient, and heightens the HIV
positive person’s fear of HIV disclosure, which is perceived/normative/felt stigma. Vicarious
stigma was the main kind of stigma that was reported in this PhD project: there were few
instances where participants reported personal experiences of enacted stigma, but there was
extensive reporting of fear of stigma that resulted from discussions/perceptions of enacted
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stigma on other people in the same community.
To increase the uptake of PMTCT services, it is important to scale-up stigma reduction
interventions in the country, particularly to poor and crowded communities like Mbare where
the effects of stigma are more salient. Stigma interventions have been classified into four
categories: 1) informational approaches to give information on HIV disease, transmission and
methods of reducing risk of acquisition, e.g. through mass media, educational lectures etc; 2)
skill building, where potential perpetrators of stigma are given skills of how to interact with
HIV positive people, 3) counselling/support to help HIV positive individuals to cope with the
disease, e.g. in support groups, and 4) testimonials from people living with HIV188,189.
Systematic reviews have found these approaches to work in reducing stigma188,189. However
many of the studies were not rigorously evaluated, and very few studies have been conducted
in developing countries. There is need for rigorously evaluated stigma reduction strategies in
settings similar to Zimbabwe, followed by scaled-up implementation of evidence-based
interventions. A lot of stigma-reduction activities are already going on in the Zimbabwe, e.g.
mass media campaigns, teaching about HIV in schools, and the National Behaviour Change
Programme, but more still needs to be done to achieve communities with low stigma levels.
Stigma reduction is particularly important for PMTCT programs because statistical modelling
has shown that stigma accounts for more than half (53%) of vertical infant HIV infections,
and that scale-up of stigma reduction interventions can avert 33% of all mother-to-child
transmissions.186,190
In addition to stigma reduction activities in the communities, Mbare Clinic could do more to
ensure that their clinical activities are undertaken in a manner that assures clients of
confidentiality and decreases risk of HIV disclosure. While the chronic disease clinic offers
efficiency given the staff shortages, it has a major disadvantage in that is has been labelled as
an HIV clinic, which deters HIV positive patients from accessing care. The City of Harare
might consider integrating this clinic with the general outpatients’ clinic so that clients feel
less worried about the possibility of unwanted HIV disclosure.
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10.3.2.5 Relationship between nurses and clinic attendees
Qualitative interviews showed that nurses’ discourteousness affected all stages of the
cotrimoxazole care cascade. Not only did it result in some women staying away from the
ANC clinic altogether, but it also resulted in those that did attend feeling unable to ask
questions about theirs or the baby’s care if they did not understand. We documented several
instances where opportunities to minimise risk of mother-to-child infections were lost. For
example we found that women whose HIV infection is not diagnosed because they did not
attend ANC are unlikely to get PMTCT interventions. Additionally, women who are unable
to request prescription refills are less able to adhere to medication. Health care worker
discourteousness has also been reported to affect uptake of PMTCT or ANC services in Cote
d’Ivoire97, South Africa191 and in a recent systematic review on barriers to poor usage of
ANC services in low and middle income countries96. It is therefore critical that health care
workers are trained on good client relationships. In addition, to ensure that staff do their work
well, health care systems might consider introducing systems for rewarding health care
workers who do their job well, and discipline those who do not. One strategy that has been
employed to improve the performance of health care systems is results based financing or pay
for performance, which refers to transfer of money or provision of material goods conditional
on achieving a certain target, e.g. delivery or utilisation of services, patient outcomes or
quality outcomes192. There are large pay for performance programs in UK, USA and
Australia193. There are fewer and smaller programs in low and middle income countries, but
there are some that have been successful, e.g. a programme in Rwanda provided health
system bonus payments based on quantity and quality of key maternal and child welfare
services. This resulted in improvements in numbers of institutional deliveries, uptake of
preventive child services and quality of services provided194. Positive outcomes of
performance-based payment on quantity and quality were also reported in Democratic
Republic of Congo, showing the feasibility of implementing such a system in a very poor and
troubled nation. 195
Addressing staff shortages and work load as discussed in section 10.3.1.1 might result in
improvement in nurses’ wellbeing and mood, which might help them to be more sympathetic
towards patients.
One of the problematic nurse-client interactions was referral to Harare Hospital for labouring
women. Because nurses referred women against a background of poor communication,
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especially after having been shouting at the women for ‘bad behaviour’, women construed the
referral as punishment. Women reported that nurses did not adequately explain their reason
for referral to either themselves or to the hospital where the woman was being referred.
Nurses need to understand that this is how referral is sometimes interpreted. This is important
because pregnant women have already devised strategies not to register in order to save
money in the event of referral. Clearly nurses need to communicate professionally and ensure
that their clinical decisions have been understood by their clients. Also, women need to be
referred with proper documentation of the reason for referral so that the receiving health care
worker will know how to manage the patient. Good clinical communication is critical to
optimise patient care.
Interviews indicated that there was widespread discussion about the nurses’ perceived
attitudes in the community, which reportedly reduced women’s attendance of the clinic. This
suggests that to improve uptake of services perceptions within the community will need to be
altered. Findings from this study point to the effectiveness of client testimonies in
disseminating information within the community so changes in attitudes and behaviour
brought about through awareness training would likely be quickly communicated.
Improvement in community perceptions on nurse attitudes might also result in an increase in
couple counselling and testing and male involvement; studies in Uganda196 and South
Africa197 have reported that men do not take up couple testing at clinics because of their
perception about nurses’ attitudes.
In addition to interventions to improve health care worker attitudes, patients and clinic
attendees need to be made aware of their rights and the kind and quality of services they
should expect to receive from health care workers. To improve patients’ ability to demand the
health care they deserve, health care systems need to explore ways of ensuring that patients
feel comfortable to ask questions or to request services from nurses. Patients should be taught
about their rights and how to exercise them. Patient charters can be a useful way of
introducing this. Although Zimbabwe has had a patient charter since 1996, more needs to be
done to ensure that the public are aware of it and what it means198. In addition, there is need
to develop and implement a patient-friendly system for addressing grievances. The
government of Zimbabwe might consider implementing an ombudsman system that will
actively deal with patient rights and patient complaints from all levels of care, as has been
done in UK199.
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10.3.2.6 Improving retention along the PMTCT cascade
The systematic review in Chapter 2 revealed that health care systems that had effective
methods of tracking defaulters had better retention outcomes than those that did not. To
improve the follow-up of women at the six-week and other regular PMTCT visits, Mbare
Clinic might consider strengthening strategies for follow-up of women who have missed their
appointments. Fortunately, provisions for this are already in place; a department for
community follow-up of patients exists but has not been actively tracking defaulters because
of short-staffing and high workload. Increased use of the lay workers, the health promoters
who are employed by City of Harare for this purpose might be beneficial. While the issue of
staffing is being sorted a more immediate solution might be follow-up of defaulters using text
messages. The majority of Zimbabweans now have access to a mobile phone; the reported
tele-density in Zimbabwe in 2012 was 90%200. Importantly, tracking efforts should ensure
that confidentiality is not compromised. The PhD project did not investigate loss to follow-up
of HIV positive women between ANC registration and delivery; however the systematic
review showed that an estimated 49% of women might be lost at this time. Tracking of
missed appointments can therefore not be over-emphasised. A potential challenge with
tracking is the false locator/contact details given by women. Reasons for this need to be
investigated and if possible addressed. In our study the reason behind giving false addresses
was related to fear of unwanted HIV disclosure, and nurses reported that sometimes women
who come from outside the Mbare clinic catchment area give false addresses because they
fear that the clinic will turn them away. Implementation of stigma-reduction interventions in
the communities as described in Section 10.3.2.4, and addressing challenges with catchment
areas might lessen this problem.
Qualitative findings about the six-week visit indicated that the main barrier to six-week visit
attendance was lack of knowledge of importance of the visit for the baby. This is a relatively
straightforward knowledge gap to bridge. It was clear from all qualitative interviews that
women value the health of their babies and would do anything to ensure uptake of
interventions for the benefit of the baby. Of note, women were less able to prioritise their
own health, for example they did not see the importance of the maternal health services
offered at the six-week visit. Given the commitment of women to their babies’ welfare,
educational messages that brand maternal health services as important not only for the mother
but also for the benefit of her babies might increase uptake of maternal health services.
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Another challenge with continued follow-up of woman-infant pairs is the non-integration of
maternity services and chronic diseases clinic. Women were referred from the maternity
services to the chronic care clinic, which was in a different building, where long-term HIV
care for the infant and the mother was provided, and nurses worried about the potential for
loss to follow-up. A study in Mozambique documented that there was significant loss to
follow-up as a result of referring clients from one building to another, even if it was at the
same institution. The health care workers at that hospital devised a simple intervention where
women who were referred were physically accompanied to the referred site (EID site), and
this resulted in a three-fold increase in the odds of uptake of EID services76. Mbare Clinic
might consider using lay volunteers or health promoters for this purpose. Related to this, the
systematic review revealed that some infants were retained in the immunisation services but
not in HIV care, so they did not get EID. Integration of immunisation services and EID
services might improve the retention of HIV exposed infants in HIV care.
10.3.2.7 Positive views about cotrimoxazole prophylaxis
This study revealed that women had very positive views about cotrimoxazole prophylaxis,
and this encouraged continued adherence. Positive views on cotrimoxazole prophylaxis were
also reported in the ARROW study, which was conducted in Zimbabwe and Uganda9. That
study found that 25% of caregivers refused to participate in another randomisation in the trial
(study arms were either continued or stoppage of cotrimoxazole prophylaxis among children
who were stabilised on ART) because they believed in the effectiveness of cotrimoxazole,
having seen its benefits during the period before their children had access to ART. The
perceived good health of the baby that is attributed to cotrimoxazole can result in a virtuous
cycle: perception that the intervention is working provides motivation which encourages
further adherence to all interventions along the cotrimoxazole care cascade. There is need for
health systems to demonstrate success at each stage of the PMTCT cascade because this
provides impetus for increased commitment to adherence.
I will now briefly discuss the HIV care of HIV positive women who participated in the study.
10.3.3 HIV care for mothers
One of the limitations of this study is that there were small numbers of HIV positive women
who were followed-up, so it was not possible to study the factors affecting successful
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enrolment of the mothers into regular HIV care. Despite this it was noted that women who
did not return to the clinic at six weeks were generally not enrolled in HIV care, while those
who were in regular follow-up at the clinic had received more care. This further underscores
the importance of follow-up of defaulters as discussed above. Qualitative interviews
suggested that not having come to terms with one’s HIV status can affect the ability to seek
HIV care. This points to the need for support and counselling of women after HIV diagnosis
to help them cope with the new diagnosis. At the beginning of the study, some HIV positive
women had challenges accessing HIV care for themselves because they could not afford the
$6 consultation fee. Fortunately this fee has now been removed. This goes further to show
that user fees can have a negative impact on access of services among the poor.
10.3.4 Reflexivity (for qualitative studies)
Interviewed participants were aware that the study team were health professionals who were
not part of the team at Mbare Clinic. This identity of the researchers might have enabled
participants to talk about intimate details of their lives which they would normally only share
with a trusted health professional. This was possibly one of the factors that enabled the study
team to get an in-depth understanding of the women’s reality. Because women were willing
to go into specific detail about the care they had received the study team was better able to
study the adequacy of the health care that the woman or her baby had received. That the study
team was viewed as external to the system also helped in that women felt able to give
detailed accounts of things they were not happy with at the clinic, particularly the perceived
inappropriate/inadequate clinical care (e.g. inadequate supplies cotrimoxazole) or treatment
they reported receiving from clinic nurses. Also, the candidate (interviewer in the qualitative
studies) fluently spoke Shona, the language that the participants used, and during home visits
she appeared relaxed in the participants’ poor surroundings, which might have helped
participants feel free to talk and less aware of the difference in social class.
The view of the researcher as a health care worker might also have influenced participant
accounts of their behaviour as they may have borne in mind what health care workers
consider as ‘good’ patients. This might explain women’s accounting around the fear of HIV
testing and nurses’ lack of compassion as barriers to ANC registration. None of the
interviewed women were ready to admit that they may have stayed away because of either of
these two factors, but they presented these reasons as general feelings among other women in
their community. They were quick to point out that it was irresponsible not to seek ANC just
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because of these reasons, and were keen to distance themselves from such actions. This was
possibly because they wanted to be viewed by the interviewer as a responsible and caring
mother with ‘good’ health-seeking attitudes.
In addition, for most HIV positive women study staff were the first people they opened up to
about their HIV infection; it might have been the first time they processed their feelings about
their HIV diagnosis and their experiences. As reported by some women this had a therapeutic
effect, which may have caused women to pour out more from their inner selves than they
would normally do. The result was the collection of vivid and often emotional accounts of
what women went through in their life journey since the time they tested HIV positive.
The professional key informants (nurses, MoHCW, City of Harare and NatPharm
representatives) understood the role of the candidate as a researcher. Being themselves
educated individuals who had good jobs, they appeared to have a similar social class as that
of the candidate. The fact that the candidate was viewed as knowledgeable around PMTCT
issues made them go into much detail about the specific challenges that they faced with
implementation.
The Ministry of Health correspondent was very supportive of the study, explaining that as a
programmer she would need information on how the health care system could be improved.
She seemed candid in her responses about the challenges that Ministry of Health faced as an
institution. Likewise, City of Harare, NatPharm and the clinic nurses understood the
importance of the research and seemed ready to talk about the institutional challenges that
they faced in the implementation of cotrimoxazole prophylaxis. However, it is likely that they
all might have also have viewed the research as something that had a potential to reveal bad
practises on their part, which might have influenced how candid they were in their responses.
As a result, more information might have been given on how institutions were failing, but
less information on how they (as individuals) might have been failing in their duties.
10.4 STRENGTHS OF THE STUDY
The main strength of this study was the ability to study various points of the cotrimoxazole
care cascade in order to get an in-depth understanding of challenges affecting each part of it.
Several studies including a systematic review were conducted. The multi-methods design was
useful in elucidating the findings. There were plenty of opportunities for triangulation of
findings from the various studies that were conducted.
Chapter 10: Discussion
235
Another strength of the study was its narrow focus on the cotrimoxazole care cascade, yet the
findings are widely applicable to other interventions along the PMTCT cascade. This
narrowing of focus allowed detailed evaluation of factors affecting uptake of the intervention;
yet addressing such factors might result in improvement in uptake of PMTCT services in
general.
The study provided a unique opportunity to investigate the reasons why there was sub-
optimal uptake/implementation of cotrimoxazole prophylaxis in Zimbabwe. MoHCW and
Harare City Health officials indicated that they were looking forward to getting the study
report as they were hoping it would provide solutions to some of the challenges they have
been grappling with. Optimal implementation of PMTCT interventions is an area of
importance for MoHCW. The study findings were presented to City of Harare in 2011, and
presentation to MoHCW and other partners is planned.
10.5 LIMITATIONS OF THE STUDY
As stated at the beginning of section 10.3, the main limitation of the study is that it was
conducted at one clinic, which might not be representative of the other health care centres in
the country. However, it may represent the best of what was happening in the public health
setting at that time.
The policy analysis would have benefited from an examination of the contribution of key
individuals to policy. Including the key individuals would have necessitated a close study of
the individuals to get information on their values and motivations. The cost of this could not
be supported by the small PhD fellowship. Also, the policy review could have benefitted
from a survey of nurses where they could be questioned about the training (on the policy)
they had received and knowledge of the guidelines on cotrimoxazole prophylaxis and care of
HIV positive mothers. This would have enabled better understanding of how well guidelines
are transmitted from Ministry of Health to clinic staff.
Another limitation is the small number of participants who were included in the cross-
sectional survey; because of this many estimates were not precise. 299 out of 553 (54%)
women were surveyed, and we were not able to get characteristics of those who were not
surveyed. However the characteristics of surveyed participants were comparable with those
of women in the retrospective clinic record survey, which suggests that the sample was
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representative of women delivering at the clinic. A related limitation is the potential for
selection bias because participants were recruited only during weekdays and during daytime
hours, and also included women who attended the 10-day postnatal clinic, who might be
different from non-attenders. The initial plan when the study was designed was to collect data
only from the post-natal ward. It was however difficult to recruit women in the ward because
they reported being too tired and feeling too much pain to go through interviews. A decision
was then made to recruit from the 10-day clinic as well, which was less ideal given the
potential for selection bias. It would have been helpful to compare the characteristics and
responses given by participants who were recruited from the two different clinics (postnatal
ward and 10-day clinic); however the data were not entered in a way that allowed this.
Fortunately the similarity of the survey data and the data for the clinic record survey for six-
week visit attendance suggests that selection bias was minimal, but we are not able to
determine whether the timing of interviews (at delivery or at day 10) influenced participant
responses.
Because participants were recruited from the clinic, the study only represents views of
women who were engaged with the health care system; the barriers affecting women who
delivered at home and did not access health services thereafter were not captured. At the
beginning of the study we sought to understand the proportion of women who deliver at
home: over a two-week period we asked the City of Harare community health workers
(health promoters) to identify all deliveries that happened within their catchment areas, and
the proportion that were home deliveries. The workers reported 8 of 58 (14%) deliveries had
happened at home and the women had not sought any health care afterwards. These figures
were interpreted with caution as it was evident that community health workers had not
captured some of the deliveries that were known to have happened at the clinic (as shown in
the clinic delivery records). However these data suggest that there were women who were
totally unengaged with health services whose views were not captured in this study. They
may have had similar challenges to those that have been reported, but may also have had
different challenges that are unique to them.
Another limitation of the study was that not all stages of the PMTCT cascade were studied.
This was mainly because of limited funding for the PhD fellowship. With adequate funding
that would allow recruitment of larger sample sizes and longer participant follow-up, it would
have been useful to look at uptake of maternal and infant ARV prophylaxis, uptake of early
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infant diagnosis (EID) and uptake of ART among infants who tested HIV positive.
Another limitation of the study is that we did not get nurses’ views/responses to concerns that
participants raised. Although nurses were asked about challenges to implementation at the
beginning of the study, a more balanced analysis may have been possible if nurses had been
given an opportunity to respond to participant concerns/complaints. A related limitation was
the inability to study BRIDH Pharmacy (the pharmacy that supplied drugs stocks to Mbare
Clinic). Getting the perspectives of BRIDH Pharmacy staff would have provided a better
understanding of the factors preventing continuous supplies of drug stocks at Mbare Clinic.
The limitations of the systematic review are discussed at the end of Chapter 3.
In conclusion, this study provided a unique opportunity to study health system and patient-
level barriers to paediatric cotrimoxazole prophylaxis. Several contextual, health system and
patient level barriers were found; addressing the challenges at each stage in the PMTCT
cascade will provide incremental benefits in provision not only of cotrimoxazole prophylaxis,
but also of other interventions along the PMTCT cascade.
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10.6 RECOMMENDATIONS
10.6.1 Recommendations to ensure optimum provision of services at health centres
10.6.1.1 Health care system financing
Government should consider increasing the budget allocation to Ministry of Health; there is
need for Government funding of City of Harare services to avoid the latter’s over-reliance on
user fees.
Since user fees present the greatest barrier to ANC registration, City of Harare might consider
reducing them or scraping them altogether. This should be carefully planned as discussed
earlier in this chapter.
There is need for improvement in the management of donor funds; avoidance of duplication
of funding (as recommended by the Paris Declaration) is important.
10.6.1.2 Health care system staffing
There is need to ensure that adequate numbers of staff are recruited to ensure that health care
centres run smoothly.
As qualified health care workers are more expensive to hire, there is need for task shifting as
discussed in the main Discussion. Ministry of Health and Child Welfare have established a
cadre called Primary Counsellor whose roles include pre and post-test counselling and
adherence counselling. This cadre is not yet available in the City of Harare system; there is
need to ensure that these positions are established.
10.6.1.3 Staff training
Staff should be trained on good client relations. A system of management should be
established to ensure that nurses provide professional and sympathetic services.
When new guidelines are introduced, there is need to ensure that training is cascaded down to
the health care workers who are on the ground. This might involve training a group of
trainers who will provide on-site training to all health care workers at each health care
institution. Government might consider introducing a system where health care workers are
not allowed to provide services unless they have received relevant training on new guidelines.
Health care workers at clinic pharmacies need to be trained on supply chain management.
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There is need for regular Ministry of Health supportive visits to health care centres; these are
important both to provide support and clarification on guidelines and for monitoring
purposes.
10.6.1.4 Enforcement of professional conduct among health care workers
There is need to develop and implement a system for rewarding health care workers who
conduct themselves professionally and are conscious of patient rights. For example, the
Government might consider introducing results-based financing to reward health care centres
with good patient-centred outcomes. Similarly, there is need to develop and implement a
system for identifying and disciplining health care workers who do not perform well or those
who do not conduct themselves professionally.
10.6.1.5 Integration of services
The Child Health Services Clinics (which provide well baby clinics and immunisations)
might be integrated with HIV care services in order to 1) reduce time spent at the clinic
through attendance of separate clinics; 2) ensure better implementation of guidelines to test
all babies whose HIV exposure status is unknown, 3) reduce loss to follow-up as a result of
referral to a different clinic, and 4) enable women to feel able to collect cotrimoxazole or
ARV prescription refills without the fear of unwanted HIV disclosure which is experienced at
the chronic diseases clinic. For this to work there is need to allow for confidential provision
of services at these clinics.
Given that the chronic diseases clinic is viewed by attendees as an HIV clinic (making it
difficult for women to collect prescription refills because of fear of unwanted HIV
disclosure), Mbare Clinic might consider integrating the chronic diseases clinic with the
general out-patients clinic.
10.6.1.6 Review of cotrimoxazole prophylaxis guidelines
Travel post-delivery is common; there is need to amend guidelines to ensure provision of
cotrimoxazole prophylaxis earlier than six weeks for the mother to take and start at six weeks.
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10.6.2 Recommendations to enable women to take up services along the PMTCT
cascade
10.6.2.1 User fees
As stated above, City of Harare might consider reducing or removing user fees for ANC
registration.
10.6.2.2 Improved education of patients/attendees
During consultation, nurses should ensure that patients/attendees are well educated:
 Patients/attendees should be taught about the meaning of an HIV diagnosis and
available PMTCT services and services for the mother’s own HIV Care. Messaging
should ensure understanding of the fact that an HIV diagnosis does not mean
impending death.
 Women should be made aware of the importance of the six-week visit, both for the
mother and the baby (if HIV-exposed).
 Patients/attendees should be encouraged to ask questions where they are not clear
(health care workers need to create an enabling environment for this).
10.6.2.3 Campaigns to improve male involvement in PMTCT programs
There is need to educate men about the importance of ANC registration.
Interventions to increase HIV testing and counselling among men are essential. Household
testing and counselling might be adopted to increase uptake of HIV testing and male
acceptability of HIV testing.
10.6.2.4 Social support for HIV positive women
Women should be encouraged to seek existing social support services which can help them
deal with challenges related to living with HIV.
Health care systems might consider developing a system where community volunteers
provide social support to HIV positive mothers. The volunteers can remind the HIV positive
women to adhere to prescription visit schedules, support medication adherence, or link the
women to HIV care services for their own health.
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10.6.2.5 Incentivising attendance of clinic visits
City of Harare might consider incentivising attendance of the six-week visit, e.g. through
reduced consultation fees for all women seeking clinic services after the six-week postnatal
period provided they can demonstrate attendance of the six-week visit.
City of Harare might also consider incentivising early ANC registration, e.g. by charging
reduced user fees for early registrants.
10.6.2.6 Follow-up of defaulters
Given the high mobile telephone density in Zimbabwe, City of Harare might consider
introducing reminder text messaging for patients who have missed their appointments.
Related to this, given the belief by some women that the clinic does not attend to people who
have missed their appointments, the clinic needs to develop and communicate a good system
for re-booking missed appointments.
10.6.2.7 Stigma reduction
There is need for continued education of communities and health care workers about the need
for avoidance of HIV stigma.
Given the fact that studies that have evaluated the effectiveness of stigma-reduction
interventions have not been rigorously done, there is need for carefully designed studies that
evaluate the effectiveness of stigma-reduction strategies in the Zimbabwean context.
References
242
REFERENCES
1. World Health Organisation. Co-trimoxazole prophylaxis for HIV exposed and HIV infected
infants and children. Practical Approaches to implementation and scale up
Geneva: WHO; 2009 2009.
2. Anglaret X, Chene G, Attia A, et al. Early chemoprophylaxis with trimethoprim-
sulphamethoxazole for HIV-1-infected adults in Abidjan, Cote d'Ivoire: a randomised trial.
Cotrimo-CI Study Group. Lancet. May 1 1999;353(9163):1463-1468.
3. Wiktor SZ, Sassan-Morokro M, Grant AD, et al. Efficacy of trimethoprim-sulphamethoxazole
prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis
in Abidjan, Cote d'Ivoire: a randomised controlled trial. Lancet. May 1999;353(9163):1469-
1475.
4. Grimwade K, Sturm AW, Nunn AJ, Mbatha D, Zungu D, Gilks CF. Effectiveness of
cotrimoxazole prophylaxis on mortality in adults with tuberculosis in rural South Africa.
AIDS. Jan 28 2005;19(2):163-168.
5. Nunn AJ, Mwaba P, Chintu C, Mwinga A, Darbyshire JH, Zumla A. Role of co-trimoxazole
prophylaxis in reducing mortality in HIV infected adults being treated for tuberculosis:
randomised clinical trial. British Medical Journal. Jul 2008;337(7663).
6. Mermin J, Lule J, Ekwaru JP, et al. Effect of co-trimoxazole prophylaxis on morbidity,
mortality, CD4-cell count, and viral load in HIV infection in rural Uganda. Lancet. Oct 16-22
2004;364(9443):1428-1434.
7. Chintu C, Bhat GJ, Walker AS, et al. Co-trimoxazole as prophylaxis against opportunistic
infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-
controlled trial. Lancet. Nov 20-26 2004;364(9448):1865-1871.
8. Walker AS, Ford D, Gilks CF, et al. Daily co-trimoxazole prophylaxis in severely
immunosuppressed HIV-infected adults in Africa started on combination antiretroviral
therapy: an observational analysis of the DART cohort. Lancet. Apr 10 2010;375(9722):1278-
1286.
9. Bwakura-Dangarembizi M, Kendall C, Bakeera-Kitaka S, et al. Randomized Comparison of
Stopping vs Continuing Cotrimoxazole Prophylaxis among 758 HIV+ Children on Long-term
ART: The Anti-Retroviral Research for Watoto Trial. 20TH conference on retroviruses and
Opportunistic Infections (CROI 2013); 2013; Georgia, Atlanta.
10. Mulenga V, Ford D, Walker AS, et al. Effect of cotrimoxazole on causes of death, hospital
admissions and antibiotic use in HIV-infected children. AIDS. Jan 2 2007;21(1):77-84.
11. Mermin J, Ekwaru JP, Liechty CA, et al. Effect of co-trimoxazole prophylaxis, antiretroviral
therapy, and insecticide-treated bednets on the frequency of malaria in HIV-1-infected adults
in Uganda: a prospective cohort study. Lancet. Apr 15 2006;367(9518):1256-1261.
12. Kamya MR, Gasasira AF, Achan J, et al. Effects of trimethoprim-sulfamethoxazole and
insecticide-treated bednets on malaria among HIV-infected Ugandan children. AIDS. Oct 1
2007;21(15):2059-2066.
13. Sandison TG, Homsy J, Arinaitwe E, et al. Protective efficacy of co-trimoxazole prophylaxis
against malaria in HIV exposed children in rural Uganda: a randomised clinical trial. BMJ.
2011;342:d1617.
14. Thera MA, Sehdev PS, Coulibaly D, et al. Impact of trimethoprim-sulfemethoxazole
prophylaxis on falciparum malaria infection and disease. Journal of Infectious Diseases.
2005;192(10):1823-1829.
15. Prendergast A, Walker AS, Mulenga V, Chintu C, Gibb DM. Improved growth and anemia in
HIV-infected African children taking cotrimoxazole prophylaxis. Clin Infect Dis. Apr 1
2011;52(7):953-956.
16. Mermin J, Lule J, Ekwaru JP, et al. Cotrimoxazole prophylaxis by HIV-infected persons in
Uganda reduces morbidity and mortality among HIV-uninfected family members. AIDS. Jul 1
2005;19(10):1035-1042.
References
243
17. Kohler PK, Chung MH, McGrath CJ, Benki-Nugent SF, Thiga JW, John-Stewart GC.
Implementation of free cotrimoxazole prophylaxis improves clinic retention among
antiretroviral therapy-ineligible clients in Kenya. AIDS. Aug 24 2011;25(13):1657-1661.
18. Zachariah R, Harries AD, Luo C, Bachman G, Graham SM. Scaling-up co-trimoxazole
prophylaxis in HIV-exposed and HIV-infected children in high HIV-prevalence countries.
Lancet Infect Dis. Oct 2007;7(10):686-693.
19. Karzung BG. Basic and Clinical Pharmacology. Vol 6th Edition. San Francisco: Appleton &
Lange; 1994.
20. World Health Organisation. Provisional WHO/UNAIDS Secretariat recommendations on the
use of cotrimoxazole prophylaxis in adults and children living with HIV/AIDS in Africa
Geneva: WHO/UNAIDS;2000.
21. World Health Organisation. Guidelines on co-trimoxazole prophylaxis for HIV related
infections among chidren, adolescents and adults: recommendations for a public health
approach. Switzerland: WHO; 2006.
22. Ministry of Health and Child Welfare, National Drugs and Therapeutics Policy Advisory
Committe (NDTPAC). Guidelines for antiretroviral therapy in Zimbabwe. Harare,
Zimbabwe: MoHCW;2010.
23. World Health Organisation. WHO recommendations on the diagnosis of HIV infection in
infants and children. Geneva, Switzerland: WHO;2010.
24. Marinda E, Humphrey JH, Iliff PJ, et al. Child mortality according to maternal and infant HIV
status in Zimbabwe. Pediatr Infect Dis J. Jun 2007;26(6):519-526.
25. Coutsoudis A, Kindra G, Esterhuizen T. Impact of cotrimoxazole prophylaxis on the health of
breastfed HIV exposed negative infants in a resource limited setting. AIDS. Jul 21 2011.
26. Date AA, Vitoria M, Granich R, Banda M, Fox MY, Gilks C. Implementation of co-
trimoxazole prophylaxis and isoniazid preventive therapy for people living with HIV. Bull
World Health Organ. Apr 2010;88(4):253-259.
27. World Health Organisation. Taking Stock: HIV in children. Geneva: Word Helath
Organisation;2006.
28. WHO/UNAIDS/UNICEF. Towards Universal Access: Scaling up priority HIV/AIDS
interventions in the health sector: Progress Report 2010. Geneva, Switzerland: WHO;2010.
29. Zimbabwe Ministry of Health and Child Welfare. Zimbabwe Ministry of Health and Child
Welfare: HIV Estimates Report 2007. Harare: Government of Zimbabwe; 2008 2008.
30. ZVITAMBO. PMTCT needs assessment report: Chirumhanzu District, Midlands Province,
Gweru. Harare 2007 2007.
31. Zimbabwe Ministry of Health and Child Welfare. HIV Estimates report, 2010. Harare,
Zimbabwe: MoHCW;2011.
32. Gill CJ, Sabin LL, Tham J, Hamer DH. Reconsidering empirical cotrimoxazole prophylaxis
for infants exposed to HIV infection. Bull World Health Organ. Apr 2004;82(4):290-297.
33. Badri M, Ehrlich R, Wood R, Maartens G. Initiating co-trimoxazole prophylaxis in HIV-
infected patients in Africa: an evaluation of the provisional WHO/UNAIDS
recommendations. Aids. Jun 15 2001;15(9):1143-1148.
34. Sibanda EL, Weller IV, Hakim JG, Cowan FM. Does trimethoprim-sulfamethoxazole
prophylaxis for HIV induce bacterial resistance to other antibiotic classes? Results of a
systematic review. Clin Infect Dis. May 2011;52(9):1184-1194.
35. Ryan M, Griffin S, Chitah B, et al. The cost-effectiveness of cotrimoxazole prophylaxis in
HIV-infected children in Zambia. AIDS. Mar 30 2008;22(6):749-757.
36. Yazdanpanah Y, Losina E, Anglaret X, et al. Clinical impact and cost-effectiveness of co-
trimoxazole prophylaxis in patients with HIV/AIDS in Cote d'Ivoire: a trial-based analysis.
Aids. 2005;19(12):1299-1308.
37. Hogan DR, Baltussen R, Hayashi C, Lauer JA, Salomon JA. Cost effectiveness analysis of
strategies to combat HIV/AIDS in developing countries. BMJ. Dec 17 2005;331(7530):1431-
1437.
38. Coutsoudis A, Coovadia HM, Kindra G. Time for new recommendations on cotrimoxazole
prophylaxis for HIV-exposed infants in developing countries? Bull World Health Organ. Dec
1 2010;88(12):949-950.
References
244
39. WHO/UNAIDS/UNICEF. Global HIV/AIDS Report: Epidemic update and health sector
progress towards Universal Access: Progress Report 2011. Geneva, Switzerland:
WHO/UNAIDS/UNICEF; 2011 2011.
40. Hutchinson E, Droti B, Gibb D, et al. Translating evidence into policy in low-income
countries: lessons from co-trimoxazole preventive therapy. Bull World Health Organ. Apr 1
2011;89(4):312-316.
41. Hutchinson E, Parkhurst J, Phiri S, et al. National policy development for cotrimoxazole
prophylaxis in Malawi, Uganda and Zambia: the relationship between Context, Evidence and
Links. Health Res Policy Syst. 2011;9 Suppl 1:S6.
42. Zimbabwe Ministry of Health and Child Welfare. HIV Estimates Report 2009. Harare2009.
43. Zimbabwe National Statistics Agency (ZIMSTAT), ICF International. Zimbabwe
Demographic and Health Survey 2010-2011. Calverton, Maryland: ZIMSTAT and ICF
International Inc.;2012.
44. Kuhn L, Aldrovandi GM, Sinkala M, et al. Effects of early, abrupt weaning on HIV-free
survival of children in Zambia. The New England journal of medicine. Jul 10
2008;359(2):130-141.
45. Kagaayi J, Gray RH, Brahmbhatt H, et al. Survival of Infants Born to HIV-Positive Mothers,
by Feeding Modality, in Rakai, Uganda. Plos One. Dec 9 2008;3(12).
46. Onyango-Makumbi C, Bagenda D, Mwatha A, et al. Early Weaning of HIV-Exposed
Uninfected Infants and Risk of Serious Gastroenteritis: Findings from Two Perinatal HIV
Prevention Trials in Kampala, Uganda. Journal of acquired immune deficiency syndromes.
Sep 25 2009.
47. World Health Organisation. Guidelines on HIV and infant feeding. Geneva, Switzerland:
WHO;2010.
48. Cournil A, de Vincenzi I, Gaillard P, et al. Relationship between mortality and feeding
modality among children born to HIV-infected mothers in a research setting: The Kesho Bora
Study. AIDS. 2013;27(00 Published ahead of print):000-000.
49. World Health Organisation. Antiretroviral drugs for treating pregnant women and preventing
HIV infections in infants. Geneva, Switzerland: WHO;2010.
50. Braitstein P, Katshcke A, Shen C, et al. Retention of HIV-infected and HIV-exposed children
in a comprehensive HIV clinical care programme in Western Kenya. Tropical Medicine &
International Health. Jul 2010;15(7):833-841.
51. Ioannidis JPA, Taha TE, Kumwenda N, et al. Predictors and impact of losses to follow-up in
an HIV-1 perinatal transmission cohort in Malawi. International journal of epidemiology.
Aug 1999;28(4):769-775.
52. Dube Q, Dow A, Chirambo C, et al. Implementing early infant diagnosis of HIV infection at
the primary care level: experiences and challenges in Malawi. Bull World Health Organ. Sep
1 2012;90(9):699-704.
53. Wettstein C, Mugglin C, Egger M, et al. Missed opportunities to prevent mother-to-child-
transmission: systematic review and meta-analysis. AIDS. Nov 28 2012;26(18):2361-2373.
54. UK National Institute for Health and Clinical Excellence (NICE). Methodology Checklist:
Cohort studies (adapted from Tooth et al 2005). London, UK: NICE;2006.
55. Tooth L, Ware R, Bain C, Purdie DM, Dobson A. Quality of reporting of observational
longitudinal research. American journal of epidemiology. Feb 1 2005;161(3):280-288.
56. von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational
Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.
Lancet. Oct 20 2007;370(9596):1453-1457.
57. von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational
Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.
Epidemiology. Nov 2007;18(6):800-804.
58. von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational
Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.
Bull World Health Organ. Nov 2007;85(11):867-872.
References
245
59. von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational
Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.
Preventive medicine. Oct 2007;45(4):247-251.
60. von Elm E, Altman DG, Egger M, et al. Strengthening the Reporting of Observational Studies
in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ.
Oct 20 2007;335(7624):806-808.
61. von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational
Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.
PLoS Med. Oct 16 2007;4(10):e296.
62. von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational
Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.
Annals of internal medicine. Oct 16 2007;147(8):573-577.
63. Vandenbroucke JP, von Elm E, Altman DG, et al. Strengthening the Reporting of
Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med.
Oct 16 2007;4(10):e297.
64. Vandenbroucke JP, von Elm E, Altman DG, et al. Strengthening the Reporting of
Observational Studies in Epidemiology (STROBE): explanation and elaboration. Annals of
internal medicine. Oct 16 2007;147(8):W163-194.
65. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled clinical trials. Sep
1986;7(3):177-188.
66. Higgins JP, Thompson SG, Spiegelhalter DJ. A re-evaluation of random-effects meta-
analysis. Journal of the Royal Statistical Society. Series A. Jan 2009;172(1):137-159.
67. Harbord RM, Higgins JP. Meta-regression in Stata. The Stata Journal. 2008;8(4):493-519.
68. Black V, Hoffman RM, Sugar CA, et al. Safety and Efficacy of Initiating Highly Active
Antiretroviral Therapy in an Integrated Antenatal and HIV Clinic in Johannesburg, South
Africa. Jaids-Journal of Acquired Immune Deficiency Syndromes. Nov 1 2008;49(3):276-281.
69. Doherty TM, McCoy D, Donohue S. Health system constraints to optimal coverage of the
prevention of mother-to-child HIV transmission programme in South Africa: lessons from the
implementation of the national pilot programme. African health sciences. 2005-Sep
2005;5(3):213-218.
70. Geddes R, Giddy J, Butler LM, et al. Dual and triple therapy to prevent mother-to-child
transmission of HIV in a resource-limited setting - lessons from a South African programme.
Samj South African Medical Journal. Sep 2011;101(9):651-654.
71. Sherman GG, Jones SA, Coovadia AH, et al. PMTCT from research to reality - results from
routine service. South African Medical Journal (SAMJ). April 2004;94(4):289-292.
72. Azcoaga-Lorenzo A, Ferreyra C, Alvarez A, Palma PP, Velilla E, del Amo J. Effectiveness of
a PMTCT programme in rural Western Kenya. Aids Care-Psychological and Socio-Medical
Aspects of Aids/Hiv. 2011 2011;23(3):274-280.
73. Hassan AS, Sakwa EM, Nabwera HM, et al. Dynamics and constraints of early infant
diagnosis of HIV infection in Rural Kenya. AIDS & Behavior. Jan 2012;16(1):5-12.
74. Anoje C, Aiyenigba B, Suzuki C, et al. Reducing mother-to-child transmission of HIV:
findings from an early infant diagnosis program in south-south region of Nigeria. Bmc Public
Health. Mar 12 2012;12.
75. Oladokun RE, Awolude O, Brown BJ, et al. Service uptake and performance of the
prevention of mother-to-child transmission (PMTCT) programme in Ibadan, Nigeria. Afr J
Med Med Sci. Jun 2010;39(2):81-87.
76. Ciampa PJ, Burlison JR, Blevins M, et al. Improving Retention in the Early Infant Diagnosis
of HIV Program in Rural Mozambique by Better Service Integration. Jaids-Journal of
Acquired Immune Deficiency Syndromes. Sep 1 2011;58(1):115-119.
77. Cook RE, Ciampa PJ, Sidat M, et al. Predictors of Successful Early Infant Diagnosis of HIV
in a Rural District Hospital in Zambezia, Mozambique. Jaids-Journal of Acquired Immune
Deficiency Syndromes. Apr 2011;56(4):E104-E109.
78. Manzi M, Zachariah R, Teck R, et al. High acceptability of voluntary counselling and HIV-
testing but unacceptable loss to follow up in a prevention of mother-to-child HIV
References
246
transmission programme in rural Malawi: scaling-up requires a different way of acting.
Tropical Medicine & International Health. Dec 2005;10(12):1242-1250.
79. Moses A, Zimba C, Kamanga E, et al. Prevention of mother-to-child transmission: program
changes and the effect on uptake of the HIVNET012 regimen in Malawi. Aids. Jan 2
2008;22(1):83-87.
80. Ahoua L, Ayikoru H, Gnauck K, et al. Evaluation of a 5-year Programme to Prevent Mother-
to-child Transmission of HIV Infection in Northern Uganda. Journal of Tropical Pediatrics.
Feb 2010;56(1):43-52.
81. Namukwaya Z, Mudiope P, Kekitiinwa A, et al. The Impact of Maternal Highly Active
Antiretroviral Therapy and Short-Course Combination Antiretrovirals for Prevention of
Mother-to-Child Transmission on Early Infant Infection Rates at the Mulago National
Referral Hospital in Kampala, Uganda, January 2007 to May 2009. Jaids-Journal of Acquired
Immune Deficiency Syndromes. Jan 1 2011;56(1):69-75.
82. Mirkuzie AH, Hinderaker SG, Sisay MM, Moland KM, Morkve O. Current status of
medication adherence and infant follow up in the prevention of mother to child HIV
transmission programme in Addis Ababa: a cohort study. Journal of the International AIDS
Society. 2011;14:50.
83. Shargie MB, Eek F, Abaychew A. Prophylactic treatment uptake and compliance with
recommended follow up among HIV exposed infants: a retrospective study in Addis Ababa,
Ethiopia. BMC research notes. 2011 Dec 2011;4:563-563.
84. Perez F, Mukotekwa T, Miller A, et al. Implementing a rural programme of prevention of
mother-to-child transmission of HIV in Zimbabwe: first 18 months of experience. Tropical
Medicine & International Health. Jul 2004;9(7):774-783.
85. Nlend AEN, Ekobo CS, Junior MB, et al. Early Outcomes of HIV Exposed Children in the
First District-wide Programme using Extended Regimens for the Prevention of Mother-to-
Child Transmission of HIV, in Yaounde, Cameroon. Journal of Tropical Pediatrics. Aug
2012;58(4):297-302.
86. Lussiana C, Clemente SVL, Ghelardi A, Lonardi M, Tarquino IAP, Floridia M. Effectiveness
of a Prevention of Mother-to-Child HIV Transmission Programme in an Urban Hospital in
Angola. PloS one. Apr 2012;7(4).
87. Nuwagaba-Biribonwoha H, Werq-Semo B, Abdallah A, et al. Introducing a multi-site
program for early diagnosis of HIV infection among HIV-exposed infants in Tanzania. BMC
pediatrics. 2010;10:44.
88. Goswami S, Chakravorty PS. Prevention of parent to child transmission of HIV (PPTCT): An
effort of 4 years in a tertiary centre. Journal of Obstetrics and Gynecology of India. August
2011;61(4):394-398.
89. Panditrao M, Darak S, Kulkarni V, Kulkarni S, Parchure R. Socio-demographic factors
associated with loss to follow-up of HIV-infected women attending a private sector PMTCT
program in Maharashtra, India. Aids Care-Psychological and Socio-Medical Aspects of
Aids/Hiv. 2011 2011;23(5):593-600.
90. Seth A, Chandra J, Gupta R, Kumar P, Aggarwal V, Dutta A. Outcome of HIV Exposed
Infants: Experience of a Regional Pediatric Center for HIV in North India. Indian Journal of
Pediatrics. Feb 2012;79(2):188-193.
91. Sam IC, Ball CS, Blott MJ, Tosswill JHC, Parry JV, Zuckerman MA. Loss to follow-up of
HIV-exposed infants in South London. International Journal of Std & Aids. Apr
2003;14(4):291-292.
92. Ferguson W, Goode M, Walsh A, Gavin P, Butler K. Evaluation of 4 Weeks' Neonatal
Antiretroviral Prophylaxis as a Component of a Prevention of Mother-to-child Transmission
Program in a Resource-rich Setting. Pediatric Infectious Disease Journal. May
2011;30(5):408-412.
93. Turan JM, Hatcher AH, Medema-Wijnveen J, et al. The role of HIV-related stigma in
utilization of skilled childbirth services in rural Kenya: a prospective mixed-methods study.
PLoS Med. 2012;9(8):e1001295.
References
247
94. Turan JM, Miller S, Bukusi EA, Sande J, Cohen CR. HIV/AIDS and maternity care in Kenya:
how fears of stigma and discrimination affect uptake and provision of labor and delivery
services. AIDS Care. Sep 2008;20(8):938-945.
95. Medema-Wijnveen J, Onono M, Bukusi EA, Miller S, Cohen CR, Turan JM. How
Perceptions of HIV-Related Stigma Affect Decision-Making Regarding Childbirth in Rural
Kenya. PloS one. 2012;7(12):e51492.
96. Finlayson K, Downe S. Why do women not use antenatal services in low- and middle-income
countries? A meta-synthesis of qualitative studies. PLoS Med. Jan 2013;10(1):e1001373.
97. Painter TM, Diaby KL, Matia DM, et al. Women's reasons for not participating in follow up
visits before starting short course antiretroviral prophylaxis for prevention of mother to child
transmission of HIV: qualitative interview study. BMJ. Sep 4 2004;329(7465):543.
98. Ghilarducci E, McCool W. The influence of postpartum home visits on clinic attendance. J
Nurse Midwifery. May-Jun 1993;38(3):152-158.
99. Centers for Disease C, Prevention. Impact of an Innovative Approach to Prevent Mother-to-
Child Transmission of HIV - Malawi, July 2011-September 2012. MMWR. Morbidity and
mortality weekly report. Mar 1 2013;62:148-151.
100. Braitstein P, Songok J, Vreeman RC, et al. "Wamepotea" (They Have Become Lost):
Outcomes of HIV-Positive and HIV-Exposed Children Lost to Follow-Up From a Large HIV
Treatment Program in Western Kenya. Jaids-Journal of Acquired Immune Deficiency
Syndromes. Jul 1 2011;57(3):E40-E46.
101. Donahue MC, Dube Q, Dow A, Umar E, Van Rie A. "They have already thrown away their
chicken": barriers affecting participation by HIV-infected women in care and treatment
programs for their infants in Blantyre, Malawi. AIDS Care. 2012;24(10):1233-1239.
102. Wachira J, Middlestadt SE, Vreeman R, Braitstein P. Factors underlying taking a child to
HIV care: implications for reducing loss to follow-up among HIV-infected and -exposed
children. SAHARA J : journal of Social Aspects of HIV/AIDS Research Alliance / SAHARA ,
Human Sciences Research Council. 2012;9(1):20-29.
103. Vreeman RC, Nyandiko WM, Braitstein P, et al. Acceptance of HIV testing for children ages
18 months to 13 years identified through voluntary, home-based HIV counseling and testing
in western Kenya. Journal of acquired immune deficiency syndromes (1999). Oct
2010;55(2):e3-10.
104. Buzdugan R, Watadzaushe C, Dirawo J, et al. Positive Attitudes to Pediatric HIV Testing:
Findings from a Nationally Representative Survey from Zimbabwe. PloS one.
2012;7(12):e53213.
105. Painter TM, Diaby KL, Matia DM, et al. Sociodemographic factors associated with
participation by HIV-1-positive pregnant women in an intervention to prevent mother-to-child
transmission of HIV in Cote d'Ivoire. Int J STD AIDS. 2005;16(3):237-242.
106. World Health Organisation. PMTCT strategic vision 2010–2015 : preventing mother-to-child
transmission of HIV to reach the UNGASS and Millennium Development Goals. Switzerland:
WHO;2010.
107. Palombi L, Marazzi MC, Guidotti G, et al. Incidence and predictors of death, retention, and
switch to second-line regimens in antiretroviral- treated patients in sub-Saharan African Sites
with comprehensive monitoring availability. Clin Infect Dis. Jan 1 2009;48(1):115-122.
108. Seidenberg P, Nicholson S, Schaefer M, et al. Early infant diagnosis of HIV infection in
Zambia through mobile phone texting of blood test results. Bull World Health Organ. May 1
2012;90(5):348-356.
109. Binagwaho A, Mugwaneza P, Irakoze AA, et al. Scaling up early infant diagnosis of HIV in
Rwanda, 2008-2010. Journal of public health policy. Nov 29 2012.
110. Wu G, Zaman MH. Low-cost tools for diagnosing and monitoring HIV infection in low-
resource settings. Bull World Health Organ. Dec 1 2012;90(12):914-920.
111. Bland RM. Management of HIV-infected children in Africa: progress and challenges.
Archives of disease in childhood. Oct 2011;96(10):911-915.
112. Walt G, Gilson L. Reforming the health sector in developing countries: the central role of
policy analysis. Health Policy Plan. Dec 1994;9(4):353-370.
References
248
113. Walt G, Shiffman J, Schneider H, Murray SF, Brugha R, Gilson L. 'Doing' health policy
analysis: methodological and conceptual reflections and challenges. Health Policy Plan. Sep
2008;23(5):308-317.
114. Stata Corporation. Intercooled Stata 9.0. 1984-2005.
115. Green JaB, J.,, ed Principles of social research. London, United Kingdom: Oxford University
Press. Black NaR, R.,, ed. Understanding Public Health.
116. Cassell C. Creating the interviewer: identity work in the management research process.
Qualitative Research,. 2005;5(2):167-179.
117. Finlay L. "Outing" the researcher: the provenance, process, and practice of reflexivity.
Qualitative health research. Apr 2002;12(4):531-545.
118. Symon G, Cassell C, Dickson R. Expanding our research and practice through innovative
research methods. European Journal of Work and Organizational Psychology,.
2000;9(4):457-462.
119. Strauss A, Corbin J. Basics of Qualitative Research: Grounded theory procedures and
techniques. London: Sage; 1990.
120. Zimbabwe National Statistics Agency (ZIMSTAT). Census 2012 Preliminary Report. Harare,
Zimbabwe: ZimStat;2012.
121. World Bank. The World Bank Website. 2013. Accessed March 2013.
122. Ministry of Health and Child Welfare. The national health strategy for Zimbabwe, 2009-
2013: Equity and Quality in Health-A people's right. Harare, Zimbabwe: MoHCW,
Zimbabwe;2009.
123. Ministry of Health and Child Welfare, Government of Zimbabwe. Getting the Zimbabwe
Health care system moving again: 100-day plan for health (Health Summit implementation
progress report). Harare, Zimbabwe: MoHCW/GoZ;2010.
124. International Conference on Primary Health Care. Declaration of Alma-Ata. USSR1978.
125. World Health Organisation. Ouagadougou Declaration on primary health care and health
systems in Africa: Achieving better health for Africa in the new millenium. WHO, Brazzaville,
Republic of Congo: WHO Regional Office for Africa;2008.
126. City of Harare. City of Harare Website. 2013; http://www.hararecity.co.zw. Available at.
Accessed 14 March, 2013.
127. Ministry of Health and Child Welfare. Essential Drugs List and Standard Treatment
Guidelines for Zimbabwe (EDLIZ). Harare, Zimbabwe2011.
128. Ministry of Health and Child Welfare. MoHCW web pages. 2011. Accessed March 2013,
2013.
129. Shamu S, Marufu T, Chirenda J. An evaluation of Health Financing Policies and Strategies
for Harare City Health Services. Harare, Zimbabwe: City of Harare;2011.
130. The Herald, Takunda Maodza. City set to incur US$12m deficit. The Herald Thursday 05
January 2012. Thursday 5 January 2012, 2012.
131. The Herald Reporters. Maternity fees to stay — Masunda. The Herald, Wednesday 26
September 20122012.
132. Government of Zimbabwe. Global AIDS Report Progress Report 2012: Follow-up to the
2012 political declaration on HIV/AIDS: Intensifying our efforts to eliminate HIV/AIDS.
Harare, Zimbabwe: Government of Ziimbabwe;2012.
133. Ciaranello AL, Perez F, Keatinge J, et al. What will it take to eliminate pediatric HIV?
Reaching WHO target rates of mother-to-child HIV transmission in Zimbabwe: a model-
based analysis. PLoS Med. Jan 2012;9(1):e1001156.
134. Ministry of Health and Child Welfare. Global AIDS Response: Zimbabwe Country Report
2012. Harare: MoHCW;2012.
135. Harare City Health Department. Annual report 2010: City Health Services. Harare,
Zimbabwe: City of Harare;2011.
136. Ministry of Health and Child Welfare. Zimbabwe National HIV and AIDS Strategic Plan
(ZNASP II). Harare, Zimbabwe: MoHCW;2011.
137. Ministry of Health and Child Welfare. Zimbabwe National HIV AND AIDS Strategic Plan
(ZNASP) 2006-2010
References
249
Harare, Zimbabwe: MoHCW;2006.
138. Ministry of Health and Child Welfare. More efficacious ARV prophylaxis for the prevention
of mother to child transmission (PMTCT) programme in Zimbabwe: A participants manual
for the integrated approach to HIV and AIDS prevention, care, treatment and follow up for
pregnant women, ther babies and families. Harare, Zimbabwe: MoHCW;2008.
139. Zimbabwe Ministry of Health and Child Welfare. More efficacious ARV Prophylaxis for the
Prevention of Mother to Child Transmission (PMTCT) Programme in Zimbabwe: a
participant manual for the intergrated approach to HIV and AIDS prevention, care, treatment
and follow up for pregnant women , their babies and families. MOHCW;2008.
140. Denzin NK. The reflexive interview and a perfomative social science. Qualitative Research,.
2001;1(1):23-46.
141. Rhodes T, Prodanovic A, Zikic B, et al. Trust, disruption and responsibility in accounts of
injecting equipment sharing and hepatitis C risk. Health, Risk & Society,. 2008;10(3):221-
240.
142. Ministry of Health and Child Welfare. Zimbabwe National Health Profile 2011. Harare:
MoHCW;2012.
143. Lagarde M, Haines A, Palmer N. The impact of conditional cash transfers on health outcomes
and use of health services in low and middle income countries. Cochrane database of
systematic reviews. 2009(4):CD008137.
144. Ranganathan M, Lagarde M. Promoting healthy behaviours and improving health outcomes in
low and middle income countries: a review of the impact of conditional cash transfer
programmes. Preventive medicine. Nov 2012;55 Suppl:S95-S105.
145. Felex Share (Herald reporter). Monthly cash for the poor. The Herald. 06 August 2012, 2012.
146. OECD. The Paris Declaration on Aid Effectiveness and the Accra Agenda for Action. Paris,
France: OECD;2005.
147. World Health Organisation. Task-shifting to tackle health worker shortages. Geneva,
Switzerland: WHO;2007.
148. Fairall L, Bachmann MO, Lombard C, et al. Task shifting of antiretroviral treatment from
doctors to primary-care nurses in South Africa (STRETCH): a pragmatic, parallel, cluster-
randomised trial. Lancet. Sep 8 2012;380(9845):889-898.
149. Sanne I, Orrell C, Fox MP, et al. Nurse versus doctor management of HIV-infected patients
receiving antiretroviral therapy (CIPRA-SA): a randomised non-inferiority trial. Lancet. Jul 3
2010;376(9734):33-40.
150. Mdege ND, Chindove S, Ali S. The effectiveness and cost implications of task-shifting in the
delivery of antiretroviral therapy to HIV-infected patients: a systematic review. Health Policy
Plan. Jun 26 2012.
151. Callaghan M, Ford N, Schneider H. A systematic review of task- shifting for HIV treatment
and care in Africa. Hum Resour Health. 2010;8:8.
152. Shetty AK, Mhazo M, Moyo S, et al. The feasibility of voluntary counselling and HIV testing
for pregnant women using community volunteers in Zimbabwe. Int J STD AIDS. Nov
2005;16(11):755-759.
153. Sibanda EL, Hatzold K, Mugurungi O, et al. An assessment of the Zimbabwe ministry of
health and child welfare provider initiated HIV testing and counselling programme. BMC
Health Serv Res. 2012;12:131.
154. Nyenwa J, Alt D, Karim A, et al. Zimbabwe HIV & AIDS Logistics System Assessment.
Arlington, Va: John Snow, Inc./DELIVER, for the U.S. Agency for International
Development;2006.
155. Ridde V, Morestin F. A scoping review of the literature on the abolition of user fees in health
care services in Africa. Health Policy Plan. Jan 2011;26(1):1-11.
156. Steinhardt LC, Aman I, Pakzad I, Kumar B, Singh LP, Peters DH. Removing user fees for
basic health services: a pilot study and national roll-out in Afghanistan. Health Policy Plan.
Nov 2011;26 Suppl 2:ii92-103.
157. Masiye F, Chitah BM, McIntyre D. From targeted exemptions to user fee abolition in health
care: experience from rural Zambia. Social science & medicine (1982). Aug 2010;71(4):743-
750.
References
250
158. Meessen B, Hercot D, Noirhomme M, et al. Removing user fees in the health sector: a review
of policy processes in six sub-Saharan African countries. Health Policy Plan. Nov 2011;26
Suppl 2:ii16-29.
159. McPake B, Brikci N, Cometto G, Schmidt A, Araujo E. Removing user fees: learning from
international experience to support the process. Health Policy Plan. Nov 2011;26 Suppl
2:ii104-117.
160. Hercot D, Meessen B, Ridde V, Gilson L. Removing user fees for health services in low-
income countries: a multi-country review framework for assessing the process of policy
change. Health Policy Plan. Nov 2011;26 Suppl 2:ii5-15.
161. The Sunday Mail: Cardus Chijongwe. Mothers give birth on hospital floors. The Sunday Mail
02 September 20122012.
162. Chandisarewa W, Stranix-Chibanda L, Chirapa E, et al. Routine offer of antenatal HIV testing
("opt-out" approach) to prevent mother-to-child transmission of HIV in urban Zimbabwe.
Bulletin of the World Health Organization. Nov 2007;85(11):843-850.
163. Centers for Disease C, Prevention. Introduction of routine HIV testing in prenatal care--
Botswana, 2004. MMWR. Morbidity and mortality weekly report. Nov 26 2004;53(46):1083-
1086.
164. Creek TL, Ntumy R, Seipone K, et al. Successful introduction of routine opt-out HIV testing
in antenatal care in Botswana. Journal of acquired immune deficiency syndromes (1999). May
1 2007;45(1):102-107.
165. Hensen B, Baggaley R, Wong VJ, et al. Universal voluntary HIV testing in antenatal care
settings: a review of the contribution of provider-initiated testing & counselling. Trop Med Int
Health. Jan 2012;17(1):59-70.
166. Larsson EC, Thorson A, Pariyo G, et al. Opt-out HIV testing during antenatal care:
experiences of pregnant women in rural Uganda. Health Policy Plan. Jan 2012;27(1):69-75.
167. Groves AK, Maman S, Msomi S, Makhanya N, Moodley D. The complexity of consent:
women's experiences testing for HIV at an antenatal clinic in Durban, South Africa. AIDS
Care. May 2010;22(5):538-544.
168. Ujiji OA, Rubenson B, Ilako F, et al. Is 'Opt-Out HIV Testing' a real option among pregnant
women in rural districts in Kenya? BMC Public Health. 2011;11:151.
169. World Health Organisation. Guidance on provider-initiated HIV testing and counselling in
health facilities. Switzerland: World Health Organisation;2007.
170. Jurgensen M, Tuba M, Fylkesnes K, Blystad A. The burden of knowing: balancing benefits
and barriers in HIV testing decisions. a qualitative study from Zambia. BMC Health Serv Res.
2012;12:2.
171. Musheke M, Ntalasha H, Gari S, et al. A systematic review of qualitative findings on factors
enabling and deterring uptake of HIV testing in Sub-Saharan Africa. BMC Public Health.
2013;13:220.
172. Skovdal M, Campbell C, Nyamukapa C, Gregson S. When masculinity interferes with
women's treatment of HIV infection: a qualitative study about adherence to antiretroviral
therapy in Zimbabwe. J Int AIDS Soc. 2011;14:29.
173. Mavhu W, Dauya E, Bandason T, et al. Chronic cough and its association with TB-HIV co-
infection: factors affecting help-seeking behaviour in Harare, Zimbabwe. Trop Med Int
Health. May 2010;15(5):574-579.
174. Skovdal M, Campbell C, Madanhire C, Mupambireyi Z, Nyamukapa C, Gregson S.
Masculinity as a barrier to men's use of HIV services in Zimbabwe. Global Health.
2011;7(1):13.
175. Aarnio P, Olsson P, Chimbiri A, Kulmala T. Male involvement in antenatal HIV counseling
and testing: exploring men's perceptions in rural Malawi. AIDS Care. Dec 2009;21(12):1537-
1546.
176. Msuya SE, Mbizvo EM, Hussain A, Uriyo J, Sam NE, Stray-Pedersen B. Low male partner
participation in antenatal HIV counselling and testing in northern Tanzania: implications for
preventive programs. AIDS Care. Jul 2008;20(6):700-709.
References
251
177. Becker S, Mlay R, Schwandt HM, Lyamuya E. Comparing couples' and individual voluntary
counseling and testing for HIV at antenatal clinics in Tanzania: a randomized trial. AIDS
Behav. Jun 2010;14(3):558-566.
178. Peltzer K, Mlambo M, Phaswana-Mafuya N, Ladzani R. Determinants of adherence to a
single-dose nevirapine regimen for the prevention of mother-to-child HIV transmission in
Gert Sibande district in South Africa. Acta paediatrica. May 2010;99(5):699-704.
179. Farquhar C, Kiarie JN, Richardson BA, et al. Antenatal couple counseling increases uptake of
interventions to prevent HIV-1 transmission. Journal of acquired immune deficiency
syndromes (1999). Dec 15 2004;37(5):1620-1626.
180. Ditekemena J, Matendo R, Koole O, et al. Male partner voluntary counselling and testing
associated with the antenatal services in Kinshasa, Democratic Republic of Congo: a
randomized controlled trial. Int J STD AIDS. Mar 2011;22(3):165-170.
181. Brusamento S, Ghanotakis E, Tudor Car L, van-Velthoven MH, Majeed A, Car J. Male
involvement for increasing the effectiveness of prevention of mother-to-child HIV
transmission (PMTCT) programmes. Cochrane database of systematic reviews.
2012;10:CD009468.
182. Turan JM, Bukusi EA, Onono M, Holzemer WL, Miller S, Cohen CR. HIV/AIDS stigma and
refusal of HIV testing among pregnant women in rural Kenya: results from the MAMAS
Study. AIDS Behav. Aug 2011;15(6):1111-1120.
183. Bond V, Chase E, Aggleton P. Stigma, HIV/AIDS and prevention of mother-to-child
transmission in Zambia. Evaluation and Program Planning. 2002;25:347-356.
184. Peltzer K, Mlambo G, Phaweni K. Factors determining prenatal HIV testing for prevention of
mother to child transmission of HIV in Mpumalanga, South Africa. AIDS Behav. Oct
2010;14(5):1115-1123.
185. Bharat S. A systematic review of HIV/AIDS-related stigma and discrimination in India:
Current understanding and future needs. SAHARA-J: Journal of Social Aspects of HIV/AIDS,.
2012;8(3):137-149.
186. Turan JM, Nyblade L. HIV-related Stigma as a Barrier to Achievement of Global PMTCT
and Maternal Health Goals: A Review of the Evidence. AIDS Behav. Mar 9 2013.
187. Steward WT, Herek GM, Ramakrishna J, et al. HIV-related stigma: adapting a theoretical
framework for use in India. Social science & medicine (1982). Oct 2008;67(8):1225-1235.
188. Sengupta S, Banks B, Jonas D, Miles MS, Smith GC. HIV interventions to reduce HIV/AIDS
stigma: a systematic review. AIDS Behav. Aug 2011;15(6):1075-1087.
189. Brown L, Macintyre K, Trujillo L. Interventions to reduce HIV/AIDS stigma: what have we
learned? AIDS Educ Prev. Feb 2003;15(1):49-69.
190. Watts C, Zimmerman C, Eckhaus T, Nyblade L. Working paper: Modelling the Impact of
Stigma on HIV and AIDS Programmes: Preliminary Projections for Mother-to-Child
Transmission. Washington DC: International Centre for Research on Women and London
School of Hygiene and Tropical Medicine;2010.
191. Abrahams N, Jewkes R, Mvo Z. Health care-seeking practices of pregnant women and the
role of the midwife in Cape Town, South Africa. Journal of midwifery & women's health. Jul-
Aug 2001;46(4):240-247.
192. Witter S, Fretheim A, Kessy FL, Lindahl AK. Paying for performance to improve the delivery
of health interventions in low- and middle-income countries. Cochrane database of
systematic reviews. 2012;2:CD007899.
193. Christianson J, Leatherman S, Sutherland K. Financial incentives, healthcare providers and
quality improvements: A review of the evidence. London, UK: The Health Foundation;2007.
194. Basinga P, Gertler PJ, Binagwaho A, Soucat ALB, Sturdy JR, Vermeersch CMJ. Paying
Primary Health Care Centers for Performance in Rwanda. Washington, DC: World
Bank;2010.
195. Soeters R, Peerenboom PB, Mushagalusa P, Kimanuka C. Performance-based financing
experiment improved health care in the Democratic Republic of Congo. Health affairs. Aug
2011;30(8):1518-1527.
References
252
196. Larsson EC, Thorson A, Nsabagasani X, Namusoko S, Popenoe R, Ekstrom AM. Mistrust in
marriage--reasons why men do not accept couple HIV testing during antenatal care- a
qualitative study in eastern Uganda. BMC Public Health. 2010;10:769.
197. Leichliter JS, Paz-Bailey G, Friedman AL, et al. 'Clinics aren't meant for men': sexual health
care access and seeking behaviours among men in Gauteng province, South Africa. SAHARA
J : journal of Social Aspects of HIV/AIDS Research Alliance / SAHARA , Human Sciences
Research Council. 2011;8(2):82-88.
198. Zimbabwe Ministry of Health and Child Welfare, USAID. Zimbabwe Health System
Assessment 2010. Maryland, USA2011.
199. UK Parliamentary and health service ombudsman. UK Parliamentary and health service
ombudsman. 2013. Accessed Feb 2013, 2013.
200. Ministry of Economic Planning and Investment Promotion, UNDP Resident Rrepresentative.
Zimbabwe 2012 MDG Progress Report. Harare, Zimbabwe: MEPIP;2012.
Appendices
253
APPENDICES
Appendices
254
APPENDIX 1: QUESTIONNAIRE AT TIME OF DELIVERY
Patient questionnaire for completion at the time of delivery
Thank you for consenting to take part in this study that will enable us to have a better understanding
of the experiences of expecting mothers in this community. I am asking you to give your responses to
the questions which follow. Some questions may make you feel uncomfortable or distressed.
Obviously if this happens we will stop the interview if you would like us to. As far as possible please
give me your honest answers.
Date of interview: _______________ Clinic of delivery: ________________
DDMMMYYYY
Date baby was born: _______________
DDMMMYYYY
1. When were you born? /How old are you?
Date of Birth: _________________ or current age__________________
DDMMMYYYY
2. What is your religion?
a. Roman Catholic
b. Anglican
c. Lutheran
d. Methodist
e. Baptist
f. Presbyterian
g. Apostolic
h. Pentecostal
i. Seventh Day Adventist
j. Moslem
k. African Traditional Religion
l. Other (Specify)_____________
m. No religion
3. What is the highest level of education that you have completed?
a. None
b. Primary school only
c. Forms 1 to 2
d. Forms 3 to 4
e. Forms 5 to 6
f. Diploma/Certificate/Degree
4. FOR RURAL PARTICIPANTS ONLY: Think about the building in your home that is the
most appealing. What material is it built of?
a. Pole and dagga
b. Wood
c. Mud bricks
d. Cement blocks
e. Stones
f. Other (Specify): _____________________
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i. For Mbare Participants:How many rooms does the house you live in have,
excluding the toilet and bathroom?
1. Specify:_______________
5. Are you staying here as?
a. House owner
b. Lodger
c. Family member
d. Other (Specify):_________________________
i. How many people live in your household? Specify: _________
6. What type of sewage disposal system do you use?
a. Flush Bowl System
b. Our own Blair toilet
c. Neighbour’s Blair toilet
d. Bush
e. Pit
f. Other (Specify):______________
7. What source of drinking water do you use in your house? (choose one main source)
a. Tapped communal
b. Own tap
c. Own borehole
d. Communal borehole
e. Unprotected well
f. Protected well
g. Stream/river
h. Other (Specify)___________________
8. In the last week, has an adult in your house skipped a meal or eaten less in order for there to
be enough food for the children?
a. Yes
b. No
9. In the last week, have you had to go an entire day without eating because there was no food in
your household?
a. Yes
b. No
10. Approximately how much money do you earn/source each month in US dollars?
a. I don’t earn any money
b. I earn $___________________
11. Are you currently married?
a. Yes, I am currently married
b. No, I am divorced go to 13
c. No, I am widowed go to 13
d. No, I have never been married go to 13
12. Approximately how much money does your partner earn/source each month in US dollars?
a. He does not earn any income
b. He earns $___________________
13. Are you financially dependent on anyone?
a. Yes
b. No go to 14
i. Who are you financially dependant on? Mark all that apply.
1. Husband/Partner
2. Parents
3. Mother/Father in law
4. Brother/sister
5. Bother/sister in law
6. Someone else (Specify)_______________________
14. How many children have you had in your life so far? (Specify)_____________
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15. Did any of your children die?
a. Yes
b. No go to 16
i. How many children died in total? Specify)________________
ii. How old was/were the child/children when they died? (Specify)
Child 1=most recent death:
Child 1________years/months Child 2_______years/months
Child 3________years/months
Other children who died:
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________
For age greater than two years use years and months for age 24 months and
younger
16. Now I am going to ask you about your children who are alive. We want to know how old they
are and what their general health status is.
Child Age Health Status
 Healthy
 Frequently ill
 Healthy
 Frequently ill
 Healthy
 Frequently ill
 Healthy
 Frequently ill
Other children:
___________________________________________________________________________
___________________________________________________________________________
For age greater than two years use years and months for age 24 months and younger
Child 1=the most recent delivery ie the new born baby
17. Combined with question 16.
18. Have you had any miscarriages?
a. Yes
b. No go to 19
i. How many miscarriages have you had? (Specify)___________
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ii. How far gone with the pregnancy were you when you miscarried? Specify in
number of weeks in each box as applicable
Miscarriage 1
Miscarriage 2
Miscarriage 3
Miscarriage 4
Miscarriage 5
Other miscarriages:
______________________________________________________________________________
______________________________________________________________________________
For some women being pregnant may be a joyful experience but for some it can be difficult.
19. For your last pregnancy, at what point did you discover that you were pregnant?
a. In the first month
b. In the second month
c. In the third month
d. More than three months into pregnancy
e. I don’t know
20. How did you discover that you were pregnant? Mark all that apply
a. I missed my monthly menstrual period
b. Symptoms like nausea and vomiting (or other symptoms)
c. I bought a pregnancy test kit and tested myself at home
d. A health care worker gave me a pregnancy test or confirmed that I was pregnant
i. What is the date of your last menstrual period? Interviewer to verify this date
with the patient records
1. Specify: ___ ___ /___ ___ ___ /___ ___ ___ ___
DDMMMYYYY
21. Did you plan to get pregnant?
a. Yes
b. No go to 22
i. Were you on a family planning method at the time you became pregnant?
1. Yes
2. No go to 22
ii. What family planning method were you using?
1. Pill
2. Injectable contraceptive
3. IUD
4. Implant
5. Other (Specify):____________________
22. How did you feel when you discovered that you were pregnant?
a. Happy go to 23
b. Troubled
c. Neither happy nor troubled go to 23
i. Why were you troubled? Mark all that apply
1. I was worried about the financial burden of having a new baby
2. I just did not want to have another baby
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3. I was worried about my health
4. I was worried about the health of the baby
5. Other (Specify): ___________________________
23. Did you seek antenatal care after you discovered you were pregnant?
a. Yes go to 24
b. No
i. Why did you not seek antenatal care?
1. I had no money
2. I did not think it was important
3. My husband/mother in law/other family member did not want me to
(Specify the family member):__________________
4. My religion does not allow me to
Other: Specify________________________ to go 33
24. Where did you seek antenatal care?
a. Local clinic
i. At this clinic (Name of clinic)
ii. At another clinic (Specify)___________
b. Local hospital
c. Private doctor
d. Other
Specify: ______________________
25. When did you first seek antenatal care? Specify:_________________
DDMMMYYYY
Interviewer to verify this date with the participant records
26. Deleted.
27. Did you keep visiting this health care centre (mentioned in 24a) after your first visit?
a. Yes go to 28
b. No
i. Did you visit another health care centre instead?
1. Yes go to iii
2. No go to a
a. Why did you not have return clinic visits for antenatal care?
i. I had no money
ii. I did not think it was important
iii. My husband/mother in law/other family member did
not want me to
1. Specify the family
member:____________________
iv. My religion does not allow me to
v. Other:Specify_____________________
go to 30
ii. Deleted
iii. Why did you change health facilities?
1. I had relocated
2. I temporarily moved to be closer to my mother/another relative while
I was pregnant
3. I did not like the care I was getting at that clinic
4. I could not afford the care I was getting at that health care facility
5. Other (Specify):_______________________
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28. Deleted.
29. Deleted.
It is common practise for women to get tested for some diseases or conditions, including sexually
transmitted infections when they are pregnant. I would like you to tell me if you got tested for the
following conditions.
30. Were you tested for high blood pressure? (Here we are talking about a procedure in which
the health care worker places a cuff around your upper arm, applies pressure to it and then
reads your bold pressure).
a. Yes
b. No go to 31
DELETED 30 i-iv
31. Were you tested for high blood sugar level? (Here we are talking about a procedure in which
the health care worker would have asked you to give a blood or urine sample that could be
tested for diabetes).
a. Yes
b. No go to 32
Deleted 31i-iv
32. Were you tested for syphilis? (here we are talking about a procedure in which the health care
worker would have collected blood that would be sent for syphilis testing)
a. Yes
b. No go to 33
If yes
i. At which month were you tested for syphilis?
1. 1st Month
2. 2nd Month
3. 3rd Month
4. 4th Month
5. 5th Month
6. 6th Month
7. 7th Month
8. 8th Month
9. 9th Month
ii. What was the outcome of the test?
1. I tested negative for syphilis go to 33
2. I tested positive for syphilis
3. I did not receive my results go to 33
DELETED 33iii-vib
33. Have you been tested for HIV?
a. Yes go to ii
b. No go to i
i. Why have you not been tested for HIV?
1. I have been not offered the test go to 34
2. I refused the test go to 34
3. Other reason (Specify)__________________________ go to 34
ii. When were you tested for HIV? Mark all that apply
1. During 1st Month of last pregnancy (for your newest baby)
2. During 2nd Month of last pregnancy, (for your newest baby)
3. During 3rd Month of last pregnancy, (for your newest baby)
4. During 4th Month of last pregnancy, (for your newest baby)
5. During 5th Month of last pregnancy, (for your newest baby)
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6. During 6th Month of last pregnancy, (for your newest baby)
7. During 7th Month of last pregnancy, (for your newest baby)
8. During 8th Month of last pregnancy, (for your newest baby)
9. During 9th Month of last pregnancy¸(for your newest baby)
10. Before I got pregnant (last pregnancy)¸ (for your newest baby)
11. I don’t remember
iii. Where was your most recent HIV test?
1. Clinic
a. This Clinic (Name of Clinic)
b. Another Clinic (Specify)
2. Hospital
3. VCT Centre
4. Other: Specify________________
iv. What was the outcome of the test?
1. I tested HIV positive
2. I tested HIV negative go to 34
3. I did not receive my results
4. I do not want to reveal my status to the interviewer go to 34
v. Are you taking antiretroviral drugs for the treatment of HIV? (interviewer
please note this is different from the More Efficacious Regimen (MER) for
PMTCT)
1. Yes
2. No go to vi
a. When did you start taking the antiretroviral drugs?
i. Before I got pregnant
ii. When I was pregnant, before I was 8 months
pregnant
iii. When I was pregnant, after 8 months of pregnancy
iv. I do not remember
b. Do you take the antiretroviral drugs as prescribed?
i. Never
ii. Sometimes
iii. Most of the time
iv. All the time
Go to xii
vi. Did you receive the antiretroviral medicine AZT (Zidovudine) that you were
to take twice daily from when you were about seven months pregnant?
1. Yes
2. No go to viii
Check with Patient Medical Card
vii. Did you take the tablets twice daily as instructed?
1. Never go to a
2. Sometimes go to a
3. Most of the time go to a
4. All the time go to viii
a. What prevented you from taking them as instructed?
i. I forgot
ii. I lost the tablets
iii. My husband/mother in law or other relative did not
allow me to (Specify)_____________
iv. My religion does not allow me
v. I was not able to collect some of my tablets from the
clinic
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vi. Other (specify)________________
viii. Did you receive nevirapine (medicine that reduces the chances of
transmitting HIV to your baby) that you were supposed to take at the
beginning of your labour pains?
1. Yes
2. No go to xi
ix. Did you take the tablets as instructed?
1. Yes go to xii
2. No
x. What prevented you from taking the tablets as instructed?
1. I forgot
2. I lost the tablets
3. My husband/mother in law or other relative did not allow me to
(Specify)_____________
4. My religion does not allow me
5. I didn’t want others to know that I was taking tablets
6. Other (Specify):________________ go to viii
xi. Why did you not receive treatment?
1. I had no money
2. I refused the treatment
3. My husband/mother in law/ other family member prevented me from
taking it (Specify which family member)___________________
4. No treatment/medicine was available at the clinic
5. Other reason (Specify):_________________________
Interviewer to check the patient medical records to see what was prescribed to the baby and
complete the following information.
Mark all that apply:
i. Single dose nevirapine 2mg/kg
ii. AZT 4mg/kg 12 hourly for 7 days
iii. AZT 4mg/kg 12 hourly for 28 days
xii. Interviewer to read as applicable:
1. If baby was given any of the above medicines: I see on your card
that your baby received medicine that helps prevent acquisition of
HIV soon after delivery go to b
2. If not given any medicine: I see on your card that your baby did not
receive medicine that helps prevent acquisition of HIV soon after
delivery go to xiii
a. Removed.
b. How many hours after you gave birth was the baby given
medicine?
i. Within 24 hours
ii. Within 48 hours
iii. Within 72 hours
iv. I do not remember
Go to xiv
xiii. Why did the baby not receive the medicine?
1. It was not offered
2. I refused
3. I do not know
4. Other (Specify)___________________
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xiv. Did you tell anyone about your HIV status after you tested positive for HIV?
1. Yes
2. No go to 34
xv. Who did you tell? Mark all that apply.
1. Husband/partner
2. Friend
3. Mother
4. Sister
5. Brother
6. Aunt
7. Sister in Law
8. Other (Specify) __________________
xvi. Deleted.
34. Has your current or most recent partner been tested for HIV?
1. Yes
2. No go to 35
3. I don’t know go to 35
ii. What was the result of the test?
1. Positive
2. Negative
3. He did not collect his result
4. He did not tell me
Now we would like to ask you about previous HIV tests you have taken.
35. Before this pregnancy, have you ever had any HIV tests?
a. Yes
b. No go to 36
i. How many times were you tested?
1. Once
2. Twice
3. Three times
4. Four times
5. Five times
6. More than five times
ii. What motivated you to do the last HIV test before the last pregnancy? Mark
all that apply
1. I was pregnant
2. I was not feeling well
3. I just wanted to know my HIV status
4. There is someone/there are people who encouraged me to get tested
5. It was a requirement for work/insurance
(Specify)_________________
6. My husband/partner and I decided to get tested before we got married
or started having sex
7. Other reason (Specify) _____________________
iii. How much time had elapsed between the last HIV test you took (before this
pregnancy) and the test you took during this pregnancy? Specify in number
of years or months___________________
OR, IF NOT TESTED DURING LAST PREGNANCY:
How long ago was the last HIV test you took?
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Specify in number of years___________________
iv. What was the outcome of the last HIV test (before the one you took during
this pregnancy?
1. I tested HIV positive
2. I tested HIV negative
3. I did not receive my results
36. For patients who accessed ANC services ie answered yes to question 23: While you were
still pregnant did you fall sick and visit the clinic between your scheduled antenatal visits to
seek treatment?
a. Yes go to ii
b. No go to 37 if HIV positive, otherwise go to 40
i. For those who did not seek antenatal care: While you were pregnant did you
fall sick and visit the clinic to seek treatment?
ii. How many times did you seek the medical care?
1. Once
2. Twice
3. Three times
4. Four times
5. More than four times
6. I do not remember
Now I want you to think about each visit you made during your last pregnancy in which you had
come to seek treatment. For each visit we want to know what you were suffering from and how far
gone in your pregnancy you were.
Visit What were you suffering from? How far gone was your
pregnancy?
 Headache
 Malaria
 Backache
 Stomach Problems
 Injury (accident, domestic violence,
physical violence)
 General unwellness
 Other problem (specify):___________
 Less than 3 months
pregnant
 Between 3 and 6
months pregnant
 More than 6 months
pregnant
 Headache
 Malaria
 Backache
 Stomach Problems
 Injury (accident, domestic violence,
physical violence)
 General unwellness
 Other problem (specify):___________
 Less than 3 months
pregnant
 Between 3 and 6
months pregnant
 More than 6 months
pregnant
 Headache
 Malaria
 Backache
 Stomach Problems
 Injury (accident, domestic violence,
physical violence)
 General unwellness
 Other problem (specify):___________
 Less than 3 months
pregnant
 Between 3 and 6
months pregnant
 More than 6 months
pregnant
 Headache
 Malaria
 Less than 3 months
pregnant
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 Backache
 Stomach Problems
 Injury (accident, domestic violence,
physical violence)
 General unwellness
 Other problem (specify):___________
 Between 3 and 6
months pregnant
 More than 6 months
pregnant
 Headache
 Malaria
 Backache
 Stomach Problems
 Injury (accident, domestic violence,
physical violence)
 General unwellness
 Other problem (specify):___________
 Less than 3 months
pregnant
 Between 3 and 6
months pregnant
 More than 6 months
pregnant
 Headache
 Malaria
 Backache
 Stomach Problems
 Injury (accident, domestic violence,
physical violence)
 General unwellness
 Other problem (specify):___________
 Less than 3 months
pregnant
 Between 3 and 6
months pregnant
 More than 6 months
pregnant
 Headache
 Malaria
 Backache
 Stomach Problems
 Injury (accident, domestic violence,
physical violence)
 General unwellness
 Other problem (specify):___________
 Less than 3 months
pregnant
 Between 3 and 6
months pregnant
 More than 6 months
pregnant
iii. I am now going to ask you about tests that may have been carried out when
you made visits to seek treatment. We want to know whether these tests were
done.
1. Were you tested for high blood pressure? (Here we are talking about
a procedure in which the health care worker places a cuff around
your upper arm, applies pressure to it and then reads your bold
pressure).
a. Yes
b. No
2. Were you tested for high blood sugar level? (Here we are talking
about a procedure in which the health care worker would have asked
you to give a blood or urine sample that could be tested for diabetes).
a. Yes
b. No
3. Were you tested for syphilis? (here we are talking about a
procedure in which the health care worker would have collected
blood that would be sent for syphilis testing)
a. Yes
b. No go to 37 if HIV positive, otherwise go to 40
i. At which month of your pregnancy were you tested
for syphilis?
1. 1st Month
2. 2nd Month
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3. 3rd Month
4. 4th Month
5. 5th Month
6. 6th Month
7. 7th Month
8. 8th Month
9. 9th Month
ii. What was the outcome of the test?
1. I tested negative for syphilis go to 33
2. I tested positive for syphilis
3. I did not receive my results go to 33
Questions 37 to 39 only for those who are HIV positive
37. Have you been told where you can access HIV related care?
a. Yes
b. No go to 38
i. Have you been told when you should seek this care
1. Yes
2. No go to 38
ii. Do you think you are going to seek the care as advised?
1. Yes go to 38
2. No
3. I have already sought care go to 38
iii. Why do you think you are not going to seek the care?
1. I do not have money
2. My religion does not allow me
3. My husband/mother-in-law/other relative will not allow me
a. Specify which relative:________________
4. People may stigmatise me if they see me seeking HIV related care
5. Other reason
38. Do you think your baby is at risk of contracting HIV from you?
a. Yes
b. No
39. Have you been given any information about how to reduce your risks of transmitting HIV to
your baby by the clinic staff?
a. Yes
b. No go to 40
i. What information were you given?
________________________________________________________________________
Are you planning to bring your baby to the six weeks baby clinic?
c. Yes end of form
d. No
i. Why do you not want to bring your baby to the six week visit?
1. I do not think it is important
2. It is too far to travel to the clinic
3. I will go to another clinic
4. It is too expensive to travel to the clinic
5. I will be too busy to get time to come to the clinic
6. My religion does not allow me
7. My husband or mother-in law or other relative does not allow it
(Specify) ____________
8. Other reason (Specify)__________________
End of form
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APPENDIX 2: QUESTIONNAIRE AT SIX WEEKS
Patient Questionnaire for Completion at Six weeks
Thank you for consenting to take part in this study that will enable us to have a better understanding
of the experiences of HIV positive women and their newborn babies. I will ask you to give your
responses to the questions which follow. Some questions may make you feel uncomfortable or
distressed. Obviously if this happens we can stop the interview. As far as possible please give me your
honest answers.
Sections in italics are not to be asked of the participant but are directed at the nurse-interviewer.
Date of interview: _______________
DDMMMYYYY
1. Since the delivery of your baby, how has your health been?
a. I feel as well as any woman who has just had a baby go to 4
b. I have been feeling generally unwell
c. I have been very unwell
2. Have you sought treatment?
a. Yes
b. No go to 3
i. Where have you sought the treatment?
1. Local clinic
a. This Clinic (Specify name)________
b. Another Clinic (Specify name) __________
2. Local Hospital
3. Private clinic/doctor/hospital
4. Traditional healer
5. Other (Specify)__________________
ii. Were you told what you were suffering from?
1. Yes
2. No go to 4
a. Is the illness HIV-related?
i. Yes go to 4
ii. No go to 4
iii. I do not know go to 4
3. Why have you not sought treatment?
a. I thought I would get better
b. I have no money
c. My religion does not allow me
d. My husband/mother-in-law/other family member does not allow me
Specify family member: _____________________
e. Other reason
4. Does the mother have a hand-held medical record from the local clinic or hospital?
a. Yes
b. No go to 5
i. Has she been examined to determine WHO clinical disease stage?
1. Yes
2. No
ii. Has she been referred for further HIV care eg clinical staging, CD4+
counts and clinical staging?
1. Yes
2. No
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5. Are you aware of where you should seek HIV-related care for yourself?
a. At the local clinic
b. At the local hospital
c. At the private doctor/private hospital
d. At the traditional healer’s
e. At the religious healer’s
f. Other (Specify)________________________
g. I am not aware of where I should seek care
6. Are you aware of when you should seek that care?
a. As soon as possible
b. When I start feeling unwell
c. I do not know when I should seek care
7. Will you seek care?
a. Yes go to 9
b. No
8. Why will you not seek care?
a. I cannot afford the money
b. I do not believe the illness could be treated by medical personnel
c. My religion does not allow me to seek care
d. My husband/mother-in-law/other family member will not allow me to
Specify which family member: _____________________
e. Other (Specify):___________________
9. From the time the baby was born, in general, has s/he been feeling well?
a. As well as any baby go to 12
b. The baby has generally been unwell
c. The baby has been very unwell
10. Have you sought treatment for the baby?
a. Yes
b. No go to 11
If yes
i. Where did you seek the treatment?
1. Local Clinic
a. This Clinic (Specify name)__________
b. Another Clinic (Specify name)_______
2. Local Hospital
3. Private clinic/doctor/hospital
4. Traditional healer
5. Other (Specify)_______________________
ii. Were you told what was wrong with the baby?
1. Yes
2. No go to 12
If yes
iii. Was the baby’s illness HIV related?
1. Yes
2. No
3. I do not know
Go to 12
11. Why did you not seek medical care for the baby? Mark all that apply
a. I did not know what to do
b. I did not have the money to seek care
c. I did not believe the illness could be treated by medical personnel
d. I thought it would get better
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e. My religion does not allow me to
f. My husband/mother-in-law/other family member did not allow me to
Specify which family member___________________
g. Other reason
12. Were you given any medicine for the child today?
a. Yes
b. No
13. Ask for the child’s hand-held medical record from the local clinic or hospital. Was the
infant initiated on cotrimoxazole prophylaxis at this visit? Care should be taken to
differentiate between cotrimoxazole given for prophylaxis and that given for treatment of
infections.
a. Yes
b. No go to 14
i. How much cotrimoxazole was dispensed? Specify in
millilitres_______________
ii. Were you told when you are return to collect additional supplies of this
medicine called cotrimoxazole?
1. Yes
2. No
iii. Are you going to be able to complete the return visit to collect more
cotrimoxazole?
1. Yes end of form
2. No
a. What will prevent you from returning to collect more
cotrimoxazole supplies?
i. I do not believe it will help the baby
ii. It is too expensive to come to the clinic
iii. My husband/mother-in-law/other family member
will not allow me to. Specify which family
member_____________
iv. My religion does not allow me to
v. I will not have time to return
vi. Other (Specify)________________ end of form
14. Were you told that the baby should take some medicine called cotrimoxazole on a daily
basis?
i. Yes
ii. No go to 16
15. Why was the medicine not given to you?
i. It was not in stock
ii. I refused it
iii. I don’t know
16. Immediately after the interview the nurse who saw the mother and infant should be asked
why the baby was not given cotrimoxazole. The reason should be documented as below:
a. Out of stock
b. Overlooked by caregiver (nurse)
c. Refusal by mother/caregiver
d. Other (Specify):__________________ end of form
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APPENDIX 3: QUESTIONNAIRE FOR CLINIC RECORD STUDY
STUDY OF SIX WEEKS ATTENDANCE AT EDITH OPPERMAN CLINIC (MBARE)
Name Date Of
Birth
Date of
delivery
ANC Booking
Status
HIV status Area of
residence
6 weeks visit conducted (Enter date at each of
5,6,7 and 8 weeks, then tick if visit was attended)
Tick if 6-
weeks visit
NOT attended
Booked
Unbooked
Positive
Negative
Unknown
5 weeks: ___ ___-____ ____-____ ____
6 weeks: ___ ___-____ ____-____ ____
7 weeks: ___ ___-____ ____-____ ____
8 weeks: ___ ___-____ ____-____ ____
Booked
Unbooked
Positive
Negative
Unknown
5 weeks: ___ ___-____ ____-____ ____
6 weeks: ___ ___-____ ____-____ ____
7 weeks: ___ ___-____ ____-____ ____
8 weeks: ___ ___-____ ____-____ ____
Booked
Unbooked
Positive
Negative
Unknown
5 weeks: ___ ___-____ ____-____ ____
6 weeks: ___ ___-____ ____-____ ____
7 weeks: ___ ___-____ ____-____ ____
8 weeks: ___ ___-____ ____-____ ____
Booked
Unbooked
Positive
Negative
Unknown
5 weeks: ___ ___-____ ____-____ ____
6 weeks: ___ ___-____ ____-____ ____
7 weeks: ___ ___-____ ____-____ ____
8 weeks: ___ ___-____ ____-____ ____
Booked
Unbooked
Positive
Negative
Unknown
5 weeks: ___ ___-____ ____-____ ____
6 weeks: ___ ___-____ ____-____ ____
7 weeks: ___ ___-____ ____-____ ____
8 weeks: ___ ___-____ ____-____ ____
Staff Initials/Date: ____________________________
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APPENDIX 4: IN-DEPTH INTERVIEW GUIDES
Interview guide for participants who did not register for ANC or delayed registering for
ANC
Thank you for participating in this study. We are trying to understand what factors affect
women decisions to seek health care when they are pregnant. Our discussion today will be
around this topic. Please try where possible to answer as fully as you can. It is possible that
some of the questions might cause you to feel uncomfortable. Obviously if this happens we
can stop the interview. As far as possible please give me your honest answers –the
information you provide will be combined with information provided by many other women
and so it will not be possible for your views or experiences to be traced back to you. We
value the information you will give us because it may help improve the way health care
services are provided to pregnant women.
1. Where do you live? (Probe how far away from Edith Opperman the house is in
terms of distance, whether it is a walkable distance)
2. Is Edith Opperman the nearest clinic to your house that offers maternity services?
(Probe: if there are nearer clinics than Edith Opperman why not go to those
instead?)
3. Do you know why women are asked to attend for antenatal care before they deliver?
4. Do you know what specific benefits antenatal care can provide?
5. In your opinion, is registering for ante-natal care (ANC) important? (Probe for
reasons)
6. At what stage in her pregnancy are women advised to register for ANC?
7. What services are offered to HIV positive women when they are pregnant?
8. Do you think many women in Mbare are aware of the need to register for ANC?
(Probe: Do they know why they should register /why ANC is important? Are
women aware of when they should register? ).
9. In our study we have noticed that many women either delay registering for ANC or do
not register at all. Why do you think this is? (Probe: financial concerns, mother-in-
law resistance, transport concerns, people don’t think important, care not
recognised to be beneficial, reluctant to test for HIV/high blood pressure,
diabetes etc).
10. Do you feel that the community you come from is generally in support of health care
services that are offered to pregnant women at health care centres?
11. Do you feel that your family is in support of health care services that are offered to
pregnant women at health care centres?
For HIV negative women who did not register for ANC/delayed registering
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12. When you answered the questionnaire previously you mentioned that you did not
register for ANC/or delayed registering, meaning you registered after 24 weeks of
pregnancy. Why did you not register earlier/delay registering?
13. What do you think could be done to encourage women to register for ANC earlier in
their pregnancy?
14. Do you have any questions or are there other things which are related to this
topic that feel might help us understand these issues better?
For HIV positive women who did not register for ANC/delayed registering
8. When you answered the questionnaire previously you mentioned that you did not
register for ANC/or delayed registering, meaning you registered after 24 weeks of
pregnancy. Why did you not register earlier/delay registering?
9. When was the first time you were told you are HIV positive?
10. Are you currently receiving any HIV-related care? (Probe: has disease stage been
assessed; CD4 count; WHO staging, commencement on ART/CTX; TB screening
/treatment; support group referral)
11. In our study we were told by some HIV positive women that they chose not to
disclose their HIV status to the nurses at the time of delivery. Why do you think this
might be?
12. If applicable: Were you asked about your HIV status at the time you came for
delivery
13. What do you think could be done to encourage HIV positive women to disclose their
status to the nurses at the time of delivery?
14. Do you have any questions or are there other things which are related to this topic that
you feel might help us understand these issues better?
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Interview guide for participants who did not complete their six weeks visit
English Version
Thank you for participating in this study. We are trying to understand what factors affect
women decisions to seek health care for themselves and their new babies. Our discussion
today will be around this topic. Please try where possible to answer as fully as you can. It is
possible that some of the questions might cause you to feel uncomfortable. Obviously if this
happens we can stop the interview. As far as possible please give me your honest answers –
the information you provide will be combined with information provided by many other
women and so it will not be possible for your views or experiences to be traced back to you.
We value the information you will give us because it may help improve the way health care
services are provided to women who have just delivered their babies.
1. How old is your baby now? Or When was the baby born?
2. Where did you deliver the baby (clinic, hospital or at home)?
3. When you were discharged from hospital/clinic at the time of delivery, were you told
when you were supposed to visit the clinic/hospital again? (Probe which
clinic/hospital was she told to visit; was the visit for the benefit of the mother of
the baby; what would be the purpose of the visit)
4. Did you visit the clinic as you per appointment? (Probe for reasons if not. If she
visited the clinic: What sort of help/services were offered? (Probe for services
offered to the mother and also to the baby)
5. Do you know why women are asked to attend a clinic visit when their baby is six
weeks old?
6. Do you feel that the community you come from is generally in support of baby clinic
visits?
7. Do you feel that your family is generally in support of baby clinic visits?
8. From our records, it appears that you did not attend the six weeks visit. Is this correct?
(Probe for reasons of non-attendance).
9. Have you taken the baby to other baby clinics? (Probe for when the baby was taken
to the baby clinic, and whether the baby has received the appropriate
immunization)
If the woman has attended the six weeks visit or other baby clinics
10. Is there any medicine that the baby was given when you attended the six weeks
visit/baby clinic? (If given probe for: what is the name of the medicine; how much (in
terms of quantity) it was, how was it supposed to be given, for how long was the baby
supposed to take it)
11. If baby was initiated on cotrimoxazole prophylaxis: Were you told why you were
supposed to give cotrimoxazole to the baby?
12. Were you told to come back for additional supplies of the medicine called
cotrimoxazole?
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13. Did you go back to the clinic to ask for additional supplies of cotrimoxazole?
14. What has been your experience in giving cotrimoxazole at home?
15. Are you always able to give the medicine at the right time? (Probe for challenges,
probe for what has worked well to ensure adherence)
16. Do you think mothers or caregivers in general would find it easy to keep giving
cotrimoxazole for a long time? (Probe for reasons)
17. What can be done to ensure the continued provision of cotrimoxazole to babies?
18. Do you have any questions or are there other things which are related to this topic that
you feel might help us understand these issues better?
If the woman has never taken the baby to the clinic/if cotrimoxazole prophylaxis was
not given
7. Are you aware that it is strongly recommended that babies born to HIV infected
women take the medicine called cotrimoxazole to protect from diseases? (If yes, probe
for reasons why she has not tried to have her child given cotrimoxazole).
8. What do you think should be done to help mothers/care givers to seek the appropriate
care for their babies at health care institutions?
9. Do you have any questions or are there other things which are related to this topic that
you feel might help us understand these issues better?
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Interview Guide for in-depth medication adherence interviews
Thank you for participating in this study that seeks to understand the experiences of HIV
positive mothers who have just had new babies. Our discussion will be around this topic and I
will ask you to give me your full responses. Some of the questions may cause you to feel
distressed. Obviously if this happens we can stop the interview. As far as possible please give
me your honest answers.
1. Where do you live?
2. Who do you live with? (Probing: Is she married (if so, how long has she been
married)? Does she live with extended family? Does she have other children
besides the baby (if so how old are they)?
3. When did you have the baby – how many days / weeks ago?
4. Do you feel you have gone back to your old self or are you still feeling like you have
just had a baby? (Probing: Has she recovered her strength, is she back to doing the
same chores she did before she had the baby?
5. You have been diagnosed as HIV infected. What does that mean to you? How do you
feel about it? Were you surprised by the result? Have you been tested for HIV before
the last pregnancy? Have you had any symptoms that might lead you to believe you
were HIV infected? Have you told your partner? Has he tested?
6. Are you aware of the care that is due to HIV infected people? Have you accessed any
HIV related care? Probing: Has she had a CD4 count? How she got to know of the
services/care. Why she has not accessed care (if applicable).
7. What is your understanding of the possible effects of your HIV infection on the
baby? Probing: How she came to that understanding.
8. Do you feel able to protect your baby from HIV? What can you do to help protect
your baby? What advice have you been given regarding feeding your baby ? do you
feel able to follow these instructions?
9. The baby has been placed on cotrimoxazole. Do you understand why s/he should get
that medicine? Do you think it is important for the baby to take the medicine on a
daily basis?
10. Are there any challenges in ensuring that the baby takes cotrimoxazole on a daily
basis as prescribed? Probing: Any problems with giving the medicine daily. Any
problems with getting uninterrupted supplies of cotrimoxazole?
11. Is there any help you get from family or friends in ensuring that the baby remains on
cotrimoxazole? Probing: Is husband/partner/mother-in-law (if applicable)
supportive
12. Are you aware of any additional HIV-related medical care that your baby should
receive? Probing: What is the source of the knowledge? Details of times when the
care processes are due. Does she intend to ensure that baby gets the care. Is she
aware that at some point the baby should get tested for HIV? Is so at what time
point?
13. Do you have any questions or are there other things which are related to this
topic that you would like to talk about?
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Thank you for taking the time to discuss your experiences which will help in
understanding the experiences of HIV infected women who have just had babies.
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APPENDIX 5: EXAMPLE OF FIELD NOTES
Field notes for participant 800-305-4
Interview conducted on 05 May 2011
Background summary information
The participant is 24 years old. She delivered her baby two weeks ago. She is married with
three children, including the baby she has just delivered. She is HIV positive. She first tested
positive when she was eight months pregnant with the recently delivered baby. Her previous
HIV test was done three years ago, and she tested HIV negative. She delayed registering for
ANC; she registered when she was 8 months pregnant. This interview was conducted to
understand her reasons for the delay.
Interview arrangements
The participant met the study nurse and was recruited into the study on 03 May 2011.
Because she sought ANC late she was asked to participate in the in-depth interview. Because
I was not at the clinic on that day, an appointment for the 05 May 2011 was made. She came
to the clinic for the interview on the appointed date. The interview was conducted in private,
in one of the clinic rooms.
Reflections of methods and account
The interview was conducted according to the interview guide. To understand what the
barriers were to seeking ANC on time, the strategy was to start with less personal questions,
eg by first asking what she thought were barriers to registration for women in the community,
before asking her what prevented her from seeking ANC on time. She quickly started to
speak about the challenge that she faced in registering before we discussed the community
challenges. She did not seem to feel uncomfortable discussing this. Throughout the interview
she seemed to be open about her feelings and her fears.
The participant thinks ANC is very important, and she believes the community she comes
from also believes the same. She delayed registering for ANC because she had no money.
Before she registered she often worried about the delayed registration because she was often
unwell. She did not seek treatment because she feared that the clinic visit would deplete the
savings she was making towards the ANC registration fees. She also worried about the health
of the baby given that she had heard stories of some babies dying in the womb without the
mother knowing.
It was apparent from this interview that the participant feels very strongly that no one besides
her husband should know about her HIV status. She feels that if people get to know one’s
HIV status they will spread the information around the community and they can even insult
them.
The participant reports that at the six weeks visit she and her baby will be commenced on
medicines. She says this is information that the nurses have given her; they have told her that
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she and her baby both have to take some drugs. However she does not sound convincing that
she got the information from the nurses, she sounds a bit hesitant when she says the
information came from the nurses. It could be that this is information she gathered from other
sources, eg listening to conversations among friends.
When asked why she thought some HIV positive people would not disclose their status to the
nurses she said it may be because they are worried that the nurse may discuss their HIV care
in the open, leading to other people getting to know of the HIV status. She narrated how she
had the same fear (that her relatives would get to know her HIV status through the nurses).
She however seems to believe very strongly that for the sake of the health of the mother and
the baby, one should disclose her HIV status to the nurses.
Additional information
At age six weeks the participant’s baby was tested for HIV and tested HIV positive.
Throughout the study there were instances where she revealed that she put a lot of effort in
ensuring that the people around her did not find out about her HIV status. For example, if she
was walking to the clinic in the company of her friends, she would not bring the remaining
medicine (as requested by the study team) for the baby because she feared that her friends
would find out about her HIV status.
Reflections on emerging themes
Importance attached to ANC registration
 She thinks it is important to seek ANC.
 She thinks the community also values ANC
No money for ANC registration
 She clearly struggles to make ends meet
 Not seeking treatment even when she felt unwell (in an effort to save up for ANC
registration)
STIGMA
 Fear of disclosing one’s HIV positive status
o Friends and family may discriminate
o Husband may leave you
 Fear of stigma makes seeking the necessary HIV-related health care difficult
o Her own experience of this
o As a possible explanation of why some women chose not to disclose their HIV
status to the nurses
Perceptions of community barriers to seeking ANC
 No money for ANC fees
 Not willing to be tested for HIV (because of the fears given above for stigma)
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Appreciates the value of ARV prophylaxis in reducing chances of HIV transmission to the
baby
Appropriate care given to the participant/baby
 The participant reports that she got the required care to ensure prevention of HIV
transmission to the baby (however since she only started on the MER regimen at
eight months or pregnancy, according to the Ministry of Health and Child Welfare
guidelines the baby must have been given ARV prophylaxis for 28 days; but was
only given for seven days)
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APPENDIX 6: EXAMPLE OF INTERVIEW SUMMARY
Interview Summary for participant 800-305-4
Interview conducted on 05 May 2011
BACKGROUND SUMMARY INFORMATION
The participant is 24 years old. She delivered her baby two weeks ago She is married with
three children, including the baby she has just delivered. She is HIV positive. She first tested
positive when she was eight months pregnant with the recently delivered baby. Her previous
HIV test was done three years ago, and she tested HIV negative. She delayed registering for
ANC; she registered when she was 8 months pregnant. This interview was conducted to
understand her reasons for the delay.
SUMMARY OF INTERVIEW
The participant spoke openly and freely about her experiences and fears.
Awareness of Importance of ANC
The participant thinks ANC is very important, and she believes the community she comes
from also believes the same. She believes ANC is important because the woman gets a
chance to be tested for HIV, and if found positive, then appropriate PMTCT is given. She
says it is also important because it ensures that the health status of the baby is monitored.
Reasons for delayed ANC registration
She delayed registering for ANC because she had no money. Before she registered she often
worried about the delayed registration because she was often unwell (sickly). She did not
seek treatment for her illnesses because she feared that the clinic visit would deplete the
savings she was making towards the ANC registration fees. During this period (before she
sought ANC), she also worried about the health of the baby given that she had heard stories
of some babies dying in the womb without the mother knowing.
Reasons why the people in the community do not seek ANC
The participant reports that the main barrier is that people cannot afford the ANC registration
fees.
The other barrier is that some women are afraid of getting tested for HIV. They are afraid
because they suspect that they could be HIV positive. They think they could be HIV positive
because they have seen their partners engaging in risky behaviour (having extra marital
affairs). The participant says testing HIV positive could have some undesirable consequences
for the woman: they could be discriminated against, and their husband could leave them. She
says husbands can just leave, giving reasons that the woman has HIV and they have not, even
though they may not have been tested themselves.
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Care that was given during and soon after pregnancy
The participant was tested for HIV at the time she registered for ANC, when she was eight
months pregnant. She was given AZT for prophylaxis (information taken from the
questionnaire at time of delivery). After delivery she and her baby were given ARV
prophylaxis drugs for seven days.
HIV-related care for the participant
The participant has not been examined to determine HIV disease progression. When asked
what she is planning to do about her own HIV-related care, she revealed that she believed she
will get some help (in the form of tablets) when she comes to the clinic for the six weeks
visit. [This actually is not the clinic procedure, women are referred to one of the
hospitals where disease progression is assessed and appropriate treatment/advice given;
one may not be given any drugs depending on how far the disease has progressed]She
said she got this information from the nurses. However she did not sound very positive when
she said the nurses gave her this information. It could be that she assumed that since she and
baby both got drugs soon after delivery, the same trend (of mother and child getting
medicines) would continue at six weeks post-delivery (line 390-391). Or this could be a myth
she could have picked up in discussions in the community, as suggested by line 393 where
she said she just heard people saying.
Disclosure of HIV status
The participant has not disclosed her HIV status to anyone but her husband. She says she
does not want to disclose to any other people because she does not trust them to uphold
confidentiality; she fears that this could be information that is spread around the community.
She feels that when people know your HIV status they may tell you off using your HIV status
(line 439-442). She fears that some people may say some hurtful things which will make her
lose her peace of mind (line 437). She says she would rather endure the difficulties of being
HIV positive on her own, and only disclose to relatives when she feels she can no longer bear
it alone (line 444-447).
When she disclosed her HIV status to her husband, he at first did not accept it. He was quick
to say that he is HIV negative and it cannot true that his wife is HIV negative. In the end the
participant convinced him that they need to get tested together, he agreed, but by the time of
the interview he had not yet been tested. The participant has been trying to implement some
of the things she was taught at counselling, including practising safer sex. This is a challenge
because the husband refuses to use condoms. He has said he would rather wait until the baby
is old enough for them to have sex. It seems there is no agreement between them how old the
baby should be when they start having sex again because she has already refused to have sex
with him, citing the reason that the baby is still too small for them to do so (line 363-366).
She is hoping that they will go for couple counselling, and that the counsellor will make him
understand what needs to be done (line 365-366). The husband however has no problem with
her adhering to drugs (or giving medicines to the baby).
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Adherence to ARV prophylaxis drugs other teachings
The participant had no problems adhering to her ARV prophylaxis drugs when she was
pregnant. She also adhered to the times when giving the medicine to the baby. She said it was
the first thing she wanted because she did not want to disadvantage the baby. She was taught
to ensure exclusive breast feeding and she says she has no problem with that.
Participant’s feelings about being HIV positive
The participant was counselled when she was given the result. The counselling made it easier
to accept the result at the time but when she got home she got distressed. She worried that she
would die and leave her small children. She says with time she got better because she realised
that she is not the only one who has HIV, and she also got additional counselling. She said
the result did not surprise her because her husband had had an affair with a woman whom she
suspected could have infected him.
Reasons why some HIV positive women do not disclose their status to the nurses
The participant thinks some women do not disclose because they are worried that the nurses
may discuss the HIV information in the presence of other people. This may result in friends
and relatives finding out about the person’s HIV status, which the woman fears may cause
discrimination and unpleasant talk. She described that she felt this way at the time she was
discharged from the clinic after delivery; there were people around who had come to take her
home. She found it difficult to collect her ARV prophylaxis drugs because she did not want
the people to find out about her HIV status.
Despite these fears the participant feels it is foolish not to disclose an HIV positive status to
the nurses because one would then have failed to protect the baby and get appropriate care for
oneself.
At the end of the interview, the participant asked a question about the risks of study
participation that had been mentioned in the informed consent form. She was worried about a
statement that other people may know about her participation in the study and assume that
she is HIV positive, and potentially discriminate against her. She worried about whether the
study team would openly discuss her HIV status when she came to the six weeks visit. She
was reassured that the study staff would do the best to uphold confidentiality.
Reflections on emerging themes
Importance attached to ANC registration
 She thinks it is very important to seek ANC
 She thinks the community also values ANC
No money for ANC registration
 She clearly struggles to make ends meet
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 Not seeking treatment even when she felt unwell (in an effort to save up for ANC
registration)
 Worrying about the baby’s health during pregnancy (not knowing whether the baby
was okay)
STIGMA
 Fear of disclosing one’s HIV positive status
o Friends and family may discriminate or say hurtful things
o Husband may leave you
 Fear of stigma makes seeking the necessary HIV-related health care difficult
o Her own experience of this
o As a possible explanation of why some women chose not to disclose their HIV
status to the nurses
o Some women may not get tested for HIV because they fear that they could be
stigmatised if they test HIV positive
 Very strong desire to make sure that people do not find out about HIV positive status
Perceptions of community barriers to seeking ANC
 No money for ANC fees
 Not willing to be tested for HIV (because of the fears given above for stigma)
Appreciates the value of ARV prophylaxis in reducing chances of HIV transmission to the
baby
 Motivated good adherence to times she was supposed to give the medicine to the baby
Appropriate care given to the participant/baby
 Participant was tested for HIV time of ANC registration
 The participant feels that she got appropriate care (however since she only started on
the MER regimen at eight months, according to the Ministry of Health and Child
Welfare guidelines the baby must have been given ARV prophylaxis for 28 days;
but was only given for seven days)
Role of husbands/partners in ensuring appropriate HIV prevention and management
practices
Inadequate/Incorrect information on the health care that is due to HIV infected people
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APPENDIX 7: EXAMPLE OF ANALYTIC MEMO
Analytic Memo
Financial Challenges to ANC registration
This was the major reason that women gave for not having registered. Most participants
reported that they had not registered because they could not afford the ANC fees. Indeed
many women gave insightful accounts of how severely affected by poverty they were. For
example participant 800-373- said after she had delivered she had to sell her bed to ensure
that she got money that she could pay before the clinic would discharge her (the clinic does
not discharge women from the clinic. Other women talked about how much they had longed
to be registered (373 and), especially because they were often sick during the pregnancy.
Participant 373 said she could not seek health care without having registered because she
thought unregistered women were not accepted at the clinic. This supports the view by some
participants that unregistered women are treated as if they do not belong to the clinic; they are
not welcome at the clinic. Another participant, 305, talked about how she could not seek care
because she feared she would deplete the savings she was trying to make towards the ANC
fees.
On the other hand, is it not possible that some women just gave financial problems as reasons
because it was easier to talk about? It could be that other reasons were seen as painting a bad
picture about the participant (eg could the participants have worried about being seen as
unfit mothers?) Participant 800-312-1 could be one such participant, the bulk of whose
interview showed that she thought of ANC registration as a way to get to a point, rather
than a way into the process.
Reflexivity: The study team were perceived of as health care workers with the same
qualifications as the nurses (participants basically addressed then as Mbuya, the term that is
used for addressing nurses at the clinic. Could it be because of this that participants may have
found it harder to admit to things that are not encouraged by health care workers?
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APPENDIX 8: JOURNAL ARTICLE FOR THE SYSTEMATIC REVIEW
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